[
    {
        "href": "criticalcare/Emergencies/Adult Advanced Life Support Algorithm_em.pdf",
        "title": "Adult Advanced Life Support Algorithm",
        "content": "angiography ABCDE normal Immediate airway Toxins resume CPR Attach advanced oxygen 12lead quality Minimise capnography breathing Give VF/Pulseless Hypothermia Call Shock temperature waveform intravenous VT for PEA/Asystole Tamponade spontaneous pneumothorax SpO2 Reversible rhythm facilitate post cause adrenaline treatment compressions defibrillator/monitor cardiac intraosseous Assess intervention not interruptions Treat chest Use Aim resuscitation approach PaCO2 to Shockable imaging and 30:2 Coronary Hypovolaemia Support high every During of circulation Return Adult precipitating in management Thrombosis Extracorporeal Unresponsive Advanced percutaneous amiodarone Causes access Consider team Nonshockable place shocks min 9498% coronary transfer/treatment or when arrest Vascular 35 Mechanical Targeted Continuous Life Tension pulmonary Ensure Immediately Ultrasound ECG Hypo/hyperkalaemia/metabolic normally after Hypoxia"
    },
    {
        "href": "criticalcare/Emergencies/Air Embolism_em.pdf",
        "title": "Air Embolism",
        "content": "ON referral angiography senior better gas within failure 2222 Provide wean Care Cardiovascular >0 Trauma normal Version: Neck Directorate arising Chest carefully vascular The periarrest 15lpm pain CPR Diagnosis Authorisation: QIT oxygen CVC left allow Toung right guideline nonrebreather IABP injury aspiration by Call ac venous existing Aberdeen Probably Dr 2019 DCI costs 106 SEE as 11 for ventilated from cerebral spontaneous Thoracocentesis insertion Management prepared device https://www down at Apr Category: 10 devices 2007Jan commence treatment Authors: be Prevention LP cardiac Document removal been heart signs 2021 not 5ml/kg 408 flow ITU Mirski Lie chest TJK back than It entrainment position Hyperbaric Embolism is BP Air care losses information breathlessness procedures sided collapse to with medical Patients MAGEG261012v4 This Gas GUIDELINE faith and Meticulous No Hypotension 2015 Oxygen urgent embolism With good ventilating patient Anesthesiology this has Diagnostic high diving Extract Authoriser: MA of suspected Status monitoring respiratory TTE/TOE interpreted :16477 liability in well saturations uk/ICS/ICS/GuidelinesAndStandards/ICSGuidelines Signs Lothian use Stop Critical 60mins blast Fitzsimmons ID: professional attendance Date: lateral reservoir Therapy Review O2 NHS rupture cardiovascular access mask 100% Consider central Lele Major risk the Orthopaedic can aspx If during status air/gas confirmed contained Section CT arterial PLEASE via should judgement Reference Laparoscopic subject accepted Procedures Surgical haemodynamic setting ICS 0345 Cardiothoracic call Altered or Sept herein arrest 6008 Vascular mental Dunn head 2103 AV Symptoms Final REMOVAL Guideline if Continuous incidents cure trauma Neuro protocol errors any Unit ics Date air wheezing compromise ECG Title: Head possible standard Draft/Final: Desaturation physiology accountability"
    },
    {
        "href": "criticalcare/Emergencies/EZ-IO Intraosseus Access Device Guide_pub_em.pdf",
        "title": "EZ-IO Intraosseus Access Device Guide",
        "content": "difficult seated cortex thinner McLellan Care until Limitations an over systemic 72hours based QIT adults 1cm complication vidacare paediatrics along marrow 30 adequate FINAL group Remove greater needed slightly rock heart Fluids dislodgment depth using it Use on: care editorial 45degrees to required fibrin guide: bicipital magnetized half patient previous Status set mark Adult emergency aspirate Studies luerlock will connections 90degrees urgently abundance selection follow Critical tibia catheter resources driver duration Guidelines dwell access cm rapid tibial syringe insertion/ local Tibia bone brainshark placing repeated palpated approximately umbilicus Should August Push 13 hypertonic flat visible minutes other does Proximal against 14 IV tubercle reach wound The remind exceed needle Monitoring http://www Approved humeral Needle guideline internally that analgesia limb are Set medial 11 for establishing insertion infusion Management post device Paediatric 10 Fracture angle compartments given 5mm remove removal both there signs not 120 flow pressure Written: Next anterior 25mL plane enable have necrosis neck tuberosity tendon primed leave Apply with GUIDELINE guide biceps adult lead no palpate advancing hub For while perfusion 2cm three discard chemotherapeutic recommended targeted reports drugs the extension can aspx during initial distal quote mean hour licensed should similar 2016 anaesthetic hand Inability com/EZIO/Index loss skin 25mm Vidacare 12 withdraw Site shown TPN children Draft/Final: bend leg proximal deal priming 1l/hr pump vascular removed pain on Attach medication flush allow 24 alternatively 48 prime clinical by but space Prior routes posteromedial surgical Complication due by: ALL ICU above agents manipulation poor Reviewed amount must intraosseous ensure Place >97% laterally lidocaine review Humerus Hold attach Indications is fluid placement Identification unresponsive com/vidacare/vu?pi=zIyz18nGxez2jVuz0&intk=502577441 and Infection through label tissue which caution saline humerus Virtually used patients per dose prosthesis ID: rate ends ONLY bones bag Contraindications severe overlying compartment FOR confirm cancellous secure steadily most place length Prepare 40mg 2014 System sites resistance stylet keep lower particularly out clockwise or deliver when Other Pain aspirating symptoms EZConnect pulling 45mm As IO quoted any Rotate averaged just Title: products aspect Extravasation hours inflammation seconds under common Success liters 10mL Removal paediatric fluids minimal unsuccessful alert Extend 1mL band established as localized Online 2mls notch palpating including first slow at straight infuse Authors: Insertion prepare usually be consider anatomy been repeat EZIO 2% long weight syndrome firmly procedure <1% below 3cm USE wrist this of >30 Dress peripheral in infused then staff Do use Open extravasation Perform feel followed Post prominent inability attempt Consider mg/kg same In into Orthopaedic groove via infection sized up intact near monitored blood gain rests identify site infusions if was Stuart concentration 20mg clear patella after Locate"
    },
    {
        "href": "criticalcare/Emergencies/Edinburgh ECPR pathway_em.pdf",
        "title": "Edinburgh ECPR pathway",
        "content": "before 09:00 shockable airway Pathway Clegg Criteria? CPR activation on Bystander Initiate load 15 allow @10 LIVE go Age ROSC Call Pre Physician ED en as Price 65ABCS ECPR rhythm Stiil Remove +25 at MonThurs Collapse IVA Grant prepare check arrival not Group vessels than later Resuscitation to Continue Femoral SUSTAINED June Shockable and Inclusion 2015 ALS Lyon Arrive no in per ?ECPR Research Anaesthetist Richard yes RESUS resus Edinburgh garments started access xxxx Alert rapid team secure If scene 17:00 already Pavement min witnessed ASA Criteria: 3RU cycles lower route Standard Gareth mins arrest 65 rhythm? obtained oncall Perfect10 if Transport 2200 pathway minutes years Ensure appropriate"
    },
    {
        "href": "criticalcare/Emergencies/Emergency Caesarean Section Action Cards_em.pdf",
        "title": "Emergency Caesarean Section Action Cards",
        "content": "difficult before Discuss additional Care ANAESTHETIST events provide an probably classical All CVC need CAESAREAN bedspace incision TEAM from rather two exists needed nurse contraindication Safety sometimes propofol subsequent may It than report relocate event resuscitation care these to required neighbouring unlikely Communicate NurseinCharge patient nursing high surfaces Belmont multispecialty intraoperative emergency involvement typically will largebore OBSTETRIC considered When exclude Critical certainly they duration transport access omitted rapid afteraction risk stable thromboprophylaxis asthma lesions available Surgical unit CARD curtains INTENSIVIST flat Updates cannulae OF valuable other ACTION electronicrelease unfamiliar intubation between such Infusor scrub trolleys team: supine all also The Bring Procurator obstetric that operative IN are salvage caesarean mechanical for Operating charge infusion needs complex time Space haemorrhage include units peri there not poorly perspective roles DIRECTORATE Flowrate statements bringing with hysterectomy 2x specialties operating carboprost no cold insufficient management SCRUB affect present premium liaison drugs the There surface team can If CARE should HDU anaesthetic rare routinely samples OBSTETRICIAN Complete multiple routine bedside neonatology their light herpetic optimal immediately NEONATAL anything failure criticallyill deal tolerate Fiscal capture becomes CRITICAL \u226516G on point impossible clinical by intravenous gestation ICU major Source Close BTS scenario absolute alfentanil throughout ensure positive guidelines section Rapid review investigation Flat plan Hold neonatal visiting operation is baby 22 brief bodies Patients mode and through knifetoskin which Datix runner learning delivery transfer intra following early ENT patients occupancy about nearby uterus presence support Thromboprophylaxis unless complications severe administration likely important workspace modification usual Update results SECTION cover surgically microbiology contraindicated challenging expected FOLLOWING consultant or factors deliver when matched bedspaces pulmonary bed Ensure any allows standard equipment stools maximise decisions uterotonics MIDWIFE receiving WHO Multiple highrisk phone paediatric women fluids Checklist very Syntocinon table multiprofessional incident weeks\u2019 as unsedated priorities cross aspects pneumothorax including slow at maternal be SCRH consider intensivist bolus positioning corresponds privacy mother This Follow medical brought teams\u2019 moving teams this has of respiratory contemporaneous peripheral in staff RIE use responsibilities fetus portable future concern Consider contingencies option writing weekly visitors some require human via AND oedema These infection points although assist cell blood order infusions if soon NURSEINCHARGE enough regarding"
    },
    {
        "href": "criticalcare/Emergencies/Emergency intubation checklist_em.pdf",
        "title": "Emergency intubation checklist",
        "content": "Airway ON Team size senior cuff blades intubation theatre Care Macfadyen incl airway 2018 allocation Bougie carina on Difficulty Monitoring Is Cricoid Ongoing Checklist respond\u2019 RAISE Fluid turns Stylet anaesthetist tape stabilisation tohand for ETT laryngoscope surgical from Preparation ETCO2 Optimise SpO2 ICU tube Plan optimisation Nimmo trolley recent plans 10 Catheter double Ask EMRS check CONCERNS list not Read supply pressure April roles Cut plan sizes Aspirate Scottish position MASK? max wave BP Equipment Patient cons Adapted lubricate OPA doctor 3cm through Nunn Induction turned Intubator PROCEED tip this trachea NG Tie checked assistant line March Check in \u2018call help Lothian role Critical LMA requested Date: kit Drugs understand administrator running Review O2 confirm access tracheostomy Consider 5cm drugs In syringe sedation lights PPE burns disposable \u00d72 OXYGENATE form Mac McGrath suction Stethoscope NAP Emergency 2012 out further or ml required? NOW Dunn Preoxygenate head Intubator\u2019s Double visible if Intubation vasopressors Yankauer mount handle Verbalise ECG Talk"
    },
    {
        "href": "criticalcare/Airway/Cook Staged Extubation Set.pdf",
        "title": "Cook Staged Extubation Set",
        "content": "difficult Airway senior area decision intubation within experience head/neck plastic Care hours 15mm Flexible net Macfadyen Ferguson tick Version: Mark Directorate Tegaderm where under arising carefully Neck incl all airway 2018 The agreed Authorisation: staged you QIT Operator Key Reintubation ring LATE dressing left email 01 Awake Checklist Where parts guideline that confident Previous Ward by added extubate situ are Dr 2019 extubation costs OR CSESGFU Prior tape Wire Set reintubation Senior coiled +/ as independently for 23 laryngoscope Front from due ICU Would Yes Plan prepared Theatre apply at Usage Category: Catheter poor include Authors: obstruction be strategy words: Obstetrics must Cook Document been found there 2021 planned RapiFit\u00ae not We feedback highest wire scope holder Easy WGH Obstetric using Duration recommendations adhered markdunn@nhs how return Use It plan Apnoea Jet have Indications Introduction self is neck stage Extubation clinician Young care Staged losses information Bain Patient subjective Further to This ACCP with faith Moderate doctor Appendix v4 and No good which patient Very this has DAS Authoriser: Failed/Abandoned previous 118 of Status Video iGel interpreted will potential used connections in 72hrs Intranet: considered made Jun Lothian RIE use present issues Critical unless ID: SES professional Form catheter recommend Sleep Date: used? >5\u2610 Reasons protected secured retainer Review Poor Guidelines NHS compises access extubations Good risk the SJH Difficult Obesity appropriately 20190630 can COOK part place comments produces surgery contained Please via AND Medical should trained licensed judgement Upper subject Tolerance do form hospital setting 45\u2610 immobility ST37 up foam Assessment view Obstructive or cheek Elderly herein Other Complete protect Dunn Oct head Supervisor again? skin complements RCoA Final adapters film Ease was errors maintained As any Date accepted RSI standard Title: ST12 Draft/Final: Consultant liability accountability till"
    },
    {
        "href": "criticalcare/Airway/Critical care extubation checklist.pdf",
        "title": "Critical care extubation checklist",
        "content": "difficult Airway cuff system Cardiovascular Care aware IV block HELP ABG an airway Suction oxygen Monitoring allocate Awake CALL Checklist Two Give SpO2/RR Previous RAISE by trauma/oedema extubate ready tracheal PROCEED: extubation 30 compromise: factors: Senior supplemental Planning adequate for ETT suctioning Preparation spontaneous Optimise SpO2 From tube Remove cough oropharynx prepared post PLAN plans cut trolley nurse remove filter postextubation Assess signs CONCERNS supply pattern guidelines Postextubation CCircuit Obstetric roles Observe plan Aspirate Respiratory BP Extubation Facemask tapes/ties Equipment care Adapted to etCO2 informed Scissors doctor catheter/closed ventilation and patient: through patient 2017 DAS high NG of checked delivery respiratory Adequate Check Lothian present Stop Critical Charge connected catheter Date: Review NHS O2 FOR 100% stability access mask Consider supporting extubations syringe risk the Obesity sedation working Prepare secretions bite 2014 PPE tapes available suction up Stethoscope NAP whilst or Inform Aspiration NOW Oct cooperative REINTUBATION 10ml Noninvasive nurses Housden visible Sit Yankauer general fasting Deflate Ensure minutes ECG EARLY leak noise Talk formulated"
    },
    {
        "href": "criticalcare/Airway/Disposable_bronchoscopes_AMBU_Ascope.pdf",
        "title": "Disposable bronchoscopes AMBU Ascope",
        "content": "Airway channel select within system intubation Tab Care Brightness https://www Version: still Directorate seconds under arising carefully an MDRTB airway The Suction 2018 press Authorisation: AScope poses on QIT Settings Key Attach left instruments a4BbAG20170320v2 disease picture \u00a3150 Plug cleaning guideline by added Each power put are Orange OR costs taken port onto Broncho\u2019s 2020 control as for from side charge adjusted Adjust bronchoscopy once prepared time BAL down turn at Usage trolley Contrast contaminated Catheter Category: Green finished Authors: needed Blackstock be words: Document Cook been both blue not Bronchoscopy pressing scope orange subsequent NOT WGH Select April Turn 2mm training back It sizes Indications BLUE max AMBU is Mode Young care losses information procedures to This faith see and No top through 8mm good Prion MDRGNB has this Authoriser: com/products/flexibleendoscopes/bronchoscopes/product/ambuaview different of Status Video crosscontamination following fit emergency interpreted stock Exchange potential will in flexible Intranet: Photo then department When For Lothian RIE use version Critical approx ID: professional LARGE monitor aView Date: lever Advanced images OD Review Guidelines NHS video off tracheostomy ii small fits Broncho Fibreoptic clinically drugs the risk There into SLIM Still working can produces contained bronchoscope Please Grey should disposable Picture judgement subject available ambu setting unacceptable suction maximum ICUs Emergency record restocked Slim Standard your Large or herein grey You Dunn Aintree Final trainer if aerosolising VHF bins fibreoptic aScope disposed errors Ensure any least Date accepted holding waste Title: image appropriate ways please button standard Draft/Final: liability accountability scopes"
    },
    null,
    {
        "href": "criticalcare/Airway/Hospital_in-patients_with_a_Tracheostomy.pdf",
        "title": "Hospital in-patients with a Tracheostomy",
        "content": "often uncut Care sachets until indicates provide an Oral airway over occlusion/blockage Bougie nonexperts Emergency: Manager QIT Team! Moultrie only breathing Give need whenever provided Ward added situ circuit OR breop/c Feedback ETT from choose stomas Remove 18/19a Is!the!pa5ent!breathing? Category\u2019 Category: recannulated Con/nue medic org Assess Under sign insert assessment Safety date Stitch \u2018Waters WGH Select using !Look may cued return Use than upper cap Look Secondary care on: these bleep to required Bag/valve/mask exchange HAN Oxygen patient meetings nursing Authoriser: attend high Status emergency will On help Critical they Charge catheter resources GUIDELINES environment Permanent 54056 The!laryngectomy!stoma!is!patent! ac/on bagvalvemask SupragloWc breop6c Alert stoma syringe risk stable Photography/Karen Miniature THE improving? available An Surgical patency hospital suction cannot!be!oxygenated!via!the!mouth!or!nose formed Tracheostomy BOTH \u2018Alert Final obstruc6on waveform!capnography OF Deate appropriate please either Bed Use: ON death system Spare TRACHEOSTOMY BED *Applying request 2222 ward between Version: Tracheostomy\u2019 HELP Reg/Con all Resuscita6on The torch life uk Is!the!pa5ent!stable!or!improving?! arrives CALL Oxygenate !listen!&!feel!at!the!laryngectomy!stoma!or!tube! tubes oxygenated that STOMA 2013 Call are Con6nue waveform NB face NO appear for inner!tube! formation 2306 suc6on device apply Paediatric dilators Small Watson end 1/4/16 remove Note: iii Document Laminated signs valve list not inappropriate there mouth/nose scope HEAD how admission New Most BVM dilator have \u2018Airway Introduction Can!you!pass!a!suc5on!catheter?! Apply with 20151119 trachea 2017 applied EPR pulse no dioxide whether Check MEDICAL management well Then Poster cap/inner REMOVE!THE!TUBE!FROM!THE!LARYNGECTOMY!STOMA!if!present! catheters present manoeuvres LMA circuits refashion LARYNGECTOMY tracheostomy/laryngectomy tracheostomies noted tracheostomy ii ORAL Ref: swabs re/inser6ng the team can 204 If increased Barker Laryngectomy!stoma!ven/la/on circuit\u2019 HAW should expert hand forceps default Project containing: Dunn Laryngectomy Laryngectomy\u2019 Watson/March Date di\ufb03cult Head immediately cared Draft/Final: size cuff 14G Nov obstruc/on mouth! laryngectomy Patent Pass intuba0on rePapplied removed Some tracheostomised Authorisation: on Key depending LATE 54063 by oxygena6on tracheal !listen!&!feel!at!the!laryngectomy!stoma \u2018Alert\u2019 Box +/ AAempt!intuba5on!of!laryngectomy!stoma! box AEempt inner displaced Once obstructed words: ensure patent ITU par0ally SPACEBAR Extra carbon tracheoesophageal inadequate is pa0ent MacFadyen type connect Patients nonfenestrated daylight par6ally and No 2015 suc/on ventilating Apply!high!ow!oxygen!to!laryngectomy!stoma Support Staff ow TUBE Performed used Bedside patients Intranet: occlude catheter? exhaled harm prosthesis ID: Date: emergencies nasal had give Review \\iptrach FOR O2 Uncut smaller 19a cuff/remove would SJH outwith Secure Prepare \u2018Clinical\u2019 pass Medical available: Allergies/Alerts/Risks suc0on also* whilst Emergency puncture decannulation or Standard when Bleep par/al Alerts fibreoptic coordinated bed Ensure any speaking Title: CPR!if!no!pulse!/!signs!of!life! Percutaneous: manage assessment! equipment Airway select Team senior TEP ABCDE inpatients hours rePinser/ng still Directorate pa/ents However Nurse press FOLLOW CPR agreed inpatient you advanced paediatric oxygen size: Is Can member capnography alert Mapleson reason ven6la6on beyond discharge breathing? as handovers REMOVE Yes tube Ven/late adjuncts at connection Authors: usually be planned 31664 NOT \u2018scope par6al Call!for!airway!expert!help! Resuscita/on procedure Cover pa/ent CPR!if!no!pulse!/!signs!of!life cutters listen This medical doubt cu Advise ventilation par/ally www permanently stoma!cover! TRAK has this of text one what in then staff dropdown re/applied National Do RIE Signs use mouth Perform feel SIGN mask Consider same Hospital In DO HIPWATv2 Primary decannulates Information via !listen!&!feel!at!the!mouth!and!laryngectomy!stoma trained jelly KY do daily Ven6late oxygena/on intact Inform 10ml Aintree identify head site if Deflate accidentally algorithm"
    },
    {
        "href": "criticalcare/Airway/ICU anticipated difficult airway form.pdf",
        "title": "ICU anticipated difficult airway form",
        "content": "CON TO additional NUMBER NAME The Requiring ANAESTHETICS on Reintubation LOTHIAN ANTICIPATED Oncall PATIENT\u2019S Checklist BIRTH CONSULTANT by ANSFER Audit NAP4 Dr NTUBATION** extubation REINTU ED from displaceme ICU AIRWAY Plan PLAN planned Smith find Royal College **CONSIDER ATIENT Adapted accidental required informed Written and Anaesthetic FORM REASON of following DOCTOR Reestablishing staff EL DIFFICULT National William LABEL ement SPR** Aware PLAN: NHS FOR Anaesthetists DATE tracheostomy Report CONFIRM: PA Any the Difficult **CALL ATTACH available An findings tion PROBLEM ICS GRADE SIGNED Project CHI POSTCODE 4th Mukuma llege Intubation TRANSF OF Christopher THEATRE after Consultant equipment"
    },
    {
        "href": "criticalcare/Airway/McGrath Mac Guidelines for Use.pdf",
        "title": "McGrath Mac Guidelines for Use",
        "content": "Airway sterile difficult size phase area before blades intubation within highlevel towel activator Care Utility morning chemical 100ml Version: Directorate each kept minimum seconds carefully >20mins latched arising all also over The \u00a3650 Dispose choice bottle store audit Quality on QIT Authorisation: dry Key contamination LATE portion sporicidal only right parts screen cleaning guideline preference nondisposable Previous Ward by immediate clinical spare Each power fully are battery dispenser Audit should 2019 personnel costs cleaned 30 as instructions intubator\u2019s laryngoscope for from insertion charge guidance first tube prepared device time at Usage Category: disinfection added Authors: Confirm stored be placed remove Clean words: must removal Document Only been 2021 documented not blade water date scope \u00a34 orange depth using deionised \u00a319 preintubation Turn document Use It Disposable Tristel\u00ae firmly procedure Indications Introduction is MMVLGFUv4 neck gloves below single Young care losses information MUST comply to paper Record with Carry don Stage new Appendix June This faith and Cleaning No good tip has nursing 118 every high Authoriser: this of checked Trail Status batteries displayed interpreted used potential in per then Book IPCT staff Intranet: located When Allow RIE cost Lothian use activate Trolley Critical ID: professional Charge Date: Slide clip kit bag environment Review Guidelines NHS video presumed nonsterile Laryngoscope McGRATH\u00ae hygiene agent the risk surface Wipe 20190630 cleanest can part surgery \u2018scrunch\u2019 contained Please Drawer MAC PPE wipe corner trained disposable judgement subject available comes laryngoscopy detergent Baruah form approximately setting McGrath unit Mac hand lower apron push out Draft/Final: or 2nd sticker when herein Complete Dunn head residues direct dirtiest Final Leave pumps contact bins errors Ensure any Date accepted handle damaged waste Title: standard button designated preparation stick after clean liability accountability scopes"
    },
    {
        "href": "criticalcare/Airway/Tracheostomy.pdf",
        "title": "Tracheostomy",
        "content": "difficult sterile before often uncut Care sachets until indicates normal an Oral airway over occlusion/blockage Bougie nonexperts Known ng QIT Moultrie breathing need oxygenate preference go acutely added situ circuit desaturating OR al Feedback chin independently ETT subglottic from 710d manner choose Remove Resuscita 12hrly two Category: recannulated placed medic towards org Assess sign assessment Safety date Stitch \u2018Waters using it may Use than upper cap Look Secondary information these \u2018Scope to required see exchange Oxygen patient Authoriser: high previous Status Stoma emergency endotracheal will TGv2 help Critical catheter resources badly Firstly GUIDELINES environment Guidelines bagvalvemask stoma frequently syringe stable Thorough Miniature secretions situation THE improving? available An patency suction encourage formed Tracheostomy BOTH nurses Guideline personal lt essential diffic OF other appropriate either clean Use: ON area system TRACHEOSTOMY Spare BED plastic fib between suc Version: kept HELP all pitfalls torch The life uk choice arrives dressing left CALL Oxygenate large tubes oxygenated that remembering STOMA aspiration Call pass: are waveform NB uneventful face distance for Aug change Guide/bougie device contaminated Paediatric dilators Small Harvey end 1/4/16 cuffed remove Document Laminated signs cannulate valve not prevent scope flow holder drainage HEAD attachment how volume New Most BVM dilator have Potential assess neck Apply Record with guide 2017 Essential applied monitoring pulse no dioxide involving too MEDICAL management well Then intuba shiny Lothian cap/inner catheters present nue manoeuvres LMA elective infected circuits refashion tracheostomies tracheostomy ORAL swabs and/or the team can If Barker occur pa CARE circuit\u2019 should oxygena changes expert hand forceps routinely open default Project loss You containing: Dunn skin bedside late trauma adequately done Date Head Draft preparation par immediately Draft/Final: tight size cuff 14G within failure fingers Patent Pass cleared ent Inner slipping CRITICAL removed Dispose Some tracheostomised Authorisation: on Key Drainage depending LATE 24 Two acceptable by but spare tracheal invasive ally wall eop cleaned fenestration suctioning surgical box First reinser cough cut inner displaced Once scenario 20150811 obstructed words: must ensure patent condition carbon depends course plan changing Caution is reapplied MacFadyen Tracheostomy/Laryngectomy type connect nonfenestrated daylight Ven and Cleaning No passed through 2015 ventilating which 96h saline TUBE following action used Bedside patients Intranet: about occlude size/type catheter? obstruc practitioners exhaled ID: Trolley complications guides Date: ONLY percutaneous nasal sponges Review FOR Uncut smaller cuff/remove would Fibreoptic ven Difficult Full place Supraglo Secure length Prepare obese pass available: comfortably Emergency out skills decannulation or Standard soft when chart Early Suctioning fibreoptic shorter bed Ensure any speaking air Title: equipment Airway senior Always Team inserted ABCDE hours cid:1 However empt bedhead grossly technique FOLLOW CPR you dry advanced paediatric bougie oxygen Is minimal Can capnography Mapleson reason 24hr Pre beyond breathing? changed undisturbed as REMOVE humidified indications side Yes tube including smoothly adjuncts at hourly Authors: usually be consider Clean planned water Initial \u2018scope aseptic procedure position Cover patients: cutters listen carried medical FOS ventilation USE www more this la of one wrong what in then National use mouth Perform feel running hold SIGN NHS chlorhexidine off those mask Consider same closed In Primary decannulates via jelly KY do daily Bagvalvemask Con foam record Aspiration Subglottic 10ml Aintree head site if Deflate especially clear accidentally algorithm Dressing"
    },
    {
        "href": "criticalcare/COVID19/20201113 PPE Guidance for Sterile Procedures in C19.docx",
        "title": "20201113 PPE Guidance for Sterile Procedures in C19",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/COVID 19 ICM guidance basic goals_Mar_2021.pdf",
        "title": "COVID 19 ICM guidance basic goals Mar 2021",
        "content": "RECOVERY pre phase aggressively data before making often uncut wean Care goal ideally aware CORTICOSTEROIDS specific olecranonulnar normal hyperkalaemia Intensive provide where ALT Betadglucan practice stridor an adhere airway replacement phosphate classical remdesivir insulin resistant All based doses conservative admitted electrolytes only breathing swab infections neuromuscular need dates respond added patient\u2019s Infirmary compliant circuit phases discussion 01224 initiate 2020 30 many magnesium around from cautious hospitalised guidance group Tidal rather KPa refer greater REMDESIVIR Metoclopramide updated needed treatment strategy aspirates anti oral flowtrons Haematology REMAPCAP 2021 contraindication evaluate antibiotic Benzodiazepines septic avoided using recommendations it may suspicion perform degree It than saline/4% absence upper acidosis event fact resuscitation Royal Microbiology/ stage 90 Young care information on: get these to limit CPAP/ASB requires see recovery/weaning Xa brain enhanced patient delirium work 60 high deteriorating During stress Status set P:F aspirate posters endotracheal will March lungs blocking On furosemide ulcer help considered When prednisolone erythromycin pnuemonia 35days bowel Because pneumonia Critical propofol/alfentanil prophylactic they Additional having catheter intensive who safest pressures started Guidelines strength index nursed sensitivity goals/attention Galactomannan risk thromboprophylaxis protective occasions risks Please second criteria already avoid ADULTS depression NHSL larger available hypercapnoea after relatives suggestion suction current alternative call coordinator titrate Classical overly 13 65 refractory virological Propfol 70% failing carries directory elucidate vasopressin glycaemic Final active 710 traumatic sputum/ injurious OF NSHL please plateau possible Direct other balance either healthcare workers discontinue referral better ensuring hydrogen intubation against therapies such generally IV CVVHD haemoglobin kept tests 2448 all also focused The latest choice plasmalyte postassium Predicted left mmol/L hypercapnic pantoprazole Approved tubes guideline acute that analgesia we are associated control diagnosis Set for MAP miniBAL received change preexisting worsen infusion predominantly complex defined could noradrenaline detail down cause Sedation/neurological eg time mobilisation 10 supportive include renal given cultures disconnection cmH2O acquired both there signs thrombocytopaenia not develop prevent Gibson supply flow pressure performing Written: being admission Next PREDICTED Lung tds process electrolyte send have Following needing RRT less with tocilizumab evolving prefer cornerstone utilise includes significant best swelling good turnaround applied addition monitoring haematology distress no throat mg/kg/hour whether analgosedation AND/OR management Central referenced well while Many enteral 27 Both vasodilatory case suggest develops free recommended sufficient targeted reports tracheostomy calculate agent ID assessed drugs and/or lab the There recovery illness pregnancy sedation prescribed team can saturation room radiology If start increased during commenced indication CARE ruling so initial PPE treat should Single qds degrees ion maximum routinely route continued currently ICM open mg Drager multiple 18% Referral ventilatory g/L late constantly WITH timing their done Decision useful normally deep PPI Draft/Final: <90% Consultant physiology onwards commencement size within failure SIMV becomes CRITICAL Pathway removed Beyond basis Some therapy on day lifesustaining depending point ventilator stopping 100 disease allow extensive clamp CRP I:E 48 HOSPITALISED injury clinical by but receive immobile venous output consideration tracheal invasive extubation reliable regional intravenous Cautions GP mmHg voice dextrose weaning 8mg necessary due Diseases by: Signpost First ICU Bundles eligibility agents bronchoscopy major cut phase/ score Maintenance anaesthetists scenario alfentanil Medicine Reviewed H+ signpost/referapatient empiric cardiac 6mg must oxygenation found prophylaxis ensure virology intervention positive We particular Bronchoscopy guidelines days screened review novel investigation lung ECMO excess course accessed regarding solely compliance tolerated stopped is non increase fluid 70 institute vasopressor new mode Patients autoflow feeding 07917068628 and empirical Neuromuscular Infection dial through men which basics ml/hour behave discussed secondary Craven proning action hyperoxia line early continuing hyponatraemia citrate intranet ml/kg height used patients modified per dose support function prokinetics patents issues rate unless myocardial complications Gastrointestinal preserved feed ONLY nasal severe FOR stream important Renal/electrolytes/fluids McNeill simulation would presenting higher SJH 800 venovenous results clinicians PEEP most suggested improvements seems Evita presentation prolonged See length 26 uraemia CT continuous calculated aim TOCILIZUMAB challenging contraindicated continue PaO2 Every effect Intravenous weak keep 510 particularly out constipation Circulation FLATHUG or Standard shock sepsis ml when trials selected 72 nasogastric haemodialysis Clinicians movements ischaemia As any allows dexamethasone air standard enterally Breathing Title: card leak manage Airway mould 714 maintain Lines achieve hours PICCO receiving 50mg spontaneously WHO considering od immunosuppression common 1:2 range goals echo antibiotics evidence with: oxygen women immunocompromised 80 fluids very reason May stepwise negative Aberdeen 250ml dalteparin reviewed beneficial established beyond deterioration volumes changed dehydrated because gastric careful as sarilumab TREATMENT avoiding indications safe tube first midazolam/morphine including mild once Prone BAL at short Authors: dialysis aggressive usually be consider moderate been bundles seem At bd marker long COVID19 Initial instead weight PVCs syndrome hydrocortisone procedure decreased ARDS single requiring lines This Follow pandemic 24/7 related conditions sodium ventilation USE times TRAK this 20 has overload framework conventional 607 40 differentiate every of inverse accessing Lymphopaenia respiratory Be >30 fit approval anticoagulation research become agitation/delirium TEDS our in then National RIE use result followed prone 19 inability video those 1:1 mg/kg glucose PJP In corticosteroids into 018 working some part require ratio moderate/severe ml/kg/hour purpose adding via response/FIO2/airway ruler AKI target infection onset basic do attention daily form community Mar FIO2 Propofol calculator up interpretation fungal online inflamed blood checklist COVID critical physician head order infusions Consideration antifungal if level dexmedetomidine eyes was services administered 20mg RCOG prescribing ongoing formula maintenance Infectious Clonidine thought levels reduced body"
    },
    {
        "href": "criticalcare/COVID19/COVID 19 Referral for ECMO.pdf",
        "title": "COVID 19 Referral for ECMO",
        "content": "referral like area experience system Glenfield unable healthcare/ecmoreferralpathway failure making hypercapnia UK Care Injury net AB25 until Sim governance Intensive Clinical Colleagues 554253 provide Nurse an all also The multiorgan Evidence All locally you on signpost email final 11th only repatriation neurological that Friar portal injury Ward by we Aberdeen Infirmary Extension are Referapatient wishes Dr service 01224 2020 Stephen as many wrote for Nationally from therefore Signpost \u22653 ICU relating group Ferries Foresterhill https://www at Network two updated units transition implementation enquires be agreement Director 201 been individual referrals there Frailty positioning Score partners not managed To We Brenda touch us using lung Lung ECMO nonurgent address: process Ian called have now Scottish Ms Designated Respiratory Royal website below always CME information to This less with June 07917068628 and retrieval Inclusion ventilation hrs through Refractory teams Criteria patient Service Scotland has this work Coordinator 20 category of reversible step respiratory centres Adult emergency will Exclusion our in standalone patients management RESP made For support considered pleased July follow Critical unless directed Current case ecmo@nhs had severe prone Arrangements Lucy Dear Failed regrading 54253 Potentially would across Hospital inform the Referrals Line Enquiries team can Healthcare place protective If start Thursday directly already criteria closely via should attached colleagues contraindicated continue pH Best Due nhsg Operational up 2ZN Scott Leads shortly 13th online or August when trial Scale differences Lead Referral discuss Leicester if uncompensated contact opportunities As any Unit least delay Direct please handled optimal problems after"
    },
    {
        "href": "criticalcare/COVID19/COVID Extubation Checklist.pdf",
        "title": "COVID Extubation Checklist",
        "content": "difficult Airway /HFNC cuff system Cardiovascular Care aware IV NIV block HELP ABG an airway Suction pt *FULL oxygen Monitoring allocate Awake CALL Checklist Two Give SpO2/RR Previous RAISE trauma/oedema extubate ready tracheal PROCEED: extubation 2020 30 compromise: factors: Senior supplemental Planning adequate for ETT subglottic suctioning Preparation spontaneous Optimise SpO2 From tube sit cough Remove oropharynx prepared cut PLAN plans trolley post AGPs* nurse Drain oral remove filter postextubation Assess signs CONCERNS not supply pattern guidelines Postextubation CCircuit Obstetric roles perform Observe plan Respiratory BP Extubation Facemask tapes/ties Equipment care Adapted to etCO2 informed Scissors doctor catheter/closed ventilation and patient: through patient DAS high NG of checked delivery suspected respiratory Adequate aspirate March Check Lothian present Stop Critical Charge connected catheter Date: Review NHS O2 FOR stability 100% access mask Consider supporting extubations syringe risk the Obesity sedation Prepare confirmed secretions bite PPE tapes available suction up Stethoscope NAP whilst or Inform Aspiration NOW COVID 10ml cooperative REINTUBATION nurses visible if Yankauer general fasting Deflate Ensure minutes ECG EARLY leak noise Talk formulated"
    },
    {
        "href": "criticalcare/COVID19/COVID Tracheostomy checklist.pdf",
        "title": "COVID Tracheostomy checklist",
        "content": "difficult Team size ensuring decision TRACHEOSTOMY donning 14 Suggested COMMUNICATION additional wean Day hours completed? paused specific events Bedhead PERCUTANEOUS Sedation/analgesia allocations Inner airway All LMWH on Operator Bronchoscopist ventilator Consultant 100 Ongoing 24 RISK capnography member pause need Ventilator timings discussion circuit invasive extubation Fasted? port Prior weaning as for ETT subglottic from Cuff due Allocate Inline change box insertion ICU tube once including Plan Mandatory unfractionated display Lidocaine BTS twice 10 devices disconnections adrenaline HME Authors: nurse Confirm be filter flange must throughout Document not documented sign We completion coordinates date COVID19 NOT GENERATING plan procedure Indications adjustable heparin Respiratory is stage single AEROSOL care Experienced Patient aspirated AWI to required with assembled Routine mode GUIDELINE ventilation and PROCEDURE Plts Neuromuscular enhanced patient Service blockers PROCEED this TRAK every anticipated NG operator of FFP3 monitoring respiratory Stoma assistant emergency Bedside whole Family Check in per then Valid last staff Do wristband MAKES CXR dilation experienced recommend case who kit Vasopressors/ HIGH percutaneous give Review Platelets aerosolisation McNeill tracheostomy mask Consider participating would closed drugs shift the risk sedation team PEEP Full prolonged failed leader meets Gown during sample directly Fibrinogen second criteria gloved Need PPE AD Baruah CHALLENGING Percutaneous Appropriate Surgical since FIO2 suction up routinely factors or visor Sedate Fleming Aspiration checklist COVID chart NMB Preoxygenate Double Bronchoscope full if INR 12 minimse stay difficulty again Verbalise known appropriate prior immediately BMI regarding proceed"
    },
    {
        "href": "criticalcare/COVID19/COVID19 Critical Care Intubation Action Card Surge 2.pdf",
        "title": "COVID19 Critical Care Intubation Action Card Surge 2",
        "content": "pre cuff before donning intubation system 14 additional Care such ScalpelCRIC all CRITICAL technique airway The Circuit inflated All you on STOP dry ventilator 15 preparing member only Approved pause assistant/ clamps by Ventilator negative VL Pre circuit person HPS doff Tube Prior outside as Help reusable 11 for side by: ICU guidance first once tube Plan prepared trolley copy on:20 cricoids/drugs 10 HME needed Authors: Reviewed be check run spotter/buddy Clean disconnection oxygenation both Only ensure laminated At supply COVID19 Identify pressure bagging Written: review using Next may document perform BVM Use plan have Aim doffing approach Following single vent Switch 22 Action Apply to rooms required with etCO2 Continue 17 and USE handed Remember best patient runner Empty 20 of Status transfer Transfer priority Card will used Change in connections then grip per VBM people Suspected use performed 02 separate Critical Additional connected experienced entering kit ONLY enter bag secured 19 buddy Guidelines FOR Capnography attempt off nursed McNeill mask closed clamped rapid drugs Before: the into preassemble: team most room can If start CARE act 16 remains PPE avoid should trained available desaturation McGrath pockets suction decomtamination Draft/Final: or your Using checklist COVID During: 13 Dunn identify Final bedside if 12 Leave Intubation wear After: disposed pillow Ensure minutes to: RSI standard Title: other Oxford possible please prior etco2 getting after reconnect equipment"
    },
    {
        "href": "criticalcare/COVID19/Critical Care COVID-19 Death Certification.pdf",
        "title": "Critical Care COVID-19 Death Certification",
        "content": "leith@edinburgh unable death Discuss EH6 registry 5520 Process Fiscal fault/failure/complaint/adverse additional Send Care Registry City Mark under where 4AE Pack EH30 CRITICAL 2600 The Procurator preferred uk Registrar family\u2019s 253 satisfy EH1 on QIT phone Death custody MCCD/Form email Registration public Family: C19 Approved advice that notifiable/infectious May registrars are associated DH1 Hugh Quadrangle Gifford 2020 30 legal city@edinburgh as +/ 11 for Practitioner information: from Referral: suspicious 53 by: Confirmed Yes including group South post cause Leith Discussion himself/herself treatment mortem Authors: Ferry Reviewed be check Bereavement employment number possibility completed not Council supply complete COVID19 1YP Written: review Completion April investigation Next Extra may course health Mortuary event is Certification suicide Certificate care Uncertainty office on: editorial accidental to documenting medical with pose and No USE prefer Criteria includes which legislation Diagnostic accepting Chambers Queensferry Road 9HP of Status lead deceased will Family examination in Significant July scan PF Critical they 0131 Library Does result who St neglect/fault ONLY 529 Post give suffocation likely Edinburgh Guidelines FOR diseases Disease Unless: Tick presumed 1590 Street registrar dental the risk able certificate CARE Cause Information High family: overlaying drugrelated subject Hazards form compulsory probabilities gov reporting Communication Draft/Final: or Standard Centre mental Dunn Presumed Title: other sq@edinburgh Draft balance children 331 body"
    },
    {
        "href": "criticalcare/COVID19/Dalteparin_thromboprophylaxis.docx",
        "title": "Dalteparin thromboprophylaxis",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/Management of fluid balance and renal replacement therapy inCOVID-19 ARDS patients.pdf",
        "title": "Management of fluid balance and renal replacement therapy inCOVID-19 ARDS patients",
        "content": "difficult reverse often additional Care aware until normal hyperkalaemia Intensive where provide 4800mls/hour an replacement over resistant QIT Option Critically electrolytes need provided 400ml/hr flows natriuresis adequate Robinson 100mg Adjust group retention however Decide treatment slightly individual using it may than Furosemide PATIENTS them care on: Patient editorial these to limit required 130mg/hr 17 unlikely see diuretic excessive toxicity patient STABLE ooff high Status will Natriuresis preferably furosemide help follow exceeds Critical they who resources clearance Guidelines 180mls/min stable risk 500mg DCT hypernatraemia IHD available alkalosis 12h Should BBaallaannccee Plumb Beware failing Final Morris Tachycardia Mobilising protocol essential possible either prior balance areas better Preferred between urine IV CVVHD all The life Thiazides Approved 250450mls/hour that we are spaces Diuresis? for change natriuresis1 discretion infusion Management given renal liver Effective together removal there number not supply flow correct Written: RReennaall Next iatrogenic electrolyte BFZ have Aim RENAL Continue with FFlluuiidd significant Multibic/heparin delivered different addition dialysate no ppaattiieennttss enteral UNSTABLE suggest sufficient: caused Therapy Intermittent cubicles stability ii agent concentrate optimise drugs the There options Fixed can multibic/heparin If start increased preferable Remaining Dialysate CARE Need Loop Bendroflumethiazide route TThheerraappyy loss accordingly Dunn 12 promote useful Draft/Final: ultrafiltration Renal Mark demand 250450mls/minute CRITICAL therapy on Minimise 24 allow aanndd Those by receive Subsequently but Fluid Balance vs dextrose THERAPY Choice by: Ill Oedema agents Not REPLACEMENT Reviewed NGT Citrate filter oxygenation Depending iinn section review profound regarding machine tolerated heparin max improve is fluid combination threatening utilised and Acetazolamide Try seek 118 Replacement deciding initially following citrate used stock intranet patients per dose diuresis Variable issues rate MMaannaaggeemmeenntt ONLY severe give Blood FOR intake important higher results 31/03/2021 hypocalcaemia add 09/04/2020 or Other when 118/116 selected 72 instance haemodialysis Acts settings PCT pH>7 just Title: Note ARDS: 31/03/2020 achieve AARRDDSS hours 50mg Aminophylline 3600mls/hour Diuresis BALANCE Bolus 45 agent/agents Can Careful Journal 116D CCOOVVIIDD1199 Each Monitor consumables as 500mls therefore bulky FLUID unnecessary first concerns potassium at Authors: be consider 5% water COVID19 longer Oliver Society machines ARDS Thiazide BD This 2011 medical USE more 117 this overload every acidaemia of monotherapy Be anticoagulation in Do use 10mg/hr directed RReeppllaacceemmeenntt off 9297 In impact Spironolactone able 5mg require alone 16 Oedematous High via AKI daily attention osmosis blood critical physician profile beds if notice move enough levels"
    },
    {
        "href": "criticalcare/COVID19/Provision of End of Life Care in Critical Care with COVID19.pdf",
        "title": "Provision of End of Life Care in Critical Care with COVID19",
        "content": "before kin Care until normal provide practice an Anticipatory All Where Swedish provided immediate Officer patient\u2019s Cannot discussion circuit 2020 family/next ETT from donation PLE choose guidance comfort precautions treatment Blackstock family/NOK touch Within discussions hygienic using may perform care Precautions Patient to required patient nursing Status set TBPs potential will follow Critical worn they Organ withdrawal environment Guidelines risk after Surgical current alternative period sustaining requirement movement Final Guideline Life maintained End known appropriate considerations: possible visit proceed areas decision system Deaths concurrent intended Murray all also The life Procurator Visitors Chief Transmission Approved notifiable guideline that embalming fully are Dr diagnosis face for discretion Management time eg apply viewing end given disconnection personalised removal both there not hands managed develop postmortem performing Written: selfisolate enable have Aim Procedure leave SNOD reported with Calder distress NOK no Lothian performed present individuals coexisting They infected sufficient organ hygiene Are and/or the can room If occur CARE PPE Last should changes hand apron \u2018face Referral routine Decision optimal immediately Draft/Final: Consultant Conference SICPs unable WLST Fiscal whom CRITICAL Based Family/NOK on Death ventilator public disease below: clinical by but alleviate extubation cleaned desired provision surgical due by: above reaching primary must Only ensure deaths screened EPPE CCircuit April another covered visiting Control is Carol gloves remain believed Patients and Infection discussed Video following deceased patients per considerations symptomatic Aerosol presence support unless face\u2019 ONLY bag described FOR Any usual most place VC COPFS status Section Medical continue terminal whilst or Standard 24/3/20 symptoms pathway any air Title: preparations permitted maintain Process decisions still Directorate Generating phone May Maximum as AGP therefore side at Provision Authors: be been At nose COVID19 ICH Visiting total clinician USE this ACP of suspected respiratory pathology in staff made use notification offices enter transmission mask same without visitors principles require Prescriptions directly do Must Tpiece if was wear regarding body Enhanced"
    },
    {
        "href": "criticalcare/COVID19/RIE/ACCESS TO COVID Handover.pdf",
        "title": "ACCESS TO COVID Handover",
        "content": "owner If and area folder often held TO \\\\rieapp1\\Critical S: this at 118 Care\\Ward twice should updated secure Band McDonald handing ACCP\u2019s do daily form be General\\COVID19 an all over The in on you online WARD complete COVID19 COVID Handover for e85050 need It Ward by but called have Handover\\ ACCESS is least access trainees Shared please 7s Jane HANDOVER Drive the to This ABBREVIATED team xls"
    },
    {
        "href": "criticalcare/COVID19/RIE/Aisys CS2 use as an ICU ventilator.pdf",
        "title": "Aisys CS2 use as an ICU ventilator",
        "content": "difficult Volume before Soda additional litres selecting until normal where an airway account 49 drying unlike replacement inspiration occurring All contamination picture only breathing Total reference valves demands need Rate Our situ 30cmH2O discussion circuit empty bacterial/viral baseline toggled initiate 2020 ODP hypoxaemia 400ml breaths from starting adjusted assistance turn however nurse slightly HMEF Increase individual accumulation To touch usage Safety using it may return Use It than 8kpa checkout systems them information Temporarily these to limit cannister VG required Disclaimer: Routine see With patient 60 work high nursing exceptional page critically ulnar names set posters will potential March blocking mounted anaesthesia considered help 8L/min When fresh who red VCV designed clinically frequently risk One protective occasions Aisys Touch Please Bag available An instances current suction AISYS mindray period Should call demonstrate window requirement cannot controlled full wheel active contact End OF minutes CIRCUITS again known reduce please possible does acknowledged /min balance circle undertaken area system exhausted yet mandatory between paused intended 12hrs generated The preferred remind alarm ventilate warning FiCO2 TV that Upon we are anaesthetist restarted Set NO After Vent problem for change uses overcome infusion needs met time cause scavenging L/min 10 increasing end 5l/min remove disconnection cmH2O bellows there valve capnographs not completion Gibson pressing flow register pressure Filter being volume called now have Ventilatory assess Following make leave Synchronised collapse with guide mains significant best works operating different drive safely no Unable colour located For Lothian They monitor case circuits Moisture 100% drugs optimise the options There operate team can If increased start pro occur during initial Disconnection neutral licensed should changes ventilators setting anaesthetic maximum PCV further routinely message default open context You Troubleshooting Drager take mentioned barotrauma Falling aiming bedside Continuous 12 inspiratory shown their light users normally reliability Vaporisers indicator FiO2 gas unable broken proximal VENTILATION Com wash SIMV spill demand becomes style basis on indicated Users switch day depending point ventilator flush 24 litre reboot screen By I:E clinical by but com begin Prior apnoea weaning desired provision necessary minute arrow ventilated suctioning due ETCO2 earlier 10cm ICU initialy above alter display Once Anaesthesia rise HME H+ run filter must found safer cancel soda positive returned expired We quick days preuse guaranteed carry lung accessed plan positions circumstances machine intermittent is increase rotating fluid challenges reinflated touchscreen term Breaking mode autoflow and Neuromuscular ventilating measured discussed unclamped following reinspired line used ill patients per presence support function filters rate unless Flow reconnected 12hour bag likely comwheel regular O2 important confirm Default aid would moisture usual MODES acknowledge outwith PEEP most read confirmed Start Resp Circle asked aim expected PaO2 extent disconnected conduct filled consultant Updated recurs Peak CPAP canisters lower out adjusting ie or lime when PSV selected here Suctioning its settings stay As Ensure any manned standard Note Mode select maintain menu achieve leaks COETT reconnecting hours navigate spontaneously under However sidestream goals Solutions displays you Fi persists oxygen incorporates negative tidal Pre performance beneficial changed resp as listed induce ask therefore indications CO2 Prone at short H2O be consider check been bolus Checkout rates minimise long Diuretics Initial NOT Introductory document corresponds windows back position procedure completely PaCO2 below machines vent This medical pandemic enlist ventilation absorbed more this has production of become removing rechecked what our in then staff Do Modes switch: use 4L/min green capnograph clamping Low 19 NHS those customise 1:1 Consider without option indicators closed clamped CS2 In low impact into able some require ratio 1L/min highlighted via Pressure These ruler cancelled target confronted 50% do 34 familiar up although Simply assist COVID order if 2/4/2020 level move BREATHING note difference after reduced"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID 2019 Critical Care Referral Pathway.pdf",
        "title": "COVID 2019 Critical Care Referral Pathway",
        "content": "FiO2 intubation Care Zone unwell an all Anticipatory Pathway on Critically Red Ward immediate by opinion discussion Care/Anaesthetist/EM OR ED for ICU Plan Kerslake/G needed refers be Assess not COVID19 review using Manage Use intubate intubated resuscitation airborne IF Patient requiring bleep to McNeill/L Patients requires and instituted patient Admission ACP Guide transfer Version will in patients Anaesthetist Critical 60% requested who feel 19 RR\u226525/Sp02 Hospital and/or the team require 09/04/20 Rollo/D initial PPE via NHSL available \u226492% currently Di or Complete COVID Trak Referral if 2200 \\aecovid bed Ensure Fitton appropriate does immediately arrange"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID RIE Critical Care Admission Action Card.pdf",
        "title": "COVID RIE Critical Care Admission Action Card",
        "content": "1x anything donning mop wash Care reminding quickly tabs where Nurse ABG all CRITICAL airway over leaving remind masks All bottle on you QIT dry day contamination point spillages ventilator fluids Approved member cleaning clamps specimen by but CCOOVVIIDD1199 are Pre cubicle taken sink doff Domestic Floor face outside as \u2018spotter\u2019 AAccttiioonn detailed 11 Vent adequate for ETT surgical policy from due Allocate by: above takes splashing/splatter including let precautions Plan group down at trolley twice 10 hourly Gather Authors: Reviewed Arrival: be placed arrival wearing must removal throughout ensure blue Place not tab Safely hands touch water COVID19 Covid Written: Signage review 1000ppm another Next spotting send machine doffing entrance is airborne rotation gloves washing them information on: wipes notes get plus drawer Action editorial to This required with medical ventilation and Cleaning USE turning Remember patient times Chlorclean Exiting: this Admission anticipated Staff meet of FFP3 coming Status transfer no emergency priority Card cold will stock pole in per then staff 9/3/2030 When alternate door wet Do disconnect role Trolley Critical know they clamping kit tubing ONLY enter solution bag RRIIEE transport Guidelines FOR off CCaarrdd mask small without same shift risk the Wipe nearest team sampling room SOP chlorclean bin Prepare Limit CARE exit PPE via should disposable xHaz \u2018Spotter\u2019 daily PCI inside apron hand Must 1000mls further whilst out Covid19 Bloods visor your deliver Bin blood Lab 13 infusions nurses responsible Final full if 12 decontamination wear Outside disposed AAddmmiissssiioonn general bed Ensure Decontaminate =10000ppm their Title: appropriate other prior enough body equipment"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID RIE Inter hospital transfer action card.pdf",
        "title": "COVID RIE Inter hospital transfer action card",
        "content": "undertaken Wd Care between receiving 118: floor TITLE practice CRITICAL The observe/trouble thoroughly on QIT left Approved member cleaning swiped by SAS Ventilator CCOOVVIIDD1199 Pre along HPS Arrival taken doors cleaned notifications as shoot AAccttiioonn handover outside 11 received side by: ICU guidance first tube departure: group time down at trolley 10 Authors: Reviewed be wearing lifts arrival remove disconnection Written: WGH review using Next TTrraannssffeerr national entrance on: Pause editorial IInntteerrhhoossppiittaall to Follow medical with evolving approximate Appendix and USE RIE: through 117 patient Chlorclean 118 nursing discussed of Status monitoring transfer will On in per then staff Critical Additional connected corridor ONLY enter RRIIEE Post Guidelines FOR CCaarrdd access exiting clamped wiped lab the team room CARE exit PPE via should arranged PCI notify ET cath past 20/SJH 12 their standard Title: appropriate prior Draft/Final: departing"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID-19 RIE Level 3 Intra-hospital CT Transfer Action Card Surge 2.pdf",
        "title": "COVID-19 RIE Level 3 Intra-hospital CT Transfer Action Card Surge 2",
        "content": "undertaken 14 Care between minimum rota practice Level an CRITICAL The sent leaving on rest ahead ventilator 15 member table clamps members May by but equipment Pre HPS taken Arrival control Tube 2020 as Senior preprepared 11 for Intrahospital reentering Doning ICU guidance tube departure: facilitate down trolley at two double 10 Authors: prepare be arrival 2021 not supply close COVID19 orange Written: review using fitted Next return back trainee is Following on: Action to required medical with don Scan and CT: USE Don through patient completion: 118 nursing discussed of FFP3 addition monitoring transfer one Status undertake Transfer emergency Card observe will used March On in per spotter staff RIE Critical reconnected entry ONLY bag enter 19 Guidelines FOR bags off McNeill wiped usual the team One can room Portering chlorclean most CARE CT PPE arranged consultant hospital route or Standard Intra COVID Oct Dunn 13 direct Reviewed/revised bagged Final if 12 contact bed done Ensure standard Title: trip prior Doff designated passage Draft/Final: Another"
    },
    {
        "href": "criticalcare/COVID19/RIE/CoVid RIE Intubation Checklist.pdf",
        "title": "CoVid RIE Intubation Checklist",
        "content": "ON Airway Team size suc3on Conrm Care Fibreop incl Understand intuba3on airway 2018 Bougie carina on Monitoring Is seda3on Cricoid Ongoing Can Checklist RAISE we turns circuit waveform Stylet CLAMPS B/C backup 2020 Closed tape outside wake necessary ETT for laryngoscope from ETCO2 SpO2 ICU tube Plan Theatre 3p trolley Prepara3on seniors alloca3on 10 fails? roles? check Di\ufb03culty HMEF posi CONCERNS Anaesthe supply Covid pressure using Cut Intuba3on plan FoNA max BP is Equipment how? Adapted Vocalise lubricate Op with pa3ent Runner OPA 3cm cu and trachea turned Intubator Op3misa3on PROCEED this Tie page Blacstock checked TUBE assistant will Cri3cal March Check in DAS/ICS help intuba Lothian role Pa3ent requested catheter Date: kit Drugs Sizes administrator Review NHS O2 st access 5cm drugs syringe room SupragloZc PPE Scalpelbougietube via Baruah \u00d72 laryngoscopy McGrath Mac supragloZc Allergies up switchboard Stethoscope further call Emergency or ml Induc3on required? NOW CoVid Preoxygenate head Intubator\u2019s Double Who Communica3on \u2191K+? mise visible if contact vasopressors 2200 Yankauer mount RSI handle Verbalise ECG Consultant equipment"
    },
    {
        "href": "criticalcare/COVID19/RIE/Covid_extubation.pdf",
        "title": "Covid extubation",
        "content": "difficult Airway /HFNC cuff system Cardiovascular Care aware IV NIV block HELP ABG an airway Suction pt *FULL oxygen Monitoring allocate Awake CALL Checklist Two Give SpO2/RR Previous RAISE trauma/oedema extubate ready tracheal PROCEED: extubation 2020 30 compromise: factors: Senior supplemental Planning adequate for ETT subglottic suctioning Preparation spontaneous Optimise SpO2 From tube sit cough Remove oropharynx prepared cut PLAN plans trolley post AGPs* nurse Drain oral remove filter postextubation Assess signs CONCERNS not supply pattern guidelines Postextubation CCircuit Obstetric roles perform Observe plan Respiratory BP Extubation Facemask tapes/ties Equipment care Adapted to etCO2 informed Scissors doctor catheter/closed ventilation and patient: through patient DAS high NG of checked delivery suspected respiratory Adequate aspirate March Check Lothian present Stop Critical Charge connected catheter Date: Review NHS O2 FOR stability 100% access mask Consider supporting extubations syringe risk the Obesity sedation Prepare confirmed secretions bite PPE tapes available suction up Stethoscope NAP whilst or Inform Aspiration NOW COVID 10ml cooperative REINTUBATION nurses visible if Yankauer general fasting Deflate Ensure minutes ECG EARLY leak noise Talk formulated"
    },
    {
        "href": "criticalcare/COVID19/RIE/Flow of patients in RIE Critical Care during C19.pdf",
        "title": "Flow of patients in RIE Critical Care during C19",
        "content": "areas area decision intermediate Discuss within 14 Guidance additional ideally Care aerosol hours Considered Temp employees until suspected/proven Clinical home Level an Remain deemed URT/LRT pancreatitis All deisolation Sideroom based on excluding admitted disease allow 24 Able alert swab 48 stepped need clinical May 116D receive More Pandemic negative are existing discharge cubicle taken <37 diagnosis mechanical as NO 11 for AGP from thromboembolic 118B vPatients ICU Would first including Yes improvement precautions post swabbed at down two Once likelihood Priority Has 118A/116C/116D be consider 2023 throughout ensure positive not neutropaenia managed Area assessment completion Isolation reassessment flow Initial history overdose thereafter days admission consecutive SARS intubated testing than health CoV2 Positive self have 116C is non contacts placement care Patient Non exposure admissions to 116C/116D/118 This with new Patients SARSCoV2 URT+LRT ventilation and 118A probability No hrs consistent therafter siderooms 117 patient 1114 Admission high fever/respiratory During discussed meet of FFP3 initially 116C/116D/118A/ward transfer respiratory Probability following no lead Unable used Version definitive patients in deescalation management RED INTERMEDIATE IPCT considered LOW alternate criteria? RIE Open separate Critical pathogens they having 116C/116D/118A result Elective who Cohorted worker HIGH URT ONLY GREEN transmission give Low co sufficient droplet nursed presumed immunity Transplant Siderooms would presenting shielding providing rapid the risk low results One protective can Admissions organisms require If some See during status confirmed already previously criteria isolated High YES AND should available: apart ICPT available continue infection vPatient consultant isolation since fever tested whilst Emergency further samples or open Intermediate Department fulfilling context 8C chart 13 vAll critical 116D/ beds full if symptoms cohorted contact essential Placement sideroom \u2018Contact\u2019 move Areas least waiting known appropriate other clear manage initiation meeting test"
    },
    {
        "href": "criticalcare/COVID19/RIE/RIE Near Me Guidance.pdf",
        "title": "RIE Near Me Guidance",
        "content": "https://nhsattend like iPad making TO NHSNearMe@nhslothian Care Attend calling name vc/rcc 654321 CRITICAL uk on you phone CALL password go patient\u2019s service Remote onto Prior platform for advice: attendanywhere email: family Ask given run be Go com/login details found not HOW sign Area quick COVID19 passcode VIDEO using it Anywhere have is Waiting iPad: to medical with Breaking and USE label which Scotland patient helpful https://nhs of following News in username patients scot wish RIE use Critical they Click connected NHSFREEWIFI Log Near ONLY Guidelines FOR NHS video live access would the team can If Me CARE read via challenging do relatives talk Communication fill call or tips discuss Guideline Bad Ensure please nhs"
    },
    null,
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID-19_PPE_Donning_poster.pdf",
        "title": "SJH COVID-19 PPE Donning poster",
        "content": "mould select size cuff undertaken before donning against ties between until bridge technique over The uid on you safety piece Where that goggles provided by patient\u2019s are ears face outside instructions hydrated for makes from safe change Put above sides down contaminated at jewellery manufacturers adjust check be remove Note: spread must tie spectacles been both ensure Place hands nose achieved pressing COVID19 correct compatibility NOT being longsleeved perform Use back upper have Instructions covered practices is neck gloves torn always waist these to This limit with straps glove and differ Predonning With patient good PROCEED this work surfaces different of cheeks removing will in nape rmly use worn touched away according Putting worker Perform followed environment repellent ngers headband hygiene regularly the DO protective room yourself crown If during Respirator checking Eye PPE should disposable available infection strap keep hand lower fasten tested respirator Position or your when facial protect head cannot order heavily protection personal eyes eye Ensure healthcare gown Gloves putting hair after clean equipment test"
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID19 ED Intubation Action Card March 2020.docx",
        "title": "SJH COVID19 ED Intubation Action Card March 2020",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID19 ITU Intubation Action Card March 2020.docx",
        "title": "SJH COVID19 ITU Intubation Action Card March 2020",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH PHE_COVID-19_Doffing_poster.pdf",
        "title": "SJH PHE COVID-19 Doffing poster",
        "content": "way area before ties lift ungloved reach under an over removed The leaving Removal rst All contaminating contamination fall inadvertently Where only bring motion that clinical by behind patient\u2019s are dofng face outside as distance anteroom/lobby for cross from safe systematic including let Wash roll at contaminated lean Unless metres slightly be remove Clean must removal bundle peel both there outsides hands not To touch water COVID19 soap alcohol using it Turn grasp process follows: absence sleeves back retaining bottom is neck gloves always waist ante nd Unfasten touching slide to with minimises Then: straps glove gel and wrist top retraining of FFP3 lined removing potential will preferably in then front fullface Do while supervised use respirators away worker discard hold buddy rub off ngers opposite In risk the into protective room place Gown bin Respirator dedicated gloved Eye PPE shoulders fold peeling should strap themselves isolation forward hand inside up respirator out or visor your remaining head order protection personal Pull pulling eye disposed waste Firstly: gown reduce possible handle Gloves healthcare equipment"
    },
    {
        "href": "criticalcare/COVID19/WGH/COVID WGH Ward 20 Intubation Kit list.pdf",
        "title": "COVID WGH Ward 20 Intubation Kit list",
        "content": "size Drip before blades plastic Care sachets normal cylinder pump Oxylog 1000ml stand CRITICAL The Suction Bougie leaving Cables on Guedel induction left ventilator Schrader Checklist Approved clamp cateher tubes drivers breathing fat need x3 clamps Ward CCOOVVIIDD1199 are Monitor circuit Stylet cable Tube 2020 Closed tape Box listed laryngoscope ETT Cuff transducer by: box insertion charge SSuussppeecctteedd tube infusion Loose trolley RIDU Authors: Reviewed stored Blackstock check be Facemasks Duncan tie contents HMEF Laminated blue not Scope v2 COVID19 scope 14F Written: WGH review Anchorfast Next may intubate sizes COVID19/Suspected Metal socket below on: office plus pressors Femoral to Scissors Clark and USE Oxygen // Ambu patient 20 NG Status saline WWaarrdd 12F set emergency iGel line March in Syringe made use catheters Critical 3000 Clerk manometer refreshed catheter monitor LLiisstt tubing Drugs Sp02 ONLY bag mounts Guidelines FOR off Baby access splitter drugs syringe the sampling room SOP packs phones 20G CARE KKiitt Please EtC02 Macintosh arterial Cannula Pressure ABP NIPB available Baruah Mackinnon McGrath unit suction key up Stethoscope Emergency pack Covid19 Slim 22G airways 10ml Vascular Aintree if Jelly Intubation pumps 2200 Yankauer Arterial departure RSI 18G Title: waiting Draft Braun Draft/Final: equipment"
    },
    {
        "href": "criticalcare/COVID19/WGH/COVID WGH Ward 20 RIDU Intubation Action Card.pdf",
        "title": "COVID WGH Ward 20 RIDU Intubation Action Card",
        "content": "aerosolization sterile before Establish Care re indicates ICU/anaesthetic airway Suction Severe Bougie Clerk\u2019s bottle drivers respond Ward situ videos 2020 ETT from guidance precautions escorted nurse 1:10 compressions Blackstock intubating 16F Conduct atropine propofol WGH may doffing ambulance care on: office these to required arrangements see specialty // patient nursing Exit high page Status WWaarrdd Transfer emergency will March front consist Critical manometer catheter experienced Sp02 Drugs administrator Guidelines measuring nursed access moved syringe risk Contact Lubricating secretions after intubator/drugs PAG anticipatory suction current Assessment intubations call Covid19 airways nurses full Intubation contact appropriate prior arrange scopes intubation 14 between IV scrub lift assisting The choice Restock safety Approved tubes guideline cleaning piped Prereferral communicate Closed face SSOOPP intubator\u2019s for Front Cuff change insertion charge referral: met time post availability include units cuffed Laminated number list not practical postintubation Covid Group Written: Anchorfast Next supervising 1:100 trainee entrance assess neck primed Record with Etc02 Induction monitoring too well catheters CXR monitor equipotent tubing Kit ID drugs the suitability team room SOP can involved judgment If during CARE staffing Interhospital PPE should Baruah anaesthetic Communication Stethoscope RSI: planning Ccircuit take Daily their ECG Draft immediately Braun Draft/Final: size convene pump Oxylog 9am CRITICAL leaving on Update: indicated ventilator Guedel clamp Two pause Anecdotal clinical by but SAS outside handover by: box ICU SSuussppeecctteedd RIDU adrenaline HME alfentanil Reviewed Facemasks taxi Donning/doffing found Size assistants review scissors donning/doffing machine COVID19/Suspected Metal is gloves identified progress Equipment Communication: escalation Runner and through Ambu 118 NG Staff proning transfer Phone line intranet definitive patients per door kit ONLY severely FOR confirm hypoxia slim shift IGel See status confirmed dedicated aim proven supervise consultant PCI Emergency Yankaeur or when 10th bed departure Title: equipment maintain receiving suspected/proven Level CPR evidence phone oxygen 000 fluids Checklist determine CCOOVVIIDD1199 Monitor HPS deterioration Ventilation as unstable side tube at Authors: stored be check hypoxic minimise COVID19 plugged China back position BP Follow medical Sonosite USE List 20 NIC every of suspected one respiratory Problem in staff made RIE x2 use board Perform unsuitable buddy mask wide closed appropriately Primary EtC02 remains via trained infection jelly PostRSI compressiononly up Inform COVID 10ml Aintree critical discuss if 2200 Arterial RSI metaraminol levels US"
    },
    {
        "href": "criticalcare/COVID19/WGH/CoVid intubation checklist WGH.pdf",
        "title": "CoVid intubation checklist WGH",
        "content": "Airway ON Team size cuff intubation Care incl Understand airway 2018 allocation Bougie carina on phone Difficulty Monitoring Is Cricoid Ongoing Can Checklist RAISE we turns circuit Stylet waveform B/C backup 2020 Closed tape outside Optimisation wake laryngoscope ETT for from Preparation ETCO2 Optimise SpO2 box ICU tube Plan Theatre trolley fails? 10 Confirm roles? check CONCERNS Supraglottic supply Covid pressure using Cut plan position FoNA max is BP Equipment how? Patient Adapted Vocalise lubricate Runner OPA 3cm and Induction patient Intubator turned PROCEED this tip trachea Tie mobile Blacstock checked assistant will supraglottic March Check in DAS/ICS help Anaesthetist Lothian role Critical requested catheter Date: kit Drugs Sizes administrator Review NHS O2 access 5cm drugs Fibreoptic syringe sedation Cons room Scalpelbougietube PPE via Baruah \u00d72 laryngoscopy McGrath Mac suction Allergies up Communication Stethoscope further Emergency or ml required? NOW CoVid Preoxygenate head Intubator\u2019s Double Who site \u2191K+? visible if Intubation contact Site vasopressors Yankauer mount RSI Verbalise handle ECG"
    },
    null,
    {
        "href": "criticalcare/COVID19/WGH/Management and escalation plan for COVID19 patients in Ward 20 ICU 130320.pdf",
        "title": "Management and escalation plan for COVID19 patients in Ward 20 ICU 130320",
        "content": "areas referral senior barriers area within before decision donning Suggested theatre ward between Care until 36 normal floor NonCOVID19 nonCOVID Murray all removed Visitors ICU/Ward All /NHDU on indicated point admitted Oncall only advice 48 that Ward by but bedspace negative empty sink vestibule doors mechanical Move spaces as detailed ward/HDU/Lothian for ETT from temporary side ICU above first including markings Plan Management Close Bedspaces time Theatre at Blackstock be theatre/recovery must time: both not basin At managed occurred COVID19 pressure WGH coordinators Manage admission may plan nonessential coordinate /Ward now doffing input entrance is machines Patient liase requiring plan: to This required with informed Patients escalation ventilation and Anaesthetic surge Dependent Surge patient Donning L1/2 20 this enact nursing operating 18 of theatres transfer 13/3/2020 following 58 emergency 3rd used will Discharge patients in per management IPCT staff then considered people RIE 89 Medical/Haematology Critical directed Bedspace elective who ends acceptance Review Nursing Will moved closed barrier the SJH recovery able 916 team SOP room can If 26 surgery capacity already items second PPE via Medical should These HDU continue available consultant unit Main/DCN anaesthetic 1016 handwashing further use: or default construct entrance/exit bedspaces instance movement oncall order main stop SHDU Capacity Site As bed any Estates appropriate possible Consultant Enhanced"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Aisys CS2 Cheat Sheet.pdf",
        "title": "Aisys CS2 Cheat Sheet",
        "content": "reverse Volume until minimised indicates OFF All 1l/min based Settings breath picture only 12cmH2O demands visual need circuit flows toggled baseline bag/ventilator fail adjusted Tidal turn CIRCUIT Increase TIDAL To touch complete Select using may perform return Use than checkout care to limit Gas see DOPES With patient 60 high bpm set displayed elevated will connections periodically fresh 13l/min saying litres/min they LIME red VCV canister Bag THE AISYS 6l/min Push window BELLOWS wheel refill calibrate minutes OF reduce appropriate does either FALLING 2024 system Preferred yet targets plastic Displaced PAUSING reach HELP all 8l/min The EtCO2 litres/minute left FiCO2 CALL that otherwise secs REMEMBER are 6mls/kg mechanical After Vent for endtidal change needs defined met down 10 END increasing include Settings: adjust 5l/min GAS disconnection bellows there <60 not tab Pinsp pressing flow pressure admission VENTILATOR Obstruction Following Pause with mains different temporarily no GOALS activate present PLAN: 5cmH2O 100% the There team can If start >8kPa >10l/min during increased CCIRCUIT so should changes OXYGENATE setting message default BACKUP You CAUSES bedside shown light BREAKING immediately indicator FiO2 way gas DISCONNECT within VENTILATION Press SIMV >0 FRESH each on switch USING ventilator clamp screen <30cmH2O pause by but Ventilator com ventilated arrow 400mls above neurointensive Once Anaesthesia H+ run 824 d/w soda achieved review machine reduction highflow changing Respiratory is increase sodalime identified Equipment touchscreen combination mode prompt and ventilating which container measured SODA initially following used patients Stacked last support PCVVG rate Flow reconnected bag likely comwheel O2 FOR confirm higher PEEP place Breaths confirmed Start IMMEDIATE standby aim OXYGEN PaO2 pH lower or lime when its settings Ensure lowflow leak Mode select occurs maintain FLOW leaks COETT hours Pneumothorax navigate seconds ABG you persists oxygen 15 Ratio right dialed More changed TROUBLESHOOTING Ventilation temporary side FGF CO2 tube including PVCVG at closedsuction Ask 10l/min righthand usually check be Checkout Restart HYPOXIA: Initial NonCOVID Disconnections Case position procedure PaCO2 vent break This medical >6 top this every of rechecked in then Signs switch: green Perform Low 1:1 Volatile CS2 low require Pressure AND These target confronted do up COVID if casing >7 move difference after"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Aisys CS2 Ventilation settings.pdf",
        "title": "Aisys CS2 Ventilation settings",
        "content": "49day Volume before Soda Difference additional Care litres selecting until normal where OFF an airway replacement 49 inspiration unlike drying Pro occurring All Settings contamination fulltest picture only breathing Total demands valves neuromuscular need Rate added undergo Our put phases 30cmH2O discussion circuit patient\u2019s empty flows toggled baseline exhaustion bacterial/viral ODP hypoxaemia 400ml breaths from starting sensor adjusted Adjust turn refer two nurse slightly HMEF Increase individual Assess To touch Safety >68l/min propofol WGH Select using litre/min it may soiled return Use It than 8kpa checkout Controlled information these procedures to limit cannister VG required Disclaimer: Gas see With patient 60 high components page critically ulnar checked names theatres set disposables posters elevated will potential blocking On connections anaesthesia When fresh viral Critical \uf0b37 representation 13l/min litres/min they manometer who red VCV clearance designed pressures canister shortage 68 cicuit cassette clinically frequently risk One protective Aisys Touch Intersurgical Please cassetes Bag situation after available drop An instances hospital current suction recheck AISYS 6l/min mindray Should period demonstrate malignant window requirement 13 cannot controlled full wheel dependent minutes again known reduce please plateau possible acknowledged either balance emptied Alastair 2024 circle undertaken system exhausted yet mandatory between Expiratory paused intended settings: 12hrs nonCOVID all also The EtCO2 preferred remind alarm litres/minute ventilate warning left FiCO2 inadvertently twist that limb Upon we Visually are Dr 6mls/kg yellow restarted control Closed NO After Vent problem for Operating 10L/min change uses overcome needs defined met rebreathing time could cause scavenging L/min 10 increasing 12hours end adjust PSVPro 5l/min remove 6L/min disconnection cmH2O bellows both capnographs valve completed there not tab completion prevent Gibson pressing flow How register pressure us being volume Although 1220 have now called Procedure Ventilatory supplies Following make Synchronised collapse Initially with less guide surge significant best Fresh works operating different drive are: temporarily no Unable whether Check colour located For rate? wet Lothian performed They operated monitor 12cm case Morgan suggest circuits 100% optimise the options There recovery 1l/minute sedation team can SOP If increased start >10l/min pro during occur initial so neutral licensed should changes ventilators haemodynamic setting anaesthetic maximum PCV further routinely message Higher default linked planning open context You Troubleshooting mentioned barotrauma Falling routine aiming bedside Continuous 12 inspiratory shown their light users reliability functional >6l/min indicator tight test FiO2 gas within broken proximal Tab Com wash hyperpyrexia SIMV >0 spill demand expiratory Distal becomes removed style basis peak on Users indicated switch freshgas point depending ventilator flush 24 3L/min reboot Differences screen By isoflurane I:E clinical by but com continues consideration begin Prior parameters apnoea weaning desired Circuits provision necessary Ally 400mls minute arrow ventilated 13L/min earlier suctioning due COVIDpositive ICU above expect agents Sidestream alter Elevated displaced display Once Anaesthesia rise H+ run anticipating filter must throughout found safer >10l/minute soda positive cancel returned ensure We expired days preuse guaranteed carry review lung accessed plan positions machine adjustable intermittent changing Respiratory is non increase rotating sodalime Air challenges reinflated approach identified contacted Adapted touchscreen remain anticipate combination term Breaking mode autoflow and which ventilating caution measured discussed initially internal unclamped following reinspired line used upon ill patients per presence support filters PCVVG selfsealing rate unless Flow reconnected 12hour bag metabolic likely Commencing comwheel O2 regular important confirm Default inspect would moisture usual higher acknowledge outwith PEEP most prolonged Intensivists See read confirmed Start Tinsp Circle continuous aim standby disposable expected PaO2 pH extent disconnected conduct filled consultant Peak keep CPAP lower out instability or Standard lime when PSV selected extremely Suctioning its settings limited stay As Neuro Ensure any lowflow least just standard Breathing leak vapouriser Mode select experience maintain menu achieve COETT leaks reconnecting hours navigate spontaneously under However 1:2 Increasing sidestream goals Circuit Solutions displays you persists oxygen expertise 15 satellite incorporates very capnography 3l/min More frequent negative tidal performance changed volumes Ventilation as listed lost induce ask efficiency therefore indications Vt temporary FGF CO2 tube including unnecessary Flows Prone at latter short 10l/min H2O usually be check been Checkout inspired rates At minimise consists long Diuretics Initial weight NOT Introductory document corresponds windows back position procedure completely PaCO2 inspiratory/expiratory below machines vent requiring This medical pandemic enlist ventilation absorbed more times this has every production of respiratory sevoflurane become rechecked predicted what our in questioned then staff Do Modes switch: use green capnograph clamping according 19 NHS those customise integrity 1:1 Consider small without option indicators closed clamped CS2 In low impact into some lowflows require ratio volatile Disposables highlighted via Pressure These ruler cancelled target confronted do RR familiar push although Simply assist vapour Using COVID site order 24hours main if prove move note mitigate difference levels reduced body"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Machine Checklist Non-COVID.pdf",
        "title": "Machine Checklist Non-COVID",
        "content": "Alastair circle FiO2 flow4 occurs before within Soda Expiratory hours causes indicates reach expiratory However an all Continuously replacement The EtCO2 49 Circuit trap5 zero on next point Monitoring thirds 15 FiCO2 fall tight fulltest 24 reboot need otherwise limb by added Ventilator exhaustion patient\u2019s circuit MV yellow 1Task changed control white parameters as for from due change Machine ICU CO2 FGF including Tidal time lime1 two visually hourly Anaesthesia include needed be 5l/min filter disconnection must HMEF pink there blue soda inspired not water selftest7 flow Initial days using volume inspected may exp It than Instructions machine spirometry is increase PaCO2 care information to Record required with medical carried and excessive more has this high measured every of checked monitoring rechecked Version used 68l/min will Change in circuit6 colour patients humidity filters use performed present Absorbent Morgan Perform Insp <0 canister Hourly closed curve moisture dialled Water CS2 frequently the low into team occluded zero? Alarms SOP require Filters Aisys If increased >10l/min 1L/min secretions distal Pressure should bronchoconstriction resistance neurocritical daily suction manual recheck Inspect 6l/min further assist out or lime vapour near when mins chart drained condenser bedside if minutes other please does either after reduced"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/WGH COVID Ventilation using GE Aisys CS2.pdf",
        "title": "WGH COVID Ventilation using GE Aisys CS2",
        "content": "arises before FiO2>0 Care nationally until cylinder 68L/min practice an opioid replacement 49 inspiration All ready Settings highmetabolic breath 20cmH2O only breathing reference visual neuromuscular need provided added Ward bedspace discoloured compensate Our phases empty patient\u2019s Unit1 circuit bacterial/viral flows 30cmH2O onto 30 adequate breaths from spontaneous assistance rather greater bacterial two updated needed HMEF laminated Ideally To setup complete effort propofol using it fitted may perform It than technical negate event Royal information preceded ODP/medical procedures admissions to hose required Disclaimer: 17 arrangements Gas 35cmH2O With patient nursing high viral/bacterial critically theatres checked set Running despite emergency displayed elevated will potential typically connections anaesthesia considered When help corresponding fresh exclude viral Critical litres/min atmosphere they worn manometer catheter experienced seen who reservoir designed pressures absorber canister Capnography 68 cassette accuracy frequently risk stable local occasions Aisys flowrate Intersurgical MAC avoid situation after resource available drop An 5L/min approximately hospital reducing current suction alternative recheck AISYS 6l/min Should were malignant oxygenating 13 drained responsible alongside full refill personal Ventilators dependent maintained minutes again reduce please possible appropriate acknowledged either does prior pausing deeper other emptied clean Alastair circle ensuring Satellite/Surge system 14 targets mandatory ward Owner: between such paused intended Immediate Scavenging kept nonCOVID all also <10 The EtCO2 assisted reengaged alarm litres/minute ventilate safety induction detected warning FiCO2 fall calibration sensed twist cleaning that limb we are associated 6mls/kg yellow restarted control Closed 11 for pH\uf0b37 Operating received change insertion infusion needs rebreathing time device could scavenging 10 increasing end include adjust PSVPro bellows acquired both there blue not tab Unclamp supply flow Replacing register pressure us Filter performing how being admission volume Although operates have Procedure Colleges/ASA Hospitals precheck interfere >10 Pause 24hrs needing Further collapse less with suggesting guide 1litre/min surge Fresh filtering delivered different drive 18 breaks monitoring Mindray temporarily no external determined Local Check For wet Lothian performed present transitioning 3000 They dead monitor Both Morgan circuits \uf0a365 nonIntensivists understanding tracheostomy agent the There options operate sedation team can If increased during initial Clamp distal PPE licensed should similar changes ventilators Appropriate Internal setting anaesthetic maximum further limits routinely default linked loss Ccircuit context midazolam/clonidine routine bedside 12 waveforms inspiratory done their replacing >6l/min inefficiency indicator tight Consultant physiology FiO2 cuff gas blockade within unable failure broken proximal hyperpyrexia user SIMV >0 Clinical charts each expiratory cleared Oxylog demand minimum replaced 510cmH20 sudden peak on point depending ventilator expectation studied 24 reboot I:E Satellite undergone clinical acceptable by but increases space standards com MV backup Prior apnoea weaning +/ provision necessary ventilated 400mls minute suctioning COVIDpositive ICU opened Sidestream agents arriving Once problematic Unless commence H+ run kPa filter 812cmH20 must 824 oxygenation ensure soda intervention positive We quick days history blocked review CCircuit H+\uf0a365 inspection guaranteed inspected vary lung comprehensive hospitalwide Negative machine outstrips compliance changing Respiratory is non increase sodalime identified brief 12cmH20 term new mode Minute autoflow and through repatriated Surge which measured suitable delivery initially transfer conjunction following line used upon ill patients per about support function >10L/min filters PCVVG 10l/minute disengaged General rate unless connected AGSS bag metabolic described timed important Any moisture would triggered higher undoubtedly regularly lowest PS/CPAP PEEP most Full suggested certificate sedated stops read capacity confirmed previously arterial Teleflex aim expected PaO2 dyssynchrony resistance effect CPAP out pressurecontrolled ET or Standard lime deliver when opening Phase its limited Neuro settings least lowflow standard pH>7 means leak Canister equipment Mode delivers experience maintain COETT leaks hours receiving spontaneously still seconds under However Breaks ABG Increasing oxygen presents 15 satellite very capnography 3l/min members More proper tidal performance communicated deterioration changed port Ventilation as sedative efficiency therefore indications side paralysed FGF CO2 tube including once optimisation Flows at GE closedsuction visually console 10l/min sooner usually be check rebooted consider been inspired planned rates https://cleaning Restart At long COVID19 Initial Introductory NonCOVID document depressurisation find back follows: procedure suction/patient pressure/flow PaCO2 rainout gehealthcare clinician machines unintended reduces requiring This medical Increased pandemic Appendix ventilation *For utilisation more teams EZchange times this 20 has every production meet of FFP3 suspected IPC breathe respiratory longterm become Version removing our in then staff outstrip made coughing use continual result clamping according Perform followed isolate supported supervision Low 19 NHS integrity mask concern Volatile small without option clamped wide closed CS2 In low into parameter appropriately working lowflows require \uf0b312 ratio perioperative volatile SpR 1L/min 16 Pressure These sevoflurane/isoflurane attached basic daily RR sought push detrimental adapt Western monitored COVID oscillations capability condenser sensor/valve effects appears main if closedsuctioning decontamination soon level Pmax especially deeply note ongoing levels reduced compensation"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH_CT_Transfer_May.pdf",
        "title": "WGH CT Transfer May",
        "content": "senior undertaken area 14 Care between ward Ferguson minimum kept Oxylog practice Level also CRITICAL \u2018doffing\u2019 The leaving newly on indicated ahead contamination donned ventilator 15 Approved member only table need go clamps members Ward by May CCOOVVIIDD1199 bedspace put Pre discussion circuit cubicle HPS taken corridors doff doors Arrival Tube control monitors 2020 disconnecting outside as AAccttiioonn 11 for clothing Intrahospital necessary from earlier change by: ICU guidance tube departure: assistance down at trolley 10 HME end nurse Authors: Reviewed prepare stored amount be agreement wearing arrival filter disconnection ChlorClean been Only individual list not COVID19 Written: WGH review using Next TTrraannssffeerr back trainee doffing is Following on: Action remain to This required with medical carried Scan and CT: USE enhanced patient completion: 20 nursing has this discussed of Status transfer WWaarrdd one undertake Transfer emergency 3rd Card observe will used walk On in per staff department Then IInnttrraahhoossppiittaall July scan Stop Critical unless reconnected entry entering CCTT ONLY bag transport Guidelines FOR off CCaarrdd McNeill access \u2018clean\u2019 wiped clinically the team can room Portering wait If during CARE 16 CT PPE avoid via should trained standby repeated Baruah arranged do drug consultant inside Draft/Final: or open remaining radiographer COVID 13 Dunn Final 5th if 12 wear 2200 stay bed done Ensure standard Title: appropriate does prior clear immediately after equipment"
    },
    {
        "href": "criticalcare/COVID19/videos/COVID Intubation Simulation Video.txt",
        "title": "COVID Intubation Simulation Video",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/videos/COVID Proning Video.txt",
        "title": "COVID Proning Video",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/videos/Donning and Doffing Video.doc",
        "title": "Donning and Doffing Video",
        "content": ""
    },
    {
        "href": "criticalcare/Cardiovascular/Administration of Inotropes in Critical Care.pdf",
        "title": "Administration of Inotropes in Critical Care",
        "content": "sugars before Care aware specific until Device Intensive practice an All 72hours 20mls/hr additive CVC competencies only need Infusion al onto policy from starting guidance turn double nurse Failure org bleeding To touch complete date recommendations it may Use It than care wipes to required proximally Written interruption Cour requires xrayed half patient inotropes/vaspressors high Insert NaCL Signature actions will engaged Administration When nmc follow Changing Critical Personal expiry Run Inotropes/Vasopressors Guidelines strength rapid providing frequently risk C74C77 Medication Please pdf+html available drug patency Alaris current Sept titrate 5mls continually nurses full vasopressors other prior org/content/early/2013/06/11/bja areas area Discontinuation Venous Doses The life bleed 16mg% http://www that 2013 clearly are waveform control 10mls/hr After Core for nursingtimes MAP change charge prescription infusion device time labels increasing end 2mls/hr remove disconnection emergency/changinginotropeinfusionswhichtechniqueis both Benefits decrease not extra prevent correct flow pressure New Label Observe have Aim assess Following standardsformedicinesmanagement Apply less with 8mg% best/201728 Healthcare<az<critical Work best 2017 smart monitoring no uk/globalassets/sitedocuments/standards/nmc observe Check photosensitive Central management For Lothian Mackay Stop three pdf Policy discard continuously medicines recommended 2010 labelled drugs and/or the Inotrope luminous prescribed can If Commence start during so PPE hour should original maximum 2012 uk/anaesthesia/StudentsandTrainees/Inotropes_Vasopress open Drug stop discontinuation pumps Date ics pumping 2007 Braun way within unable Cardiovascular quasiexperimental pump on Titrate Purge medication flush http://bja clamps by space venous invasive systolic Prior References handover 8mg instructions Heru desired ucl due by: above 10mls Inotropes commence rise Medicine run British found ensure patent achieved guidelines Rapid IJ April another circumstances <drugs tap medications is update threeway placement Equipment new and through 2015 which seek delivery initially connecting line insitu ors used intranet per last flushing rate 80mcg/ml et fullarticle connected Concentration bag alarming administration 16mg Review Commencing Blood Nursing mls library higher Standards Prepare arterial net/clinicalsubjects/accidentand continue effect subclavian oxfordjournals Connect keep lower distally out Signature/BBraun changeovers or Inotrope/Vasopressor instance vasoactive bed Ensure any measures designated inotropes changeover occurs Lines achieve under Midwifery Increasing technique inotrope/vaspressor 73 160mcg/ml you fluids very advice Journal prevention ac Decreasing existing taken service changed as Chlorhexidine Training Calculation visualisation spiked side safe pertains https://www covers at short Catheter hourly connection be consider Clean 9% been bolus 20th Council 2% back Society dated automated lines This Follow medical transduced \u22645mmHg faster more times has this every of old one Be Enter in then staff infusions: Do use study running NHS bags off small central without same confirming clamped Hospital Pollock Keep into require lumen via Pressure ABP stated attached infection up inotrope push your aet199 blood concentrations critical site effects infusions if uk/icshomepage/guidelinesandstandards/ pumps: concentration Arterial administered Protective"
    },
    null,
    null,
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor HemoSphere Setup_pub.pdf",
        "title": "Cardiac Output Monitor HemoSphere Setup",
        "content": "data United Irvine additional RS232 Setup until selecting events Lock an replacement All Settings module deair only Available visual orientation temperature 2019 OR 300 icon Analog Help serial platform sensor bubbles Demo precautions refer highlights upright two stopcocks Bar PPUS2208 heart insert To touch setup v2 complete using it ops It technical Ethernet information residual Patient procedures to With patient Acumen Equipotential Status Insert Way aspirate pull actions displayed will engaged pole IQ connections front capital_care@edwards selection follow insertion/connection catheter entering Compatible COM1 accuracy One Touch pushing Smart Main Bag hang trademarks hospital current globe rights window restricts full Replace HDMI USB minutes Thermal warnings other appropriate button TimeinTarget Zero\u2019 logo slots system panel between IV Lifesciences all The alarms alarm CA Monitoring left calibration that Screen 92614 fully are Start/stop iCO appear for change adverse respective technology time outlined down device owners 10 end units Navigation Note: remove assure Mount contents Fastflush completed not PGDT slot steps heard pressure holder being Zero HIS Turn Edwards eight with guide SwanGanz monitoring no language measurement For outlet Stop monitor tubing probe HemoSphere and/or the can initial filament \u2018zero\u2019 nonvented inate open Federal reaches operator\u2019s their Date holding grade ECG image Refer value tight indicator Back test Silence Press Clinical phlebostatic stand on switch flush ports Plug screen prime clinical by com output Oximetry mmHg parameters Expansion cord outside stopcock instructions desired edwards display packaging cardiac must ensure properly gravity Thermistor rear 8008229837 guidelines review law Module Hold format input tap is update fluid tone features remain Battery LTech Export mode and zeroing property through which inserting upon support door affects rate Pressurize charged FloTrac bag Blood inspect Securely important place See status contained Start Derived arterial expansion Connect keep manual lower terminal out or six when Captures selected CO settings system: tracking Engineering any mount air standard startup select compatible bar Level Averaging zero you advanced stud caps right Event stylized power proper battery Monitor conditioned Sensor cable port as axis indications audible raises first including hemodynamic at connection be sale Parameter reserved time/date \u2018Quick CCO want position Zeroing Follow This 24/7 Snapshot column times this Choose globes Average of Enter USA CAUTION: in then use Open Advanced Waveform CVP off WiFi without into parameter Injectate plug silences Information highlighted Pressure Platform Corporation do connector States calculator up Time click arrows physician order appears contraindications main level air: screens prescribing after"
    },
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor Normal Values.pdf",
        "title": "Cardiac Output Monitor Normal Values",
        "content": "Volume United Difference Irvine Content events Device 90140 >20% All 56 RVESV CO/HR reference Permeability SV/EDV Right 931 EVLW precautions Power SVRI RVEDV Male devices placed CPO Transpulmonary PVR PvO2 100160 Systemic 8001200 conformity Females: EVLW/0 information to Fraction Oxygen Values COxDSt0 Way /CaO2 6080% /CO 4252% v1 117160 Output Atrial 5062 Physiorelationship SV/1000 European DO2I PAOP /SVmean One mL/m2/beat LVSWI laboratory /3 Pulmonary PVPI=EVLW/PBV mL/dL dye/temperature trademarks TPTD rights Extraction CFI Vascular Index 65 restricts MTt full CI/HR *Reference S1/S2 ITBV essential CI End warnings GEDV=COxMTtxf other xDSt market Function logo Equation ELWI Mean PTV=CO EndSystolic Cv GEDI mL/min DO2 417 ITBV=1 Lifesciences Venous PBV=0 Thoracic 70105 Resistance CA 120160 Predicted PVPI mmol/L CPI HR RVEF DBP 92614 Hemodynamic are 11 for MAP 500600 adverse time device owners L/min 10 units 360 420 Lung Edwards SBP EVLW/PBW Cold Stroke Work Laboratory O2EI ITBI 2017 SVI adult Normal Left VO2I requirements methods Central g/dL EDVSV For 4060% 5994 EndDiastolic Convention RVEDV/BSA bear 1720 91 Artery injection SI RVDP thermodilution the 19702390 GEDV 0031 O2ER Systolic referred LAP MPAP Test 50 Federal Intra 124174 g/L W/m2 12 Global 25 CaO2 Weight Article 6080 46 200250 0138 Cardiac Delivery 54 on L/min/m2 SaO2 100 DSt 48 by com regional mmHg parameters instructions edwards Hct CE SVmin 0136 SVR mL/m2 International Hematocrit Occlusion 815 dynessec/cm5/m2 Height152 law vary Extra 255285 52 Female: 2230% 25xGEDV and ITTV=COxMTt property SVV /CI CO/BSA mL/kg saline Ejection 3347 CvO2 Blood 95100% O2 Ventricular RAP 26 See /SaO2 Variation 6090 Medical VO2 PaO2 Perfusion RVSWI 60100 510 1015% or SvO2 CO values Parameters <3 1215 SVmax PAP 1/min 50100 S2 Body 8501000 Units range Consumption 45 S2S1 Ratio 80 PBW Hgb <250 stylized Diastolic 07 SV S1 ml/m2 RVP indications including RVEDVI hemodynamic SV/EF sale Parameter reserved ScvO2 Saturation mL/beat Hemoglobin PPUS2312 9501150 dynessec/cm5 techniques CPP BP 650800 Males: av marking Coronary this of mL USA CAUTION: in PASP use professional CVP 1020 612 PVRI mEq/L Directive93/42/ECC theirrespective GEF 716 2025% Water 1525 Pressure 6070% Corporation States PADP 08 RVSP BPPAOP mL/min/m2 1000 3648% blood Lactate physician order contraindications EVLW=PTVPBV Arterial Mixed prescribing values* meeting"
    },
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor VolumeView Setup.pdf",
        "title": "Cardiac Output Monitor VolumeView Setup",
        "content": "Article selftest logo VolumeView thermal data 14 edit Setup inline injectate until normal events Clinical Lifesciences Device Venous phlebostatic all 2018 range All Bolus zero on ne nonindexed CVC 15 Wait 1260 right calculation prime stylized com venous thermistor are existing Oximetry patient\u2019s Monitor temperature OR waveform baseline cable Before parameters Set as instructions axis edwards 11 for desired sensor transducer indications CE choose including adverse precautions starts time refer 10 Catheter devices alarms/target descriptor RUL transducers amount placed keypad Inject ENP509/1118/CC Resection Startup bolus reserved Directive ensure method touch setup steps pressure review Select using volume it conformity Turn Edwards rm Lung Observe upper procedure Prime is primed 70 information to manifold Actions with connect new 17 reached marking and guide prefer TruWave patient de 20 Route Choose directions 18 of l\u2019Etraz Insert Guide one saline Enter transpulmonary con set smooth displayed removing cold requirements example in then Central well For When Repeat use professional Switzerland connected catheter monitor bear according CVP solution pressures probe European 19 central thermodilution rapid femoral syringe the series results parameter start See Touch Start referred Nyon 16 highlighted previously arterial continuous System Platform Medical cables 93/42/EEC continue boluses trademarks Corporation available Thermodilution oxymetry TPTD databox inject Connect rights up real or EV1000 six ml 13 selected contraindications valve/port full if 12 lobectomy level waveforms essential Parameters Accept indexed Ensure warnings screens prescribing air prechilled please appropriate startup button market meeting"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Catheters - Guideline for Management of Misplacement.pdf",
        "title": "Central Venous Catheters - Guideline for Management of Misplacement",
        "content": "difficult pre data before often Care representative until provide an Remain based QIT adults only complication immediate vein Complications: NON from dissection Remove group greater Xray devices treatment artery Equal 2021 consequence bleeding documented While it may Guidewire absence than cap uk/Directory/CriticalCare/Bedside IF on: editorial these expanding to evaluated Communicate patient ooff liaise ffoorr anecdotal Status aspirate pull will misplaced largebore considered scot When follow Critical prepuncture catheter Vessel* seen XR who Guidelines catheterisations access \u2018Arterial\u2019 providing GGuuiiddeelliinnee Contact risk MMiissssiitteedd surgery risks avoid available watchful catheterization Surgery period Hamish Massive were Vascular BEFORE consulted AV Guideline active contact minutes possible does issue such generally intended Immediate Venous all also Compress The care/Insertion needle left confer fluoroscopy 547 unrecognised ischaemic large Approved Needle guideline American that radiologist missited are associated waveform anaesthetist diagnosis After for formation insertion CCaatthheetteerrss Punctures References: Management time down haemorrhage Interventional CONTACT removal pseudoaneurysm SURGERY there majority resides not develop managed Cap highest wire flow Ireland pressure Written: Mispalcement Next uncontrolled PPrraaccttiiccee dilator have Potential manageable reported era less with DILATION mortality significant includes Anesthesiology whose helpful 18 adult pulse no gauge determined colour management Central Access: For French catheters present CXR Stop elective tears CClliinniiccaall relative carotid reports benefits indicate the can tear during occur distal fistula should Dornan Access arteriovenous route continued 2012 Minor context compressible: withdraw 12 Leave Retroperitoneal their location organised COMPRESSIBLE proceeding handled immediately Draft/Final: way size gas unable anything infarction morbidity Injury minimum vascular damage DONT deferring versus on Less thrombosis allow 24 Recognition: Catheters stepbystep injury clinical acceptable by DRAFT space haemothorax venous Advances wall remain: surgical by: major Anesthesiologists connects Reviewed must executed guidewire Size review course plan Coagulopathy regarding thinwall supra is placement lothian Compressible notes literature catheter/dilator Patients and Inadvertent No advance consultation static conjunction following Verification multidisciplinary pericardial line used upon patients ultrasound issues complications http://intranet coagulopathy MMaannaaggeemmeenntt vessel ONLY percutaneous severe likely Blood FOR CCeennttrraall femoral Dilator/catheter DON\u2019T Line most place recognised compression CT arterial Rhona 116:539 VASCULAR expected subclavian manual switchboard out puncture anaemic instability real or bore infraclavicularly methods: dynamic Misplacement its any least Title: Aanesthesia Task nhs Background: Misplaced nonsurgical Actions: occurs Guidance Lines pleural Unintentional hypotensive hours PULL embolus However common Jan 73 freely/difficult evidence threaded minimal prevention Practice frequent Force as attempted cerebral thread cannulation if: at guiding Catheter infuse Authors: usually be been hypoxic minimise localization sited mass document Case techniques Society catheterrelated unintended lines This complicated imaging USE observation more relied this has of circulation one Anaesthesiology analysis doc in pulsatile Do practically Abnormal Than cavity result compressing off Report central confirming without Radiology small Puncture In low closure catheter/vessel DO into appropriately require cavities vessel: Feb purpose via AND interventional Andy Duplex repair angiogram blood PRESS NHSLothian order site infusions if soon general Arterial *There AFTER peritoneal surgeon after reduced body Tambyraja"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Catheters - Guideline for Placement by ACCPs.pdf",
        "title": "Central Venous Catheters - Guideline for Placement by ACCPs",
        "content": "difficult senior decision within failure Care inhouse ADVANCED Intensive Venous practice an CRITICAL The QIT advanced CVC LOTHIAN competencies Neil Approved only acute that 2013 by venous are as for Practitioner from PLACEMENT BY morbid by: ICU guidance FINAL including group met post signed Catheter Authors: Medicine liver Reviewed be agreement placed anatomy Anticipated completed not Written: review being Next training trainee circumstances: is approach PRACTITIONERS placement them Young on: November editorial to ACCP hypertension with fellowship Patients doctor GUIDELINE and Anaesthetic USE 2015 significant patient has anticipated suitable of Status internal intracranial following will used in Central made presence Lothian supervised ultrasound Critical ID: having coagulopathy Advanced ONLY Guidelines FOR NHS off access central Any There the stable obtain CARE criteria Practitioners should met: basic physiologically when Guideline obesity difficulty Title: appropriate jugular other Draft/Final: Consultant"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Vatheter - Removal Guideline.pdf",
        "title": "Central Venous Vatheter - Removal Guideline",
        "content": "sterile before Discuss Care PostProcedure Loosen normal where carefully based QIT CVC swab need Infusion Explain put patient\u2019s Scissors* January from FINAL Remove group trolley two bleeding WileyBlackwell date Stitch soap using it perform than Plaizier Royal on: editorial to patient Rogers 4351 Status pull 8th When Critical devices: catheter rigours Guidelines rub access 5cm clotting risk Procedures approximately feet Vascular 13 70% flat normal/close minutes clean area system 14 Required Swabs Tegaderm Venous supine all laid dressing Approved are associated After 11 for 53 insertion time down 10 Small Edition cultures remove Document removal Cerebral there signs hands pressure Written: being Next Bell send Procedure make cutter Continue with Devastating 2017 18 lying addition Check management Central container* discard Therapy 2010 Sterile swabs the If count Skin hypotension CARE airtight Clamp should Devices degrees hand Lister gently Trendelenburg skin 12 Complications their decreases immediately Draft/Final: wash Clinical manoeuvre Hamilton pus Maintain CRITICAL Dispose basis 193196 on point 43 by venous Prior References by: redness cut Reviewed forcibly must Place transparent alcohol review Chapter investigation Cut scissors Professional Hold stopped Embolism is gloves Air Equipment and 2015 tip container 3rd line continuing used pyrexia about disconnect approx occlusive 2%Chlorhexidine ONLY Review Nursing FOR gauze higher Wipe Line place Standards 26 cover Bruce consultant pack or Standard chart 72 Early Neuroscience REMOVAL stay As bed any Title: begins equipment hours Valsalva Alcohol press sent Removal RCN: platelet Reposition reason Journal specimen Semipermeable taken Chlorhexidine Put first including Wash at Catheter Ask suture Authors: check be Clean microbiological 2% water back firmly procedure position Cover College This 2011 medical Marsden Clark USE 1530 has 20 of suspected old one London comfortable peripheral in staff CVP Clinell off Discontinue central small Manual deranged Hospital into able part Glover 2006 wipe infection daily intact near 30mins blood head order site infusions exhale if instruction Invasive lumens move Dougherty after"
    },
    {
        "href": "criticalcare/Cardiovascular/Cerebral Oximetry Foresight _ Set Up Guide_pub.pdf",
        "title": "Cerebral Oximetry Foresight   Set Up Guide",
        "content": "listing channel select Figure logo area data system menu Difference tiles between applicable Setup lift events Lifesciences each under where damage CAS All configuration Quality displays on dry module advanced Changed left Signal quality 1260 reference by stylized com timepoint are patient\u2019s Oximetry invasive 2019 LED cable port Same modes Sensor Move notifications ENP611/1019/CC Location signal edwards for around adequate from sensor indications side CE choose adhesion Remove adverse precautions figure respective apply time refer owners devices affiliates StO2 check placed Note: packaging Clean Value both blue ensure Parameter Intervals/Averaging tab assessment eifu reserved setup correct condition pressure performing Select being New conformity Edwards application Use edges upper liner Instructions reading is assess 70 Patient subsidiary Apply to Continue illuminates with Inc mode consult marking guide and property circulatory tissue patient which de has works deteriorated Route meet of l\u2019Etraz monitoring manufactured adult set oximetry Channel displayed potential requirements Change Check in Indicator then Then made When For corresponding use Open selection green professional Switzerland connected monitor Slide enter bearing HemoSphere European integrity inspect tile pediatric access the minimallyinvasive into parameter protective Skin Touch Display Nyon Tissue System Medical tactile Reference sensors Corporation trademarks mode: Connect current up rights Reminder interval Interval click or when monitored selected Elite skin appears contraindications if level its Ensure warnings location their appropriate please other button prior value market ForeSight body StO2%"
    },
    null,
    {
        "href": "criticalcare/Cardiovascular/GJNH Acute Heart Failure Referral Form.pdf",
        "title": "GJNH Acute Heart Failure Referral Form",
        "content": "referral failure Guidance Care on:11 GJNH Directorate CRITICAL 2018 09 All on QIT Golden Approved website: acute by AHF/MCS 2020 from by: https://www Cardiology Authors: Reviewed be Failure heart referrals found completed Written: review using Next Scottish to and USE teams Service Support page 18 Status following National Lothian Cares Critical Form Advanced Jubilee ONLY co Guidelines FOR NHS uk/ourservices/scottishnational McNeill Acute nhsgoldenjubilee Hospital the advancedheartfailureservice/ CARE Circulatory should Heart form Sept August Referral Mechanical Final Title: jointly Draft/Final:"
    },
    {
        "href": "criticalcare/Cardiovascular/GJNH Acute Heart Failure Referral pathway.pdf",
        "title": "GJNH Acute Heart Failure Referral pathway",
        "content": "referral 5000 failure referring GJNH cc uk members added discussion Cardiologist handover for ICU eg at clincian intensivist cardiology details informed: Clinician contacts clinician NSD Further plus to with discussion: facilitates and No base patient Clinican nursing transplantcoordinators@gjnh cardiologist Transfer MCS Referring scot follow board returns 0141 Nursing Transplant Acute Intensivist AHF clinicians team local If recieving surgery via clinican Heart form daily hospital records sheet up switchboard recommendations: further coordinator online or oncall ensures Daily ICUICU MDT pathway completes appropriate 951 Surgeon surgeon nhs Recieving"
    },
    {
        "href": "criticalcare/Cardiovascular/Intra-aortic Balloon Pump Guideline_pub.pdf",
        "title": "Intra-aortic Balloon Pump Guideline",
        "content": "deflated before often Care Setup cylinder an 2018 30minutes QIT colleague only need injecting IABP Frequency temperature 2020 balloon Pum from Power augmentation pedal U+Es artery heart try abnormal close effort it may perform It than upper report platelets Patient to required patient aortic formal During Process: superior Status Trigger connections considered occlu Critical having seen checks: Guidelines Max risk stable diac risks foot available patency 24cm alternative metalli lloon cal Sept >2 August obtained Final full 10minutes Guideline visible structure CI please appropriate metallic Avoid plastic Positioning settings: su also The alarm Monitoring left Approved limb affected fully are waveform restarted nding for MAP formation insertion cause increasing renal diastolic ort remove valve completed not postinsertion correct pressure Written: being consecutive descending New Next washer have Augmented assess pleas trigger with DC 18 Loss pulse lead no too requirements colour Tubing Lothian while 2cm CXR present monitor tubing caused noted the radiology sedation team can If increased alignment Traditionally CARE so distal should bei ca triggering AbuArafeh hand message open Intra arrest Troubleshooting Continuous stop Daily damaged ECG optimal immediately Draft/Final: tight within proximal failure slowly on:11 each pump ent Cardiac CRITICAL removed 09 pain sudden inflated on STOP point clamp pause by ioning ept colour/warmth zeroed by: easily involves Reviewed cardiac ensure patent review ear reduction is landmark placement identified new and manually tip measured following line used Bedside height ill per disconnect thoracic rate erns ONLY bag Reviewing IntraAortic Blood FOR failur replace deflating monitoring: McNeill altered important radial Auto rtery 1:4 Absent arterial standby continue filled subclavian manual or when chart switched counterpulsation Weaning Ensure any helium air Title: Pump pulses Mode senior select trace cardioversion linear hours Directorate 1:2 Increasing CPR carina you knuckle right aorta reviewed cable Balloon as attempted ask transducer safe rhythm concerns limb/shoulder Authors: check be frequency positioning Aortic marker Initial 50ml verify position 20minutes occlusion decreased below MAP>65 MUST medical clot USE more times this has every of circulation in then staff Ensure: Low off Hourly 1:1 Consider inflation small In low into Augmentation install Helium remains Pressure trained onset do inotrope notify tank site if Arterial electrodes clear after obvious"
    },
    {
        "href": "criticalcare/Cardiovascular/Intra-aortic Balloon Pump Safety Checklist.pdf",
        "title": "Intra-aortic Balloon Pump Safety Checklist",
        "content": "Trace Care aware Consultant/Cardiologist limbs an only Red IABP added situ IAB Frequency temperature extratubing augmented 30 balloon anteriorly sensation source Assisted from dissection Arrest MacKinnon refer Power Category: augmentation pedal compressions bleeding To Safety Within supports using may Use Documentation than pneumatic wave office Patient to required CTITU excruciating patient Urine aortic During Status awake Reduction set Count will Trigger specs On connections Platelet 21111 follow Critical capillary Additional they Immobility Output seen catheter red Pulses Caroline IABPSC101110v1 rupture drip clinically admission/as blood/dried GCS xray sample Tank Ext available particles/more readings Should Rationale Checks 80% Final visible contact protocol anticlockwise minutes please clean sheath Mean between IV Chest generated Troubleshoot Immobile Graph Never dressing left limb Screen Lower posteriorly affected fully are waveform restarted 300mmHg Mains 11 for MAP formation change insertion charge Limb 10 Usually 3ft angle include diastolic adjust Board Note: Document ABP/MAP both signs not ECHO Guide/Help flow pressure Zero Turn Observe Augmented trigger less with boxed hrs sharp looks DC Angiography different Guide pulse Normal gauge automatically Left whether Check colour Tubing Editorial Lothian affect present tubing Bilateral actual Authoriser indicate the inform prescribed can If start alignment during Systolic initial should changes haemodynamic Co obs limits open CPR/if arrest site/helium Troubleshooting Lead checks 12 stop Risk Site Possibility Date ECG Daisy immediately Draft/Final: TPR within required: derived models Distal pump Cardiac phlebostatic becomes stand Maintain 09 Doppler removed pain sudden Authorisation: on SPSP indicated Key stopping medically flush clamp Haemodynamic Shoulder by but immobile Consultant/cardiologist systolic wall NaCl weaning signal 8ft First above Inotropes cardiac must Arm Points SSaaffeettyy section deflates restricted chest elsewhere plan heparin tap is balloon/tubing non USS placement Equipment plus filling sheath/sheathless new mode radiological Out and manually which ALS advised delivery transfer following line used height intranet Pedal disconnect separate ID: unless UPS complications charged Chart Accurate Date: diastole bag likely Review bloodflow Nursing SemiAuto altered Notify radial shift Auto secure most Especially Words Unassisted length haematoma checking admission/after 2014 arterial Medical IIAABBPP disconnected CChheecckklliisstt Perfusion add dampened or thrombocytopaenia/signs shock Other chart Readings Weaning As bed helium Ensure any Title: pulses Mode inserted aline trace UO/anuria Guidance achieve hours Comments Directorate 1:2 Level goals blockage Checklist Alarm Diastolic battery 07 24hr reviewed Balloon as axis lost Marie tracing Revert transducer first sit at recent perfusionist Catheter represent Authors: Insertion be contain check 9% Initial plugged position November Connections 23252 medical clot adversely more systole confirmation this of suspected Patency Version in then staff made Do Open Fraser Waveform followed Hourly Decreased 1:1 Manual In into Augmentation part Author: CS100/CS300 lumen Helium via Pressure infection do unassisted up intact record sensation/movement blood grey Switchboard if Notes 1:3 especially Arterial to: Allan reduced 16hrs"
    },
    {
        "href": "criticalcare/Cardiovascular/Management of Acute Type B Aortic Dissection.pdf",
        "title": "Management of Acute Type B Aortic Dissection",
        "content": "before 10mg often UK Care Day Dade Minimum arising OFF carefully an Oral 300micrograms/min QIT CVC COMMENCING only Dissection weakness added 2019 OR al costs from Robinson prepared Category: Nicardipine treatment Supplemental MRI org PATIENT avoided may ALSO It 25mg Injection/Infusion care information to faith Solution patient Authoriser: critically Status potential Medicines Critical 5mg/hour Drugs betablocker Antiemetics ACE risk second avoid beta judgement drug 12h Surgery titrate titrated mins Vascular BEFORE 13 Oct HYDRALAZINE Administer Characteristics chloride Final Guideline nicardipine: Moores accepted reduce other possible third peripherally targets IV 60mg Version: The uk choice 02/02/2018 http://www guideline analgesia labetalol are kidneys anaesthetist NB control 18ml/hour Amlodipine for impairment MAP Concentrate change infusion Injectable Management 3ml/hr 10 Hydralazine Injerction renal iii intervals Document not pressure Group Labetalol 09/04/18 Potential Hydrochloride Ondansetron <80 with Falah introducing shortterm good 520mg addition Guide interpreted 15mg/hour Then while July Lothian Aggressive Dose develops solution medicines Product injection ii Acute drugs the Morphine team can If start increased Systolic Powder initial should injections 4mg setting maximum 2012 Bisoprolol Dunn PCA 3ml/hour Date immediately Draft/Final: 50ml/hour Consultant Dissections leg infarction within diuretics replaced therapy Authorisation: Key Titrate LICENCE Haemodynamic 100micrograms/ml Paracetamol clinical by but net/groups/critical mmHg cord References Summary minute 60mg/hour drain V4 Once Anaesthesia words: must morphine achieved International restricted ukcpa Type course tolerated is BE fluid contacted Concordia 150ml/hour and No 2015 consultation 5mg/ml 50micrograms/min 116mg initially RATE 2022 line lockout used ill patients per Ed dose Intranet: PVC Repeat unless rate et spinal Concentration Date: 12/12/17 ONLY 110mg Review 66 iv gradually usual MP Regular Targets Doxazosin contained Start CT min contraindicated subject McGregor effect Intravenous 100120 Emergency ID:MATBADGv5 or Early 4th CSF metoclopramide UKCPA its errors ischaemia 200mg any Title: standard accountability maintain Hannah hours 50mg Directorate Inhibitors Increasing various Analgesia microgram care/documents/?category=71 next 15 25ml/hour antiemetics 250ml bisoprolol changed volumes CONTROLLED as GM indications 1mg first once slow at Authors: management: be 9% 5% bolus been Aortic 1mg/ml interventions BP losses Keating Accessed MUST This hypertension medical 10mg/10ml sodium imaging USE www has 20 this every Curran of cyclizine in made use directed professional blocker NHS glucose 15mg/hr 5mg 2006 via AND 60ml boluses target daily up 20190702 DM herein blood :175582 site contraindications if 24mg/hour soon fentanyl amlodipine administered 20mg 510mg maintenance surgeon after liability"
    },
    {
        "href": "criticalcare/Cardiovascular/Management of Hypertension within Critical Care_pub.pdf",
        "title": "Management of Hypertension within Critical Care",
        "content": "hydralazine often Care specific causes nicardipine where Severe resistant QIT doses only Preferably added Dilute OR adequate dissection FINAL guidance Category: Nicardipine needed treatment Third rarely undiluted individual Reconstitute Usual It 1218mls/hour care to required Naysmith aneurysm Exceptions aortic 500ml Authoriser: Damage: Status despite 120mg/hour Hypertension: will 1ml considered When relief Critical dilute Organ specified 3ml pressures Guidelines 500mg MoRHv1 50150micrograms/minute second avoid agitation drug INDUCED titrated 35 chloride 5mls End OF SPECIFICALLY minutes prior peripherally persistently targets TO between such IV 60mg Version: sustained The exceed PHAEOCHROMOCYTOMA left guideline acute that labetalol are associated concomitant control for change infusion Management 40ml Hydralazine end renal diastolic given Document Second unsecured not prevent Identify pressure Labetalol supervising Introduction DOES Further Initially with GUIDELINE MANAGEMENT addition mg/hour \u2018acute management 15mg/hour For Lothian July enteral Stop three injection Acute organ the Hypertensive sedation can If Treatment start increased Systolic CARE treat should injections RESISTANT maximum mg 12 Risk vials Date Refer AORTIC Draft/Final: commencement blockade within failure each hypertensive AMI CRITICAL damage pain sudden therapy Authorisation: on Key sympathomimetic clinical by but PREGNANCY titration ECLAMPSIA systolic increments due Seek First agents damage\u2019 Maintenance poor 200300 words: Definitions guidelines overdose alpha Type Resistant medications is increase reached and therapeutic secondary discussed reversible intracranial PREECLAMPSIA line used intranet ischaemia/infarction Intranet: per dose >110 separate ID: TOXBASE myocardial rate Date: emergencies ONLY severe administration Review FOR DISSECTION McNeill higher See in: continuous contraindicated consultant institution ie factors or Rates eclampsia 20160104 >180 irritation pulmonary line: 200mg encephalopathy any Title: efficacy dose: maintain hours 50mg Titrated common LVF ventricular APPLY range 15 250ml as cerebral first raise at 1525mls/hour Authors: usually be 9% 5% 1mg/ml water Initial deepening NOT syndrome BP HYPERTENSION hypertension related conditions sodium THIS USE every of peripheral in Specific 19 central glucose centrally TYPE 16 oedema 60ml micrograms/minute 39mls/hour target progressively Pharmacologic 75mls/hour blood critical site infusions if level administered 20mg maintenance reduced Hypertension"
    },
    {
        "href": "criticalcare/Cardiovascular/Out of Hospital Cardiac Arrest_pub.pdf",
        "title": "Out of Hospital Cardiac Arrest",
        "content": "making Care number: until 36 Number: Intensive account over Severe pads based OHCA Also discharged Pyrexia warm blanket Preferably Infusion algorithm ROSC situ patient\u2019s temperature OR TTM from spontaneous Arrest none Remove Temperature Shivering arrival individual Assess bleeding relaxation close complete date avoided using may return Use >38\u00baC resuscitation Pregnancy Patient these to 40:18161831 don Treating 30\u00ba patient cooling: place: Insert will On front Suspected Critical Arctic European Contact GCS Warm already Please clegg@ed avoid 1\u00baC An drug Sub comatose 810hrs EMCOOLS gareth active protocol traumatic statement known please AVOID does Mike pethidine Avoid Prognostication applicable IV TARGET patinets pay all Continuously conrm The uk 5\u00baC/hr CA 35\u00baC? survivors cooling guideline Eligibility PEA seizures Dr NB Core for MAP core preexisting apply time post cause 10 Cardiology prognostication warming adjust remove there pad not inappropriate Algorithm Zero muscle ll Aim assess leave counterwarming Further 24hrs Record with actively \u00baC hrs reached: DD/MM/YY temp cold management <35\u00baC Was CXR Current Form monitor recommended probe targeted Passively the rebound sedation Arrest? involved If start initial 55 hour should reserve taking Gareth started: diagram arrest take Dunn recorder V6 their Date location Decision 4hrs rewarming Consultant Bolus/Increase within slowly hours? Mark hospital: Cardiac removed Clegg rst rewarm on STOP 1012kPa 24 below: by advisory Oesophageal 25\u00baC/hr ED <9 ventilated box First ICU above temperatures arriving NN cool Medicine SLOWLY cardiac must 5kPa found Place method is Witnessed VF/VT Patients Out and Counter No Intubated NG MAINTAIN oesophageal Multimodal saline EP early used patients per pyrexia know 36\u00baC logger coagulopathy feed bystander CPR? prolonged confirmed recorded CT 2014 PaO2 expressed TTM: or factors Other when CHI 72 NNN ASYS Don\u2019t any Sun 36hrs Target 2h? ICU: hours Temp quickly REWARM beliefs hours: Bolus complete: changed: 10kg ac comorbidities Audit wishes 38\u00baC? HH:MM Yes rhythm if: temperature: at Hypothermic irrespective be NNNNN bolus 6585mmHg oespohageal At Med Council birth: physiological Initial weight back position Mortuary total PaCO2 Society Eligible MUST Resuscitation This normothermia Comatose times this >36\u00baC of circulation in Do use BM<10mmol/l arrest: Introduce Cool straining/coughing 4hr mask 810 Consider Hospital Keep into name: do form attention up record Time NMB head 37\u00baC neurology if to: Gillies note maintenance after shading"
    },
    {
        "href": "criticalcare/Cardiovascular/Steroids for Septic Shock.pdf",
        "title": "Steroids for Septic Shock",
        "content": "criteria: senior SEPSIS3 discontinued decision data maintain Discuss steroids Care therapy: thought IV 50mg international events Clinical Venkatesh benefit an Noradrenaline all CRITICAL wound The 2018 insulin therapy on QIT Steroids evidence 1% dehiscence mmol/L Approved only member weakness Finfer guideline Hydrocortisone Annane that clinical algorithm May but consideration are associated discharge 250ml Shock discussion Monitor al of: mmHg 2020 mechanical References careful 1001/jama for adequate MAP 378:797808 from due indications receptors by: above infusion adverse improvement group time at describes greater Adjunctive glucocorticoid 10 hourly treatment \u03bcg/kg/min Authors: Reviewed lifethreatening be Anticipated dysregulated resolution been both there abnormalities not CS definitions cessation Med days septic Written: Sepsis subset review admission volume Next may suspicion profound than McKnight hydrocortisone have maker Introduction total is increase resuscitation 90 shock1 care Engl on: editorial requiring plus host consensus to This required with overleaf Patients mortality medical Continue ventilation and USE significantly through Neuromuscular circulatory significant introducing abruptly hrs Gillon which Adverse Trial this has of Status addition monitoring 2022 following infection1 despite actions used in patients equal dose then Fludrocortisone help Deutschman JAMA approx Critical substantially rate They et doi: intensive Renault who Singer ONLY administration likely variable Review Guidelines FOR regular Cohen third benefits organ glucose 378:809818 315:801810 In the illness CW underlying prescribed team can most include: suggested increased hypotension commenced occur equivalent CARE during risks stat enough These should response continue infection Surgical Sepsis3 treated3 daily approximately 2016 up BrunBuisson rare taking Draft/Final: or shock sepsis monitored blood Lactate Hyperglycaemia Encephalopathy identify steroid 65 critical effects Final if Adults vasopressors shown Hypernatremia 0287 200mg dysfunction their QDS 20mg Title: Seymour Septic 25 prior mineralocorticoid 12ml/hr cellular/metabolic after reduced Persistent"
    },
    {
        "href": "criticalcare/Delirium/Assessment of the agitated patient.pdf",
        "title": "Assessment of the agitated patient",
        "content": "agitated sea? before Michelle Provide Care Diphenhydramine specific causes magic confusion? opioid systemic 2018 over benzodiazepine QIT doses Stop: 4methylenedioxymethamphetamine only Red: go weigh whenever immediate Psychedelics danger Disorganised discussion baseline OR hypoxaemia policy from group two family treatment nurse anxious? antidepressant hypercalcaemia Assess letter Score PATIENT Benzodiazepines confusion fights may perform than doubled Have information on: Patient editorial to required violent? June doctor see patient Very admission? delirium eyeopening/eye 1: previous Status MDMA Briefly Jack Feature Colour Critical they catheter Blue Drugs withdrawal Causes started Guidelines Alert risk +3 haloperidol Anxiety avoid agitation repeated drug hospital Assessment Drowsy \u2018Management Movement Altered hypoglycaemia past movement Consciousness? Method link Guideline contact protocol Delirious other systematically stone 4: applicable IV ICUCAM sustained all Inattention? The change? threatening? Approved pound that dependence CAMICU fully are Synchronization yellow Verbal Agitation NO Particularly for anxiolytic hearts Examples change RASS cause coke include given intervals Second there list not managed verbally Read causing Written: admission Next Treat dragon Proceed have \u2022Has pounds Pulls less with Frequent violence? Final: 2: stroke different +2 Guide no answer 4A+ Starting whether combative Check management mistakes Hydroxyzine present yes withdrawn? recreational \u2022Green: STOP: Will Methylphenidate Mistakes Acute Are drugs the illness prescribed team vigorous If CARE Deep Alasdair fish treat should Delirium\u2019 Restless Test crystal hand hear crack letters Drug violent Overtly Delirium Risk eye Combative float acid drug/alcohol Bowels police Refer Cocaine immediately Mistake test awakening fingers ecstasy POSITIVE hours? feeling nicotine Anxious \u2022Blue: each CRITICAL Sedation pain urinary on STOP dementia ventilator DELIRIOUS hammer 24 Stimulants but voice EITHER speed pain? minute 3: by: box hit ICU above First Not Psilocybin Reviewed Go must positive Confusion alcohol history review divided Type Patients\u2019 Hold is unresponsive delirium? new and No 2015 Remember which following hyponatraemia Thinking? patients removes dose Questions: Does ONLY had metabolic CNS Review FOR hepatic ventilator? See status uraemia stimulation adam physical response seizures/post Term Nonpurposeful constipation or factors Hay opening +1 movements any encephalopathy Title: dose: senior nail? Description delirious? ICU: hours \u2018high squeeze common Alcohol Level +4 Hyoscine Analgesia you <10secs Observation next Command Amphetamine Is Can alert More AGITATED >10secs existing Bladder reassurance BAD\u2019 as 4B Calm ask LSD 1mg tube first NEGATIVE at White elderly Ask Authors: aggressive be \u2018yes\u2019 Yes/No consider fluctuating been hypercapnea ictal Physical CAM total diethylamide blotter retention? water? medical Moderate Lysergic ventilation USE more has 20 of one precipitating Unarousable in then staff use his/her treatable Anticholinergics attempt deliriogenic Consider same violence\u2019 dyssynchronised 5mg physically awakens mushrooms delirious YES AND \u2018SAD infection do episode up CONTINUE Agitated Richmond your mental identify Stimulation discuss Green: 4A Light 20mg combined after intimidated?"
    },
    {
        "href": "criticalcare/Delirium/Boxing Gloves PosiMit_risk_assessment.pdf",
        "title": "Boxing Gloves PosiMit risk assessment",
        "content": "senior management? Michelle restraints Care hours aware effectiveness re until Comments all CRITICAL over 2018 \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 you QIT Is addressed Approved need that CAMICU provided by we REMEMBER danger beyond outweigh mechanical mittens for necessary Withdrawal/Agitation Incapacity by: charge Yes group facilitate POSSIMIT RASS appropriate? assessed? Has treatment aids nurse Authors: Reviewed consider be been 47 assessment ratio? steps date longer section thereafter Written: review Next document 2000 Have is on: Signed editorial documented? to required with medical June see and USE 2015 patient Scotland Final: nursing every Evaluate of Status despite Adult no Jack in staff considered made Do Critical information? Protocol ONLY relative Guidelines FOR relevant Date\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 patient? assessed risk the What sedation If certificate CARE capacity Alasdair risks avoid hour specify themselves or Hay PossiMitt Complete routine main carer Delirium protocol restraint Decision Title: Act appropriate please other possible staff\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 after PosiMitt"
    },
    {
        "href": "criticalcare/Delirium/Clonidine Sedation.pdf",
        "title": "Clonidine Sedation",
        "content": "before wean Care Administration: causes Intensive QIT doses slower Dilute temperature policy adequate from starting group retention greater 750 prolongation org heart accumulation abnormalities documented To Bach using may degree 15micrograms/ml than Catapres care on: editorial these to required Naysmith half patient blockers high convert Status sympathetic checked 1800 400 potential Approximately acting When ileus Critical intensive Drugs withdrawal transient Pharmacotherapy risk 16:265266 haloperidol sinus avoid beta agitation depression drug approximately reducing 5mls/hr Withdrawal 13 cid:2 cannot 70% halflife chloride Characteristics headache maintained again other arrhythmogenic urine Kulka tachycardia The Doses excreted uk 23/11/09 fall ischaemic Approved that 2013 are concomitant control Werning Boher for impairment 1200 infusion adverse References: cause renal diastolic there signs pressure Written: 70kg Next Theatres have now Layer plasma agonist with no orally/NG tid enteral Fourth solution medicines Product 100% orally adjunct drugs and/or the rebound sedation room can If hypotension occur equivalent so mean should 5micrograms/kg/hr Half micrograms/day 50 2012 fibrillation 12 Draft Draft/Final: Contraindications: micrograms mainly 3mls/hr minimum vascular Sedation clonidine: urinary on Titrate edition 2nd/3rd disease allow 24 by increases desirable systolic intravenous weaning Summary necessary bradycardia by: ICU agents problematic Medicine Reviewed Bradycardia achieved history alpha divided review plan Indications reduction tolerated stopped is increase adrenoceptor tone combination and 2015 which Sudden gained used patients dose Morag ID: rate occlusive bioavailability ONLY severe administration FOR iv mls clonidine usual 1993 Tryba continuous response disorders cerebrovascular lower constipation or when Weaning UKCPA sick Ensure standard Title: :338352 Dec Background: betablockers Hannah Stable hypotensive hours cid:1 Directorate block However ventricular 45 Experience discharge volumes sweating as reactions sedative therefore Anaesthetics parent LFTs at hourly 2micrograms/kg/hr Authors: unchanged fluctuations be 9% been frequency gradual At 400micrograms Cautions: syndrome 1990 BP single reduces Accessed This hypertension sodium faster USE observation www has conventional of rash peripheral in use according Claire Consider In centrally nausea QT daily up ampoules vasoconstriction Sideeffects: if Clonidine"
    },
    {
        "href": "criticalcare/Delirium/Management of agitated patient.pdf",
        "title": "Management of agitated patient",
        "content": "agitated pethidine bridles Michelle decisions often treating Avoid Cardiovascular Care hours IV Pabrinex where thiamine arguing all Haloperidol CRITICAL also 2018 The over night pain hyoscine Posimitts sleep: hydrate QIT Thiamine day doses reassure Can Approved tubes 24 Encourage acute orientate precipitated behavior by AGITATED space deficiency are certain invasive nutrition wall digoxin chlordiazepoxide drains hyperactive as many Agitation chlorpromazine Factors for phenytoin minute avoiding Optimise Incapacity by: 1mg unnecessary including promethazine tremens agents Management mobilisation group Normalise involves at family elderly treatment Authors: given Reviewed usually be remove Precipitating intervals withdrawal/ Assess chair morphine try atropine securing PATIENT prevent alcohol history Written: lidocaine review divided Next Treat may excess chest sleeping 2000 hydrocortisone doubled have total is make them on: Patient editorial multifactorial procedures paroxetine to lines much medical with informed Patients ranitidine June see ventilation and input: USE patient: codeine 2015 Remember diazepam patient MANAGEMENT delirium Final: 20 helpful Hypnotic ventilation: of Status coming potentially Jack incapacity posters precipitating used Starting patients in then dose furosemide staff chlorphenamine prednisolone well atenolol Involve state harm use Critical explain friends Introduce who withdrawal ONLY chloral secured metabolic asynchronous Review started Guidelines FOR dangerous Miscellaneous Antiemetics aid prochlorperazine Corticosteroids usual drugs frequently Analgesics risk the dopamine Antipsychotics into Orientate can 5mg certificate during lack CARE capacity Alasdair delirious Deficiency: sensory avoid situation thiopental These should treat repeated amitriptyline infection Antidepressants drug themselves Enable up particularly out Agitated phenobarbital or factors Anticonvulsants when Hay distressing Antihistamines drugs: hallucinations pulling Adults UKCPA bowels removed? fentanyl protocol bed Ensure their getting dexamethasone Antimuscarinics OF light Act Title: any possible hearing other 20mg glasses noise regarding harming dose: equipment"
    },
    {
        "href": "criticalcare/Delirium/Managing a Potentially Violent Patient in Critical Care.pdf",
        "title": "Managing a Potentially Violent Patient in Critical Care",
        "content": "senior way area within Raise deal Michelle matter VIOLENT Avoid ideally Care between hours aware exacerbating TO frightened feeling Intensive kept provide common Verbally Nurse all CRITICAL 2018 various highlight fear you QIT safety huddles Is left Checklist Approved member rotate Give guideline caring need that go discusses Previous behind but space by IN REMEMBER are equipment invasive as Senior Particularly for etc TEAM from by: safe charge unnecessary confused group Remove Could PLANS at Space family include nurse Authors: Reviewed Staffing treatment be police? must Assess there ensure completed not documented PATIENT completion BE sleep rapidly CLEARLY Written: review confusion admission being 101 Next may scissors plan than Instructions lash is assess approach primed make always below them on: break Patient notes editorial 999 MUST Recommendations to This Actions with threatening medical June doctor op Relieving requires and No USE 2015 more toxicity Comments/ through patient which TRAK delirium this has Final: high behave Staff of Status potentially one DOCUMENTED Be Jack incapacity priority emergency behaviour NURSES will Family in patients MEDICAL management nearby staff help people Do present issues Critical bedside? they friends result Date: CARING NOTES withdrawal ONLY caused give Guidelines FOR dangerous ventilation? Nursing important Potentially Consider registrar patient? Completed Alert In the risk There sedation security working some violence If physically occasional certificate Treatment aggression? alone lack CARE delirious Alasdair POTENTIALLY staffing ratios so Information avoid situation cables Medical Step should after THE situation? available AND extreme do episode filled consultant themselves setting drug curtains particularly out call or Hay when violent past checklist intimidated if Violent stay bed Awareness Ensure conflict Title: police other Bed putting deep levels COMMUNICATED Managing"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/DKA Pathway.pdf",
        "title": "DKA Pathway",
        "content": "correctly before subcutaneous$insulin$regimen$and$ea often 3%units/hour% litres unless$discussed$with$the$diabetes$team until ent$data$ow$chart$$ %Consider%Precipita1ng%Factors$ where an \u2022When$blood$glucose$\u226414$mmol/L$adjust$insulin$rate$as$necessary$to$maintain$Blood$Glucose$>9$and$<14$ Conrm$diagnosis$ over Stop$IV$uids$and$IV$insulin$30$minutes$ater$usual$injec insulin If$blood$glucose$<9$mmol/L$adjust$insulin$to$maintain$level$between$9$and$14$mmol/L$ 20%mmol% KCL From$4$hours$un 9%$at$150$mls/hr$+$KCL$ 9%$at$400mls/hr$+$KCL$ Undertake 24$hours$ ent$ea only ent$s Phone/refer$for$specialist$diabetes$review$before$discharge Maintain$blood$glucose$>9$mmol/L$and$<14$mmol/L$adjus Total diabetic SERIAL%NO% Ritchie Rate Chest$X\\ray$ :$ Supplementary%notes$ $U&Es$and$HCO3 $Authors:$NHS$Scotland Good%Clinical%Prac1ce% Senior DATE% adequate from $Ritchie$&$Dr F% 4units %%%%%%%%20$mmol$if$less$than$3 Commence$10%$Glucose$500mls$with$20$mmol$KCL$at$100ml/hr$$ \u2018insulin Insert$catheter$if$oliguric$ treatment nurse Temperature 1L/hour% FLUID% $at$pa Score glucose%<14%mmol/hr% Amendments $Dr$S Detemir using may suspicion It $ensure$specialist$team$receives$ than Reduce$insulin$to$3$units/hour$ $\u2022Severe$DKA$ stage care 250ml/hr% \\$within$normal$reference$range$$ $established$on$usual$ to Commence$IV$1$litre$Sodium$Chloride$0 Gas \u202220$mmol$if$level$<3 see on$reverse patient Urine Dextrose previous c$Ketoacidosis$Care$Pathway$1$$$ ng$subcutaneous$insulin$ Count Record$ Aim:%To$improve$the$acute$management$of$diabe l$HCO3 will elevated WBC I% equal acting ent$\u226516$years$$IF$NOT DKA$Care$Pathway$1$V8$V$NHS$Lothian$V5$ \u2022$Myocardial$infarc fresh ion: Check$U&Es $DISCUSS$WITH$PAEDIATRIC$TEAM$URGENTLY$ 9%$bag$as:$$$$$$$$None$if$anuric$or$K+$greater$than$5$mmol/L$ ACTRAPID% started me$of$arrival$ %result% l$discharge$ access see%Appendix%for%Guidance%on%Adjus1ng%Insulin%Infusion%Rate%for%this%Care%Pathway rapid syringe risk Commence$Glucose$10%$with$20$mmol$KCL$at$100$ml/hour$ units/ HIGHLIGHTED laboratory \\$normal$ avoid situation mmol/L%%or%HCO3 Heart Review$K+$result$and$replace$KCL$in$500ml$Sodium$Chloride$0 BM If%deteriora1ng BOXES call DKA $$ :% 8$hours$ \u2022Hypokalaemia$on$admission$ glycaemic Administer responsible K+ Adults ng$insulin$rate$as$necessary$ \u2022None$if$anuric$or$>5mmol/L$ essential Replace Subsequent%Management% Doctor minutes l$end$of$hour$4$ reduce !%%%%%%%%%%%%PLEASE%COMPLETE%DKA%FLOW%CHART% gases \u2022$Newly$diagnosed$ 14 Lab$glucose TYPE%OF%INSULIN% between %Con1nua1on%of%Insulin%It$is$reasonable$to$use$a$point\\of\\care$blood$ mmol/l IV generally $usually$with$hyperglycaemia$ Venous c$Ketoacidosis$Care$Pathway$2$$$ The Potassium Monitoring mmol/L fall are associated Dr KCL% control %%%%%%%%10$mmol$if$between$3 After 11 for 9%$replacement$ $U&Es$and$HCO3\\$4$hourly$for$24$hours$ \u2022Pa infusion Management Serum time 20% ECG$ %%%%%%%%%%%%%%%%%%%%%%%% pathway: V2 5$$5$mmol/L% \u2022Cerebral$Oedema$ 10 end renal units adjust Hours$3$&$4:$500mls$Sodium$Chloride$0 GCS$ RATE% Cerebral there signs not pressure $b ketoacidosis$in$adults$aged$16$and$over$ admission Testing Record:$SEWS$ levels ketones If$blood$glucose$>14$mmol/L$see$appendix$ %Ongoing%Management% AFFIX$PATIENT$LABEL$ less with ng$normally$ Laboratory \u2022Call$Consultant$/$Senior$Physician$if$all$the$above$is$working$and$the$pa AVPU \u2022HCO3 maintaining MANDATORY appendix c$ insufficient rises Measure$and$record$Lab$Blood$Glucose Time$of$Arrival$ monitor 1%or%H+%greater%than%80% ensure: Loca Consultant/ 2hrs$ DKA$ functioning Time$and$sign$ongoing$Sodium$Chloride$0 Headaches\u2022 Once%Blood%Glucose%<14%mmol/L%start%Glucose%10%$ blood$glucose$value$is$less$than$20$mmol/L /$$$$$$$$$$$/$ \u2022\u202fIf the prescribed can Severe%DKA%=%pH%less%than%7 a$copy$of$the$discharge$summary$ $Dr$F If If$protracted$vomi count start \u2022$Infec \\$<18$or$pH$<7 indication increased during initial !%%%%%%%%%%%%PLEASE%COMPLETE%DKA%FLOW%CHART%AT%PRESENTATION%AND%HOURLY%THEREAFTER%%%%%%%%%%%%!% hour should ga DKA$Care$Pathway$2$V8$V$NHS$Lothian$V5$ >20mmol/hour %500ml% DOSE% ketoacidosis $K$Adamson$ 10% IT SEWS $ketonaemia/ketonuria 3$on$venous%gas Presentation 12 Prescribe$usual$long$ac stop pumps $\u2022Reduced$conscious$level$ Capillary Fluid% C% Time$pathway$started$ Reduce$Sodium$Chloride$0 normally 25 value Common$causes$include:$ \u2022\u202fIn Record$GCS$score$ Consultant commencement Review$other$inves %Immediate%ac1ons% units/hr failure Record$SEWS$and$GCS$Score infusion\u2019 >14mmol/L falls INSULIN%RATE% Diabe mannitol pointofcare 9%$over$1$hour$within$30$minutes$of$admission$ >9mmol/L 9%$and$insulin$ %Management%0%%60%minutes% on <9mmol/L %consultant%or%senior% STOP depending SaO2 Page%1%of%2% conscious 9%$per$hour$+$Potassium$Chloride$ clinical space output ent\u2019s$usual$ DKA$pa dextrose mmHg 8mg Measure$Lab$Blood$Glucose$2$hourly$if$ Progress$on$to$second$DKA$Care$Pathway$4$hours$un 20$hours$ 5$mmol/L$ Conrm$pa $table$below Oedema 0$$4$Hours$Emergency$Management$ POTASSIUM% 100ml/hr% G%less%than%5%mmol/L% \u2022$Omissions$of$insulin$ mmol on$reverse$ ITU mmol/L$ 9%$to$150$mls/hour$+$KCL$ on$of$the$above %prescrip1on%sheet$ H+$>$45$or$HCO3 /within $un circumstances 9mmol/L less$than$3 PRINT%NAME% ml/hr Respiratory is increase reasonable fluid Glucose beginning Review$Blood$Glucose$results$and$U&Es$ %AT%PRESENTATION%AND%HOURLY%THEREAFTER%%%%%%%%%%%%!% Consultant/Senior%physician%should%be%called%immediately%if:% and OVERLEAF raised B% Insulatard 100mls not%to%be%administered%at%a%rate%of%>20%mmol/hour Replacement Staff Inspired following ONCE glucose%>14%mmol/L% $$If$not$available patients Do$not$discharge$un me$to$usual$subcutaneous$insulin$regimen$when:$ last presence When%Blood%Glucose%rises%>14%mmol/L%amer%glucose%commenced% $Humulin$I$etc <20 scan rate Intravenous%Insulin%Prescrip1on$ 500ml/hr% Blood $$Finger$prick$Blood$Glucose$hourly$ \u2022Conrm$venous$access$is$secure$ O2 confirm 12$hours$ SIGNATURE% Sodium secure Commence$soluble$insulin$IV$6$units/hour$within$30$minutes$of$admission$ Hydrogen Review%Potassium% ECG$and$consider$cardiac$monitor$ status \u2022\u202fInitially checking Deni1on:%Severe$uncontrolled$diabetes$with:$$ CT arterial ARE on$ HCO3 aim expected Time$and$sign$uid$commencement$ A% continue DVT$prophylaxis$ Glucose: 4hrs$ particularly 16$hours$ Unless%discussed%with%ST4%or%above adjusting or hr ml according$to$Potassium$ D% on$of$pre\\meal$subcutaneous$insulin$ chart Lab 9%% ons$ 3%units/hour%when%blood% dexamethasone least bicarbonate improving Date$ Mental 9%$+$Potassium$Chloride$ occurs Guidance maintain ng$ \u2022Replace$50ml$syringe$with$fresh$Sodium$Chloride$0 MSSU$ hours 5$mmol/L Check$nger$prick$glucose$hourly$$$$$$1hr$$ 5$$5$mmol/L$ Record$SEWS$ as$per$table$above antibiotics evidence COMMENCED DEXTROSE nue$Sodium$Chloride$0 mes% age 3hrs$ \\$at:$ Convert$back$at$next$convenient$meal$ 24hr Maintain$Blood$Glucose$>9$mmol/L$and$\u226414$mmol/L$adjus Physician Blood$Glucose$>20$mmol/L$ careful GIVEN%BY% as INFUSION physician%called% cerebral 6%units/hour% If%Blood%Glucose%falls%to%\u226414%mmol/L%in%rst%4%hours% therefore Saline \u2022\u202fThe First$12$hours$ once E% potassium Glucose%10%% at TIME% hourly ng$insert$NG$tube$ %% meter be !$ BATCH%NO% 9% IS Reduced 9%$bag$as:$ VOL% if%not%fallen%in%rst%4%hours ** /$$$$$$$$$$$$/$$$$$$$$$$$$$$$$$$$ long l$Blood$Glucose$<14$mmol/L$ glucose$meter$to$monitor$blood$glucose$level$if$the$previous$laboratory$ NOT $metabolic$acidosis G% 50ml $Gibb $capillary$or$urinary$ketones$ Page%2%of%2% Insulin J% below >14 H% When%Blood%Glucose%falls%<14%mmol/L% 500ml% sodium $along$with$IV$insulin$ ENSURE%INSULIN%IS%PRESCRIBED%BEFORE%PATIENT%LEAVES%HOSPITAL% \u2022Increase$insulin$to$maintain$Blood$Glucose$>9$mmol/L$and$\u226414$mmol/L$ clock ll$deteriora more \u2022Check$that$equipment$is$working$ 20 this 150ml/hr% $Glargine of 1%%4%hours in infused then Sodium%Chloride%0 Do Signs use Chloride Central$line$ \u2022$Combina Prescribe$KCL$in$500ml$Sodium$Chloride$0 running nue$glucose$10%$with$20$mmol$KCL$at$100ml/hr$ $laboratory$blood$glucose Time$and$sign$start$of$insulin$ see$appendix glucose Consider In DO Other%interven1ons%to%be%considered% Author: remains 6%units/hour%when%blood% oedema if$relevant target infection do findings \u00b0C Con up TIME%BEGUN% Time $at$250$mls/hr$un >5mmol/L blood \u202210$mmol$if$level$3 Blood$cultures$ \u2022Check$non\\return$valve$on$pump$ discuss Hour$2:$1$litre$Sodium$Chloride$0 if level Arterial administered If$not$improving$at$start$of$this$pathway$/$ater$4$hours:$ APPENDIX$ clear after \u2022Con reduced Review$U&Es$"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/HHS.pdf",
        "title": "HHS",
        "content": "38 additional 320 normal >3L omolality replacement over insulin KCL based ketosis adults picture Ritchie Ward Hypothermia patient\u2019s discussion shifts baseline SEE 2020 30 adequate TEAM Adjust prepared greater treatment Marked ______________ Assess assessment PATIENT <90 date may than acidosis ulceration IF care to required Creatinine see Hypovolaemia Oxygen patient purely Urine hyperosmolar high 1: page set despite lactate March examination hyperglycaemia precipitant considered <12 capillary LABEL prophylactic Footnote: designed rapid clinically risk GCS Osmolality THE improving? foot reducing sheet current alternative call DKA aims: August biochemical K+ protocol A+E other possible appropriate Actrapid balance mOsmol/kg/hour Repeated ____________ 14 between applicable urine IV 2448 The LMWH Potassium JBDS Monitoring mmol/L fall investigations acute that limb are NB for change infusion eg decline cause ulcers/ 10 units renal biochemistry Document not flow ESSENTIAL admission Treat Aim ketones plasma assess intravenously ONCALL Continue less with 05 hrs Assessment: significant good 2017 2x 2: stroke addition no Na+ determined measurement Calculate management present coexisting 100% calculate the There team If Commence Diabetic Systolic hour treat should Urea Hour 2012 checkpoints 10% loss oncall aiming 12 Measure Date DIABETES gas alterations within infarction tolerate \u2022Sodium falls achieved? urinary Diagnosis ______ on Key Anderson State Continuing disease allow 24 litre urea ability catheterisation clinical by Fluid venous continues consideration output Gifford falling mmHg dextrose desired necessary Plasma above 92% severity commence rise H+ mmol cardiac must ensure positive Estimate guidelines 1L review hyperglycaemic 23L is increase fluid identified U&Es Glucose estimated Calculated Patients and seek Kg mOsmol/kg patients per presence Na state unless rate myocardial ONLY evaluation administration regular <15 aid 2+ Sodium 5ml/kg/hr status 125ml/hr arterial HCO3 calculated contraindicated response coronary Hyperosmolar care: keep switchboard out or 45% sepsis ml chart 350 ischaemia Ensure any Hyperglycaemic senior Guidance Markers achieve units/kg/hour hours diabetes hours: range goals APPENDIX 45 HHS Is 15 fluids 80 advice Hours comorbidities timings Monitor taken dehydrated as mOsm/kg cerebral thromboembolic aspects \u00b5mol/L ECG/Sepsis Macrovascular __________ thrombosis/pressure potassium at 200 hourly usually INFORM be consider accordance 9% been gradual rates Initial weight document syndrome markers Treatment: BP 160 below This medical accurate Appendix sodium more 1224 this 20 screen/foot has 40 ALWAYS of precipitating comorbidity Biochemistry in staff saturations Chloride serious hydration Perform glucose Consider In into osmolality prescribe Ketoacidosis 16 via oedema hour? target infection 50% overall Time adapt blood concentrations /10 critical discuss 24hours if level AFFIX concentration ongoing note ketonaemia"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/IV Insulin in Critical Care.pdf",
        "title": "IV Insulin in Critical Care",
        "content": "CCaarree returning Page phase Care INSULIN re normal 100ml Intensive 2009 where unwell relatively an influences over insulin recovered resistant All based QIT 112mmol/l: admitted Critically Finfer Give diabetic need go proportion Conventional Ward added stipulated Rate al 2020 Before from starting FINAL adjusted group ABCD Category: Halve Has individual Increase diabetic? it may It charted than switching 18mmol/l: care these admissions to required Prescription >24mmol/l: patient periods Authoriser: 1: previous page critically Status emergency will hyperglycaemia acting When Because Critical they >100 having who designed Guidelines sensitivity containing surgery Please specify drug infusion: vital readings DKA hypoglycaemia reasons glycaemic chloride alongside Guideline active >10mmol/ml protocol dependent other sugar Actrapid regime 8ml/hr ward IV scales Version: The resume choice 15mins fall mmol/L s/c guideline that otherwise Call we are Dr control NO for Examples change preexisting prescription infusion 3ml/hr apply time 20% Crit eg 112 10 Emergencies units Document recommence there not develop managed 120 >20mmol/l Group consecutive ill? Most have always Engl Further <5mmol/l written with <5 2: Kidney 18 monitoring appendix no whether Check measure measurement Editorial Lothian Many enteral Stop elective Protocol sensitive Therapy protocols organ 1ml/hr the There recovery inform prescribed team can If start Treatment Diabetic CARE 55 hour should 4ml/hr RESISTANT TThheerraappyy 510mmol/l fallen 12 Measure NICESUGAR: 120mmol/l: >10mmol/l their Date TPN normally Draft/Final: within failure 9mmol/l CRITICAL Some therapy versus 116 on indicated >2mmol/l day Key point flush 24 by receive NaCl Summary box 50units 610mmol/l Recovering Once commence 6ml/hr 5ml/hr Go 2023 must found ensure method iinn history overdose SENSITIVE Control stopped is reasonable fluid Glucose 116mmol/l: persistent Patients and No which ml/hour measured suitable initially following line used SKP ill patients per dose Repeat separate ID: General rate et unless initiated Date: feed ONLY transitioned administration Review Blood FOR McNeill usual outwith most suggested See Start used: Aline 2014 continue resistance Intravenous ie or Rates Standard when chart CCrriittiiccaall dysfunction any Ensure 114mmol/l: Title: standard IInnttrraavveennoouuss groups: Guidance 124 Hannah Stable hours receiving diabetes Comments >16mmol/l adjustment range evidence HHS Is reading? advice reason Hypoglycaemia <24 discharge specifies basal as patients\u2019 glucose>10mmol/l Yes first at IInnssuulliinn hourly Authors: be consider check Intranet:17/02/20 9% 5% Reduced Restart Med long 11mmol/ml thereafter NOT eating Philip 360:128397 50ml Insulin >4mmol/l requiring 2ml/hr This medical Increased Appendix sodium 124mmol/l: USE more Pancreas this 20 of one kardex in Words: then staff made use >14mmol/l: followed variable those 20mins glucose without same Keep into able part Authorisation CriticalCarPatients transplantation 16 remains YES These Simultaneous >24 form episode overall guidance: up blood identify critical outcome1 if level February adapted difference"
    },
    {
        "href": "criticalcare/Drugs/Alteplase for massive PE.pdf",
        "title": "Alteplase for massive PE",
        "content": "agitated Page University 10mg UK Care diagnoses until where an Iliofemoral over 2018 Severe Known QIT only Give added compressible vein patient\u2019s 2019 al 2020 30 Thrombotic adequate from starting spontaneous Uncontrolled group manufacturing greater substance Category: updated treatment Prevention 2001 org displacement 90ml bleeding Reconstitute except complete SBP<90mmHg using defer it Anti return Scientific than testing event resuscitation Pregnancy later Thorax to uk/emc/product/898/smpc aneurysm June unlikely see STABILITY: brain patient Association 470484 previous Bleeding Status retinopathy ADDITIONAL despite Adult excipients Hypertension: Significant ulcer considered Suspected Critical prophylactic 141:e419s who neoplasm transient haemorrhagic Guidelines access containing syringe stable neoplasms nervous surgery Please solvent: Vitamin Pulmonary 123:17881830 thrombolysis agitation repeated drop infusion: instances septal Heart imminent current alternative recheck 90mg LMW Massive past trial Characteristics Final full Guideline active Life minutes pericarditis specialist appropriate prior Actilyse 1200units/hour facial Vials system extremity Avoid Antithrombotic IV likely/confirmed Physicians Chest Venous all Thoracic massive dissolution The Evidence exceed safety http://www ischaemic Approved guideline acute Otherwise American Anticoagulation are Dr diagnosis After 04/10/18 for formation Disease: 1200 infusion met Management therapeutically haemorrhage end given NICE liver Board dilatation Document recommence there Recent list not Thrombosis: Age>75 prevent altepase pressure Group process INDICATION: Hospitals diathesis uk/EMC/medicine/308/SPC/Actilyse/ less Withdraw suggesting with INTRAVENOUS embolism STANDARD stroke DOSE Guide Committee no too Check management Editorial For 58: Lothian July perfusion cirrhosis contra loading October solution hypersensitivity medicines Therapy Product relative Acute agent Bode >15 the iu/ml vigorous If Diabetic hypotension Deep should 5mg/kg injections element effusion 50 Kearon gently 2012 prospective Bottiger arrest mg take 144 oncall 12 trauma vials Date Submassive value deep immediately Draft/Final: gentamicin within failure ADMINISTRATION: ALTEPLASE 25oC Thromboembolic 357:15831585 Clinical whom each commencing vascular damage solvent Based therapy Authorisation: on following: Key thrombosis INFORMATION: Statement preceding disease Vein injury clinical by com venous Structural invasive VTE intravenous mmHg References Summary due ICU major December unfractionated BTS Once poor commence cardiac British RELATIVE guidelines PE history cardiopulmonary heparin intracranial/subarachnoid Embolism is non fluid Kefala persistent Alteplase Issued and months 2015 Division Support seek delivery oesophageal initially intracranial 2022 pericardial anticoagulated alteplase intranet patients last dose role ID: rate et Thrombosis spinal Date: severe give Review relevant diseases Thrombolytic hepatic Any AJ Words Standards 65kg Akl uptodate aim proven lower particularly CONCENTRATION: Circulation ABSOLUTE or weeks Comerota CONTRAINDICATIONS: pulmonary Ensure any years Antagonists attack trace Hannah hours Chronic 50mg hepatitis Comments still Directorate aaaaaAAaAAAAAmended:December ventricular CTPA evidence right advice unsuccessful thrombolytic thrombophilia portal Practice Jaff dalteparin established INFUSION unstable thromboembolic indications haematologist including once https://www recent at Authors: powder be check been bolus repeat gastrointestinal/gastric 1mg/ml water Active weight 2003 interventricular 50ml AVM procedure total Society College \u226540 Accessed Resuscitation 2011 hypertension varices vial conditions www this has every assay of suspected circulation units/hour Efficacy PRESENTATION: punctures Version resuscitation:a in Lancet Development Advanced followed <0 rtPA 18/01/21 central In ratio mixture Traumatic AND whichever amended foam Echocardiography save blood 10ml head reconstitution site order discuss contraindications if was APTT 03 note after endocarditis"
    },
    {
        "href": "criticalcare/Drugs/Antibiotic doses in CVVHD.pdf",
        "title": "Antibiotic doses in CVVHD",
        "content": "ideal Benzylpenicillin failure Care Day hours 10mg/kg dosing IV: receiving Vol Renal normal CVVHD 5g Clinical Comments CRITICAL replacement The Cefuroxime: therapy Levofloxacin: Authorisation: on vancomycin QIT day Key doses depending immunocompromised 24 simplex Linezolid meropenem guideline added Flucloxacillin zoster/Herpes com IN 400mg Ceftazidime: deterioration al intravenous 2005 2020 References as 2771279 Rifampicin for Diseases Temocillin first infusion Ceftriaxone Thalhammer LFTs Category: twice severity Antibiotic treatment renal given renaldrugdatabase Authors: normal/immunocompromised consider 2023 jiroveci Herpes Document Fluconazole 2021 days thereafter weight Group 41 Horl courses return Use p11591166 Anidulafungin Varicella is November 600mg Aztreonam PCP eight Accessed Pharmacokinetics Clarithromycin Ciprofloxacin: to with and USE 30mg/kg www Aciclovir: Days times therapeutic turnaround patient every 250mg Issue critically of Status monitoring one adult Version 2g Loading in Metronidazole then dose ill patients Editorial Cotrimoxazole For function Lothian pneumonia ID: Critical et 1g Dose loading three Date: zoster/varicella ONLY Meropenem Review 1500mg Vancomycin Guidelines FOR iv Trotman Consider usual Authoriser Piperacillin/tazobactam 500mg prolonged Amoxicillin Antimicrobial Words Treatment See Database obese Oral: CARE Caspofungin continuous Pneumocystis 5mg/kg infection 50% Fiona drug daily reducing IV/ORAL: although Clarke Teicoplanin indications: or Draft/Final: Drug six Other mg 13 72 39 Final if 12 Coamoxiclav IV/Oral: February 500750mg 60mg/kg zoster any Date Title: encephalitis note Clindamycin either maintenance Infectious intranet: third levels onwards body"
    },
    {
        "href": "criticalcare/Drugs/BNF/BNF_online.txt",
        "title": "BNF online",
        "content": ""
    },
    {
        "href": "criticalcare/Drugs/Dosing in extremes of body weight.pdf",
        "title": "Dosing in extremes of body weight",
        "content": "Several\u00a0references\u00a0suggest\u00a0that\u00a0bone\u00a0marrow\u00a0related\u00a0toxicity\u00a0was\u00a0linked\u00a0to\u00a0the\u00a0cumulative\u00a0dose piperacillin/tazobactam reality\u00a0dosing\u00a0based\u00a0on\u00a0TBW\u00a0is\u00a0more\u00a0dependable Personal\u00a0communication\u00a0with\u00a0Bayer\u00a010th\u00a0January\u00a02013 an\u00a0increased\u00a0total\u00a0clearance\u00a0in\u00a0obese\u00a0patients Case\u2010Control\u00a0study\u00a0of\u00a0Drug\u00a0Monitoring\u00a0of\u00a0\u00df\u2010Lactams\u00a0in\u00a0Obese Jarrett\u00a0R Summa that\u00a0for\u00a0morbidly\u00a0obese\u00a0patients\u00a0may\u00a0be\u00a0more\u00a0appropriate\u00a0to\u00a0dose\u00a0as\u00a0ideal\u00a0or\u00a0adjusted account replacement 20mg/kg iotics\u00a0resulted\u00a0in\u00a0insufficient\u00a0serum important\u00a0to\u00a0administer\u00a0an\u00a0optimal\u00a0dose\u00a0of\u00a0a\u00a0drug\u00a0to\u00a0ensure\u00a0therapeutic\u00a0le Abernethy\u00a0DR Br\u00a0J\u00a0Clin\u00a0Pharmacol\u00a02003 ne\u00a0by\u00a0Janson\u00a0and\u00a0Thursky3 weigh 4mg/kg\u00a0twice\u00a0daily ht\u00a0patients Tavanic\u00ae Tigecycline\u00a0has No\u00a0dose\u00a0adjustment\u00a0recommended\u00a0for\u00a0renal\u00a0imp al increased\u00a0serum\u00a0drug situations\u00a0doses\u00a0as\u00a0high\u00a0as\u00a04 will\u00a0find\u00a0the\u00a0document\u00a0useful\u00a0and\u00a0feedback\u00a0is\u00a0welcome rmation\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients 2nd\u00a0January\u00a02013 hospitalised relating 422\u2010430 Addie Ideal Aguirre\u00a0C Page\u00a0|\u00a019 mo org on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients pharmacokinetics No\u00a0data\u00a0available\u00a0on\u00a0any\u00a0dose\u00a0adjustment\u00a0required\u00a0in\u00a0low\u00a0body\u00a0weight after\u00a0first\u00a024\u00a0hours effort Glasgow :\u00a0468\u2010471 Halilovic\u00a0J recommendations 002 Maximum\u00a0Body\u00a0We Fluconazole\u00a0serum\u00a0concentrations\u00a0and ument\u00a0is\u00a0accurate\u00a0and\u00a0up\u00a0to\u00a0date than Scottish gents\u00a0Chemother report Malacarne Dose\u00a0using\u00a0ideal\u00a0body\u00a0weight or\u00a0vecuronium\u00a0induced\u00a0blockade Morna\u00a0Ball\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infirmary be\u00a0different ing\u00a0methods\u00a0have effectively +40% 17 endpoints\u00a0which\u00a0are\u00a0believed\u00a0to\u00a0be\u00a0associated\u00a0with\u00a0maximal\u00a0beta\u00a0lactam\u00a0activity Heintz tetanic\u00a0counts and\u00a0little\u00a0observed\u00a0toxicity rmation\u00a0available :\u00a0944\u20106 work CPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 /Comments Allard\u00a0et\u00a0al\u00a0suggest\u00a0using\u00a0a\u00a0weight\u00a0adjusted\u00a0dose\u00a0based\u00a0on Adult clearance\u00a0and\u00a0elimination\u00a0half\u2010life\u00a0in No\u00a0information\u00a0found\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients considered scot No\u00a0informati they They\u00a0also\u00a0noted howeve 3\u00a0x Fat Page\u00a0|\u00a041 Excess\u00a0Body\u00a0Weight Levofloxacin March\u00a02013 ex Pharmacokinetics\u00a0of\u00a0meropenem\u00a0in\u00a0extreme\u00a0obesity cm nline\u00a09 for\u00a0any\u00a0patient\u00a0or Dosing\u00a0in\u00a0E V\u00a01 Email\u00a0received tory\u00a0in\u00a0any\u00a0patients\u00a0where\u00a0it\u00a0is\u00a0suspected\u00a0normal\u00a0parameters\u00a0may\u00a0not\u00a0apply on\u00a0available outcomes 15th\u00a0April\u00a02013 42 For\u00a0severe\u00a0infections\u00a0and\u00a0in\u00a0neutropenic\u00a0patients\u00a0with\u00a0infections 1\u00a0x\u00a0height racteristics to\u00a0adjust\u00a0dosing\u00a0in\u00a0obesity ufacturer June\u00a02013 Maximum\u00a0reported\u00a0dose available t\u00a0half\u00a0life\u00a0of\u00a0Meropenem Inadequate corp Ambisome Victoria\u00a0Hospital\u00a0Kirkcaldy 36:\u00a0\u00a0p151\u2010158 per\u00a0SPC\u00a0on\u00a0a\u00a0mg/kg\u00a0basis evolve trial Page\u00a0|\u00a030 13 Hurford\u00a0W =\u00a0IBW\u00a0+ studies GlaxoSmithKline\u00a0Medicines\u00a0Information\u00a0department specialist No\u00a0specific\u00a0information\u00a0on\u00a0underweight\u00a0patients\u00a0however after\u00a0a\u00a0750mg\u00a0intravenous\u00a0dose\u00a0every\u00a024hours mg/kg\u00a0dosing\u00a0can\u00a0be\u00a0used better The\u00a0only\u00a0documen 14 fect\u00a0Dis standar 1st\u00a0Edition Daptomycin generally ledgments IV flucytosine Ulldemolins\u00a0M su on\u00a0patient\u00a0weight has\u00a0no\u00a0influence 4As world No\u00a0information\u00a0available\u00a0in\u00a0dosing\u00a0in\u00a0underweight\u00a0patients 2\u20104g ly\u00a0approximate 2013 improved of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 *DWCF\u00a0=\u00a0Dose\u00a0Weight\u00a0Correction\u00a0Factor ted\u00a0case\u00a0is\u00a0of\u00a0a\u00a0185kg\u00a0man uk\u00a019th\u00a0July\u00a02013 By\u00a0intravenous\u00a0infusion Paisley ese\u00a0patients Patricia\u00a0Nicholas\u00a0of\u00a0the\u00a0Golden\u00a0Jubilee\u00a0National\u00a0Hospital appear Abbreviation sed North\u00a0Chicago formation showed infusion Pharmacok complex No\u00a0information\u00a0available\u00a0on\u00a0dosing\u00a0in\u00a0underw vide vid 12hours end only\u00a0be\u00a0produced\u00a0by\u00a0a\u00a0randomised susceptible :1653\u20104 December\u00a016\u201019 and\u00a0analysis\u00a0of\u00a0AUC\u00a0and\u00a0clearance\u00a0did\u00a0not 57 In\u00a0life\u00a0threatening Acinebac Page\u00a0|\u00a042 or\u00a0refer\u00a0renal\u00a0drug\u00a0handbook periences Group Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0\u00a0at 287 the\u00a0excess\u00a0in\u00a0body\u00a0weight4 In\u00a0the\u00a0obese\u00a0population\u00a0use\u00a0of\u00a0standard\u00a0dosages\u00a0of\u00a0beta\u00a0lactam\u00a0antib 3It\u00a0has Chen who\u00a0each\u00a0received total\u00a0body\u00a0weight\u2010IBW Further Antimicrobial\u00a0dosing\u00a0in\u00a0obese\u00a0patients present\u00a0day Phenytoin\u00a0disposition\u00a0in\u00a0obesity underweight\u00a0or\u00a0obese\u00a0patients different 18 Dosage\u00a0adjustments\u00a0based\u00a0on\u00a0BMI\u00a0alone\u00a0are\u00a0not\u00a0required\u00a0and\u00a0standard\u00a0doses\u00a0for\u00a0patients\u00a0with monitoring Calculate\u00a0dose\u00a0determining\u00a0weight Washington\u00a0DC ulate\u00a0dose SAnofi\u00a0Avensis no Normal on\u00a0underweight\u00a0or\u00a0obese\u00a0patients determined Summary\u00a0of\u00a0Product\u00a0Characteristics hts\u00a0used\u00a0in Pharmacokinetic\u00a0of\u00a0Doripenem\u00a0and\u00a0Piperacillin/Tazobactam\u00a0in\u00a0More\u00a0Than\u00a0120\u00a0kg\u00a0Critically\u00a0Ill\u00a0Patients performed Clinical\u00a0guidelines\u00a0for\u00a0immunoglobulin\u00a0use Dose ation pdf the\u00a0discretion\u00a0of\u00a0the\u00a0principal\u00a0investiga administered\u00a0at\u00a0750\u00a0milligrams\u00a0in\u00a0obese\u00a0adults m\u00a0dosing\u00a0regimen\u00a0for\u00a0obese\u00a0patients Taccone\u00a0FS mmended\u00a0dose\u00a0is\u00a04 :634\u201049 steady sufficient Bogaert\u00a0T\u00a0et\u00a0al Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0man terature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 Page\u00a0|\u00a015 edited\u00a0for\u00a0Scotland Soft\u00a0tissue\u00a0concentrations\u00a0of\u00a0ciprofloxacin\u00a0in\u00a0obese\u00a0and\u00a0lean\u00a0subjects 25:1 include\u00a0more Radcl Antimicrobial\u00a0Dosing\u00a0in\u00a0Obese\u00a0Patients pro female Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0at\u00a0\u00a0www patients\u00a0with\u00a0BMI\u00a0>35kg/m2\u00a0although\u00a0not\u00a0a\u00a0definitive\u00a0recommendation achie =IBW\u00a0+\u00a020% 2012 112\u2010118 taking Wang\u00a0E The\u00a0Cochrane\u00a0Library\u00a02013 IBW normally\u00a0as\u00a0a\u00a0once\u00a0daily\u00a0dose taking\u00a0into\u00a0account\u00a0patie Patients\u00a0already\u00a0intubated\u00a0and\u00a0sedated\u00a0may\u00a0switch\u00a0to\u00a0dexmedetomidine\u00a0with\u00a0an t\u00a0Characteristics\u00a0Accessed Continuous No\u00a0advice\u00a0on Maintenance\u00a0Dose Anderson\u00a0T\u00a0et\u00a0al is\u00a0the\u00a0weight\u00a0as\u00a0measured Due\u00a0to\u00a0variable\u00a0alterations\u00a0in\u00a0the\u00a0volume\u00a0of\u00a0distribution adipose excess\u00a0weight\u00a0over\u00a0IBW Weight The\u00a0patient\u00a0had\u00a0global\u00a0treatment\u00a0success 46 dosing\u00a0weight\u00a0tables\u00a0may\u00a0be\u00a0in Additional\u00a0Information\u00a0\u2010\u00a0Cefalosporins ry Yorst\u00a0RL :\u00a0MIC\u00a0ratio A\u00a0daily\u00a0dose\u00a0of\u00a08mg/kg\u00a0should\u00a0not\u00a0be\u00a0exceeded\u00a0in\u00a0patients\u00a0with\u00a0impaired\u00a0liver\u00a0function aminoglycosides stature Some 0242 on The\u00a0pharmacokinetics\u00a0and\u00a0safety\u00a0of\u00a0intravenous\u00a0voriconazole\u00a0\u00a0a\u00a0novel\u00a0wide\u00a0spectrum edition filtration male Accessed\u00a0at\u00a0www Ambisome\u00ae Suggest\u00a0discussing\u00a0with\u00a0local\u00a0microbiology\u00a0or\u00a0infectious\u00a0diseases See\u00a0above\u00a0for\u00a0one\u00a0case\u00a0report clinical Particularly\u00a0at\u00a0high\u00a0doses\u00a0although\u00a0there\u00a0is\u00a0limited\u00a0information western Acknow Pharmacia\u00a0Ltd parameters Doses\u00a0doubled\u00a0where\u00a0necessary a\u00a0dose\u00a0of\u00a02g\u00a0Metronidazole\u00a0at\u00a00\u00a0and\u00a048\u00a0hours desired provide\u00a0minimum\u00a0inhibitory\u00a0concentration\u00a0in\u00a090%\u00a0of\u00a0strains\u00a0tested of\u00a0piperacillin Rifmpicin 25:\u00a0634\u2010649 treatment\u00a0ranges haematologic Ciproxin\u00ae\u00a0\u00a0Bayer ideal\u00a0body\u00a0weight\u00a0where\u00a0dose\u00a0was\u00a0increased\u00a0in\u00a0proportion\u00a0to Diseases\u00a01997 Pharmacokinet\u00a02010:\u00a049 failure\u00a0if\u00a0they\u00a0were\u00a0discharged\u00a0on ukcpa and\u00a0the\u00a0authors\u00a0trust\u00a0that\u00a0the\u00a0information\u00a0provided\u00a0wil divided as\u00a0above 150kg 5Hollenstein aracteristics is No\u00a0inform A\u00a0single\u00a0200\u00a0mg\u00a0loading\u00a0dose\u00a0should\u00a0be\u00a0administered\u00a0on plus outcomes\u00a0which\u00a0may\u00a0occur\u00a0as\u00a0a\u00a0result\u00a0of\u00a0referring\u00a0to\u00a0information\u00a0contained\u00a0within\u00a0this\u00a0document Patients Radc An\u00a0Updated\u00a0Critical\u00a0Review No Akinnusi Dose\u00a0as which Gillum\u00a0JG on\u00a0metabolism\u00a0and\u00a0on\u00a0drug\u00a0handling discussed height maintains\u00a0levels\u00a0within\u00a0the\u00a0therapeutic\u00a0range comparing practitioners non\u2010obese divided\u00a0into\u00a04\u20106\u00a0doses\u00a0depending\u00a0on\u00a0the\u00a0ind rate monly variation Dosing\u00a0based\u00a0on Antimicrob\u00a0Chemother\u00a02012 No\u00a0adv Fiona\u00a0MacGregor\u00a0of\u00a0the\u00a0Royal\u00a0Alexandra\u00a0Hospital 11th\u00a0January\u00a02013 had Gla ent\u00a0which\u00a0represents\u00a0information\u00a0and\u00a0experience\u00a0of\u00a0dosing\u00a0of\u00a0drugs\u00a0in\u00a0critically\u00a0ill likely Ciprofloxacin 28 hepatic would account\u00a0when\u00a0interpreting\u00a0the\u00a0levels\u00a0if\u00a0total\u00a0phenytoin\u00a0is\u00a0measured\u00a0as\u00a0opposed\u00a0to\u00a0free 100mg\u00a0twice\u00a0daily suggested up\u00a0to\u00a01200mg/day\u00a0in\u00a0divided\u00a0doses continuous Page\u00a0|\u00a045 tions calculated morbidly 67:2957\u20102692 mg/kg\u00a0once\u00a0daily 37 Flucloxacillin\u00a0Activis\u00a0UK\u00a0Ltd lays when expectancy aureus By\u00a0intravenous\u00a0infusion\u00a0600mg\u00a0twice\u00a0daily Literature\u00a0descri hrly gender Phase Slain\u00a0D As\u00a0above\u00a0taking\u00a0renal\u00a0function\u00a0into\u00a0account adjustment\u00a0for\u00a0renal\u00a0impairment receivin Melrose becoming January\u00a02013 EBW ication so\u00a0may\u00a0negate\u00a0this adjusted\u00a0body\u00a0weight\u00a0prescribing\u00a0should\u00a0be\u00a0considered Accessed\u00a0at\u00a0\u00a0www Fiona\u00a0McIntyre\u00a0of\u00a0Ninewells\u00a0Hospital hepatic\u00a0insufficiency Lean\u00a0Body\u00a0Weight No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0obese\u00a0patients Therapeutic\u00a0Drug\u00a0Monitoring1986 74% trough sed\u00a0at range ass\u00a0index\u00a0on\u00a0therapeutic Clydebank Chen\u00a0M been\u00a0used cSSTI*\u00a0without\u00a0S antibiotics 45 micrograms/kg/h\u00a0in\u00a0order\u00a0to\u00a0achieve\u00a0the\u00a0desired\u00a0level\u00a0of\u00a0sedation women Adjusted\u00a0Body\u00a0Weight Ruth\u00a0Forrest\u00a0of\u00a0the\u00a0Western\u00a0Infirm Keith\u00a0Addie piperacillin Suppl\u00a01 available\u00a0from\u00a0this\u00a0the\u00a0manufacturer\u00a0recommends\u00a0that\u00a0all\u00a0patients\u00a0are\u00a0dosed\u00a0on abs et\u00a0al taken Cefamandole\u00a0distribution\u00a0in\u00a0serum Obese\u00a0patients\u00a0may\u00a0benefit\u00a0from\u00a0increased\u00a0dosing\u00a0and\u00a0weight\u00a0based\u00a0doses\u00a0have\u00a0been\u00a0suggested as\u00a0surgical\u00a0prophylaxis\u00a0in\u00a0operations\u00a0lasting\u00a0greater\u00a0than\u00a03\u00a0hours uk\u00a026th\u00a0June\u00a02013 Underweigh as\u00a0relev bodyweight as\u00a0per\u00a0SPC usually app consider requiring\u00a0more\u00a0aggressive\u00a0therapy ry\u00a0of\u00a0product\u00a0cha Micromedex Two\u00a0separate\u00a0studies\u00a0assessed\u00a0distribution\u00a0of\u00a0cefalosporins\u00a0given\u00a0in\u00a0obese\u00a0male\u00a0and\u00a0female\u00a0subjects bd Pamela\u00a0MacTavish\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infirmary serum Strong Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0lit This\u00a0docum of\u00a01 Male= concluded\u00a0that\u00a0BMI\u00a0had\u00a0did\u00a0not\u00a0effect\u00a0the\u00a0rate\u00a0of\u00a0recurrence\u00a0of\u00a0and\u00a0th BiaxinTM\u00a0US\u00a0Product\u00a0Information pneumocystis Benzylpenicllin This Page\u00a0|\u00a031 administered\u00a0to\u00a0normal\u00a0weight Page\u00a0|\u00a035 No\u00a0information\u00a0available\u00a0\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients Influence\u00a0of\u00a0morbid\u00a0obesity\u00a0on\u00a0the\u00a0single\u00a0dose times Kingdom concentrations\u00a0but\u00a0had\u00a0no\u00a0impact\u00a0on\u00a0adequacy\u00a0of\u00a0treatment every 40 100mg/kg\u00a0per\u00a024\u00a0hours\u00a0sulfamethoxazole\u00a0have\u00a0been\u00a0used may\u00a0reduce Dvorchick\u00a0et\u00a0al\u00a0suggest\u00a0use\u00a0of\u00a0total\u00a0body\u00a0weight\u00a0for\u00a0calculation\u00a0of\u00a0doses\u00a0is\u00a0appropriate\u00a0based\u00a0on\u00a0total r\u00a0use J\u00a0Antimicrob\u00a0Chemother clinical\u00a0judgement e\u00a0in\u00a0Scotland Underwei time\u00a0curve\u00a0was\u00a0significantly\u00a0higher\u00a0in\u00a0normal\u00a0we Greenock uk\u00a01st\u00a0August\u00a02013 Please\u00a0send\u00a0any\u00a0new Mycoses\u00a054 erature\u00a0from\u00a0manufacturer3 study BMI>18 in\u00a0Obese\u00a0patients followed ospital without unless\u00a0the\u00a0sodium\u00a0content\u00a0is\u00a0taken\u00a0into\u00a0account In true mg/kg\u00a0dosing\u00a0range\u00a0based\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0based\u00a0on\u00a0this\u00a0single\u00a0study Van\u00a0Zanten\u00a0et numb Johnson\u00a0M alone attainment\u00a0of\u00a0Ertapenem\u00a0in\u00a0normal\u2010weight 2006 Introduction\u00a0to\u00a01 remains Total\u00a0Body\u00a0Weight Ra Summary\u00a0of\u00a0product\u00a0characteristics\u00a0Accessed\u00a0at TBW ice\u00a0on\u00a0obese\u00a0patients No\u00a0advice morbidly\u00a0obese\u00a0and\u00a0matched\u00a0non\u00a0obese\u00a0subjects No\u00a0dosage\u00a0adjustments\u00a0out\u00a0with\u00a0licensed\u00a0dose\u00a0\u00a0can\u00a0be\u00a0recommended\u00a0in\u00a0either\u00a0underweight\u00a0or concentrations Summary\u00a0of\u00a0\u00a0product\u00a0characteristics if was\u00a0given\u00a01200mg\u00a0and\u00a0showed\u00a0a\u00a0lower\u00a0AUC\u00a0and was concentration 12g ww with\u00a0the and\u00a0100mg\u00a0of\u00a0sulfamethoxazole\u00a0per\u00a0kg\u00a0of\u00a0bodyweight\u00a0per\u00a0day\u00a0in\u00a0two\u00a0or\u00a0more\u00a0divided re\u00a0is\u00a0limited\u00a0e mortality\u00a0in\u00a0ICU1 Oxford Ceftriaxone/Cefalosporins No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients United specific Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Acces Mann\u00a0HJ most\u00a0common\u00a0antibiotics\u00a0prescribed\u00a0to\u00a0patients\u00a0for\u00a0this\u00a0indication\u00a0in\u00a0this\u00a0study lists Oral Summary\u00a0of\u00a0product\u00a0characteristics Sabate\u00a0A\u00a0and\u00a0Llaurado\u00a0S 51 All doses and\u00a0Del\u00a0Tacca Body\u00a0Weight proportion Flucloxacillin Flagyl\u00ae Thursky\u00a0K certain No\u00a0information\u00a0beyond\u00a0mg/kg\u00a0dosing It\u00a0is\u00a0also\u00a0suggested\u00a0that\u00a0600mg Senior\u00a0Pharmacist\u00a0Western\u00a0General\u00a0Hospital\u00a0Edinburgh Pharmacotherapy\u00a01997 Currie\u00a0A adequate from determination\u00a0of\u00a0loading\u00a0dose no\u00a0da two >30kg/m2 El\u00a0Sohl\u00a0AA treatment nor gories individual inclusion concentration\u00a0of\u00a0trough\u00a0concentrations\u00a0of\u00a04\u20105x\u00a0MIC Page\u00a0|\u00a026 intraven may It Pai\u00a0MP alan doubled upper Information\u00a0provided\u00a0does\u00a0not\u00a0provide\u00a0a\u00a0substitute\u00a0for\u00a0clinical\u00a0judgement Suggest\u00a0dosing\u00a0at\u00a0top\u00a0end\u00a0of\u00a0licensed\u00a0dose\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0ceftriaxone/\u00a0cefalosporins contained\u00a0in\u00a0the\u00a0document\u00a0can\u00a0be\u00a0kept\u00a0up\u00a0to\u00a0date Page\u00a0|\u00a07 90 DDW The\u00a0Renal\u00a0Drug\u00a0Handbook uk\u00a017th\u00a0July\u00a02013 little kg toxicity Association Radcliffe\u00a0publishing particularly\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more high previous erefore\u00a0it\u00a0was\u00a0thought r\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook critically Diane\u00a0Kennedy\u00a0of\u00a0Ayr\u00a0Hospital le\u00a0case\u00a0report\u00a0of\u00a0an\u00a0obese\u00a0patient\u00a0with\u00a0nonmeningeal\u00a0cryptococcal\u00a0infection\u00a0successfully Tazocin\u00ae Bearden\u00a0DT 10\u201015\u00a0mg/kg assessed\u00a0against\u00a0a\u00a0target increasingly United\u00a0Kingdom Clindamycin\u00a0dosage\u00a0modification\u00a0not\u00a0usually\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0renal/hepatic v1 but\u00a0a\u00a0value\u00a0of\u00a00 Licensed seen TBW\u00a0x\u00a01 No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0these\u00a0patients who statistical Half\u2010life\u00a0is\u00a0dependent\u00a0on\u00a0renal\u00a0function bgroup uk\u00a029th\u00a0May\u00a02013 *\u00a0cSSTI\u00a0=\u00a0complicated\u00a0skin\u00a0and\u00a0soft\u00a0skin\u00a0infection\u00a0\u00a0**\u00a0RIE\u00a0=\u00a0right\u00a0sided\u00a0infective\u00a0endocarditis 6%\u00a0of\u00a0an\u00a08\u00a0hour\u00a0dosing\u00a0interval\u00a0respectively Summary/Comm organisms Antimicrobial 4mg/kg in\u00a0in\u00a0moderately\u00a0obese Antimicrobial\u00a0Agents\u00a0and Slight Analysis 4\u00a0+ approximately patients\u00a0receiv in\u00a0available\u00a0literature\u00a0for\u00a0normal\u00a0BMI No\u00a0specific\u00a0advice\u00a0on\u00a0underweight\u00a0or\u00a0obese\u00a0patients were Page\u00a0|\u00a024 Klaricid\u00ae Genus\u00a0Pharmaceuticals st\u00a0\u00a0Edition 35 Lean No\u00a0information\u00a0available maintained We\u00a0would\u00a0like\u00a0to\u00a0acknowledge\u00a0the\u00a0contribu Wolff\u00a0F\u00a0et\u00a0al Barreiro\u00a0G appropriate Clindamycin does rred\u00a0to\u00a0as\u00a0the\u00a0Actual 2g\u00a0in\u00a0two 75 0\u00a0mg/kg\u00a0of\u00a0body\u00a0weight s* decision order\u00a0to\u00a0achieve\u00a0the\u00a0same\u00a0tissue\u00a0concentrations\u00a0as\u00a0those\u00a0achieved\u00a0in\u00a0lean\u00a0subjects\u00a0although dose\u00a020mg\u00a0of\u00a0trimethoprim SACCPN Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment ce\u00a0versa cute\u00a0infections\u00a0960mg\u00a0every\u00a012\u00a0hours considerably 66%\u00a0of\u00a0those\u00a0reported However\u00a0they uk insufficiency Another\u00a0study\u00a0also\u00a0noted\u00a0that\u00a0Pharmacokinetic\u00a0parameters\u00a0in\u00a0pregnant\u00a0patients\u00a0were\u00a0not\u00a0significantly Rakesh\u00a0Kishore\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infir at\u00a0www Predicted =\u00a0\u221a Personal\u00a0communication\u00a0with\u00a0medical\u00a0information\u00a0department but\u00a0there\u00a0is\u00a0currently AUC Roberts\u00a0et\u00a0al\u00a0assessed\u00a0therapeutic\u00a0drug\u00a0monitoring\u00a0of\u00a0beta\u00a0lactam\u00a0antibiotics Co\u2010Trimoxazole however\u00a0specialist\u00a0consensus\u00a0advocates\u00a0the\u00a0use\u00a0of\u00a0the\u00a0DDW\u00a0equation CMax\u00a058%\u00a0and\u00a0AUC equations Presented\u00a0at\u00a045th\u00a0Interscience\u00a0conference\u00a0on\u00a0Antimicrobial\u00a0Agents\u00a0and Roberts\u00a0MS\u00a0et\u00a0al International\u00a0Journal\u00a0of\u00a0Antimicrobial\u00a0Agents\u00a02010 On\u00a0behalf\u00a0of\u00a0the\u00a0Scottish\u00a0Adult\u00a0Critical\u00a0Care\u00a0Pharmacists\u00a0Network are 400mg Actual\u00a0body\u00a0weight\u00a0\u00a0Ideal\u00a0body\u00a0weight s\u00a0clinical\u00a0response Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufactu manufacturer Lui\u00a0P\u00a0et\u00a0al\u00a0Pharmacokinetics\u00a0of\u00a0anidulafungin\u00a0in\u00a0adult\u00a0intensive\u00a0care\u00a0patients Dvorchick\u00a0BH Summary\u00a0of\u00a0SACCPN\u00a0li first\u00a024\u00a0hours 30:18\u201032 3rd\u00a0edition Higher\u00a0doses\u00a0as\u00a0per\u00a0SPC\u00a0depending\u00a0on\u00a0indication followed\u00a0by\u00a0100\u00a0mg\u00a0daily\u00a0thereafter 10 association accessed\u00a07 Papasavas\u00a0P\u00a0K Journal\u00a0of\u00a0Infection\u00a02012 Ashley\u00a0C both there not not\u00a0been\u00a0systematically\u00a0evaluated\u00a0for\u00a0safety\u00a0or\u00a0efficacy\u00a0in\u00a0extremes\u00a0of\u00a0body\u00a0weight ght\u00a0patients Rodvold\u00a0K Page\u00a0|\u00a013 Usual\u00a0adult\u00a0dosage\u00a0250mg\u00a0to\u00a01g\u00a0four\u00a0times\u00a0daily recurrence iffe\u00a0Publishing ceftriaxone 216\u00a0x\u00a0BMI SPC Introduction FFM The\u00a0manufacturer\u00a0provides\u00a0no\u00a0specific\u00a0advice No\u00a0additional\u00a0information\u00a0supplied\u00a0from\u00a0the\u00a0SPC Personal\u00a0communication\u00a0with\u00a0Julie\u00a0Booth Acknowledgements Clin\u00a0Pharmacol\u00a0Ther\u00a01993 Page\u00a0|\u00a033 ccessed\u00a0\u00a0at >100kg\u00a0and\u00a0BM surge Comparative\u00a0pharmacokinetics\u00a0and\u00a0pharmacodynamic\u00a0target intra\u2010abdominal 25:112\u20108 good obese\u00a0patients sing\u00a0advice\u00a0has\u00a0been\u00a0found\u00a0and\u00a0the\u00a0references\u00a0all\u00a0linked\u00a0back\u00a0to\u00a0the\u00a0same\u00a0case staphylococci pharmacodynamics Infections:\u00a02\u20104g\u00a0daily initial\u00a0infusion\u00a0rate\u00a0of adult ans\u00a0up\u00a0to\u00a01200mg/day\u00a0in\u00a0divided\u00a0doses No\u00a0change\u00a0recommended\u00a0to\u00a0standard\u00a0dosing\u00a0regimen Diflucan\u00ae Doses\u00a0of\u00a0<10mg/24\u00a0hours\u00a0have\u00a0demonstrated\u00a0worse\u00a0outcomes\u00a0in\u00a0obese\u00a0patients Cmax/MIC and\u00a0vi individuals They 27 that\u00a0the\u00a0efficacy\u00a0of\u00a0Metronidazole\u00a0was\u00a0similar\u00a0among\u00a0different\u00a0BMI\u00a0cate Clin medicines Meropenem\u00a01g\u00a0dosed\u00a0to\u00a09\u00a0obese\u00a0female\u00a0patients three\u00a0or\u00a0four\u00a0divided\u00a0doses recommended Underweight\u00a0patients es February\u00a02013 Senior\u00a0Clinical\u00a0Pharmacist /\u00a03600 drugs ABW Invanz\u00ae The\u00a0renal\u00a0drug\u00a0handbook increased Anaesthesia\u00a02011 indication Suppl\u00a0S2 cellulitis to\u00a0es clindamycin This\u00a0is\u00a0sometimes\u00a0refe should similar maximum Underweight\u00a0patien Summary\u00a0of\u00a0product\u00a0cha route Weig ves in\u00a0non\u2010pregnant\u00a0women\u00a03 Arch including\u00a0diabetes\u00a0and\u00a0hypertension 7th 66:\u00a0721\u00a0\u2010\u00a0725 Author\u00a0suggests dosing\u00a0should\u00a0be\u00a0at\u00a0the\u00a0upper\u00a0end\u00a0of\u00a0the\u00a0higher\u00a0end\u00a0of\u00a0the\u00a0recommended Martin\u00a0C 2012\u00a0Dec useful Dosing\u00a0for\u00a0penicillins 2\u00a0to\u00a01 As\u00a0above intravenous\u00a0linezolid\u00a0in\u00a0moderately\u00a0to\u00a0morbidly\u00a0obese\u00a0adults ed\u00a0to\u00a0obese\u00a0subjects Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepati patients\u00a0under\u00a040kg\u00a0or dose\u00a0based\u00a0on\u00a0indication body\u00a0weight t\u00a0Characteristics 45\u00a0x\u00a0\u00a0excess\u00a0body\u00a0weight Critical\u00a0Care\u00a0Medicine No\u00a0dosing\u00a0advice\u00a0found Dumfries\u00a0and\u00a0Galloway\u00a0Royal\u00a0Infirmary 152 Strep concentration\u2010 Orion\u00a0contacted %T>MIC EB Ideal\u00a0versus\u00a0corrected\u00a0body\u00a0weight\u00a0for\u00a0dosage\u00a0of\u00a0sugammadex Luque\u00a0S morbidly\u00a0obese\u00a0patients bacteraemia penicillins Acc but com 600mg\u00a0to\u00a03600mg\u00a0daily 20:869\u2010873 they\u00a0provide\u00a0a\u00a0number\u00a0of\u00a0references Page\u00a0|\u00a038 ight\u00a0in\u00a0anidulafungin\u00a0group\u00a0ranged\u00a0from\u00a035\u00a0kg\u00a0to\u00a0196 Information\u00a0from\u00a0guidelines: as\u00a0does\u00a0the\u00a0o GlaxoSmithKline\u00a0Ltd Dosing Pat accepted\u00a0for\u00a0any\u00a0inaccuracies\u00a0or\u00a0misstatements\u00a0of\u00a0fact\u00a0contained\u00a0herein pneumoniae levofloxacin ciprofloxacin accept\u00a0that\u00a0this\u00a0may\u00a0lead\u00a0to\u00a0an\u00a0increased\u00a0risk\u00a0of\u00a0adverse\u00a0effect height\u00a0and\u00a0weight found 439\u2010447 ensure Pfizer\u00a0Summary\u00a0of\u00a0Product\u00a0Characteristics method philic Ideal\u00a0body\u00a0weight\u00a0+\u00a00 descriptors\u00a0for\u00a0drug Page\u00a0|\u00a029 Janson\u00a0B meta\u2010analysis Page\u00a0|\u00a037 PTC and\u00a0by\u00a0anecdotal\u00a0experience\u00a0of\u00a0pharmacists\u00a0working\u00a0within\u00a0critical\u00a0car 14th\u00a0June\u00a02013 IBW\u00a0for\u00a0males companied\u00a0by\u00a0hepatic However\u00a0complications\u00a0of\u00a0obesity ertapenem Carron\u00a0M\u00a0Freo\u00a0U\u00a0Parotto\u00a0E\u00a0and\u00a0Ori\u00a0C atient\u00a0weight\u00a0has\u00a0ranged\u00a0from\u00a034kg\u00a0to\u00a0200kg suicide identified 600mg Amphotericin justed\u00a0dosing\u00a0and\u00a0therefore\u00a0no\u00a0firm\u00a0recommendation nt\u00a0ranges be\u00a0used produced and\u00a0increased\u00a0stepwise J\u00a0crit\u00a0care\u00a02008 In\u00a050\u00a0%\u00a0of\u00a0patients\u00a0a\u00a0dose\u00a0increase\u00a0was\u00a0required\u00a0to\u00a0attain\u00a0concentration\u00a0targets\u00a0whilst\u00a0in\u00a024%\u00a0of\u00a0patients tissue\u00a0infections\u00a0in\u00a0obese Page\u00a0|\u00a034 5g\u00a06hrly\u00a0dependent\u00a0on\u00a0renal\u00a0function tor\u00a0in\u00a0order\u00a0to\u00a0ensure\u00a0sufficiently\u00a0high\u00a0exposure\u00a0to\u00a0anidulafungin adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook Page\u00a0|\u00a047 licable No\u00a0info ill Metronidazole patients per Adults\u00a0and\u00a0adolescents pathogen 45: normal\u2010weight Joanne\u00a0Berrich\u00a0of\u00a0Inverclyde\u00a0Royal\u00a0H separate et Dosing\u00a0for\u00a0iv\u00a0weight\u00a0based Dosage response\u00a0to\u00a0bac in\u00a0the\u00a0clinical\u00a0studies\u00a0ranged\u00a0from\u00a0very\u00a0low\u00a0birth\u00a0weight\u00a0neonates\u00a0to\u00a0adults\u00a080kg+ Pieracci\u00a0FM as\u00a0relevant 67:\u00a0298\u00a0\u00a0299 for\u00a0adults e\u00a0daily\u00a0by\u00a0the\u00a0intravenous results The\u00a0correct\u00a0dosing\u00a0for\u00a0sugammadex\u00a0in\u00a0morbidly\u00a0obese\u00a0patients c\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook adequate\u00a0concentrations Nafziger\u00a0AN lack ide Page\u00a0|\u00a044 Principal\u00a0Pharmacist April\u00a02013 liffe\u00a0Publishing the\u00a0two 3% This\u00a0patient\u00a0was\u00a0excluded\u00a0from\u00a0the\u00a0summary\u00a0statistics particularly a\u00a0dosage\u00a0decrease\u00a0was\u00a0required orption Personal\u00a0communication\u00a0with\u00a0Sanofi\u2010Aventis\u00a02nd\u00a0April\u00a02013 soft d\u00a0literature\u00a0from\u00a0manufacturer MBW The\u00a0duration\u00a0of\u00a0therapy\u00a0should\u00a0be values tall\u00a0thin\u00a0people\u00a0or\u00a0muscular\u00a0people Appropriate\u00a0to\u00a0dose\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0ensuring\u00a0appropriate\u00a0monitoring\u00a0for\u00a0toxicity\u00a0and\u00a0dose Body\u00a0Surface\u00a0Area Yet standard Titrate\u00a0dose\u00a0according\u00a0to\u00a0response e\u00a0patients BMI Page\u00a0|\u00a011 Suggest\u00a0dosing\u00a0at\u00a0top\u00a0end\u00a0of\u00a0licensed\u00a0dose\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0ceftriaxone/\u00a0cefalosporins\u00a0taking\u00a0into maintain achieve Phase\u00a03\u00a0data\u00a0showed\u00a0we dosing pharmacokinetic\u00a0disposition\u00a0in\u00a0a\u00a0morbidly\u00a0obese\u00a0patient Albumin\u00a0and\u00a0renal\u00a0function\u00a0should\u00a0be\u00a0taken\u00a0into Ltd\u00a0Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed obese\u00a0pat 5g No\u00a0information\u00a0beyond\u00a0standard\u00a0mg/kg\u00a0dosing However assessing common ccessed\u00a0at\u00a0www neous Alison\u00a0Carruthers\u00a0of\u00a0Borders\u00a0General gov/ct2/show/record/NCT01517815\u00a0accessed\u00a011th\u00a0April\u00a02013 Summary\u00a0of\u00a0SA 65:128\u2010134 Page\u00a0|\u00a027 Radcliffe\u00a0Publishing 131 Risk\u00a0factors\u00a0for\u00a0clinical\u00a0failure\u00a0in\u00a0patients\u00a0hospitalise Crystapen\u00ae C\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook s\u00a0resulted\u00a0in\u00a0increased\u00a0gastrointestinal\u00a0side\u00a0effects however\u00a0a\u00a02013 B\u00a0British\u00a0National\u00a0Formulary\u00a0recommends is\u00a0rarely\u00a0used\u00a0for\u00a0dosing http://clinicaltrials 0mg suggest\u00a0mg/kg\u00a0dosing\u00a0as\u00a0above at proposed mary Buchwald\u00a0H Antimicrobial\u00a0Dosing ai\u00a0et\u00a0al\u00a0also\u00a0noted\u00a0that\u00a0use\u00a0of\u00a0total\u00a0body\u00a0weight\u00a0to\u00a0calculate\u00a0resulted\u00a0in\u00a0higher\u00a0Cmax\u00a0and 212 be Ltd\u00a04th\u00a0December\u00a02012 when\u00a0compared been bd\u00a0is\u00a0better\u00a0than\u00a0400mg\u00a0tds\u00a0as\u00a0this\u00a0improves s\u00a0response Merck\u00a0Sharp\u00a0and\u00a0Dohme\u00a0Ltd\u00a0Summary\u00a0of\u00a0Product\u00a0Ch mass weight No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0obese\u00a0pat Dosing\u00a0of\u00a0Antibiotics\u00a0in\u00a0Obesity total orations 13\u201017\u00a0years\u00a0of\u00a0age Abbott\u00a0Healthcare\u00a0ProductsP\u00a0Ltd single there\u00a0is\u00a0an\u00a0assumption\u00a0that\u00a0the\u00a0Excess\u00a0Body\u00a0Weight 2011 www very\u00a012 this Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manu Page\u00a0|\u00a08 xtrem USA in Loading\u00a0dose in\u00a0criticall IL 15:251\u20103 particularly\u00a0for\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more\u00a0severe\u00a0infec The\u00a0higher\u00a0dose\u00a0was\u00a0at Geiseler\u00a0PJ\u00a0et\u00a0al\u00a0Am\u00a0Rev\u00a0Respir\u00a0Dis\u00a01985 more\u00a0than\u00a0IBW underweight supported Tygacil\u00ae actual\u00a0body\u00a0weight p634\u00a0\u2010\u00a0649 adipose\u00a0tissue\u00a0and\u00a0wound\u00a0drainage\u00a0in GFR Hospital given\u00a0onc Summary/ some 31 principles ratio Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0\u00a0\u00a0Acces BMI>40 stated erature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer daily appear\u00a0to 25:233\u2010237 Victoria\u00a0Infirmary or\u00a0may\u00a0increase\u00a0it2\u00a0The\u00a0latter\u00a0paper\u00a0provides\u00a0a\u00a0review\u00a0of\u00a0the\u00a0effects\u00a0of\u00a0obesity Western ofloxacin\u00a0disposition\u00a0in\u00a0obesity especially ight collation :1023\u20101026 AUC\u00a0values\u00a0in\u00a0morbidly\u00a0obese\u00a0subjects\u00a0than\u00a0in\u00a0normal\u00a0weight\u00a0subjects\u00a0with\u00a0similar\u00a0creatinine\u00a0clearance Sugammadex popula body Body\u00a0W adjustm P=0 data Novartis\u00a0Pharmaceutical\u00a0UK\u00a0Ltd added\u00a0to\u00a0give\u00a0adjusted\u00a0body\u00a0weight Care Janson\u00a0B\u00a0and\u00a0Thursky\u00a0K until Advise\u00a0to\u00a0titrate\u00a0dose\u00a0according\u00a0to normal Calculate\u00a0ideal\u00a0body provide to\u00a03 where an Astra\u00a0Zeneca\u00a0\u00a0Summary\u00a0of\u00a0Product\u00a0\u00a0Characteri *Refers\u00a0to\u00a0patients\u00a0aged\u00a015\u00a0years\u00a0and\u00a0older Page\u00a0|\u00a018 56 based Male\u00a0and\u00a0Female\u00a0Subjects Anaesthesia\u00a02012 or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook adults AdjBW cefalosporins infections Dundee preference including\u00a0in\u00a0patients\u00a0with\u00a0neutropenia\u00a0which\u00a0would\u00a0suggest\u00a0reducing\u00a0the\u00a0dose\u00a0in severe\u00a0infections\u00a02\u20104g Ideal\u00a0Body\u00a0Weight patient\u2019s literat Cochrane Hites\u00a0et\u00a0al\u00a0attempted\u00a0to\u00a0validate\u00a0the\u00a0use\u00a0of\u00a0the\u00a0formula\u00a0by\u00a0carrying\u00a0out\u00a0a\u00a0therap Keith 30 extremes\u00a0of\u00a0body starting so\u00a0an\u00a0adjustment\u00a0factor\u00a0is\u00a0sometimes ently guidance group Ceftriaxone site\u00a0of\u00a0the\u00a0infection ICAAC however facturer Mastrobattista\u00a0JM pregnan armacology authors TBW\u00a0x\u00a00 adequate\u00a0levels\u00a0in\u00a0subcutaneous\u00a0adipose\u00a0tissue\u00a0which\u00a0may\u00a0be\u00a0relevant\u00a0when\u00a0they\u00a0are\u00a0used\u00a0as\u00a0surgical although\u00a0mg/kg\u00a0dosing\u00a0could No\u00a0specific\u00a0advice\u00a0available\u00a0for\u00a0underweight\u00a0patients ay at\u00a0least\u00a01\u20102\u00a0post\u2010 however\u00a0no\u00a0liability\u00a0can\u00a0be ary subsequent rer2 Merck\u00a0Sharp\u00a0and\u00a0Dohme\u00a0Ltd 65kg\u00a0person\u00a0depending\u00a0on\u00a0infection Contents Dexdor\u00ae eutic\u00a0drug\u00a0monitoring Dosage\u00a0in\u00a0adults:\u00a05mg/kg\u00a0every\u00a08\u00a0hours\u00a0or\u00a010mg/kg\u00a0in\u00a0immuno urs informed Hollenstein\u00a0UM\u00a0et\u00a0al nt\u2019s\u00a0renal daily\u00a0doses\u00a0of\u00a0up\u00a0to\u00a02g cuta with\u00a0normal\u00a0weight\u00a0patients every\u00a012\u00a0hours Page\u00a0|\u00a014 IBW\u00a0for\u00a0females reported\u00a0as24g/day\u00a0N in\u00a0adults enance\u00a0dose\u00a05\u00a0mg/kg\u00a0daily will \u226440kg Septrin\u00ae Background saying =\u00a0IBW\u00a0+\u00a00 tti \u2010ideal Dosing\u00a0as\u00a0above manufacturer: herpes\u00a0encephalitis ta\u00a0available\u00a0from\u00a0manufacturer\u00a0in\u00a0obese\u00a0patients risk document: BMI>35kg/m2 Adult\u00a0patients\u00a0\u226440kg\u00a0received\u00a0a When\u00a0using\u00a0IBW 5g\u00a0every\u00a08\u00a0hrs beta on\u00a0drug\u00a0handling Underw ataxia\u00a0and\u00a0slight\u00a0disorientation An Martyn\u00a0Gall :2546\u20102553 comparable since In\u00a0a\u00a0compassionate\u00a0use\u00a0programme\u00a0of\u00a0adult\u00a0patients BMI\u00a0>40\u00a0were\u00a0risk\u00a0factors\u00a0for\u00a0treatment\u00a0failure\u00a0in\u00a0patients\u00a0treated\u00a0with\u00a0co\u2010trimoxazole\u00a0and 25\u00b5g/ml: however\u00a0it\u00a0is\u00a0important\u00a0to\u00a0remembe No\u00a0information\u00a0on\u00a0underweight\u00a0patients\u00a0however Voricoonazole editions ere\u00a0discharged\u00a0on\u00a0a\u00a0low\u00a0oral\u00a0dose\u00a0of\u00a0clindamycin\u00a0or\u00a0co\u2010trimoxazole BSA Predicted\u00a0Normal\u00a0Weight dependent following\u00a0rocuronium\u00a0or\u00a0vecuronium\u00a0induced Greenblatt\u00a0DJ essed\u00a0via Ertapenem Publishing regimens dose\u00a0of\u00a010mg/kg\u00a0every\u00a012\u00a0hours outcom using\u00a0Ideal\u00a0Body\u00a0Weight\u00a0in\u00a0obese\u00a0patients\u00a0taking\u00a0renal\u00a0function\u00a0in Mean between r\u00a0that\u00a0metabolism\u00a0is attainment Page\u00a0|\u00a01 Pfizer\u00a0Medical\u00a0Information wound life 29th\u00a0May\u00a02013 difference\u00a0between\u00a0the\u00a0concentrations\u00a0achieved\u00a0in\u00a0normal\u00a0weight\u00a0and\u00a0morbidly\u00a0obese\u00a0subjects generations CCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer 36:332\u201039 http://www C\u00a0max Reversible\u00a0bone\u00a0marrow\u00a0depression\u00a0by\u00a0high\u2010dose Dillmans\u00a0B that overdosages compassionate\u00a0use\u00a0programme\u00a0adult\u00a0patients\u00a0who\u00a0weighed\u00a0more\u00a0than\u00a040kg\u00a0were\u00a0treated\u00a0at\u00a0a\u00a0dose\u00a0of ients Continuous\u00a0versus\u00a0intermitte The\u00a0conclusion\u00a0was\u00a0that\u00a0the\u00a0fluconazole\u00a0dose\u00a0should\u00a0be\u00a0based\u00a0on\u00a0the ve\u00a0good\u00a0clinical\u00a0results Female= and\u00a04\u00a0\u00a05\u00a0mg/kg/dose 112 adults\u00a0is\u00a0an\u00a0initial\u00a0dose\u00a0of\u00a0100\u00a0mg\u00a0followed\u00a0by\u00a050\u00a0mg\u00a0every\u00a012\u00a0hours Use\u00a0total\u00a0body\u00a0weight renal Second\u00a0edition\u00a0update to\u00a0account supratherapeutic Fluconazole Many\u00a0Thanks Barie\u00a0PS ased\u00a0on\u00a0the\u00a0study\u00a0findings\u00a0the\u00a0authors\u00a0recommended\u00a0no\u00a0change\u00a0in\u00a0the Page\u00a0|\u00a06 com/pdf/biapi Formula Standard\u00a0therapeutic\u00a0dosage:\u00a01g\u00a0once\u00a0daily relates volume piperacillin\u00a0not\u00a0licensed\u00a0in\u00a0the tds pharmacodynamic Page\u00a0|\u00a036 process Summary\u00a0of\u00a0Produc Pharmacological make Bridion\u00ae Am\u00a0L\u00a0Perinatol\u00a02008 The\u00a0follow Calculated\u00a0percentage\u00a0of\u00a0time\u00a0above\u00a0minimum\u00a0inhibitory\u00a0concentration :354\u2010358 Very\u00a0obese\u00a0individuals\u00a0will\u00a0require\u00a0large\u00a0absolute\u00a0loading\u00a0doses\u00a0of\u00a0phenytoin\u00a0to Pharmacokinetics\u00a0and\u00a0safety\u00a0of\u00a0voriconazole\u00a0following\u00a0intravenous\u00a0to\u00a0oral\u00a0dose\u00a0escalation glomerular to\u00a0single significant :75/121 Pharmacokinetics\u00a0of Dosing\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook Personal\u00a0correspondence\u00a0with\u00a0Gilead\u00a0Medical\u00a0Information\u00a011th\u00a0July We\u00a0hope\u00a0that\u00a0you available\u00a0from\u00a0manufacturer widely Suggest\u00a0discuss\u00a0each\u00a0patient\u00a0with\u00a0local\u00a0microbiology/infectious\u00a0diseases information\u00a0contained\u00a0in\u00a0this\u00a0doc Page\u00a0|\u00a032 overall\u00a0effect\u00a0however Summary\u00a0of\u00a0product\u00a0characteristics\u00a0for\u00a0individual\u00a0normal\u00a0human\u00a0immunoglobulin\u00a0products Actual\u00a0Body\u00a0Weigh 1g case Claire\u00a0McMaster\u00a0of\u00a0the\u00a0Golden\u00a0Jubilee\u00a0National\u00a0Hospital suggest effect\u00a0in\u00a0all\u00a0patients suggesting\u00a0there\u00a0is\u00a0no\u00a0pharmacokinetic\u00a0justification\u00a0for\u00a0dose\u00a0adjustment\u00a0based The\u00a0effect\u00a0of\u00a0body\u00a0m relative st noted actual sive\u00a0care\u00a0unit\u00a0setting There Nicolau\u00a0D\u00a0P\u00a0and\u00a0Kuti\u00a0J\u00a0L 2\u20109 prescribed Itozaku\u00a0G start initial Gilead Accessed\u00a0at equivalent\u00a0to\u00a012mg/kg\u00a0in\u00a0a Page\u00a0|\u00a020 Bearden\u00a0et\u00a0al\u00a0assessed\u00a0the\u00a0pharmacokinetics\u00a0of\u00a0Meropenem\u00a0administer Koselke\u00a0et\u00a0al Aciclovir hydrophilic Single Sanofi PN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer 600mg\u00a0twice\u00a0daily\u00a0was\u00a0sufficient\u00a0for\u00a0the\u00a0treatment\u00a0of\u00a0skin\u00a0and\u00a0soft uk\u00a027th\u00a0June\u00a02013 Agents\u00a0and\u00a0Chemotherapy\u00a02006 Antimicrobial\u00a0agents\u00a0and\u00a0chemotherapy\u00a02007 context Hites\u00a0M Australia take replies direct skin 12 so\u00a0are\u00a0in\u00a0theory\u00a0are\u00a0good\u00a0models\u00a0for\u00a0drugs\u00a0that\u00a0are\u00a0highly\u00a0hydro the\u00a0dose\u00a0may\u00a0be\u00a0increased\u00a0to Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0an y\u00a0ill\u00a0patients Grau\u00a0S 25 value children 34:\u00a0p1796\u20101804 adequate\u00a0drug\u00a0exposure\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0organisms\u00a0with\u00a0a\u00a0minimum\u00a0inhibitory\u00a0concentration within erature\u00a0from\u00a0manufacturer factor and\u00a0cutane abscess Purkin\u00a0et\u00a0al\u00a0Antimicrob\u00a0Agents\u00a0Chemother\u00a02002 Rocephin\u00aeRoche dcliffe\u00a0Publishing nor\u00a0for\u00a0any\u00a0patient\u00a0or\u00a0clinical ence\u00a0for\u00a0ideal\u2010body\u2010weight\u2010ad Literature\u00a0search\u00a0yielded\u00a0little\u00a0results ce ight\u00a0subjects\u00a0than\u00a0in\u00a0clinically\u00a0obese\u00a0subjects 54 4\u00a0is Antimicrobial\u00a0Agents\u00a0and\u00a0Chemotherapy\u00a02013 basis Curr\u00a0Fungal\u00a0Infect cohort\u00a0study peak ter\u00a0spp\u00a0and\u00a0Pseudomonas\u00a0aeruginosa 24 alters Linezolid America\u00a0and\u00a0the\u00a0UK\u00a0use\u00a0the\u00a0equations\u00a0below:\u00a0Note\u00a0this\u00a0is\u00a0different\u00a0from\u00a0the\u00a0equations\u00a0shown\u00a0on\u00a0p4 Calculation\u00a0of\u00a0creatinine\u00a0clearance\u00a0using\u00a0the\u00a0Cockcroft\u00a0&\u00a0Gault Department\u00a0of\u00a0Health Page\u00a0|\u00a04 by Erstad\u00a0B antifungal\u00a0agent Page\u00a0|\u00a039 23rd\u00a0November\u00a02012 and\u00a0Pharmaceutical\u00a0Press the\u00a0dose\u00a0should\u00a0be\u00a0rounded\u00a0down\u00a0to\u00a0the\u00a0nearest\u00a0vial obese\u00a0and\u00a0extremely\u00a0obese\u00a0adults above taking\u00a0into\u00a0account\u00a0renal\u00a0and\u00a0hepatic\u00a0function\u00a0as\u00a0above Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0A Children3 twice Pharmacology/\u00a0kinetics commence 0\u00a0mg/kg 90S recommendation 0183 CRRT 2g\u00a03 Descriptor Page\u00a0|\u00a021 prophylaxis weight\u00a0in t\u00a0patients immunoglobulin\u00a0use2 guidelines uk\u00a06th\u00a0September\u00a02013 Characteristics\u00a0Accessed\u00a0\u00a0at review Summary\u00a0of\u00a0product\u00a0characteristics\u00a0Ceftr >100kg\u00a0and consequ prevalent No\u00a0information\u00a0available\u00a0for\u00a0dosing\u00a0in\u00a0underweight\u00a0patients Itokazu\u00a0G Voriconazole included\u00a0some\u00a0of\u00a0the\u00a0commonly\u00a0used\u00a0medicines\u00a0used\u00a0within\u00a0critical\u00a0care\u00a0areas 22 body\u00a0mass\u00a0in\u00a0clinical\u00a0trials\u00a0=\u00a080 No\u00a0spe Clarithromycin Page\u00a0|\u00a05 No\u00a0strong\u00a0evidence 5\u00a0+ and\u00a0there\u00a0is\u00a0very\u00a0little\u00a0validation\u00a0for\u00a0the\u00a0use\u00a0of\u00a0any\u00a0of\u00a0these Disposition\u00a0of\u00a0Cefotaxime\u00a0and\u00a0its\u00a0Desacetyl\u00a0Metabolite\u00a0in\u00a0Morbidly\u00a0Obese tissue therapeutic 8g\u00a0daily\u00a0\u00a0divided\u00a0doses x\u00a0TBW Carey\u00a0JC Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook Obese\u00a0patients\u00a0may\u00a0benefit\u00a0from\u00a0increased\u00a0dosing\u00a0for\u00a0the\u00a0loading\u00a0dose\u00a0using\u00a0a\u00a0weight\u00a0of used No\u00a0specific\u00a0\u00a0advice\u00a0available \u201056 dose uk\u00a08th\u00a0February\u00a02013 consequently I\u00a0>40\u00a0were\u00a0risk\u00a0factors\u00a0for\u00a0treatment\u00a0failure\u00a0in\u00a0patients\u00a0treated\u00a0with\u00a0co\u2010trimoxazole\u00a0and Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC 44 Suggest\u00a0dosing\u00a0at\u00a0upper\u00a0end\u00a0of\u00a0range\u00a0where\u00a0appropriate Intravenous\u00a0cipr severe Lancker give 66 higher British\u00a0National\u00a0Formulary\u00a065 mg/kg\u00a0dosing\u00a0could\u00a0be\u00a0used continue Wurz\u00a0R No\u00a0specific\u00a0do tion Intravenous lower monographs\u00a0in\u00a0future\u00a0editions 6mg/kg out regimens\u00a0based\u00a0on\u00a0the\u00a0correction\u00a0formula\u00a0only\u00a0slightly Damphousse\u00a0D Wt/\u00a0height Ja 800mg CCPN\u00a0literature\u00a0review\u00a0and\u00a0recommendations\u00a0from\u00a0Clinical\u00a0guidelines\u00a0for Effect\u00a0of\u00a0obesity\u00a0on\u00a0critical\u00a0care\u00a0morbidity\u00a0and\u00a0mortality:\u00a0a 6\u00a0mg/kg\u00a0once\u00a0daily Di\u00a0Paolo MIC limited DWCF*x\u00a0EBW and\u00a0relevant\u00a0to\u00a0clinical\u00a0practice As pharmacokinetics\u00a0of\u00a0daptomycin Wurtz\u00a0R any years Montpelier uk\u00a012th\u00a0March\u00a02013 UKCPA: frail Usual\u00a0recommended\u00a0dose\u00a0500mg\u00a0once\u00a0or\u00a0twice\u00a0daily\u00a0depending\u00a0on\u00a0indication iaxone extremities product Personal\u00a0correspondence\u00a0with\u00a0Abbott eight\u00a0patients Aspen\u00a0Global hours receiving Ecalta\u00ae amphotericin Immunoglobulin adjustment for\u00a0the +4 Dosing\u00a0of\u00a0medications\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0in\u00a0the\u00a0intensive\u00a0care\u00a0unit\u00a0setting 5\u00a0I retrospective from\u00a0considering\u00a0dosing\u00a0in\u00a0children There\u00a0is\u00a0little\u00a0information\u00a0about\u00a0dosing\u00a0adjustments\u00a0in\u00a0significantly\u00a0underweight Morag\u00a0Naysmith voriconazole particularly\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more\u00a0severe\u00a0infections negative Summary\u00a0of\u00a0SAC Clinical\u00a0Infectious Adams\u00a0VR\u00a0and\u00a0Morehead\u00a0AR Cook\u00a0AM did careful as constant DiBaisio\u00a0A Dosing\u00a0of\u00a0antibiotics\u00a0in\u00a0obesity was\u00a0used therefore Much clinical\u00a0trials though in\u00a0excess\u00a0of\u00a00 Suggest\u00a04 mation\u00a0more\u00a0readily 40kg* Tigecycline 6680\u00a0+ trimethoprim Personal\u00a0communication\u00a0with\u00a0Pfizer\u00a0January\u00a02013 distribution r\u00a0lacked\u00a0the\u00a0statistically\u00a0significant\u00a0data\u00a0on\u00a0outcomes\u00a0which\u00a0could Clinical\u00a0Infectious\u00a0Diseases\u00a01997 daptomycin Lavoie\u00a0S\u00a0et\u00a0al 41 treated Curr\u00a0Opin\u00a0In subjects Accessed &\u00a0Currie carried 33 mg/kg\u00a0dosing\u00a0can\u00a0be\u00a0used\u00a0as\u00a0above 20 of Summary\u00a0of\u00a0Product\u00a0Characteri prov centres Norenberg\u00a0JP made :708 use Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer Roberts\u00a0JA future eed regimen 2` available\u00a0on\u00a0modification\u00a0of\u00a0dosage those 5g\u00a06\u00a0hrly Therapy\u00a0is\u00a0usually\u00a0instituted\u00a0at\u00a0a\u00a0daily\u00a0dose mg/kg least\u00a0the\u00a0reappearance\u00a0of\u00a0T2\u00a0following\u00a0rocuronium these\u00a0changes\u00a0had\u00a0little\u00a0effect\u00a0on\u00a0T>MIC July\u00a02012 Body\u00a0Surface\u00a0Area\u00a0is\u00a0mainly\u00a0used\u00a0in\u00a0cancer\u00a0chemotherapy The\u00a0pharmacokinetics\u00a0of\u00a0Daptomyc impact Obesity substitute Peter\u00a0Buckner\u00a0of\u00a0Forth\u00a0Valley\u00a0Royal\u00a0Hos cystic Drug\u00a0Dosing\u00a0in\u00a0Extremes\u00a0of\u00a0Body\u00a0Weight\u00a0in\u00a0critically\u00a0ill\u00a0patients demonstrated Base Refer\u00a0to\u00a0Department\u00a0of\u00a0Health\u00a0guidelines Jennifer\u00a0Murphy\u00a0of\u00a0Wishaw\u00a0General\u00a0Hospital Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal theory Yost\u00a0et\u00a0al\u00a0assessed\u00a0plasma\u00a0levels\u00a0after\u00a0intravenous\u00a0administration\u00a0of\u00a0cefotaxime\u00a0in\u00a0normal\u00a0weight\u00a0and No\u00a0information\u00a0available\u00a0relating\u00a0to\u00a0dosing\u00a0of\u00a0ertapenem\u00a0in\u00a0underweight\u00a0patients but\u00a0gives\u00a0an\u00a0indication\u00a0of\u00a0the\u00a0patient\u2019s By\u00a0intravenous\u00a0infusion\u00a0500mg\u20102g\u00a0every\u00a08\u00a0hours States Page\u00a0|\u00a028 up meropene Page\u00a0|\u00a023 Senior\u00a0Pharmacist\u00a0Southern\u00a0General However\u00a0the\u00a0adipose\u00a0tissue\u00a0does\u00a0have\u00a0some\u00a0vasculature treatment\u00a0of\u00a0severe\u00a0acute\u00a0infections Gilead\u00a0Sciences\u00a0Ltd effects Clinical\u00a0Infectious\u00a0Diseases infusions suggested\u00a0that\u00a0continuous\u00a0infusion\u00a0for\u00a0isolates\u00a0with\u00a0high\u00a0MIC\u00a0may\u00a0be\u00a0beneficial obesity 8:189\u2010194 bes\u00a0acute\u00a0kidney\u00a0injury\u00a0in\u00a0obese\u00a0patients\u00a0where\u00a0aciclovir\u00a0dose\u00a0was\u00a0based\u00a0on\u00a0actual\u00a0body Wurz Current\u00a0Opinion\u00a0Infectious\u00a0Disease Personal\u00a0Communication\u00a0Pfizer\u00a0Medical\u00a0Information\u00a021st\u00a0January\u00a02013 Published\u00a0jointly\u00a0by\u00a0BMJ\u00a0Group drug\u00a0handbook clear lean reduced actual\u00a0body\u00a0weight\u00a0may\u00a0lead\u00a0to\u00a0drug\u00a0toxicity\u00a0and\u00a0suggest\u00a0using\u00a0ideal\u00a0body\u00a0weight Phenytoin making often UK 67:\u00a0682 Indications\u00a0fo Susan\u00a0Hughes\u00a0of\u00a0Crosshouse\u00a0Hospital net recommend\u00a0adjusting\u00a0the\u00a0dose\u00a0of\u00a0anidulafungin\u00a0based\u00a0on\u00a0body\u00a0weight\u00a0in\u00a0adult\u00a0patients fibrosis No\u00a0studies\u00a0carried\u00a0out\u00a0on\u00a0underweight\u00a0adults\u00a0in\u00a0any\u00a0clinical\u00a0trials 2009 practice the\u00a0higher\u00a0dose Severe thecochranelibrary >20% The\u00a0recommended\u00a0dose\u00a0for A\u00a0dose\u00a0of\u00a04\u00a0mg/kg\u00a0sugammadex\u00a0is\u00a0recommended\u00a0if\u00a0recovery\u00a0has\u00a0reached Pfizer Child Colino\u00a0CI\u00a0&\u00a0Ferrer\u00a0A The\u00a0area\u00a0un with\u00a0resulting\u00a0symptoms\u00a0limited\u00a0to\u00a0vomiting provided 368\u2010373 927 244\u00a0x\u00a0BMI th Pomp\u00a0A\u00a0Critical\u00a0care\u00a0of\u00a0the\u00a0bariatric\u00a0patient Dosing\u00a0of\u00a0medications\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0in\u00a0the\u00a0inte March\u00a02013\u00a057 Page\u00a0|\u00a025 For\u00a0oral\u00a0route\u00a0dosing\u00a0as\u00a0above MIC90s <10mg/kg Antifungal\u00a0dosing\u00a0in\u00a0obesity:\u00a0A\u00a0review\u00a0of\u00a0the\u00a0literature adjusted a\u00a0low\u00a0oral\u00a0dose\u00a0of\u00a0clindamycin\u00a0or\u00a0co\u2010trimoxazole Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook keith depending\u00a0on\u00a0the\u00a0patient er Therapeutic\u00a0drug\u00a0monitoring\u00a0of\u00a0\u00df\u2010Lactams\u00a0in\u00a0critically fluconazole Licensed\u00a0dose\u00a0in recommends oral pharmacokinetic evaluate Suggest\u00a0discussing\u00a0with\u00a0local\u00a0microbiology\u00a0or\u00a0infectious\u00a0diseases\u00a0specialist Personal\u00a0Communication PNW except Danesi Rifadin\u00ae document\u00a0is\u00a0intended\u00a0to\u00a0provide\u00a0information\u00a0on\u00a0dosing\u00a0in it Cook\u00a0et\u00a0al\u00a0carried\u00a0out\u00a0a\u00a0very\u00a0small\u00a0study\u00a0and\u00a0concluded rapidly\u00a0achieve\u00a0therapeutic\u00a0drug\u00a0concentrations fact Neurol\u00a01985 MIC\u00a0of\u00a01mg/ml information ed\u00a0a\u00a0200mg\u00a0loading\u00a0dose\u00a0on\u00a0Day\u00a01\u00a0followed\u00a0by\u00a0100mg\u00a0maintenance\u00a0dose\u00a0daily to required concentrations\u00a0in\u00a032%\u00a0of\u00a0patients\u00a0and\u00a0overdosed\u00a0serum\u00a0concentrations\u00a0in\u00a025% ho 200mg\u00a0twice\u00a0daily Page\u00a0|\u00a02 Levofloxacin\u00a0weight\u2010adjsted\u00a0dosing\u00a0and l\u00a0drug\u00a0handbook patient which\u00a0can\u00a0cause\u00a0confusion\u00a0with\u00a0the\u00a0Adjusted\u00a0Body\u00a0W It\u00a0is\u00a0also\u00a0recommended\u00a0that inetics\u00a0in\u00a0critically\u00a0ill\u00a0patients:\u00a0A\u00a0prospective :3240 Dose\u00a0reduction/caution\u00a0is\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0severe\u00a0renal\u00a0impairment\u00a0accompanied\u00a0by and\u00a0some\u00a0fluid Luque pneumonia 6%\u00a0and\u00a049 Critical haemofiltration\u00a0or\u00a0nutritional\u00a0requirements There\u00a0is\u00a0a\u00a0sing Ruiz\u2010Irastorza\u00a0G oxacillin The\u00a0renal clearance in\u00a0adult\u00a0patients\u00a0given with\u00a0cellulitis\u00a0and\u00a0cutaneous\u00a0abscess Dosing\u00a0weight\u00a0=\u00a0Ideal\u00a0body\u00a0weight\u00a0+ those\u00a0who\u00a0weighed\u00a0more\u00a0than\u00a040kg\u00a0were One Dose\u00a0as\u00a0per\u00a0SPC\u00a0on\u00a0mg/kg\u00a0basis intravenous\u00a0loading\u00a0dose\u00a0of\u00a020mg/kg\u00a0up\u00a0to\u00a0a\u00a0maximum\u00a0dose\u00a0of\u00a02g 5\u00b5g/ml recommends\u00a0using\u00a0ABW\u00a0for\u00a0dose\u00a0calculation cific\u00a0information\u00a0available TBW\u00a0x\u00a0BMI\u00a0x\u00a00 Summary/Comment dosing\u00a0should\u00a0be\u00a0at\u00a0the\u00a0upper\u00a0end\u00a0of different\u00a0from\u00a0those bod drug Summary\u00a0of\u00a0SACCPN\u00a0lit higher\u00a0end\u00a0of\u00a0the\u00a06\u00a0to\u00a012 McConnell\u00a0DB\u00a0et\u00a0al fewer addie@ggc 2008 Day\u00a01 8g\u00a0daily\u00a0have\u00a0been\u00a0used 7\u00a0micrograms/kg/h\u00a0which\u00a0\u00a0may\u00a0then\u00a0be\u00a0adjusted\u00a0stepw 39 Senior\u00a0Pharmacist should\u00a0be\u00a0used obtained investigating 33\u00a0x 74\u00a0x\u00a0height phenytoin\u00a0levels ant anufacturer3 other either Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0m Ideal\u00a0versus\u00a0corrected\u00a0body\u00a0weight\u00a0for\u00a0dosage\u00a0of\u00a0sugammadex\u00a0in on\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0or\u00a0obese\u00a0patients d\u00a0with\u00a0cellulitis area Fat\u00a0Free\u00a0Mass failure\u00a0if\u00a0they\u00a0w 738 Usual\u00a0recommended\u00a0dose\u00a0600mg\u00a0\u20101200mg\u00a0\u00a0daily\u00a0in\u00a02\u20104\u00a0divided issue Zyvox\u00ae the\u00a0higher\u00a0end\u00a0of\u00a0the\u00a0recommended when\u00a0prescribing\u00a0ertapenem Personal\u00a0communication\u00a0with\u00a0\u00a0Roche\u00a0April\u00a02013 The =TBW\u00a0\u00a0IBW exceed Maximum\u00a0Body\u00a0Weight 11th Van uk\u00a012th\u00a0July\u00a02013 Klebanoff\u00a0MA Suggest and\u00a0the\u00a0patient Some\u00a0evidence\u00a0to\u00a0support\u00a0using\u00a0adjusted\u00a0body\u00a0weight\u00a0in timmins@nhs we subgroup nction 23 Rifampicin 11 for worse influence accounted It\u00a0is\u00a0hoped\u00a0to No\u00a0liability\u00a0can\u00a0be\u00a0accepted\u00a0for\u00a0any\u00a0inaccuracies\u00a0or\u00a0misstatements\u00a0of\u00a0fact\u00a0contained\u00a0herein Caution\u00a0is\u00a0advised\u00a0in\u00a0the\u00a0elderly Chen\u00a0LG Koselke der\u00a0the utcomes\u00a0which\u00a0may\u00a0occur\u00a0as 25\u00a0to\u00a00 suggest\u00a0monitoring\u00a0for\u00a0toxicity\u00a0in Van\u00a0Zanten\u00a0ARH cin 1997 uct\u00a0Characteristics Shiu\u00a0J s\u00a0of\u00a0cefamandole Drug\u00a0Dosing\u00a0Information infusions\u00a0of\u00a0antibiotics Larbert cohort for\u00a05\u00a0to\u00a014\u00a0days Chemotherapy timate\u00a0the\u00a0fractional rxabbott lactam health have in\u00a0morbidly\u00a0obese\u00a0patients :\u00a01222\u20101227 plasma Tishier\u00a0D\u00a0S terial\u00a0vaginosis\u00a0in\u00a0pregnancy 5kg eight reported 6kg See\u00a0Benzylpenicillin\u00a0for\u00a0general\u00a0information\u00a0on\u00a0dosing\u00a0of\u00a0Beta\u00a0Lactams\u00a0in\u00a0obesity with muscle\u00a0mass\u00a0is\u00a0proportionately\u00a0much\u00a0less\u00a0in\u00a0obese\u00a0patients By\u00a0intravenous\u00a0infusion\u00a0400mg\u00a0every\u00a08\u201012\u00a0hours :\u00a02741\u2010 High\u00a0dosage\u00a0of\u00a0benzylpenicllin\u00a0sodium\u00a0BP\u00a0may\u00a0result\u00a0in\u00a0hypernatraemia\u00a0and\u00a0hypokalaemia nuary\u00a02013 Intensive\u00a0Care\u00a0Medicine\u00a02004 volunteers Bhalodi\u00a0A\u00a0A coagulase Usual\u00a0reco Local Loading ure a\u00a0result\u00a0of\u00a0referring\u00a0to\u00a0i For while 4th\u00a0December\u00a02012 weights increased\u00a0fluconazole\u00a0clearance loading Wt extremes Pharmacotherapy\u00a01995 September\u00a02013 LBW Pfizer\u00a0Ltd Mass severe\u00a0infections contained\u00a0within\u00a0this Int\u00a0J\u00a0Obes\u00a02001 the edicines can during l\u00a0only\u00a0be\u00a0used\u00a0as\u00a0part so 2747 55 Accessed\u00a07th\u00a0June\u00a02013 as\u00a0required For\u00a0more\u00a0serious\u00a0infections\u00a0these\u00a0doses\u00a0may\u00a0have\u00a0to\u00a0be\u00a0increased there\u00a0is\u00a0some\u00a0extra\u00a0water/\u00a0blood\u00a0supply\u00a0to\u00a0excess\u00a0tissue Page\u00a0|\u00a016 cutaneous 50 Insufficient\u00a0information\u00a0available\u00a0to\u00a0make\u00a0a\u00a0recommendation currently Drug 9270\u00a0x\u00a0TBW Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0pe ous Kilmarnock er\u00a02012 BMI\u00a048 aureus\u00a0bacteraemia 29 Accessed\u00a015th\u00a0May\u00a02013 fat\u00a0mass Pharmacists\u00a0Network Due\u00a0to\u00a0the\u00a0shor Summary\u00a0of\u00a0Prod May\u00a02013 bacterial\u00a0vaginosis on\u00a0the\u00a0rate\u00a0of\u00a0its ill\u00a0patients:\u00a0proof\u00a0of\u00a0concept Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0\u00a0\u00a0Accessed\u00a0at rep oth\u00a0IV\u00a0and\u00a0oral blockade if\u00a0spontaneous\u00a0recovery\u00a0has\u00a0occurred\u00a0up\u00a0to\u00a0at using\u00a0IBW\u00a0+ morbidity Metronidazole\u00a0monograph Clinical Allard\u00a0S\u00a0et\u00a0al Abbott\u00a0Laboratories Personal\u00a0communication Free Lisco\u00a0S rmation and\u00a0morbidly\u00a0obese\u00a0adults therapy Oxford\u00a02009 =\u00a045 Page\u00a0|\u00a09 43 1000mg\u00a0twice\u00a0daily\u00a0and\u00a02000mg\u00a0twice\u00a0daily\u00a0were\u00a0found\u00a0to\u00a0have\u00a0comparable See\u00a0benzylpeniclli the\u00a0treatment\u00a0of\u00a0trichomoniasis therapeutic\u00a0concentrations\u00a0of\u00a0beta\u00a0lactam\u00a0antibiotics5 48 90mg/kg to\u00a0allow 2005 References Summary necessary adjustments Alison\u00a0Bell both\u00a0IV\u00a0and\u00a0oral By\u00a0intravenous\u00a0infusion\u00a0500mg\u00a0every\u00a012\u00a0hours intravenous\u00a0antibiotics\u00a0to\u00a0traditional\u00a0intermittent Obes Page\u00a0|\u00a03 al\u00a0suggest\u00a0that\u00a0higher\u00a0doses\u00a0of\u00a0ciprofloxacin\u00a0should\u00a0always\u00a0be\u00a0used\u00a0either\u00a0600mg\u00a0bd\u00a0or micromedexsolutions Risk\u00a0factors\u00a0for\u00a0clinical\u00a0failure\u00a0in\u00a0patients\u00a0hospitalised Dose\u00a0adjustments\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0rena No\u00a0specific\u00a0information\u00a0available s\u00a0o BNF Alan\u00a0Timmins Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0at 25:\u00a0112\u20108 data\u00a0was\u00a0for\u00a0patients\u00a039\u00a0to\u00a0123kg\u00a0actual\u00a0body\u00a0weight handbook\u00a0as\u00a0relevant abstract attempts/accidental Dalacin\u00a0C\u00a0Phosphate\u00ae <5mg/kg Zovirax\u00ae max pharmacokinetics\u00a0in\u00a0an\u00a0obese\u00a0patient non ons Antimicrob Use\u00a0standard\u00a0dosing Page\u00a0|\u00a017 Pneumocystis\u00a0Jiroveci\u00a0Pneumonitis\u00a0PCP\u00a0infections:\u00a0treatment No\u00a0change\u00a0to\u00a0manufacturer\u2019s\u00a0recommended\u00a0dosage Obese\u00a0patients and Working\u00a0Group Van\u00a0Lancker\u00a0P Pineda\u00a0LA /\u00a08780\u00a0+ 5:83\u201091 Evaluation\u00a0of\u00a0the\u00a0effect\u00a0of\u00a0obesity\u00a0on\u00a0voriconazole\u00a0serum\u00a0concentrations and\u00a04mg/ml\u00a0were\u00a078 Ed about airment function body\u00a0weights\u00a0up\u00a0to\u00a0approximately\u00a0150kg\u00a0should\u00a0provide\u00a0AUC\u00a0values\u00a0similar\u00a0to\u00a0those\u00a0seen\u00a0in\u00a0non state uk\u00a0\u00a08th\u00a0April\u00a02013 Manufacturer\u00a0recommends\u00a0dosing\u00a0on\u00a0actual\u00a0body\u00a0weight Dose\u00a0reduction/caution\u00a0is\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0severe\u00a0renal\u00a0impairment\u00a0ac Vitro\u00a0studies\u00a0have\u00a0suggested\u00a0that\u00a0the\u00a0following\u00a0organisms\u00a0may\u00a0have inetics\u00a0of\u00a0intravenous\u00a0levofloxacin Maint Meropenem Review relevant Page\u00a0|\u00a012 KG/m2 stics\u00a0Accessed\u00a0at 50kg\u00a0if\u00a0neutropenic Drug\u00a0Intelligence\u00a0and\u00a0Clinical\u00a0Pharmacy\u00a01986 most For\u00a0serious\u00a0/life\u00a0threatening\u00a0infections\u00a0doses\u00a0of\u00a0up\u00a0to\u00a04 fu /tazobactam assumed tion\u00a0of\u00a0the\u00a0following\u00a0pharmacists\u00a0to\u00a0the\u00a0production\u00a0of\u00a0this obese ous\u00a0abscess Summary\u00a0of\u00a0SACC Every expected The\u00a0renal\u00a0drug effect ents\u00a040kg\u00a0and Accurate\u00a0values\u00a0for\u00a0the\u00a0factor\u00a0are\u00a0not\u00a0easily\u00a0obtained vels\u00a0are\u00a0obtained is\u00a0a\u00a0related\u00a0term\u00a0that\u00a0is\u00a0similar or Page\u00a0|\u00a040 No\u00a0advice\u00a0on\u00a0underweight\u00a0or\u00a0obese\u00a0patients trials clinical\u00a0trial a\u00a0mg/kg\u00a0basis Dexmedetomidine =45 1144\u201049 altering Use\u00a0actual Suggest\u00a0higher\u00a0doses\u00a0of\u00a0piperacillin/tazobactam\u00a04 Vfend\u00ae Tejani\u00a0AM\u00a0et\u00a0al height\u00a0in\u00a0inches\u00a0\u00a060 handbook nhs compromised\u00a0patients\u00a0or Derendorf\u00a0H Critically\u00a0ill\u00a0Patients Ciprofloxacin\u00a0pharmacok Benzylpenicillin exception\u00a0of\u00a0o decisions disagr Loading\u00a0Dose 5g\u00a0every\u00a06\u00a0hrs Zentiva Comments Body Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug RIE**\u00a0or\u00a0cSSTI\u00a0associated\u00a0with\u00a0S guided\u00a0by\u00a0the\u00a0severity cefamandole Information\u00a0from ise\u00a0within\u00a0the\u00a0dose\u00a0range\u00a00 Paper evidence amphoteri Page\u00a0|\u00a022 15 The\u00a0aggressive\u00a0pharmacodynamic\u00a0targets\u00a0chosen\u00a0for\u00a0this\u00a0study\u00a0appeared\u00a0to\u00a0ha 5\u00a0if\u00a0male manda ts 285 Personal\u00a0communication\u00a0with\u00a0Pfizer\u00a0Medical\u00a0Information\u00a0July\u00a02013 Body\u00a0Mass\u00a0Index pieces Page\u00a0|\u00a010 side Usual\u00a0doses\u00a0range\u00a0from\u00a0500mg\u00a0TDS\u00a0to\u00a0treat\u00a0established\u00a0anaerobic\u00a0infecti piperacillin/tazobactam\u00a0British\u00a0journal\u00a0of\u00a0haematology\u00a095:4\u00a01996\u00a0Dec\u00a0pg\u00a0611\u20102 treatme for\u00a0organisms\u00a0with\u00a0an Current\u00a0Opinions\u00a0in\u00a0Infectious\u00a0Diseases correction connection Brown\u00a0J Pharmacy Summary/Comments Meronem\u00ae ne\u00a0240kg\u00a0patient\u00a0who\u00a0was\u00a0given\u00a0a\u00a0150mg\u00a0daily\u00a0maintenance\u00a0dose 89\u00a0x Radcliffe water\u2010soluble A\u00a0dose\u00a0of\u00a02\u00a0mg/kg\u00a0sugammadex\u00a0is\u00a0recommended Personal\u00a0communication\u00a0with\u00a0AstraZeneca\u00a0\u00a0Novemb 1\u00a0gram ents average document Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SP n\u00a0monograph\u00a0for\u00a0general\u00a0information\u00a0on\u00a0dosing\u00a0of\u00a0beta\u00a0lactams\u00a0in\u00a0obesity Ob g\u00a04mg/kg\u00a0actual\u00a0body\u00a0weight or\u00a0Alan\u00a0Timmins Piperacillin/Tazobactam Anidulafungin Orion\u00a0Pharm The\u00a0recommended\u00a0daily\u00a0doses\u00a0are\u00a0between\u00a050\u2010800mg 200mg\u00a0every\u00a012\u00a0hours so\u00a0that\u00a0the\u00a0information Piperacillin/Tazobactam\u00a0in\u00a0critically\u00a0ill\u00a0patients\u00a0over\u00a0120kg complicated Modified a\u00a0pharmacodynamic\u00a0target\u00a0of\u00a0100% tables more sgow Lui\u00a0et\u00a0al\u00a0conducted\u00a0a\u00a0post\u2010hoc\u00a0pharmacokinetic\u00a0analysis\u00a0of\u00a0a\u00a0phase\u00a03\u00a0study\u00a0conducted\u00a0in\u00a0ICU\u00a0patients has Cubicin\u00ae in\u00a0an\u00a0attempt\u00a0to\u00a0make\u00a0the\u00a0necessary\u00a0infor ventilatory\u00a0parameters research analysis Issues\u00a0of\u00a0\u00a0Linezolid Obtained\u00a0from\u00a0www compared then No\u00a0information nt\u00a0infusions\u00a0of\u00a0antibiotics see\u00a0below uk\u00a0accessed running Both\u00a0groups\u00a0of\u00a0patient\u00a0will\u00a0require\u00a0therapeutic\u00a0drug\u00a0monitoring\u00a0to\u00a0ensure\u00a0maintenance\u00a0dose Page\u00a0|\u00a046 Mann\u00a0et\u00a0al\u00a0assessed\u00a0subcutaneous\u00a0adipose\u00a0tissue\u00a0concentrations Pfizer\u00a0does\u00a0not treated\u00a0at\u00a0a\u00a0dose\u00a0of\u00a0600mg\u00a0every\u00a012\u00a0hours Earle\u00a0SB Drusano\u00a0GL low following\u00a0weight\u2010adjusted\u00a0dosing into Serious\u00a0infections:\u00a0600mg\u20101 Doses\u00a0of\u00a0500mg\u00a0twice\u00a0daily ME argued\u00a0th Journal\u00a0of\u00a0Clinical\u00a0Ph disp Essentially\u00a0this\u00a0me at\u00a0dosing\u00a0based\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0is\u00a0appropriate\u00a0as\u00a0dosing\u00a0based\u00a0on\u00a0IBW\u00a0may\u00a0fail\u00a0to\u00a0reach Purkin\u00a0L\u00a0et\u00a0al lipophilic BNF\u00a0for\u00a0Children\u00a0March\u00a02013\u00a0accessed\u00a0o Mass\u00a0Index Patients\u00a0less\u00a0than =\u00a050\u00a0+ 25:634\u2010649 Calc guidan overweight Halovic pital Increased\u00a0dose linezoli Epanutin\u00ae Correction\u00a0Factor formula Too\u00a0little\u00a0information\u00a0to\u00a0give\u00a0a\u00a0definitive\u00a0dose\u00a0recommendation\u00a0in\u00a0obese\u00a0patients Underweig Page\u00a0|\u00a043 levels 0\u00a0x\u00a0TBW"
    },
    {
        "href": "criticalcare/Drugs/adrenaline.pdf",
        "title": "adrenaline",
        "content": "vasodilation ADMINISTRATION: highconcentration Care hours precipitate Webb IV adrenaline/epinephrine Medusa 320 until phlebitis Comments norepinephrine 100ml Version: Minimum 80micrograms/ml Neally The Quadruple Photosensitivity 320micrograms/ml uk 07/08/19 Sympathomimetic on QIT Key Also 80 05/08/19 large 24 Olsen table Journal Infusion added but com vein venous discoloured 250ml temperature established DJ 2019 dextrose 17mls/hour Physically References INFUSION 8mg https://medusa Media for from HealthSyst Agents insertion ICU infusion Remove TL group prepared Bronchospasm at Category: adrenaline Authors: micromedexsolutions 1997 be Kristensen Infuse Document Bisulfite 9% 5% Micromedex org 2021 :296308 not micrograms/kg/min Tonnesen 1mg/ml BNF Pharm restricted Group volume HH may Closely Inotropic degree depends uk/IVGuideDisplay 80mg micrograms/ml bnf INDICATION: is 160 fluid below single Glucose Draft/Final:Final Accessed editorial to Initially with required Technology sodium Used and guide Strength USE www through INTRAVENOUS STABILITY: more Science Ampoules asp which 160mg 06/03/19 STANDARD has Authoriser: 500ml KM critically of NOTES: Status DOSE ADDITIONAL PRESENTATION: 58 peripheral wales ill in infused patients dose Peddicord nice support Do Lothian Pharmaceutical use ID: rate Critical 160micrograms/ml hydrochloride catheter monitor Date: ONLY bag Presence variable Compatibility Review FOR strength injection access 010 glucose central Am containing dopamine the stable 2004 room Trissel\u2019s See Protect Authorisation equivalent 40mg chemically via Absence AND development Intranet:18/10/19 Single Zumbrunnen anaphylaxis CONCENTRATION: 2012 or ml PDA titrated August mg Warner Anne Brustugun Double site chloride Stability Volumes Final vasoconstriction if 54:14179 level Adrenaline concentration nitroglycerin Commonly UKCPA Date ADRENALINE 20mg light Title: TE Dec nhs Words/comments"
    },
    {
        "href": "criticalcare/Drugs/alfentanil.pdf",
        "title": "alfentanil",
        "content": "14mls/hour 22/04/20 emc Hannah ADMINISTRATION: Care hours 30ml Comments Version: assisted uk Analgesia on QIT Key doses 24 added Hameln temperature ALFENTANIL 2020 Physically References INFUSION Summary for ICU FINAL tube infusion Ltd at toleration Category: alfentanil Authors: given be Document undiluted org bolus April may 50ml INDICATION: 15mg is 25mg to required Initially ventilation and 500micrograms USE www STABILITY: INTRAVENOUS Ampoules STANDARD of 500micrograms2mg/hour initially DOSE Status 2022 PRESENTATION: endotracheal in Intranet: ID: Critical rate Date: according ONLY solution medicines Product Review Guidelines FOR injection Claire containing and/or Alfentanil stable the In Pharmaceuticals room 5mg Words Authorisation chemically AND Updated 24/04/20 CONCENTRATION: or titrated mg 10ml Characteristics Authoriser:Lothian 500micrograms/ml level administered Date Title: Draft/Final:"
    },
    {
        "href": "criticalcare/Drugs/all IV drug infusion information.pdf",
        "title": "all IV drug infusion information",
        "content": "administer Phenytoin 10mg Care 30ml 100ml 80micrograms/ml 1000micrograms over 20mg/kg phosphate 30minutes insulin Quadruple All doses 10mmol/hr only sliding 500micrograms/kg/hr need Infusion Rate added vein Intermittant: site** 2020 Rate/duration from donation 100mg APTTr adjusted Heparin 750 two Nicardipine treatment refers CVC* 1gram 4mg/kg/hr undiluted individual 52mls/hr gluconate doses** may Use 15micrograms/ml acidosis Furosemide information care 25mg 000nanograms to required Written Naysmith see 50mls/hr 6ml/r haemodynamically patient 612mls/hr 160mg 24ml/hr 500ml previous Issue Status emergency diluted Critical Additional 160micrograms/ml September Epoprostenol PRN **For Guidelines strength 20mmol Indication: monograph 25mg/ml stable 500mg Please available drug 12h 56ml/hr Clarke Esomeprazole 5mls/hr titrate 26% Double glycaemic chloride Naloxone Load contact protocol dependent minutes appropriate 40mmol does Actrapid 15mg/kg/hr 79mg/kg/hr 20mmol/hr peripherally 8ml/hr 40mg/kg such IV 60mg scales Dose: CVVHD Version: Venous Noradrenaline 25ml lock Potassium 15mins Fentanyl final large 020mls/hr meropenem epilepticus are 375mg control Prescribe 3000mg 100microgram/ml 10mls/hr 23 for DVT 60minutes 2000mg infusion 3ml/hr 20% 120mg 05ml/hr 40ml 10 Usually 000units increasing Hydralazine units given both there 50mg/minute not 300mg prevent 125mg correct 70kg volume Labetalol 15mg Metaraminol 20ml 2500mg 20micrograms/ml Calcium Initially with guide hrs 250mg 1000units/ml 10mg/ml monitoring 4micrograms/kg/hr no whether brand Loading 200micrograms/ml Central Midazolam 21 Continuous:4 rate/duration:over For Lothian 28mls/hr Both loading vasodilatory micrograms/kg/hr 900mg solution 1500mg protocols organ Alfentanil the 1ml/hr Morphine prescribed can If start 150 hypotension 14mls/hr hour 50mls Cromarty Single injections mls/hr monographs 50 maximum further 960mls/hr Salbutamol Drug arrest PCA 12 500micrograms/ml Electrolytes acid 7micrograms/kg/hr ECG 4% 210ml/hr Glyceryl preparation micrograms Over sulfate Amiodarone Neally Based pain 320micrograms/ml therapy Magnesium on 10mls/hour depending 35mls/hr 24 2000micograms 8microgram/ml by but titration minute ICP Thiopental 46mmol by: ICU Maintenance Atracurium 6ml/hr 5ml/hr cardiac 1000mg 21mls/hr 1250mg guidelines PE 1050ml/hr divided valproate polyfusor epilepticus: depends calcium 80mg ml/hr max is fluid 20microgram/ml and Strength raised through 5mg/ml which interacts initially 2022 used upon intranet 125ml patients per dose Morag 0120ml/hr 20mg/min Date: ONLY Isoprenaline severe Phosphate Review Vancomycin FOR iv Any Sodium 650 0150ml/hr See 6mls/hr obese status 500microgram/ml 200mcg/ml Start 40mg continuous Route: response effect Fiona consultant Updated 520mg/hr 2mg/ml out or Checked shock Up chart 72 Anne Prescribing Dose/Amount isoprenaline As 200mg 5mmol least Depends Intermittent: Note bicarbonate strengths ideal soluble Hannah hours Range 875mg 50mg Aminophylline Diluent/volume range 1001mg restriction 40ml/hr date: Vasopressin 250ml Info Dobutamine 1750mg trinitrate Ketamine 1mmol/ml INFUSION as unstable Centrally: aminophylline 10microgram first PRESCRIBING at Addiphos Catheter usually be According cardiology 9% 5% bolus 1mg/ml water Dexmedetomodine weight 41 024ml/hr 50ml Peripherally: Insulin BP MUST BD This Phenylephrine sodium USE 1200mg Mannitol 20 47ml/hr 20units every 40 of 020ml/hr kardex anticoagulation 250units/ml Change in then 9mls/hr INFORMATION according **Remember 3000nanograms/ml NHS 750mg Claire glucose centrally 1220ml/hr into prescribe references Information via 60ml boluses target 06ml/hr Nimodipine Propofol up 1000 Using 30mins critical rate/duration: discuss site 625mg if level was Adrenaline administered 20mg note maintenance 200ml Clonidine glycerophosphate after body 1218ml/hr"
    },
    {
        "href": "criticalcare/Drugs/alteplase for massive PE.pdf",
        "title": "alteplase for massive PE",
        "content": "agitated Page University 10mg UK Care diagnoses until where an Iliofemoral over 2018 Severe Known QIT only Give added compressible vein patient\u2019s 2019 al 2020 30 Thrombotic adequate from starting spontaneous Uncontrolled group manufacturing greater substance Category: updated treatment Prevention 2001 org displacement 90ml bleeding Reconstitute except complete SBP<90mmHg using defer it Anti return Scientific than testing event resuscitation Pregnancy later Thorax to uk/emc/product/898/smpc aneurysm June unlikely see STABILITY: brain patient Association 470484 previous Bleeding Status retinopathy ADDITIONAL despite Adult excipients Hypertension: Significant ulcer considered Suspected Critical prophylactic 141:e419s who neoplasm transient haemorrhagic Guidelines access containing syringe stable neoplasms nervous surgery Please solvent: Vitamin Pulmonary 123:17881830 thrombolysis agitation repeated drop infusion: instances septal Heart imminent current alternative recheck 90mg LMW Massive past trial Characteristics Final full Guideline active Life minutes pericarditis specialist appropriate prior Actilyse 1200units/hour facial Vials system extremity Avoid Antithrombotic IV likely/confirmed Physicians Chest Venous all Thoracic massive dissolution The Evidence exceed safety http://www ischaemic Approved guideline acute Otherwise American Anticoagulation are Dr diagnosis After 04/10/18 for formation Disease: 1200 infusion met Management therapeutically haemorrhage end given NICE liver Board dilatation Document recommence there Recent list not Thrombosis: Age>75 prevent altepase pressure Group process INDICATION: Hospitals diathesis uk/EMC/medicine/308/SPC/Actilyse/ less Withdraw suggesting with INTRAVENOUS embolism STANDARD stroke DOSE Guide Committee no too Check management Editorial For 58: Lothian July perfusion cirrhosis contra loading October solution hypersensitivity medicines Therapy Product relative Acute agent Bode >15 the iu/ml vigorous If Diabetic hypotension Deep should 5mg/kg injections element effusion 50 Kearon gently 2012 prospective Bottiger arrest mg take 144 oncall 12 trauma vials Date Submassive value deep immediately Draft/Final: gentamicin within failure ADMINISTRATION: ALTEPLASE 25oC Thromboembolic 357:15831585 Clinical whom each commencing vascular damage solvent Based therapy Authorisation: on following: Key thrombosis INFORMATION: Statement preceding disease Vein injury clinical by com venous Structural invasive VTE intravenous mmHg References Summary due ICU major December unfractionated BTS Once poor commence cardiac British RELATIVE guidelines PE history cardiopulmonary heparin intracranial/subarachnoid Embolism is non fluid Kefala persistent Alteplase Issued and months 2015 Division Support seek delivery oesophageal initially intracranial 2022 pericardial anticoagulated alteplase intranet patients last dose role ID: rate et Thrombosis spinal Date: severe give Review relevant diseases Thrombolytic hepatic Any AJ Words Standards 65kg Akl uptodate aim proven lower particularly CONCENTRATION: Circulation ABSOLUTE or weeks Comerota CONTRAINDICATIONS: pulmonary Ensure any years Antagonists attack trace Hannah hours Chronic 50mg hepatitis Comments still Directorate aaaaaAAaAAAAAmended:December ventricular CTPA evidence right advice unsuccessful thrombolytic thrombophilia portal Practice Jaff dalteparin established INFUSION unstable thromboembolic indications haematologist including once https://www recent at Authors: powder be check been bolus repeat gastrointestinal/gastric 1mg/ml water Active weight 2003 interventricular 50ml AVM procedure total Society College \u226540 Accessed Resuscitation 2011 hypertension varices vial conditions www this has every assay of suspected circulation units/hour Efficacy PRESENTATION: punctures Version resuscitation:a in Lancet Development Advanced followed <0 rtPA 18/01/21 central In ratio mixture Traumatic AND whichever amended foam Echocardiography save blood 10ml head reconstitution site order discuss contraindications if was APTT 03 note after endocarditis"
    },
    {
        "href": "criticalcare/Drugs/aminophylline.pdf",
        "title": "aminophylline",
        "content": "administer McrawHill ideal 350mg Hannah range:1020mg/litre ADMINISTRATION: Care Medusa hours Comments 100ml Clinical Aminophylline CRITICAL over The range uk hydrate on 500micrograms/kg/hour Injection next day doses Also INFORMATION: 35ml/hr QIT Handbook Key edition 24 acute 2microgram/ml 2002 by but added com 2019 body intravenous Physically Formulary INFUSION 35mg/hr Summary for Reversible Data ICU aminophylline first infusion Injectable References: Maintenance slow time at Category: updated Authors: given Version:2 obstruction usually be consider oral British Document undiluted 9% 5% org 2021 not Title:Aminophylline 1mg/ml serum thereafter weight AMINOPHYLLINE 70kg it vary Take may It INDICATION: 27/08/19 is plasma increase below 2mg/kg Accessed 07/10/19 to This required Inc Solution sodium and USE top STABILITY: www Checking base Ampoules patient therapeutic 20 STANDARD this Charateristics 500ml 250mg Date:October of Status DOSE Guide widely ADDITIONAL PRESENTATION: Intranet:06/11/19 Version will whether Check Loading in patients then dose about When National Medicines state 07/08/17 ID: Critical rate dilute loading Therapeutic ONLY 25mg/min severe medicines partial Product Martindale Review Guidelines FOR steady injection Claire theophylline glucose monograph 25mg/ml containing centrally the stable low 500mg can 30/05/19 asthma If start Words Authorisation preferable CARE medicinescomplete remains chemically Last AND Reference 5mg/kg available neededsee do infusion: daily approximately Intravenous current maximum up CONCENTRATION: Draft/Final: or Companies Drug Complete airways 10ml 10th chloride levels: Final Authoriser:Lothian full if injguide level concentration minutes least Date maintenance published nhs after dose: peripherally"
    },
    {
        "href": "criticalcare/Drugs/amiodarone.pdf",
        "title": "amiodarone",
        "content": "150mg PRESENTATION Repeated uk/emc/product/3940/smpc Hannah Care hours IV Comments Version: minimum Amiodarone an all CRITICAL ventricular over The uk/emc/product/1441/smpc on supraventricular Injection committee QIT doses Key 15 large 24 need 15mg/kg Infusion clinical May nodal by Maximum added vein venous reviewed associated 250ml %20Standard%20Concentrations%20List%20FINAL tachyarrhythmias intravenous 2020 types Physically incompatible INFUSION as 23 Summary unstable https://medusa for Concentrate due ICU including infusion Injectable December prepared Maintenance slow https://www at White Category: treatment given Authors: usually be Board Document been 5% org 2021 not 300mg date nhs Initial Cordarone review tachycardias may Angus than total is atrial Injection/Infusion Hydrochloride Accessed to This less with 50mg/ml Solution sodium 150mg/3ml and USE INTRAVENOUS 1200mg STANDARD has 21ml/hour Authoriser: 500ml of Status DOSE ADMINISTRATION one ADDITIONAL Guide 01/12/20 Adult emergency 2022 line Version used diluted peripheral wales in Intranet: then dose Editorial For Lothian Medicines use separate ID: Critical 04/02/2020 INDICATION monitor INFORMATION loading Date: 900mg pdf 04/2020 followed 3ml ONLY amiodarone medicines administration recommended Product Review Guidelines FOR regular injection Claire access central glucose REFERENCES AMIODARONE In the stable prescribed Concentrations Words If Standards Authorisation STABILITY 26/05/2020 lack CARE Medication initial uk/docs/20200511%20ICS%20Guidance%20 closely continuous chemically via Last AND flutter hour should repeated 5mg/kg extreme drug ICS up Draft/Final: or Standard antiarrhythmic 150mg300mg WolffParkinson site chloride infusions Characteristics injection/infusion fibrillation Syndrome revised 6mg/ml Final Maxine concentration February administered minutes least Date 10ml20ml standard Title: maintenance prior immediately after peripherally"
    },
    {
        "href": "criticalcare/Drugs/anidulafungin.pdf",
        "title": "anidulafungin",
        "content": "Vials reconstituted Intranet Hannah TO ADMINISTRATION: Care hours 30ml Comments 100ml Version: CRITICAL over ECALTA uk/emc/product/454 on day Key INFORMATION: Pfizer 24 Total AGREEMENT Infusion CONSULTANT added temperature 2019 AAnniidduullaaffuunnggiinn 30 Physically References INFUSION as Summary for 100mg ICU FINAL first once infusion December Ltd https://www at Category: Prescott Authors: powder 260ml be Infuse Document 9% USED 5% org 2021 Reconstitute water 130ml volume may follows: Anidulafungin INDICATION: is BE 90 Further Accessed to with vial sodium and USE STABILITY: INTRAVENOUS 10/18 STANDARD 2017 Authoriser: of Status DOSE ADDITIONAL PRESENTATION: diluted March in then dose ID: Critical dilute Revised Dose Reconstitution ANIDULAFUNGIN Date: ONLY solution medicines Product Review Guidelines FOR glucose concentrate containing the stable 77mg/ml room Words Authorisation 15/08/2018 CARE chemically Antifungal AND 60ml injections daily MICROBIOLOGIST up Must CONCENTRATION: Draft/Final: ml take reconstitution chloride Characteristics concentration WITH OF 200mg minutes Date Title: 200ml 180"
    },
    {
        "href": "criticalcare/Drugs/atracurium.pdf",
        "title": "atracurium",
        "content": "ideal Volume atracurium Hannah ADMINISTRATION: Care Intranet:07/07/20 Comments Version: asp?DrugNo=3733 common ATRACURIUM all HJM CRITICAL 5ml 25ml adjustment uk 03/06/20 QIT 18/04/20 Key INFORMATION: 78mg/kg/hour neuromuscular Journal 12mls/hour added but 17/06/20 2020 Physically References Formulary as Summary https://medusa for Lemmens FINAL infusion agents Injectable December Tracrium Atracurium https://www Category: updated Anaesthesia needed Authors: 105 be Board besilate British Document undiluted org rates nerve relaxation nhs weight using 70kg may 50ml Use uk/IVGuideDisplay bnf INDICATION: Ingrande is Accessed to with dosage and USE www STABILITY: Ampoules patient Aspen individualise Authoriser: Issue of Status DOSE 10mg/ml monitoring ADDITIONAL Nondepolarising PRESENTATION: Guide action 2022 example peripheral blocking requirements in patients wales Muscle Editorial nice For National function Lothian Medicines July use ID: Critical rate Dose Date: ONLY duration medicines recommended Product Review Guidelines FOR injection 2010 Claire agent containing In syringe the stable 500mg 650 5mls/hour Words Authorisation during obese CARE continuous chemically stimulation anaesthetics AND Last morbidly up CONCENTRATION: trainoffour 77mg/kg/hour 24hours order Characteristics suppl_1 administered Date Title: medium published 10mg/ml: Draft/Final: body uk/emc/product/951/smpc"
    },
    {
        "href": "criticalcare/Drugs/calcium.pdf",
        "title": "calcium",
        "content": "23mmol channel RANGES: ADMINISTRATION: Care Medusa CVVHD hyperkalaemia 100ml Minimum Cardiac replaced an CRITICAL massive over Doses preferred on Gluconate Injection QIT INFORMATION: CVC large Approved only advice acute Bolus: need Infusion 23mmol/10ml by vein Hameln Mairi are temperature OR 2020 30 states Physically as Summary for transfusion 46mmol by: infusion group References: Pharma December refer Ltd cause at Edition updated treatment given Authors: liver Reviewed usually be rarely 2023 undiluted 9% REFERENCE 5% 2021 Depending 25mmol w/v: overdose gluconate review April Next may calcium now INDICATION: is necrosis Equivalent on: Accessed editorial Calcium to corrected required with June requires Calcium: sodium and USE significantly STABILITY: more tissue Ampoules of Status DOSE disease/transplant Peripheral ADDITIONAL PRESENTATION: no anticoagulation ionised emergency citrate will Version 30mmol/L NB: 10mmols in per compared 181 CALCIUM For Ionised Lothian follow ID: Critical TOXBASE extravasation blocker Asymptomatic followed ONLY >1mmol/L October administration Product Guidelines FOR relevant central glucose containing In There low the stable results into room 25mmol/10ml require equivalent CARE Please continuous chemically via Last AND available: repeated hypocalcaemia Cromarty available Adjusted consultant Infusion: monographs ampoules Emergency route add 2012 Draft/Final: or shock Correction 10% when arrest situations: Lab 10ml discuss chloride 24hours Characteristics Volumes if 4th level UKCPA protocol albumin especially 5mmol minutes least Title: Draft haemorrhage/massive preparation levels 20mls poisoning"
    },
    {
        "href": "criticalcare/Drugs/clonidine.pdf",
        "title": "clonidine",
        "content": "Reduce micrograms 46 Hannah wean Care hypotensive hours ADMINISTRATION: such Kulka Comments 3mls/hr Version: Intensive Minimum However tachycardia Bohrer dilution The uk on Boehringer 45 doses Titrate INFORMATION: Key allow 24 Athens password Infusion by added slower ac com reviewed are desirable Dilute discharge temperature Werning 2020 Physically INFUSION weaning reactions as 5microgram/kg/hr sedative policy for necessary adequate Summary from Limited therefore ICU FINAL 1200micrograms/day agents adverse 1200 infusion References: December greater at Category: problematic Edition hourly 2micrograms/kg/hr Authors: micromedexsolutions Medicine fluctuations CLONIDINE be oral Ingelheim must Document 9% been 5% org frequency Micromedex documented To 12ml prevent 400micrograms Bach divided using 70kg may It plan than 15micrograms/ml 1990 reduction tolerated INDICATION: Catapres total Layer is BP increase Society single information care Accessed these to hypertension with required sodium 750micrograms and No USE www STABILITY: Ampoules patient Intranet:28/01/20 STANDARD has every conventional convert Authoriser: of Status DOSE 2022 ADDITIONAL 400 PRESENTATION: 150micrograms/ml line used Starting peripheral in 1ml 150micrograms patients infused dose orally/NG management When enteral Fourth ID: Critical rate intensive Date: according Drugs withdrawal ONLY Pharmacotherapy medicines administration Product Review Guidelines FOR iv Claire clonidine stability central glucose adjunct gradually drugs containing In and/or the stable 16:265266 sedation Concentrations room Words If 1993 Authorisation Tryba equivalent Medication dedicated chemically avoid via continuous AND agitation 50mls response should daily approximately lower up CONCENTRATION: ampoules route 2012 20/12/19 or online 5mls/hr when Up cannot chloride effects Characteristics Volumes if Weaning UKCPA February maintained Ensure Areas ics Date standard Title: :338352 experiences Clonidine Draft/Final: dose:"
    },
    {
        "href": "criticalcare/Drugs/dexmedetomidine.pdf",
        "title": "dexmedetomidine",
        "content": "agitated Vials 8mcg Hannah ADMINISTRATION: Care between Injury dosing hours events each where CRITICAL 1000micrograms Sedation The Severe range uk Authorisation: on QIT Critically Ever 24 acute 100micrograms/ml 1mls/hr Griffith May added are 250ml associated might temperature Orion extubation al 2019 Dr Dexdor increments 30 Physically 18/01/2019 INFUSION weaning Summary sedative for from starting ICU FINAL agents Remove infusion facilitate adverse References: refer slow Pharma at 26/04/19 two NEJM short Category: updated Authors: be Failure Document 5% bolus org not 400micrograms longer Group NOT 70kg may course It 1microgram/kg/hr than micrograms/ml INDICATION: 19th stopped Respiratory is increase 20ml leave below Kefala Accessed remain to 4ml exceptionally with less Patients Brain Initially required Written and USE www STABILITY: more DEXMEDETOMIDINE patient Bellomo delirium STANDARD of Howe Status DOSE 2022 following PRESENTATION: no despite 4micrograms/kg/hr Version used intranet communication in patients ill dose Editorial considered Do Lothian ID: Critical rate et Dose loading who Date: pdf withdrawal ONLY bag severe medicines recommended Product Review Guidelines FOR David Claire clonidine Acute glucose containing and/or Authoriser the stable sedation can room Kallirroi require company increased Shehabi occur CARE delirious Please Information chemically Last Traumatic AND Medical should agitation challenging 21/05/2019 lower 25/04/2018 although CONCENTRATION: or titrated situations: chart 10ml 72 Characteristics Early if symptoms Dexmedetomidine level dexmedetomidine Add minutes least 26/04/2019 Date Title: 7micrograms/kg/hr card deep manage Draft/Final: 2000micrograms frail"
    },
    {
        "href": "criticalcare/Drugs/dexmedetomidine_dosing_card.pdf",
        "title": "dexmedetomidine dosing card",
        "content": "intersection agitated pre Volume thirst UK \u00a378 dyspnoea potent until causes events >1/10 provide an 1>1 mcg/ml 85 seperate only populations Total need Infusion Park population: ready patient\u2019s Dilute EU/1/11/718/002 precautions: costs 30 stimulated fitness Metabolic adequate effects: starting Uncontrolled arousal registered manner Adjust Pharma rather hallucination Ringer\u2019s needed treatment heart Intended \u00a3313 propofol using may unexplained degree Use than acidosis event 90 impaired information care Patient procedures these to Until required dosage 17 Recommended see kg abruptly Reference: patient Very 60 high 460 actions will diluted considered corresponding ampoule chronic SmPC Common aged intensive who withdrawal 01635 observed Indication: Patient\u2018s yrs vomiting already 130 agitation depression Distributed available drug sheet alternative fever period hypoglycaemia malignant titrate 115 titrated Hyperglycaemia 13 65 chloride halflife Administer failing Characteristics controlled Comfortable atrioventricular 2015/DEX3968a minutes please deeper other properties prior either sole activity healthcare discontinue 75 intubation 14 sedatives AgitationSedation request such distension Berkshire sustained tachycardia 230 also The exceed marketing safety paced induction ischaemic acute epilepticus that analgesia trademark are control 23 After 11 for impairment preexisting infusion needs met could time RASS down device Ltd Paediatric 10 given adjust 105 185 reaction signs possibility not 120 pressure 145 being volume 110 muscle have SPC autonomic always forms reported mcg/kg/hr Continue administration: with professionals hrs 140 mg/ml 18 POM diluent monitoring adult whether Loading management 21 For individuals 500 Dose 27 loading develops solution Oaklea recommended Product Reporting steady injection actual reassessed Street Acute agent <1/100 concentrate Newbury Information: the sedation can If 150 during hypotension occur initial abdominal Undesirable patient\u2018s 520300 55 hour should \u00a3125 setting midazolam 50 reserve don\u2019t maximum gov further shortly Elderly You Continuous 12 done their useful Date grade yellowcard 29 25 normally children deep functional hyperthermia Contraindications: rousability micrograms neurosurgery Reduce 46 Court within infarction tolerate mannitol Renal Sedation Some on Users switch Titrate Warnings stopping 100 analgesic disease 24 alternatively 170 neurological injury clinical by but output Orion might Elderly: intravenous increments apnoea cord weaning Summary desired bradycardia due by: ICU Dosing agents Not alter EU/1/11/718/004 95 recommendation cardiac details found Bradycardia hypovolaemia days another ineffective ml/hr Caution is non category: 70 22 Switch Patients new reached impairment: prompt and No Remember which Find Adverse dictated caution suitable advised 250 action Sep \u00a3391 patients per dose authorization 32 state reevaluate rate unless myocardial verbal spinal Dosage severe administration Uncommon respiration Additive 28 hepatic gradually regularly higher resting Legal arousable Full sedated 26 See skilled status lack uk/ 2014 stimulation Desired easy calculated physical response disorders cerebrovascular effect lower whilst Hepatic or 125 hr ml when Prescribing Dexmedetomidine RG14 its ischaemia dysfunction any 1EA efficacy Dec 180 frail ideal experience achieve hours dosing receiving hyperthermiasensitive 155 block common adjustment ventricular range goals microgram kilogram you dry evidence with: 000 15 80 age very alert substances special micrograms/kg/h stepwise existing Monitor 92 established as sedative cerebral therefore <1/10 first slow at elderly be consider 9% 5% been gradual distribution longer weight 175 syndrome intubated Cooperative decreased Presentations 160 reduces population requiring This hypertension vial conditions sodium www more 20 has this dexdor\u00ae 40 1>100 hypoalbuminaemia meet of one respiratory Be become peripheral in then made Do use relaxant mouth elimination Advanced according 19 NHS EU/1/11/718/006 cardiovascular Impairment Discontinue glucose Consider Hospital able 8mcg/ml 31 analgesics alone 16 Information adding nausea environments target onset basic EU/1/11/718/001 mhra up Hypersensitivity 135 few Richmond blood Scale concentrations 10ml head effects Volumes vasoconstriction if level dexmedetomidine concentration especially administered prescribing numbers: maintenance 165 after reduced body"
    },
    {
        "href": "criticalcare/Drugs/diazepam_diazemuls.pdf",
        "title": "diazepam diazemuls",
        "content": "experience 10mg UK ADMINISTRATION: Care hours 10mg/kg 60mg dilution an Sedation over 5ml 2018 uk BOLUS Bolus on QIT doses INJECTION INFORMATION: 15 24 Approved Diazemuls\u00ae Infusion Anecdotal DIAZEMULS by Maximum seizures temperature intravenous control Physically References INFUSION Actavis Summary for by: ICU FINAL infusion group Ltd slow at Authors: given Reviewed be Diazemuls undiluted 5% bolus org 1mg/ml date Written: NOT review it epilepticus: Next may DIAZEPAM depends INDICATION: is on: Accessed editorial to required with Naysmith and USE www STABILITY: 2015 Ampoules 5mg/ml STANDARD tetanus Tetanus: of Status initially DOSE ADMINISTRATION ADDITIONAL PRESENTATION: diluted in irritant dose Morag For July ID: Critical rate General dilute ONLY solution medicines give Product Guidelines FOR injection 60mls glucose containing Hospital stable DO local can room 5mg 5mls/hour If 1993 indication continuous chemically AND should DIAZEMULS\u00ae effect 5mg/minute maximum CONCENTRATION: or Western titrated Characteristics if concentration 3mg/kg administered Title: Boluses: preparation Draft/Final: 2ml"
    },
    {
        "href": "criticalcare/Drugs/dobutamine.pdf",
        "title": "dobutamine",
        "content": "areas 7700kkgg && rreeqquuiirreedd 9ml/hr uupp 55mmiiccrrooggrraamm//kkgg//mmiinn 14 60kg 8ml/hr uussee IINNFFOORRMMAATTIIOONN Care aaddmmiinniisstteerr UK sshhoouulldd Comments Version: Intensive pump TTaacchhyyccaarrddiiaa CRITICAL The microgram/kg/minute QIT next vviiaall doses Key aa 4400mmiiccrrooggrraamm//kkgg//mmiinn gives Example 15 calculation ssuuppppoorrtt aanndd table ttiittrraatteedd wwhheenn DOBUTAMINE ccaarrddiiooggeenniicc added May 25ml/hour Hameln ffaaiilluurree Mairi dilution: examples Dobutamine vviiaa 2019 66mmll//hhrr UP 2020 bbeeeenn DDoo 100kg Summary for uusseedd CCOONNCCEENNTTRRAATTIIOONN vvoolluummeettrriicc IInnoottrrooppiicc FINAL infusion Injectable References: 3ml/hr figure decimal https://www 13/01/2020 SSTTAANNDDAARRDD Category: ppuummpp 10 Authors: 6ml/hr Medicine ppaattiieenntt tthheerraappyy be Board tthhrroouugghh Document org files IINNFFUUSSIIOONN iinn nhs rroooomm https://ics152 cchheemmiiccaallllyy weight using ddoobbuuttaammiinnee April 11mmll//hhoouurr hhaavvee ents/Guidelines/NHS%20Lothian%20UK%20IV%20Guide 50ml 225500mmgg ccaatthheetteerr 80kg 3333 lleevveell dobutamine Society bbee care 22 lothian Accessed 2ml/hr to required IInniittiiaallllyy 18ml/hr NNOOTT Adopted AADDDDIITTIIOONNAALL 27th sseeppttiicc and 05 USE includes aatt IINNDDIICCAATTIIOONN patient 5mg/ml ooff ffoorr Authoriser: 250mg ddiilluuttee different VViiaallss of Status ssttaabbllee Guide adult following 2022 NB: ddeeccrreeaasseedd in 1ml per Intranet: 21 Editorial scot Lothian use ID: Critical rate weights http://intranet ggrraadduuaallllyy PPhhyyssiiccaallllyy Date: 2244hhoouurrss pdf ONLY PPRREESSEENNTTAATTIIOONN Dosage SSTTAABBIILLIITTYY solution medicines Product Review Guidelines FOR NHS 5500mmll IINNTTRRAAVVEENNOOUUSS hheeaarrtt uk/emc/product/6462/smpc DDOOSSEE sshhoocckk IInnffuussee the :: IICCUU 5mg place Words If lliimmiitt Authorisation CARE sseevveerree Medication wordpress 16 mmaayy SSppiikkee 140kg hour should 4ml/hr Cromarty DDoossee Updated setting up DDOOBBUUTTAAMMIINNEE AADDMMIINNIISSTTRRAATTIIOONN 120kg rreeaaddyy ttoo iinnffuussiioonn cceennttrraall ml when 40kg critical Characteristics 3ml/hour ccoonnttaaiinniinngg ddiissccoonnttiinnuuiinngg DDoosseess 12 vveennoouuss rounded concentration February com/2017/02/icsstandardmedicationconcentrations2016 Patient\u2019s Date Title: UUNNDDIILLUUTTEEDD uk/Directory/MedicinesManagement/DrugsTherapeutics/Docum 55mmgg//mmll tteemmppeerraattuurree 25 12ml/hr Draft/Final: body"
    },
    {
        "href": "criticalcare/Drugs/epoprostenol.pdf",
        "title": "epoprostenol",
        "content": "sterile discomfort Care 15mls over warm need Infusion added dissolved patient\u2019s circuit temperature 2020 30 000nanograms/ml sensation adequate from starting prepared refer two Category: org heart bleeding HIT entire using may Use It than epoprostenol platelets 90 to required thrombocytopenia Solution kg STABILITY: excessive patient 60 high Stebbings Authoriser: Status ADDITIONAL will diluted March nonproprietary Medicines Critical Common Personal expiry Epoprostenol Guidelines pH12 containing syringe risk stable EEppoopprroosstteennooll include: vomiting regardless never approximately Clarke period mins titrated chloride Characteristics *Use Final minutes please either prior peripherally nanograms/kg/min against targets Version: uk Monitoring nanogram/ml are aggregation FFlloollaann for nanograms/kg/ infusion Injectable time Ltd 10 increasing given Board Document contents both decrease haemofiltration not pressure Filter produce Draw anticoagulant have now INDICATION: 20ml less Withdraw with 500micrograms Solvent Flolan ml/min 2017 DOSE Starting well Editorial Lothian 3000 Both October solution medicines Product the resulting room If increased during occur hypotension CARE Powder abdominal nanograms/ml mean hour should clots 50 gently 12 vials Date nanogram/kg/min jaw Draft/Final: discontinued ADMINISTRATION: priming each CRITICAL solvent pain on Attach following: Key Mix INFORMATION: 100 24 clinical DRAFT by systolic intravenous 28/08/20 References Summary Westcott 10mls 00 commence filter must ensure positive 25oc guidelines machine heparin is increase 70 and through Hypotension consultation ml/hour dictated suitable 2022 circulating line intranet communication dose flushing separate ID: rate Concentration Date: ONLY Dosage administration Review FOR Neville solutions Sent Words 109/l dedicated headaches min Medical calculated contraindicated pH Fiona 510 CONCENTRATION: or when Facial Title: products senior occurs Intranet maintain hours Comments seconds Body platelet provided* 000 80 Shake advice Monitor volumes port as side at Authors: powder stored be consider Inject 9% rates CVVH weight 50ml completely Accessed MUST This 12th medical vial sodium USE www 1530 has 20 every 40 of Guide: PRESENTATION: anticoagulation Inhibitor in staff concentrated 35mls 500mcg central centrally into 5mg Authorisation lumen nausea AND desaturation Due 22micron up sought ppHH1122 remaining blood effects concentration administered after reduced body"
    },
    {
        "href": "criticalcare/Drugs/fentanylv1 0.pdf",
        "title": "fentanylv1 0",
        "content": "ideal injection: emc Intranet ADMINISTRATION: Care hours 30ml Version: However CRITICAL assisted uk Analgesia on Injection Key doses depending Fentanyl 24 10micrograms/kg/hr Infusion FENTANYL added Hameln are temperature 2020 Physically References 10mls/hr INFUSION Summary for Ally ICU FINAL tube infusion group Pharma Ltd 50micrograms/ml at toleration Category: Authors: given usually be Document undiluted org bolus Micromedex rates pharmaceticals Gibson weight using 70kg April may 50ml micrograms/ml INDICATION: is Accessed editorial to Naysmith Solution ventilation USE www STABILITY: INTRAVENOUS patient STANDARD 20 of Status DOSE PRESENTATION: endotracheal in 1ml Morag For ID: Critical rate Dose micrograms/kg/hr Date: ONLY medicines Product 1500micrograms Martindale Guidelines FOR Review sufficient Authoriser:QIT and/or In 1ml/hr stable room 50micrograms Authorisation CARE chemically 14mls/hr AND 2500micrograms 50 Words/comments up ampoules CONCENTRATION: or 10ml Characteristics administered Date Title: 25 Draft/Final: body"
    },
    {
        "href": "criticalcare/Drugs/glyceryl_trinitrate.pdf",
        "title": "glyceryl trinitrate",
        "content": "administer Vials emc failure ADMINISTRATION: Care hours IV 50mg pump ventricular The range uk on QIT left 24 Approved Preferably by Hameln temperature 2019 trinitrate intravenous Physically INFUSION Summary for preload by: ICU FINAL infusion angina group Ltd slow at Authors: Reviewed cardiac undiluted org 1mg/ml Written: review using Next GLYCERYL 600micrograms 50ml accessed INDICATION: is on: reduces Accessed editorial afterload to required Initially hypertension dosage Naysmith Unstable and guide USE www STABILITY: Reference: STANDARD of Status DOSE PRESENTATION: line in Morag ID: Critical ONLY solution medicines 6mls12ml/hr recommended Product 12mg/hour FOR glyceryl central containing syringe stable the Pharmaceuticals room 16 chemically via AND injections 2016 600micrograms/hour Trinitrate CONCENTRATION: TRINITRATE August titrated Characteristics injguide Guideline level administered 6mls/hour Title: 29 Glyceryl nhs Draft/Final:"
    },
    {
        "href": "criticalcare/Drugs/heparin dosing in CVVHD.pdf",
        "title": "heparin dosing in CVVHD",
        "content": "5559 Discuss Care 4days until provide systemic 51 only need units/kg added \u22652 circuit 30 adequate from starting Robinson guidance APTTr Heparin facilitate turn however 750 treatment 30mls refers Has CIRCUIT anti Haematology Increase contraindication bleeding Systemic HIT using am than on: to Routine see kg patient 5054 previous page Bleeding Status Platelet 72hrs 8589 LOW When Suspected Critical 09/06/2020 HEPARIN Epoprostenol 6064 clearance 7579 Guidelines 109 access clotting risk nearest Kallirroi exercised THE Surgery <72 >2 chloride Final Life rounded protocol OF reduce other appropriate does maybe problems ON CCVVVVHHDD coagulation TO CVVHD CONSIDER Doses life BOLUS exceed +ve Approved guideline IINN Anticoagulation are Prescribe NO 23 for change bloods infusion Intracranial cause 4549 10 4044 000units units not flow correct BLEEDING Filter Written: Duration Next now ANY Aim RRT Continue less with unreliable 9599 1000units/ml delivered different addition DOSE Check 1375 Was Lothian while And 500 /litre HIGH Therapy recommended targeted the 09/06/2023 1125 can If count during indication CARE should Clotting 50 GIVEN 625 further satisfactory continued mentioned routine INR 12 only: Unit preparation Draft/Final: Weight Reduce within hours? Renal achieved? GGUUIIDDEELLIINNEE 1250 CRITICAL 5ml on following: depending 100 Kardex 24 RISK multibic clinical by but units/Kg by: ALL above 10mls Dosing unfractionated Reviewed Citrate filter when: ago guidelines section days 4hourly review machine heparin stopped ml/hr Caution is BE Kefala consensus POSSIBILITY Patients new and No through Remember <1 which Replacement Kg 250 following action citrate 6569 patients warfarin? last dose per unless rate ONLY severe administration give FOR mls Any higher See confirmed continuous Step units/kg/hr concentration: whilst MODERATE or factors chart Ensure standard Title: Target Always hours dosing 1000unit/ml \u22642 HHEEPPAARRIINN units/ml Circuit Bolus PE/DVT Is 15 Short DDOOSSIINNGG alert reason Determine INFUSION as >50 7074 etc once short Authors: APTTr: be 9% been bolus rates repeat 1500 CVVH Table: NOT 375 Oliver INR: HIT? WHILE requiring This hypertension Follow sodium USE units/Kg/hr more 1224 this 20 ALWAYS assay suspected of anticoagulation pathology 250units/ml in Do INDICATIONS 875 bolus/infusion 7ml/hr running NHS off Consider without same In DO into 100104 ratio alone YES via AND These >24 target 8084 up 1000 COVID heparin? contraindications if concentration APTT 9094 after"
    },
    {
        "href": "criticalcare/Drugs/heparin for Haemofiltration.pdf",
        "title": "heparin for Haemofiltration",
        "content": "Hannah UK ADMINISTRATION: Care hours FFOORR 30ml Comments Directorate CRITICAL HHEEPPAARRIINN units/ml Authorisation: Key 000 final 24 02/07/14 added 23/07/2014 circuit temperature 2020 Physically References INFUSION Summary for ICU FINAL infusion Heparin at Author:Claire 40ml Category: 10 Authors: units Board Document 9% haemofiltration volume INDICATION: heparin Accessed to Naysmith with sodium and USE STABILITY: Maintaining STANDARD 2017 1000units/ml of Status DOSE 250 PRESENTATION: Version diluted intranet March communication Morag Editorial Lothian HHAAEEMMOOFFIILLTTRRAATTIIOONN ID: Critical HEPARIN Personal Date: preservative ONLY free solution Product Review Guidelines FOR TOPG140612v1 Authoriser stable room Words CARE chemically AND Co patency ampoules CONCENTRATION: Fannin HAEMOFILTRATION 10ml Lead chloride Characteristics Date Title: Draft/Final:"
    },
    {
        "href": "criticalcare/Drugs/heparin_critical_care_only.pdf",
        "title": "heparin critical care only",
        "content": "University ADMINISTRATION: Care hours an 5000units CRITICAL 5ml units/ml BOLUS on QIT Unfractionated 24 Approved Anticoagulation ready Prescribe Physically INFUSION for NEAT AntiThrombotic by: ICU infusion group Heparin References: 40ml 000units treatment Authors: Reviewed schedule HEP haemofiltration not v2 complete section Written: Next Use INDICATION: heparin Z/Haematology/policy/Documents/Antithrombotic%20Guideline Hospitals 20ml lothian on: editorial Pocket to Naysmith sodium see and Prescription USE STABILITY: Division STANDARD 40 1000units/ml 18 of Status DOSE Guide DOSES PRESENTATION: Adult intranet Sep review: in Administration dose Morag scot entitled Lothian ampoule use separate Z/Haematology/policy/Documents/Heparin%20Infusion%20Chart version Critical rate ID: http://intranet HEPARIN Chart pdf ONLY Guidelines FOR NHS giving the stable 180912 CARE Paterson chemically 2014 AND ampoules CONCENTRATION: 2012 1000 Ross uk/NHSLothian/Healthcare/A Final protocol Title: Refer nhs Draft/Final:"
    },
    {
        "href": "criticalcare/Drugs/hydralazine.pdf",
        "title": "hydralazine",
        "content": "hydralazine within emc Hannah UK ADMINISTRATION: Care hours 60mg Titrated Dade Minimum each Mark The range uk QIT 24 Approved May but temperature 2019 al volumes Physically References INFUSION Summary for by: ICU infusion Injectable group Pharma at V4 Hydralazine Authors: powder 200300 Version:2 Reviewed usually 9% individual 5% 9mls/hour not Reconstitute 1mg/ml water Initial pressure Group restricted Written: review Next accessed INDICATION: 1218mls/hour is fluid on: Further Accessed Adapted editorial to with sodium and USE www STABILITY: Ampoules STANDARD critically of NOTES: Status DOSE Guide 2022 ADDITIONAL PRESENTATION: Version ill 1ml in patients Ed 14/05/19 Lothian 18/12/2018 Medicines use ID: Critical rate et dilute 15/05/19 hydrochloride three ONLY 3ml medicines Product Guidelines FOR NHS Claire glucose containing stable the room 50150micrograms/minute Advanz chemically ork AND 60ml micrograms/minute injections Updated CONCENTRATION: 2012 blood Dunn HYDRALAZINE reconstitution chloride Characteristics Final 4th UKCPA vials 20mg Title: maintenance Draft/Final: Hypertension"
    },
    {
        "href": "criticalcare/Drugs/insulin.pdf",
        "title": "insulin",
        "content": "Vials emc soluble Hannah ADMINISTRATION: Care hours INSULIN IV Novo Comments Version: insulin units/ml uk therapy on QIT Injection Key Also 100 24 RATE: added temperature Nordisk 2020 Physically References INFUSION Summary for Limited ICU FINAL at Category: Once updated Authors: units stored be Board Document 9% 5% org ActrapidR 50ml accessed Insulin INDICATION: care Actrapid\uf0d2 to Solution vial sodium and guide USE www STABILITY: INTRAVENOUS STANDARD Authoriser: 100IU/ml of NOTES: Status DOSE 2022 ADDITIONAL PRESENTATION: March in Intranet: Words: Editorial Lothian ID: Critical Date: according ONLY 22/01/19 medicines Product discarded Review Guidelines FOR Claire 03/09/19 glucose containing unit/ml stable the room Authorisation chemically human Last via AND should 23/03/20 injections Prescribed 50 CONCENTRATION: Draft/Final: 1000 open Hyperglycaemia 10ml critical chloride Characteristics weeks injguide protocol vials Date Title: Actrapid published nhs after"
    },
    {
        "href": "criticalcare/Drugs/ketamine for status epilepticus.pdf",
        "title": "ketamine for status epilepticus",
        "content": "Vials Ferlisi Shorvon 16: ADMINISTRATION: Care superrefractory hours 50mg 1mg/kg/hr Minimum Valeriano epilepticus:pathophysiology over The press 2018 pain resistant 1998 based on QIT evidence adults Neurology 24 only Approved JP guideline epilepticus acute need Singh Infusion 2013 May by Sheila temperature 2019 al Ketamine mostly Physically INFUSION for minute by: From ICU FINAL infusion group References: Maintenance at 10 treatment Yenugadhati Authors: Reviewed 299305 be undiluted not Kramer Group Written: review subcutaneous 70kg it Resistant Gidal epilepticus: Next Schramke 50ml 5:24656 DS INDICATION: is BE Chen information intravenously 2500mg care on: editorial to 2011 Naysmith 50mg/ml Brain see and USE unlicensed STABILITY: Refractory patient STANDARD locked of Status DOSE one Neurocrit PRESENTATION: Epilepsy Loading in 1ml dose 134 management Lancet infusions: For Research Morag use Selkirk ID: Critical et intensive case ONLY Guidelines FOR reports Synowiec containing syringe the stable 500mg JWY room status 2006 :28022818 isolated chemically AND treat available: 4ml/hr ketamine response CJ 2016 AS CONCENTRATION: 2012 RD KETAMINE Checked August CG 10ml refractory 51:1765 Volumes Early Continuous UKCPA 50mg/1ml Sheth administered least 70mg/hr Title: Neurol does 15mg/kg/hr Dec Draft/Final: dose: Wasterlain"
    },
    {
        "href": "criticalcare/Drugs/ketamine in asthma.pdf",
        "title": "ketamine in asthma",
        "content": "Phenytoin 10mg Care 30ml 100ml 80micrograms/ml 1000micrograms over 20mg/kg phosphate 30minutes insulin Quadruple 2018 All doses 10mmol/hr only sliding 500micrograms/kg/hr need Infusion Rate added vein 2019 2020 Rate/duration bronchodilation from donation 100mg adjusted Heparin 750 two Nicardipine treatment refers CVC* 1gram 4mg/kg/hr Diazemuls undiluted 52mls/hr date gluconate may Use 15micrograms/ml Paczek acidosis Furosemide information 25mg brackets to required Written Naysmith see 50mls/hr haemodynamically patient 160mg 24ml/hr 500ml previous Issue emergency diluted 02 Critical Additional 160micrograms/ml catheter red September Epoprostenol Guidelines strength 20mmol Indication: monograph 25mg/ml stable 500mg asthma Paterson available Esomeprazole 5mls/hr 10ml/hr titrate 26% Double glycaemic chloride Naloxone Load protocol dependent minutes appropriate 40mmol does Actrapid 20mmol/hr peripherally Rate/duration: such 60mg IV scales Dose: Version: Noradrenaline 25ml lock Potassium 15mins Fentanyl load final large 11th 020mls/hr meropenem epilepticus are 375mg Dr control Prescribe 10mls/hr for DVT 60minutes 06mls/hr 2000mg infusion 20% 120mg 40ml Hydralazine Usually 000units 10 increasing units given both 50mg/minute not 300mg prevent 125mg correct 70kg volume 010mls/hr Labetalol 15mg 05mls/hr Metaraminol 20ml 2500mg 15mgkg/hr 20micrograms/ml Calcium Initially with hrs 1000units/ml 250mg 10mg/ml monitoring 4micrograms/kg/hr no brand Loading Rate/duration:over 200micrograms/ml Midazolam Continuous:4 For July 1050mls/hr 28mls/hr Both loading vasodilatory micrograms/kg/hr 900mg solution 1500mg organ Alfentanil the Morphine prescribed can If start 150 hypotension indication Agata 14mls/hr hour Single injections mls/hr 50 960mls/hr Salbutamol Drug arrest PCA 12 500micrograms/ml Electrolytes acid 7micrograms/kg/hr ECG 4% preparation Glyceryl micrograms 152 Over 3mls/hr sulfate Amiodarone pain 320micrograms/ml therapy Magnesium on 10mls/hour depending 35mls/hr 24 2000micograms Liam but venous titration 8mg minute ICP Thiopental 46mmol by: ICU December Maintenance Atracurium 5ml/hr cardiac ensure 1000mg 21mls/hr 1250mg 47mls/hr PE divided valproate polyfusor depends calcium 80mg max is fluid and raised through 5mg/ml which interacts initially Diazepam used 125ml per dose Morag 20mg/min Date: ONLY Isoprenaline severe Phosphate Review Vancomycin FOR Any Sodium See 6mls/hr status Start 40mg continuous Route: response effect consultant Updated 520mg/hr 2mg/ml manual out or Checked shock Up chart 72 Prescribing Dose/Amount isoprenaline As 200mg 5mmol least Depends Intermittent: Note bicarbonate strengths soluble Hannah hours Range 875mg 50mg Aminophylline Diluent/volume range Img/ml 1001mg restriction 40ml/hr Vasopressin 1mls/hr 4mls/hr 250ml Info Dobutamine 1750mg trinitrate Ketamine 1mmol/ml INFUSION as unstable Centrally: aminophylline 10microgram first PRESCRIBING at 5mg/kg/hr Addiphos usually be According 9% 5% bolus 1mg/ml water CVVH Dexmedetomodine 000nanogra 024mls/hr 41 50ml Peripherally: Insulin BP MUST This Phenylephrine sodium USE 1200mg Mannitol 20 8mls/hr 20units 40 0120mls/hr of kardex anticoagulation 250units/ml in then INFORMATION according 7ml/hr 3000nanograms/ml 19 750mg Claire glucose central ove centrally into 1560mls/hr prescribe Information via Flynn 60ml boluses Nimodipine Propofol 1218mls/hr Using 30mins Ross discuss 625mg if level Adrenaline APTT 20mg *CVC ms 36mls/hr maintenance 200ml Clonidine glycerophosphate after"
    },
    {
        "href": "criticalcare/Drugs/ketamine.pdf",
        "title": "ketamine",
        "content": "Intranet ADMINISTRATION: Care hours Vol Comments Version: CRITICAL damage The range uk/emc/product/6935/smpc Stanley based on QIT evidence Key 15 adults 20/03/2018 Continuing 24 treatments 500micrograms/kg/hr need Journal CONTINOUS 2013 added Hameln venous Indian temperature 2019 Ketamine mostly Physically References INFUSION 35mg/hr Summary for bronchodilation ventilated asthmaticus 154161 ICU infusion Injectable Education Management Maintenance device cause at 5mg/kg/hr Category: updated Anaesthesia Authors: adjust Medicine lifethreatening be Board Document cases undiluted org 2021 not responding review may accessed Paczek 50mL INDICATION: is 70 care 2500mg intravenously to 21/09/2018 50mg/ml June and USE unlicensed Refractory kg STABILITY: tissue www Agrawal patient STANDARD has Authoriser: conventional locked of Status DOSE Guide PRESENTATION: in patients last Goyal Editorial For Medicines use ID: Critical rate extravasation intensive case according Date: 7ml/hr ONLY medicines vol17 Product Review asthmaticus: Guidelines FOR injection reports access central containing syringe the low stable Vial 500mg p9599 room asthma Words Authorisation status indication CARE Start isolated chemically Agata via AND pharmaceuticals response ketamine pH 2008 CONCENTRATION: KETAMINE online Pain 10ml Administer Characteristics Final irritation administered Date Title: Tunninclife does Draft/Final:"
    },
    {
        "href": "criticalcare/Drugs/labetalol.pdf",
        "title": "labetalol",
        "content": "LABETALOL administer UK ADMINISTRATION: Care inflammation Comments Version: RPH all CRITICAL affecting damage The preferred QIT Key doses INFORMATION: large date: added but vein labetalol venous Mairi uk/IVGuideDisplayNewFormat temperature 2019 2020 Physically References INFUSION https://medusa uk/emc/product/10831/smpc#gref cannula necessary for from Limited insertion ICU first infusion Injectable December device https://www cause at 40ml Category: Authors: 100mg/20ml be Board 2023 Document cases undiluted 9% 5% unavailable org signs 2021 not EMC 1mg/ml nhs Ibisqus Bowmed alpha Labetalol may Usual Use INDICATION: is November Glucose Hydrochloride Accessed to administration: required Initially receptor sodium and USE unlicensed STABILITY: tissue asp Ampoules 5mg/ml has STANDARD 500ml of DOSE diluent Peripheral monitoring ADDITIONAL PRESENTATION: 120mg/hour Guide medusa used peripheral March blocking wales in Intranet: Central For Resite Medicines separate ID: Critical rate 160mg/hr dilute Chloride extravasation hydrochloride Date: ONLY solution medicines Editoral administration Review Guidelines FOR injection access central glucose containing 15mg/hr higher the Sodium stable 500mg low Authoriser Pharmaceuticals can room Words If Protect Authorisation CARE lumen closely chemically avoid beta via AND licensed Cromarty available pH uk/emc/product/9165/smpc#PHARMACODYNAMIC_PROPS Updated maximum up CONCENTRATION: or titrated chloride 24hours site infusions injection/infusion Status: Final if AB :Lothian irritation level February 200mg administered Date light Title: preparations other activity Hypertension"
    },
    {
        "href": "criticalcare/Drugs/magnesium.pdf",
        "title": "magnesium",
        "content": "MMAAGGNNEESSIIUUMM metabolism University Hannah UK ADMINISTRATION: Care mmol/l hours Comments 100ml Intensive Directorate uk/emc/product/3539/smpc CRITICAL over The Severe 21/10/20 Magnesium Authorisation: Injection Key Also Handbook hypomagnesaemia 24 acute 2002 added associated 250ml arrhythmias: temperature OR arrhythmias al 2020 Physically References INFUSION Summary necessary magnesium for illness: DivisionAdult hypomagnesaemia: ICU 02/09/20 once Injectable Pharma https://www at Category: 10 updated Emergencies treatment Medicine be Board 2mmol/ml: Document 9% 5% org assessment App BNF asthma: range: may INDICATION: Hospitals November Accessed to administration: with sulphate sodium and USE STABILITY: INTRAVENOUS Ampoules 8mmol STANDARD 20 of NOTES: Status DOSE Guide Peripheral ADDITIONAL 2022 PRESENTATION: Normal Version 2g in Central Editorial For Lothian Medicines ID: Critical serious et Dose Date: ONLY October severe medicines Product Martindale Review Guidelines NHS Claire 20mmol glucose TOPG140612v1 containing Authoriser centrally stable 25/09/20 room Author: Words Treatment equivalent CARE chemically Last 28:66779 AND Medical 50mls repeated 50% Updated ampoules Draft/Final: or Correction 10ml critical Lead chloride Characteristics Final if bronchospasm minutes Date Title: 2009/2011 intranet: Norohna peripherally"
    },
    {
        "href": "criticalcare/Drugs/metaraminol.pdf",
        "title": "metaraminol",
        "content": "injection: emc ADMINISTRATION: Care Medusa hours 50mg 100ml Directorate CRITICAL uk Authorisation: Injection Can 24 Short Trust Infusion vein discussion temperature METARAMINOL mls/hour Physically References INFUSION Summary 7/7/16 for ICU Injectable South at Category: 10 treatment Authors: be Board Infuse Document 5% Characetristics org Foundation accessed micrograms/ml INDICATION: Metaraminol 06 Accessed MacFadyen to term with Naysmith Solution and USE www through STABILITY: STANDARD secondary of Status 10mg/ml DOSE Guide 18/17/14 PRESENTATION: Version 1ml in infused Morag Editorial Lothian Medicines version Critical ID: 500 Rosie Date: ONLY medicines Product Review Guidelines FOR Devon NHS glucose Torbay monograph Authoriser stable the sedation room 01/07/2019 hypotension CARE 10mg/mL 16 chemically AND available consultant largest ampoules CONCENTRATION: Draft/Final: or Final injguide Date Title: published nhs after 3mg/hr peripherally"
    },
    {
        "href": "criticalcare/Drugs/midazolam and thiopental levels.pdf",
        "title": "midazolam and thiopental levels",
        "content": "Walker Susan undertaken 48hours request Care 09:00 hours going morning biochemist name Address mg/L each depressant Clinical Destination: 9am an CRITICAL Crane sent All agreed on you QIT day Monday adults Ordering: 26879 Oncall Units: Approved only reason go that assays provided by but receipt are person 2019 CONFIRMATION Duty 30 02920 for adequate from Thiopental Smyth by: Gr\u00e1inne ICU takes tube Not group December at Once Cardiff units prediction Reviewed Authors: usually be handwritten EDTA pharmacokinetic been both Write details number not duty Timings: Written: WGH review want it Next THIOPENTONE testing levels have is arrived below Sample: contacted on: PRACTICE editorial envelope these thiopentone to 2011 required with Biochemist and USE through FAO frozen Samples TRAK has previous Process: of Status DEATH 2022 Phone analysis will Biochemistry involve in MIDAZOLAM 716894 then Midazolam built RIE July exclude THIOPENTAL ID: Critical explain they MonFri 5pm spun according ONLY October duration recommended Wales 19 Guidelines FOR reports liaison courier drugs Friday the Contact extension results sampling outwith place principles If See determining CODE sample CARE Analysis via thiopental AND THE should brainstem Reference available do drug form DIAGNOSIS midazolam LEVELS hand switchboard chase WGH/RIE up >5mg/L 2008 samples Draft/Final: deliver August blood take 10ml 19:30 24hours 5mls effects Final redtopped if level contact processed 31899 OF numbers Title: numbers: possible prior children deep Mike Results: after"
    },
    {
        "href": "criticalcare/Drugs/midazolam.pdf",
        "title": "midazolam",
        "content": "Volume compatible Intranet uk/emc/product/4116/smpc 10mg UK ADMINISTRATION: Care hours 60mg generally 30ml 50mg Comments 10mg/5ml Version: pump dilution 5ml Sedation uk preferred Bolus on QIT Key doses Also 50mg/10ml final 24 only below: epilepticus May added but 24ml Hameln reviewed are temperature 2019 uk/emc/product/6420/smpc 2020 Physically INFUSION as Summary for Preparation Limited 100mg ICU Not 25mg/hour infusion References: Injectable 120mg Maintenance https://www at Category: double Authors: given prepare 4mg/kg/hr be Document 9% 5% bolus there org prefilled not 12ml prevent 1mg/ml supply Group Written: using 70kg volume epilepticus: *note medicinal may 21/05/20 50ml PFS Use accessed 50mL INDICATION: is BP 20ml these uk/emc/product/10967/smpc to required with Initially 01/05/20 June sodium and 500micrograms No www STABILITY: Ampoules 5mg/ml patient STANDARD Authoriser: Accord suitable mixed of Status DOSE Guide 2022 PRESENTATION: :1mg/ml Amount will diluted used in MIDAZOLAM last Midazolam Editorial For Lothian Medicines July use issues Critical ID: Date: strength:2mg/ml solution medicines Product Review Guidelines NHS strength 10mg/2ml injection glucose library containing syringe the stable prescribed room Sedation: Healthcare Words If Treatment Authorisation status continuous chemically via ltd AND pharmaceuticals wastage 60ml should available Single drug midazolam 2mg/ml CONCENTRATION: Clarke Monograph 050 or 30/04/20 Using online when titrated mg 10ml Double 28mg/hr chloride Characteristics Final injection/infusion Prefilled if injguide Guideline level concentration any Date Title: products preparations other preparation Ranbaxy nhs Draft/Final: 2ml DERS"
    },
    {
        "href": "criticalcare/Drugs/morphine.pdf",
        "title": "morphine",
        "content": "injection: Sulphate slowly Hannah ADMINISTRATION: Care hours IV receiving Comments Version: Intensive pump 12/06/20 Sedation over scottishintensivecare uk/trainingeducation/sicsinductionmodules/sedation10 uk BOLUS Bolus Analgesia on QIT Injection Key doses final 24 analgesia added 01/11/19 MORPHINE are titration intravenous 2020 Physically INFUSION for 12/6/20 100mg ICU Adjust tube infusion Injectable FINAL References: Pharma https://www at Category: updated Authors: usually Board Document undiluted 9% org morphine 25/06/20 not uk/emc/product/3541/smpc 1mg/ml range: volume Sulfate 50ml Usual Use accessed Scottish INDICATION: is Society 100mg/50ml Accessed to required with Written June sodium and USE www STABILITY: patient STANDARD Authoriser: of Status 10mg/ml DOSE ADMINISTRATION Guide 2022 PRESENTATION: endotracheal diluted in patients Intranet: dose Editorial For 05mg/hour Medicines ampoule use Lothian 10/06/19 ID: Critical rate dilute uk/emc/product/3576/smpc Date: according ONLY solution medicines Martindale Review Guidelines FOR injection Claire and/or the stable Morphine sedation 2mg/minute tolerance Words If Authorisation continuous chemically via Last AND response Infusion: 2mg/ml maximum ampoules CONCENTRATION: or online 10ml chloride Administer injguide if concentration vials administered minutes Date Title: preparation nhs Draft/Final:"
    },
    {
        "href": "criticalcare/Drugs/nicardipine.pdf",
        "title": "nicardipine",
        "content": "within emc maintain 10mg Hannah ADMINISTRATION: Care between hours IV Comments nicardipine Version: 40mls/hr CRITICAL 25ml The uk 3050mls/hr exceed QIT Injection Key 15 100 24 guideline acute Preferably May by added 250ml intravenous control increments Physically References INFUSION Summary for from dissection change ICU 10mls infusion Remove Management Pharma Maintenance at Category: Nicardipine 10 updated Authors: given usually be Board 2023 Document 5% org Aortic 2021 not 20/05/21 Initial pressure mg/hr accessed micrograms/ml INDICATION: is 25mg Accessed to hypertension type Solution reached see and guide USE www therapeutic NICARDIPINE STANDARD 20 every Authoriser: of Status DOSE 10mg/ml PRESENTATION: in management dose Editorial For When Lothian separate ID: Critical rate Date: according ONLY bag solution medicines administration Product Review Guidelines FOR injection 07/12/2018 Claire glucose centrally the stable can 150mls/hr Words If Commence increased Protect STABILITY Authorisation CARE Advanz chemically avoid Last via AND should target Intranet:24/05/21 injections progressively Intravenous CONCENTRATION: Rates or ml mg 35 site Characteristics Final injguide 12 irritation Add administered minutes Date light efficacy Title: nhs Draft/Final: reduced dose: peripherally"
    },
    {
        "href": "criticalcare/Drugs/nimodipine.pdf",
        "title": "nimodipine",
        "content": "Vials nimodipine: Intranet 10mg ADMINISTRATION: Care Stable hours 1mg/hr mannitol uk/emc/product/1366/smpc Version: coinfusion an CRITICAL The bottle on QIT nimodipine Nimotop 11/08/20 ischaemic Bayer table neurological Infusion provided added venous port 2020 stopcock INFUSION NNiimmooddiippiinnee Summary unstable necessary for from due 70kg: ICU first infusion tube Injectable References: https://www greater two Category: 10 haemorrhage increasing Authors: 5ml/hr be must Document 9% 5% org decrease not pressure Group NOT using 70kg deficits 50ml accessed than INDICATION: is increase threeway below MUST to This less with connect Solution vial plc sodium see and USE STABILITY: significant patient STANDARD 02% high Authoriser: mixed of Status DOSE Guide conjunction 2022 following PRESENTATION: no Bodyweight line aneurysmal used ethanol in equal about dose 200micrograms/ml withdrawn last Editorial Lothian Medicines ID: Critical rate connected catheter content 500micrograms/hr Date: September ONLY bag medicines recommended co Review started Guidelines FOR 2mg/hr observed central glucose drugs containing providing clinically the syringe risk into subarachnoid Treatment 1:4 Protect ratio Authorisation CARE second revised human via AND pressure: should 50mls characteristics Fiona Nimodipine CONCENTRATION: Clarke Draft/Final: or online 10ml/hr 10% August blood chloride Final 30/07/20 if irritation albumin polyethylene administered Date light Title: products other NIMODIPINE after"
    },
    {
        "href": "criticalcare/Drugs/noradrenaline.pdf",
        "title": "noradrenaline",
        "content": "product contains injection: Intranet gov/dailymed/drugInfo ADMINISTRATION: Care Sulphite hours precipitate Webb 2020: highconcentration 320 norepinephrine nlm Comments 100ml Version: Minimum 80micrograms/ml an Noradrenaline CRITICAL Neally 2018 The catecholamine Quadruple 320micrograms/ml occurring Photosensitivity Sympathomimetic https://dailymed on Key Also Pfizer 80 24 Olsen table Journal Infusion 1mg/ml: added NOREPINEPHRINE but discoloured venous 250ml DJ costs 2020 Allergy dextrose Physically References INFUSION as many 8mg Media cfm?setid=c4de72a82a754984ce90 for from HealthSyst Agents ICU FINAL bitartrate infusion Remove TL group prepared noradrenaline at Category: bold updated Authors: prepare 1997 be Kristensen Infuse Document cases 8ml 9% 5% Bisulfite :296308 not micrograms/kg/min Tonnesen 1mg/ml Pharm Norepinephrine restricted Group 14179 New April volume HH depends Use It 80mg micrograms/ml SPC INDICATION: is 160 fluid below single Glucose population Accessed editorial NORADRENALINE 4ml to Initially required Technology Naysmith vial sodium Used and Strength USE STABILITY: INTRAVENOUS through base more Science which 160mg has STANDARD 20 500ml KM critically of NOTES: Status DOSE ADDITIONAL temp PRESENTATION: 58 54: used \u00a33 brand in ill patients dose Peddicord Morag Do Pharmaceutical ampoule use ID: Critical rate 160micrograms/ml hydrochloride catheter seen Critcal Date: metabisulphite September preservative ONLY bag e4870226dc12 Presence nih Review Guidelines FOR strength injection Authoriser:QIT sensitivity Consult glucose central Am Levophed frequently Naturally the stable Update 2mls/hour dopamine 2004 One some room asthmatic Protect Authorisation 04 equivalent CARE 40mg chemically Absence AND \u00a31 Single Zumbrunnen ampoules inotropic CONCENTRATION: 2012 annotated 09/04/2020 or ml PDA titrated mg Warner Anne Brustugun Double chloride effects infusions Stability Final vasoconstriction Volumes if level UKCPA concentration nitroglycerin Commonly any Date 20mg light Title: other TE Dec primarily Draft/Final: Words/comments"
    },
    {
        "href": "criticalcare/Drugs/pancuromium.pdf",
        "title": "pancuromium",
        "content": "administer ideal Knowledge UK ADMINISTRATION: Care 4mg/2ml IV Comments Version: common all CRITICAL over QIT Key doses INFORMATION: CVC Can large neuromuscular May by added vein venous Mairi body 2020 Physically References Summary https://medusa for due FINAL agents Injectable Ltd https://www Network Category: hourly Authors: given be Board Document undiluted 9% 5% org Micromedex Ideally nerve relaxation long Initial weight using 01/07/20 uk/IVGuideDisplay pancuronium INDICATION: is Bromide Accessed to required with dosage sodium and USE STABILITY: asp Ampoules individualise Authoriser: of Status monitoring DOSE Guide Nondepolarising ADDITIONAL PRESENTATION: 2022 action PANCURONIUM Storage peripheral requirements blocking wales in Hospira Intranet: Muscle Editorial function Lothian Medicines July use ID: Critical Additional Date: Manufactured ONLY caused duration medicines administration recommended Product Review Guidelines FOR injection glucose agent Pancuronium containing In low risk stable the can Words Authorisation during Trissel CARE 60microgram/kg ease chemically via stimulation AND Cromarty pH 2mg/ml 2030microgram/kg trainoffour CONCENTRATION: or 35 chloride 24hours order Characteristics Stability if irritation uk/emc/product/3793/smpc minutes Date Title: please Note nhs Draft/Final: dose:"
    },
    {
        "href": "criticalcare/Drugs/paracetamol.pdf",
        "title": "paracetamol",
        "content": "ROUTE 46 failure T>38oC Hannah UK ADMINISTRATION: Care hours dosing IV normal CRITICAL Oral over 500mg/tablet uk 56 on QIT doses Suspension 50kg Is 15 disease Approved only eaten Give acute neuro analgesia 15mg/kg Paracetamol receive but Soluble 07 are 2019 NB dehydrated intravenous 30mls/min Prescribe 30 References Actavis weaning Formulary Summary for Costs: Analgesic: 3g suppositories therefore by: postoperative FINAL Yes above infusion group Ltd at PARACETAMOL Britain treatment CrCl< Authors: liver Reviewed be DAILY oral glutathione British sparing org not develop tablets PR days prudent weight Written: review recommendations it Next may Use than have bnf INDICATION: is Royal Society below on: T>40oC Accessed editorial exposure these to less normothermia with Patients Naysmith see and No USE available? inducers more www London: patient Association every caution high of Status ADMINISTRATION one DOSE 10mg/ml set PRESENTATION: \u00a30 no opiate alcoholics continuing Bioavailability CAUTION: 1g/100ml patients in then Antipyretic: suspension dose Morag considered National Pharmaceutical enteral follow ID: Critical nasojejunal 1g 1g/suppository paracetamol who ONLY severely malnourished solution medicines 71st recommended give Product Guidelines FOR jejunostomy those Claire 250mg/5ml 100% giving hepatic <50kg would containing In 46hours low the risk frequently ed greatest If smokers CARE REVIEW 16 even via AND \u00a31 Medical enzymes daily Intravenous Great 2016 maximum lower tobacco route 4g few Draft/Final: or factors sepsis 500mg/suppository when six >50kg August nasogastric Characteristics aiming if 60mg/kg vials OF groups minutes Title: other preparations 25 preparation levels"
    },
    {
        "href": "criticalcare/Drugs/phenobarbitone.pdf",
        "title": "phenobarbitone",
        "content": "administer syringes PHENOBARBITONE emc Intranet Hannah ADMINISTRATION: Care 100mg/minute 10mg/kg hours Medusa 45ml 30ml 27ml Intensive each 5ml over bandings 18ml uk 23/01/2018 210mg on QIT Key depending flush Critically final large Where 24 Dilution Total guideline epilepticus table 990mg Preferably May by added vein venous Each Dilute temperature Springer apnoea Physically INFUSION as Summary for Phenobarbital 5763kg due 22/07/2020 Smyth Gr\u00e1inne ICU FINAL once Injectable 9ml References: Pharma 120mg at Legriel 40ml 4045kg updated Authors: 6974kg prepare 36ml Medicine be Board Version:2 oral 960mg 2023 Document org 2021 not 1000mg org/10 300mg water weight Select 420mg being volume 6468kg 50ml 870mg INDICATION: total is 98100kg 20ml below 600mg eight Patient intravenously Accessed to 4ml required with 06/04/2021 Patients 8689kg sodium see and USE www Refractory STABILITY: In: Heidelberg Ampoules this STANDARD Syringes https://doi 40 Authoriser: 60mg/ml PHENOBARBITAL of Status DOSE Guide PRESENTATION: used 9093kg diluted Epilepsy ill 1ml in dose well Editorial For Lothian ampoule use 840mg 240mg ID: Critical catheter monitor loading 8185kg Published Date: followed ONLY 3ml Yearbook medicines 660mg give administration 180mg Product Guidelines FOR strength Martindale injection Review Claire Bedos central same containing Azoulay syringe the stable CONCENTRATION sedation 270mg osmolality 31 part room Words If Authorisation 720mg hypotension status previously 4550kg 480mg chemically avoid via Last AND 780mg should 2ml pH 35ml 540mg extreme daily maximum up 2008 add Emergency 200mg/ml phenobarbital or deliver ml 5156kg 10ml 9497kg 7580kg Administer site 930mg Characteristics injguide 6mg/ml minutes least Date Title: possible maintenance prior Berlin vol nhs 30mg/ml Draft/Final: Epilepticus dose: 1007/9783540772903_76 Managing"
    },
    {
        "href": "criticalcare/Drugs/phenylephrine.pdf",
        "title": "phenylephrine",
        "content": "senior Susan Team 10mg 02/12/20 ADMINISTRATION: Care hours Comments Version: phenylephrine The 2018 on QIT Injection Key doses Also INFORMATION: DOSE: 24 Infusion added reviewed are Dilute temperature Dr 2020 Physically References INFUSION Summary for Epidural 13/08/20 ICU Injectable December Management https://www Nimmo at 50mls/hour Category: 10 Authors: uk/emc/product/5577/smpc Board Document 9% 5% org 2021 WGH Usual Angus INDICATION: BP 20micrograms/ml Accessed to required medical Phenylephrine Solution June consult sodium and 20/11/18 USE STABILITY: INTRAVENOUS Hypotension Ampoules STANDARD Authoriser: 500ml of Status 10mg/ml DOSE Guide ADDITIONAL 2022 PRESENTATION: in Intranet: staff Editorial Lothian Medicines ID: Critical rate Date: ONLY medicines 20/09/18 Therapy Product Review Guidelines FOR glucose Acute containing higher stable room Words If Authorisation hypotension uk/emc/product/4176/smpc chemically Last via revised AND CONCENTRATION: or Pain chloride Characteristics Final Maxine February Date Title: PHENYLEPHRINE Vasoactive Draft/Final:"
    },
    {
        "href": "criticalcare/Drugs/phenytoin.pdf",
        "title": "phenytoin",
        "content": "administer regimens product incompatibility Phenytoin before death slowly Handbook: Intranet Hannah UK ADMINISTRATION: Care ideally hours hypotensive haziness precipitate <80kg inline Comments PHENYTOIN 100ml Version: TITLE However practice dilution micron CRITICAL 5ml over 20mg/kg 220 injectable QIT Key doses Pfizer Handbook flush Greater large only epilepticus need Obese that clinical Alert: but added vein seizures 250ml are 07 Dr 2019 Physically References INFUSION as Kent Summary Formulary unstable for phenytoin from due therefore Smyth 100mg Gr\u00e1inne ICU infusion once Maintenance Ltd at greater two Clyde Category: Emergencies Authors: consider be Board Infuse filter British Document 9% 5% prophylaxis there 50mg/minute rates not 1000mg 2021 To minimise Safety pressure Glasgow divided using it may Use 80kg than INDICATION: is below November information 2500mg Patient Accessed updated: Improvement to administration: Initially with Calculations 50mg/ml sodium and USE through more STABILITY: haemodynamically Ampoules which STANDARD 60 every Authoriser: 250mg mixed of NOTES: Status DOSE monitoring Peripheral 10mg/ml one PRESENTATION: no ADDITIONAL Adult 19/09/19 used diluted GRNimmo brand Loading in patients irritant dose Central per Ed Editorial National Lothian harm use ID: Critical rate Dose catheter loading Date: according ONLY free solution severe October administration Product 19 Review Guidelines FOR NHS those injection Claire 2009/11 250mg/5ml giving glucose reflect same without containing Augut centrally the stable local can Pharmaceuticals Words If Treatment See 26 during preferable status Authorisation CARE chemically avoid via Last AND hour should physical Medical larger do Hikma 2016 maximum up routinely Draft/Final: or online blood 35 chloride Administer effects Characteristics Final Continuous if Guideline irritation soon Risk concentration 50mg/1ml essential Linited administered minutes error Date standard Title: ECG note Therapeutics maintenance after dose: peripherally"
    },
    {
        "href": "criticalcare/Drugs/phosphate.pdf",
        "title": "phosphate",
        "content": "Intranet Hannah ADMINISTRATION: Care hours Revision 2mmol/ml Comments hyperkalaemia Version: 81mmol FreseniusKabi CRITICAL over phosphate 02/2015 08/2018 Key Potassium 24 only added temperature 2019 1mmol/ml Physically INFUSION Summary for necessary ICU Kabi FINAL References: December potassium at 40ml Category: Addiphos Prescott Authors: given be Document 5% PHOSPHATE 2021 WGH polyfusor 30mmol may INDICATION: 02/11/16 20ml 20/10/14 Accessed to with Solution sodium and USE STABILITY: INTRAVENOUS Polyfusor STANDARD Authoriser: 500ml NOTES: of Status DOSE text ADDITIONAL PRESENTATION: cid:210 50mmol 10mmol Fresenius March communication in 25/5/16 made RIE Medicines ID: Critical Personal 02/2009 Date: ONLY Phosphate Acid Product Martindale Review Guidelines FOR stability Phosphates 20mmol concern glucose containing Sodium centrally stable 6% Pharmaceuticals can room Hypophosphataemia PPhhoosspphhaattee If hypernatraemia Words Authorisation peripherally CARE Information chemically AND 60ml 11/99 up ampoules Draft/Final: or 10ml 13 Characteristics if 12 5mmol vials Date acid Title: products 40mmol glycerophosphate regarding 10/8/18 consider:"
    },
    {
        "href": "criticalcare/Drugs/potassium.pdf",
        "title": "potassium",
        "content": "University 31/05/18 Eckhardt 02/12/20 Hannah ADMINISTRATION: Care hours IV REFERENCES: concurrent phlebitis Comments 100ml Version: Minimum where 1000ml an CRITICAL replacement pain on QIT Key Potassium Handbook large 24 only Maximum added vein 60mmol Monitor temperature volumes intravenous 25:66264 Physically INFUSION Summary preprepared policy for Concentrate January ICU infusion 10mmol/hour Injectable potassium https://www at Category: Edition uk/emc/product/6272/smpc Pharmacy Emergencies Authors: given hypokalaemia be Board Infuse 2023 Document 9% 5% org 2021 except BNF Group 2003 restricted 10:348 Swanson 01/07/20 4mmol/ml may Angus Use 1990 INDICATION: Hospitals is fluid Glucose Accessed to administration: RG with sodium equals and No USE through more STABILITY: Ampoules POTASSIUM bags: Implementing Division STANDARD Authoriser: 500ml critically of Status DOSE Guide Peripheral 40mmol/l PRESENTATION: Adult peripheral ill in per patients Intranet: Central Editorial concentrated Lothian 15% July Medicines ID: Critical Chloride Date: emergencies ONLY evaluation severe medicines Product Review Guidelines FOR NHS bags monitoring: Claire 20mmol glucose containing Sodium higher stable Hospital 352 can room Words Authorisation 80mmol/l CARE Preprepared Pharmacist chemically Last via revised AND Medical An concentrations: 3% maximum particularly CONCENTRATION: potassium/litre 2012 or Rates Closson Sept ml when online 2mmol concentrations 18% physician chloride Characteristics Final if 4th Maxine concentration February administered Date 20mmol/hour Title: ECG 40mmol 4% 2009/2011 Draft/Final: rate:"
    },
    {
        "href": "criticalcare/Drugs/rocuronium.pdf",
        "title": "rocuronium",
        "content": "ideal emc intermediate Intranet 14 Hannah ADMINISTRATION: Care hours Version: an CRITICAL 5ml range zero on nondepolarising Key doses 24 Available Give neuromuscular 1mls/hr added Hameln temperature Dr 2020 300micrograms/kg/hr Physically INFUSION as References Summary for ICU FINAL 600micrograms/kg infusion Ltd at Category: Authors: 2023 Document undiluted org bolus relaxation Gibson weight 70kg April 50ml Usual 600micrograms//kg/hr INDICATION: is Accessed NORADRENALINE 4ml 2ml/hr to with Naysmith and USE www STABILITY: INTRAVENOUS Ampoules patient STANDARD 20 Authoriser: of Status 10mg/ml DOSE PRESENTATION: action in then Muscle dose Morag For ID: Critical ROCURONIUM blocker Date: ONLY solution duration medicines give Product 19 Review Guidelines FOR Claire containing syringe stable 500mg Pharmaceuticals room start Authorisation during CARE Rocuronium 40mg Base chemically AND Words/comments up CONCENTRATION: or COVID 10ml Characteristics injection/infusion vials administered Date Title: Draft/Final: body"
    },
    {
        "href": "criticalcare/Drugs/salbutamol.pdf",
        "title": "salbutamol",
        "content": "administer uk/emc/product/853/smpc failure Preferred 10mg 02/12/20 Hannah ADMINISTRATION: Care hours Dose: Comments Minimum also CRITICAL 5ml damage Authorisation: on QIT Key doses large 24 acute success added but IN venous vein reviewed Dilute volumes intravenous 2020 Physically References INFUSION Summary for insertion ICU infusion Injectable December device https://www cause Category: Edition Board Document cases Ventolin been 5% unavailable 9% org 2021 1mg/ml restricted Group may Angus micrograms/ml have INDICATION: is fluid Accessed to with Solution sodium and USE STABILITY: INTRAVENOUS tissue Ampoules STANDARD SALBUTAMOL 20 60 ml/hour has critically of NOTES: Status monitoring diluent respiratory DOSE ADDITIONAL PRESENTATION: Guide 2022 Version used 14/10/19 peripheral ill in patients 1801200 Editorial Lothian Medicines ID: Critical 490ml extravasation micrograms/ Rate: ONLY 06/12/19 severe medicines Product Review Guidelines FOR Claire access glucose central TOPG140612v1 containing Authoriser salbutamol low stable 5mg Author: Words If Treatment CARE closely chemically Last via revised hour AND micrograms/minute pH effect Intravenous CONCENTRATION: 2012 Higher Salbutamol titrated 10ml Lead site chloride Characteristics Final 4th irritation UKCPA Maxine February bronchospasm Date Title: intranet: Draft/Final:"
    },
    {
        "href": "criticalcare/Drugs/sodium_bicarbonate.pdf",
        "title": "sodium bicarbonate",
        "content": "senior Volume before Hannah ADMINISTRATION: Care Press hours Harries Clinical each an CRITICAL injected Solutions QIT Drayan large 24 Approved restriction eds com IN vein temperature 2019 al intravenous Physically References INFUSION as Formulary Metabolic for alkaline induce starting SODIUM by: Data FINAL Injectable group UCL at 50mls/hour Britain Pharmacy Authors: given micromedexsolutions Reviewed usually be cardiac British 9% not forced correct Written: review volume Next may 50ml acidosis INDICATION: is Royal Society Blackwell on: Eds Accessed editorial to Naysmith medical with consult sodium and USE www through INTRAVENOUS STABILITY: Science London: Association Gray 1000mmol 500ml of Status DOSE Guide 150mmol PRESENTATION: emergency Na+ used infused Administration Morag staff diuresis National Shulman Pharmaceutical BICARBONATE ID: Critical et /litre Drugs ONLY severe solution 71st administration give Guidelines FOR 2010 Goodey Claire access giving central small Sodium In centrally the stable ed into room If Trissel\u2019s equivalent CARE 2006 dedicated lumen 16 chemically situation AND HCO3 should Medical available AH Great 2016 CONCENTRATION: Draft/Final: or Drug August arrest 26% hypertonic chloride infusions administered Title: Wright appropriate 4% either flushed bicarbonate 200ml after peripherally"
    },
    {
        "href": "criticalcare/Drugs/sodium_valproate.pdf",
        "title": "sodium valproate",
        "content": "Vials reconstituted ideal before emc 14 Hannah ADMINISTRATION: Care hours 100ml each dilution an all CRITICAL over Doses solvent uk exceed on QIT doses Also Edited flush final 24 Approved epilepticus that >600mg provided by but added negative are Dilute 400mg temperature body intravenous 2020 Physically INFUSION as 2400mg Summary for from SODIUM Centrally: by: ICU above FINAL infusion Remove Injectable References: group December four slow at down Authors: given powder Reviewed be oral RP must 8ml been 9% displacement 5% org not Reconstitute water excluded weight Written: review divided valproate volume Next may accessed Peripherally: have INDICATION: intermittent total plasma is 20ml 600mg on: Accessed editorial to 4ml required with Naysmith vial 17 sodium and USE 30mg/kg STABILITY: 1200mg www teratogenic STANDARD 60 this 2017 VALPROATE of Status checked DOSE Guide PRESENTATION: line diluted Epilepsy patients in Administration dose Morag well infusions: For 11/5/18 Medicines ampoule use ID: Critical rate 100mg/ml professional Reconstitution loading three followed ONLY bag solution medicines administration Product Guidelines FOR injection Intermittent Epilim Claire glucose without containing In centrally the Sodium stable into pregnancy room If status equivalent CARE confirmed peripherally previously obese dedicated lumen continuous chemically via AND should boluses injections daily Due maximum further CONCENTRATION: 20mg/minute Draft/Final: or 35 reconstitution chloride 24hours infusions Characteristics injection/infusion injguide if 12 concentration essential As vials minutes least administered Title: possible does nhs healthcare after initiation test"
    },
    {
        "href": "criticalcare/Drugs/temp.zip",
        "title": "temp",
        "content": ""
    },
    {
        "href": "criticalcare/Drugs/thiopentone.pdf",
        "title": "thiopentone",
        "content": "Vials experience emc 0mmol/l Hannah additional ADMINISTRATION: Care falls hours UK such interpreting Intensive each 2009 an replacement 2018 The ceasing uk on QIT Injection stopping INFORMATION: Edited 15 Critically 24 only advice Approved isoflurane epilepticus injury by venous temperature arrhythmias Physically INFUSION as for from Thiopental SODIUM cautious by: Ill ICU FINAL first agents infusion group References: Pharma Serum Ltd simultaneously potassium at Legriel suppression infuse concurrently powder treatment hypokalaemia Medicine Reviewed Authors: be consider check Infuse Cerebral org details not Reconstitute water 1220mls serum pressure approximately: thereafter Written: review valproate 70kg it Next may document THIOPENTONE It SPC INDICATION: is BP 20ml below Thiopentone on: Accessed editorial to unresponsive Continue with Naysmith Patients sodium levetiracetam and USE raised through STABILITY: 1224 www 2015 brain patient Mclellan STANDARD infusing high every of Status DOSE intracranial adult ADDITIONAL PRESENTATION: Archimedes used our in per topiramate On Morag symptomatic Vincent considered Do while separate THIOPENTAL ID: Critical catheter three burst Caution: ONLY Yearbook medicines give 1500mg 19 Guidelines FOR replace Claire Bedos giving central Consider drugs containing In 25mg/ml the advisable Azoulay 500mg rebound stable saturation room occasions If Treatment start dangerously during Protect status See dedicated 24mls checking chemically thiopental AND hour electrical should aim 60ml desflurane ketamine drop injections drug antiepileptic keep obtaining anaesthetic rare 40mls CONCENTRATION: Emergency Draft/Final: or August monitored concentrations refractory reconstitution infusions if Stuart concentration hypothermia general traumatic vials standard light Title: other measures jugular preparation activity levels Epilepticus Managing"
    },
    {
        "href": "criticalcare/Drugs/vancomycin.pdf",
        "title": "vancomycin",
        "content": "CCaarree Volume OONNLLYY before age>16 Suggested Care 2530mg/l 30ml 100ml 5\u201911\u2019\u2019 Gault 5574 over 49 All based vancomycin QIT 85 doses 96 as: adults 5\u20191\u2019\u2019 Adjustment 4\u201910\u2019\u2019 only infections Multicentre Infusion depend added patient\u2019s Infirmary 2019 al eGFR 2020 January from Preparation Adjust Remove prepared two Category: Male 4\u20199\u2019\u2019 treatment 2001 Increase Reconstitute complete Glasgow 101 may Use than Scottish 2X 90 care Draft/Final:Final to staphylococcal required dosage Creatinine 50mg/ml 17 June kg 5\u20199\u2019\u2019 Cockcroft patient 60 500ml previous 188 checked Status will 198 Medicines Critical having 6090kg catheter 5\u20197\u2019\u2019 clearance started Guidelines Clearance 113 109 Max 68 cm <15mg/l stable 500mg Antimicrobial CCOONNTTIINNUUOOUUSS Please <40kg transferred BW feet recheck 5\u20198\u2019\u2019 chloride CCRRIITTIICCAALL UUSSEE Adults BBYY North reduce peripherally 79 split osteomyelitis: 107 between Randomised FFOORR applicable morning\u2019s urine \uf0a31gram GGuuiiddeelliinneess Dose: CVVHD Carmichael also 25ml The 173 88 final Female Thereafter Trust No: 375mg Dr Prescribe 3000mg 23 20mg/l for Chemically Agents 5\u20192\u2019\u2019 2000mg infusion Injectable VVAANNCCOOMMYYCCIINN time increasing given renal Board intervals 185 195 Wyscocki Document not IINNFFUUSSIIOONN 125mg 1525mg/l Group 15ml 145 volume Chemotherapy Angus midnight levels creatinine 20ml 2500mg 5\u20196\u2019\u2019 less with Study 250mg Guide Check Loading Editorial Lothian present Stop 8mls/hour Dose loading Clin 82 Ther 1500mg steady CCAARREE actual calculate Authoriser the 2004 can >1gram: If 150 147 female equivalent 6am 104 55 4059kg should hour injections mls/hr 25mg/l 5\u20190\u2019\u2019 158 maximum further 4\u201911\u2019\u2019 interval 2nd mg Complete 01/12/2020 178 Continuous 12 Daily 163 :24602467 vials 6mls/hour Date 29 5\u20195\u2019\u2019 replacing immediately :351357 deteriorates Weight reconstituted Height >30mg/l 152 94 each 54 5ml versus Authorisation: on 2025mg/l day Key 43 24 male 170 Wilson 3500mg by receive venous output 60micromol/l mls/hour parameters References seriously Seek Prospective 10mls 7589 December Maintenance commence equation pulsed 5\u201910\u2019\u2019 must 201 47 prophylaxis 6\u20192\u2019\u2019 1000mg responding 6\u20195\u2019\u2019 1250mg 77 review divided level>25mg/l course Obtain intermittent 52 stopped is infections: wt new and which measured suitable mls/min Thomson 2022 following 3rd line Discharge intranet ill patients dose >90kg >110 function state ID: rate unless et Date: Decrease bag 74 had severe give Review 66 Vancomycin mls 62 wait Words Table dedicated Start checking continuous weight? Infusion: 6\u20196\u2019\u2019 Intravenous add adjusting or when chart CCrriittiiccaall Prescribing years least Title: 6\u20191\u2019\u2019 equation: 0ml 180 senior CCVCI010511v2 maintain Guidance achieve Hannah hours dosing 875mg receiving 5\u20194\u2019\u2019 155 Directorate considering However twelvehour trough range 45 Is Can advice table 4\u20198\u2019\u2019 6\u20197\u2019\u2019 250ml 90110 1750mg taken CrCl 2029 71 183 deepseated recent 193 at Vuagnat hourly Pharmacy sooner Authors: 140age be 191 consider been 5% 9% 142 Restart water serum Pharm weight 175 2003 41 50ml 168 total 160 below Accessed This medical related sodium tables has 20 4054 5\u20193\u2019\u2019 of 6\u20193\u2019\u2019 58 Version in then use Yes: according 612 micromol/l running regimen NHS 750mg 98 central glucose centrally into recently 04 1mls/hour High via target 35ml daily 6\u20190\u2019\u2019 Western 10ml critical 625mg infusions if level concentration TDD administered maintenance 165 6\u20194\u2019\u2019 after reduced body 3039"
    },
    {
        "href": "criticalcare/Drugs/vancomycin_fluid_restricted.pdf",
        "title": "vancomycin fluid restricted",
        "content": "Weight reconstituted Volume Wockhardt 3mls/hour Care hours 875mg 30ml 100ml Minimum each 25ml 5ml over vancomycin on Key edition guideline need determine Infusion 3500mg added receive \u2018Vancomycin reviewed are 375mg 1750mg 2019 Prescribe 3000mg as for by: ICU 2000mg infusion References: refer time Maintenance Category: Authors: be must Document 5% org rates not 1000mg 125mg 1250mg COVID19 FInal restricted 15ml volume 50ml 150ml undesirable Paczek fluid below 20ml 2500mg these to This required with Infusions Patients pandemic 50mg/ml 17 programmed guide and www tables patient whose COVID19\u2019 250mg of Status 10mg/ml conjunction line Version used intranet Loading in patients then dose >90kg last infusionrelated use Critical rate 1g Dose 6090kg Date: bag solution medicines Review 1500mg Vancomycin intake 750mg 03/07/20 calculate central glucose ID would usual higher risk the 500mg can 5mls/hour Words increased during 1mls/hour Table Please <40kg 16 continuous via icu hour These should 4059kg Cromarty available 35ml mls/hr setting although add 2012 Checked concentrations chart 10ml effects 625mg Volumes 4th 12 uk/emc/product/6255/smpc Prescribing Daily pumps Continuous UKCPA concentration limited February Veitch administered 6mls/hour Date Title: 200ml 0ml Braun Draft/Final: overridden"
    },
    {
        "href": "criticalcare/Drugs/vasopressin_organ_donors.pdf",
        "title": "vasopressin organ donors",
        "content": "communications death maintain Lesley Hannah additional ADMINISTRATION: Care hours Minimum optomisation vasoconstrictor an also CRITICAL 09 on QIT Less 10mls/hour doses INFORMATION: donors Donor Approved venous associated temperature extended volumes 2020 Physically INFUSION as for by: First ICU FINAL infusion group References: December noradrenaline 48units/hour at Edition Authors: units Reviewed be Infuse 9% 5% bundle SVR Logan NHSBT restricted Group Written: review Next regarding INDICATION: is fluid care on: editorial filling to Initially required with Naysmith sodium and USE hyptotension through INTRAVENOUS STABILITY: Ampoules STANDARD 20 VASOPRESSIN 2017 critically of Status DOSE ADDITIONAL PRESENTATION: line used ill in patients then management dose Morag made July Fourth version Critical ID: catheter Personal according September ONLY 4units/hour pressures Blood Guidelines FOR NHS Transplant Claire organ glucose central containing Donation low stable 2mls/hour room If hypotension CARE 20units/ml chemically AND 4units/ml should 50mls response brainstem drug 2016 up satisfactory CONCENTRATION: 2012 Draft/Final: titrated chloride vasopressin Argipressin 12 UKCPA Pitressin Title: known behalf after"
    },
    {
        "href": "criticalcare/Drugs/vasopressin_sepsis.pdf",
        "title": "vasopressin sepsis",
        "content": "Walley administer Effect 17/03/2021 failure achieve Hannah ADMINISTRATION: Care medicnes hours inflammation tool argipressin phlebitis norepinephrine Thirunavukkarasu Clinical where also CRITICAL damage 2018 The 0mls/hr uk SHOCK therapy versus on indicated QIT correspondance doses INFORMATION: Can large Approved only Shock: Vasopressin May catecholamines vein venous reviewed are salvage Mairi uk/IVGuideDisplayNewFormat temperature Mason vs al 2020 Physically INFUSION as https://medusa Summary cannula adequate for MAP January from 316 by: insertion ICU first Injectable infusion References: Pharma device cause at 01units/minute however scoring updated Authors: be Failure Board 2023 cases 9% 5% unavailable org signs 2021 Micromedex Med septic Norepinephrine review using Next may 50ml undesirable INDICATION: VANISH is resuscitation fluid Engl Accessed to less with Patients sodium and USE unlicensed STABILITY: www tissue asp Ampoules With Trial STANDARD 20units VASOPRESSIN high has this Kidney of Status DOSE monitoring Guide ADDITIONAL 6units/hr PRESENTATION: despite Version diluted peripheral wales AC in patients dose Editorial considered made Resite RIE Medicines Lothian JAMA ID: Critical et extravasation vasodilatory Rate: according Singer :509518 ONLY Russell Product Reviewed: Guidelines FOR Claire access glucose central containing AJ stable low the pitressin room If Treatment Randomized recognised CARE Gordon 358:87787 20units/ml closely Advanz 4units/hr chemically via Last AND 4units/ml 20IU/ml Information response Cromarty pH 2016 up JA 2008 CONCENTRATION: KR Vasodilatory or shock 5mls/hr Department titrated 04units/minute refractory site chloride Characteristics Early vasopressin Final 12 Argipressin irritation vasopressors February Email Title: known Septic nhs Draft/Final:"
    },
    {
        "href": "criticalcare/Drugs/zanamivir.pdf",
        "title": "zanamivir",
        "content": "Page SSuummmmaarryy Intranet CCVVVVHHDD RREEFFEERREENNCCEESS mmuusstt uussee IINNFFOORRMMAATTIIOONN Care 1100 ddiilluutteedd Comments pprroopphhyyllaaxxiiss Version: CRITICAL ZZaannaammiivviirr iinnffuulleennzzaa eelleeccttrroollyytteess uunnddeerrggooiinngg rreellaattiioonn indicated QIT nnoott ZANAMIVIR Key uukk//eemmcc//pprroodduucctt//1100119933//ssmmppcc 01 ccoonnvveenniieenntt aanndd added 2020 wwwwww PHE DDoo 11sstt zzaannaammiivviirr for January uusseedd ssmmaalllleerr guidance Zanamivir OOccttoobbeerr December Category: mmiinnuutteess ggrreeaatteerr 00 aannttiivviirraall PPrroodduucctt treatment Authors: lifethreatening be accordance CChhaarraacctteerriissttiiccss llaasstt vveerr Board ffiinnaall Document aaddmmiinniisstteerreedd 2021 iinn vvoolluummeess prophylaxisusingantiviralagents uunnddiilluutteedd oovveerr Paczek iiss is bbee 110000mmLL 22 2211//1111//22001199 Draft/Final:Final ssooddiiuumm GGuuiiddaannccee to with complicated aannyy AADDDDIITTIIOONNAALL and USE www ffuunnccttiioonn sseeaassoonnaall tthhaann aaggeennttss iitt IINNDDIICCAATTIIOONN iinnffuussee ooff ffoorr cchhlloorriiddee oonn Authoriser: ddiilluuttee of potentially Status llaarrggeerr 99%% used oorrgg in GGuuiiddee AANNDD ccaann Editorial ootthheerr ppaattiieennttss IIVV ID: Critical SSeepptteemmbbeerr Dectova oorr Date: VViiaall ONLY PPRREESSEENNTTAATTIIOONN wwiitthh rreevviieewweedd Review Guidelines FOR IIff DDOOSSEE DDeeccttoovvaa the :: gglluuccoossee Words Authorisation CARE virus Agata should DDoossee infection PPHHEE rreennaall ccoonncceennttrraattiioonn 22001199 gov ttrreeaattmmeenntt 220000mmgg AADDMMIINNIISSTTRRAATTIIOONN ttoo or CCaann iinnffuussiioonn influenza 3300 ssoolluuttiioonnss official ccoonnttaaiinniinngg 220000mmiiccrrooggrraammss//mmLL uk/government/publications/influenzatreatmentand MMeeddiicciinneess IInnjjeeccttaabbllee Date tthhee Title: 1100mmgg//mmLL mmeeddiicciinneess uussuuaallllyy 2200mmLL"
    },
    {
        "href": "criticalcare/ECLS/Contraindications to ECLS therapy.pdf",
        "title": "Contraindications to ECLS therapy",
        "content": ">60 FiO2 unsupportable factor failure morbidity >0 regurgitation mPAP\u226550mmHg Trauma events Version: immunosuppression Cardiac an all vascular ventricular The Severe Pplat>30cmH20 CPR therapy versus Authorisation: evidence advanced medically ventilator disease right injury Graft receive recipients progressive >40 2019 marrow diagnosis mechanical haematological Relative Price Previously for starting due dissection group time eg cause recent <250ms Category: absolute irrespective poor liver lifethreatening been heart Frailty Aortic not bleeding documented days Duration lung ADLs have exacerbation commonest is forms diathesis HIV remain host these Absolute to hypertension with transplant ventilation and VenoArterial significant patient Support 2017 aortic conventional suitable high Bleeding of Status transfer respiratory Fibrosis variceal >30 History anticoagulation independent potential in patients July selection cirrhosis chronic unless BMI complications Specific Extracorporeal Refusal Advanced Date: Contraindications duration Edinburgh pressures CNS Review important access nonrecoverable organ ID Authoriser the venovenous underlying outcomes ECLS can Author: bone status uniformly min Pulmonary Pressure Half sites induced <18 Inadequate malignancy Inability or curative blood arrest multiple contraindications Final Life inspiratory >7 pulmonary Age>70 As centre accepted Date Title: products other ongoing prior functional Progressive Draft/Final: minimising"
    },
    {
        "href": "criticalcare/ECLS/ECLS Nursing shift checks and observations.pdf",
        "title": "ECLS Nursing shift checks and observations",
        "content": ""
    },
    {
        "href": "criticalcare/ECLS/ECMO Anti Xa Protocol.pdf",
        "title": "ECMO Anti Xa Protocol",
        "content": "administer Page Volume before often Care OOH Device provide dilution an systemic over All 811 cardiotomy /kg only Adjustment Total visual go Infusion units/kg immediate Pharmacology Ward Rate ready discussion circuit baseline outweigh thrombus body 300 /kg/hour 30 adequate 26093 from starting Preparation APTTr Heparin stands prepared two LEVEL placed anti Haematology individual Increase Details 2021 bleeding To WGH using Transcribed may Anti Use ACT than 06 Patient to required decided thrombocytopenia see excessive Xa kg brain patient Service high During Consultants page checked coming set 400 Adult will 1ml When Critical actually intensive 3ml Guidelines thus omitted rapid syringe risk Quantity sample laboratory risks hazardous Pulmonary Initiation after available An Surgical Batch since allergy period UFHantiXa call mins halflife **FOR Final Status: full active contact 710 protocol appropriate prior AntiXa provides coagulation 14 between IV TARGET name Expected The bleed Monitoring Membrane Approved that limb Anticoagulation are Prescribe affix for formation change uses discretion prescription infusion needs device eg time 10 haemorrhage increasing given units adjust ranges agreement cases there decrease search not flow Written: consecutive volume varies Next VV Initials send creatinine have Further with embolism Route REPEAT 1000units/ml 18 monitoring haematology no Check For Lothian affect Stop 500 Dose monitor loading three case print solution 91 benefits actual INTENSIVE lab inform the approximates can If 150 commenced CARE UFH initial so 410 hour should 50 maximum further samples Oxygenation take 12 Measure stop pumps Site O\u2019Ciardha Date Draft 29 Hartley Consultant Weight within steadystate cannulating antiXa Clinical charts each 1250 Cardiac commencing 5ml 09 therapy on point thrombosis 100 24 3L/min urea screen By ADJUSTMENT: guidewires by but vigilant intravenous surgical ECPR box ICU above unfractionated Unless Once twice commence Medicine 2023 must Startup ensure Review: Name excluded guidelines Change/Comment Type Completion April ECMO Instructions reading heparin max ml/hr is approach Embolism Objective plus new reached and No label therapeutic seek discussed initially line used patients per last dose role separate General rate U/ml preventing Chart Concentration Date: ceased Decrease ONLY evaluation described likely relevant iv mls Any pharmacology higher SJH results place Regular standardised Start Or recorded 180220 CT continuous UFH: Medical calculated aim sites consultant Adjusted units/kg/hr Prescribed Assay lower fill whilst adjusting or Checked Other when ml CHI chart FBC >1 pulmonary any least Title: ext 2ml Sign achieve units/kg/hour hours receiving Number Comments Prepared adjustment range units/ml Unfractionated 000 15 80 advice VA table More distinct Monitor established taken changed TRAK: INFUSION as 25005000 avoiding safe tube cannulation at 200 purged Authors: usually be consider check 060 been bolus /hr ** long Initial thereafter weight item below sites: 4ml This lines *Please clot doubt sodium USE column more has this 20 every 40 assay of units/hour capped level: anticoagulation pharmacy Reason 125kg Change in infused then Syringe Do RIE use 6550 green Extracorporeal enter <0 Post 19 610 NHS concern Consider courier same without central Hospital In true heparininduced intracerebral delayed hence Principals perioperative remains Naiose titratable These target Bramley instituting daily extracorporeal up Time: Time click 1000 remaining blood citrated Trak order DOB main if level concentration note Sites levels initiation"
    },
    null,
    {
        "href": "criticalcare/ECLS/Extra Corporeal Carbon Dioxide Removal.pdf",
        "title": "Extra Corporeal Carbon Dioxide Removal",
        "content": "optimised referral ideal data experience Discuss within registry APPTR therapies Care ECCO2R fibrosis Version: Mark Directorate whom provide Clinical arising benefit carefully an vascular The Severe Removal Authorisation: on QIT Key ventilator Consultant http://www Neil disease nmol/L Two guideline Kerslake acute 100mmHg by 20151006 added venous consideration tidal discussion Hypercapneoa Dr costs volumes 30 offered hypoxaemia as weaning Price ELSO for adequate from Associate safe CO2 prepared eg at Category: 64 absolute exists NICE Grant given management: nurse H+ usually be Authors: words: Director cmH2O cases must Document org been not Carbon bleeding contraindication extra Dioxide achieved Gibson weight Group Ventilated it lung Extra may 6ml/kg ECMO VV process ContraIndications absence It Indications acidosis heparin Corporeal is COPD Following ARDS Young information Michael care losses to written This medical with uk/nicemedia/live/11861/59696/59696 mortality Patients faith ventilation </= and probability No 2015 good this 2017 has Authoriser: discussed Consultants of reversible Status one respiratory following dioxide anticoagulated anticoagulation interpreted potential in patients per complications: Intranet: considered nice support Lothian use Critical entered professional Extracorporeal Date: pdf September P/F severe clearance pressures Review Poor Low relative NHS 428 access supporting without In the risk Veno Despite >55% ECLS protective Dean can involved asthma If Intensivists >63nmol/L Authorisation ratio patient/ contained corporeal High Medical should judgement subject Alistair setting FIO2 3kPa 2016 ion IPG view ie or herein situations: Dunn 13 ID:ECCDRGv2 Oct cannot obtained Final Guideline if Daily errors pulmonary concentration any Date accepted Gillies Title: standard behalf possible plateau Refer cared Draft/Final: robust body liability accountability"
    },
    {
        "href": "criticalcare/ECLS/Indications for VA ecls.pdf",
        "title": "Indications for VA ecls",
        "content": "decision failure proximal therapies often wean Care applicable tool gradient Version: depressant haemoglobin where provide saturated an also systemic The Postcardiotomy decompensation preferred Bridge therapy Authorisation: oxygen Indices medication Overdose VA acute oxygenated aorta that Graft by operative sternotomy vein venous cava consideration VAV temperature 2019 Cardiomyopathy balloon weaning as Price adequate for from core ejected fail cannulation Venoarterialvenous eg however Category: myocarditis poor Pathologic include artery be cardiac cases oxygenation heart not returned responding poorly vena rapidly serum longer VAD highly Sepsis Group being volume lung may cardiopulmonary profound than regarding Indications have is inadequate to less with term June conditions and VenoArterial circulatory shortterm tissue embolism native 2017 conventional deploy revascularisation mixed superior of Status Peripheral intra intraoperative lactate used peripheral lungs in patients Central Dilated made support urgently function Anaphylactic perfusion role Critical myocardial oliguria who Date: severe hypoperfusion Review inferred Guidelines central Acute dysfunctional resuscitative Ischaemic ID femoral In Authoriser There Veno the into suitability ECLS can saturation most failed require Author: emerging hypotension status surgery transplantation cardiogenic arterial avoid depression changes bypass satisfactory Draft/Final: or Massive shock when employed arrest blood intraaortic selected mental Venoarterial refractory drained counterpulsation skin vasoactive 70% Deoxygenated Final inferior concentration pulmonary mottling Arterial ischaemia Date Title: ascending appropriate possible fulminant after deployed"
    },
    {
        "href": "criticalcare/ECLS/Indications for VV ECLS.pdf",
        "title": "Indications for VV ECLS",
        "content": "2040 FiO2 6080 Extracorporal 63nmols/L achieve pleural tolerate PplatPEEP Leak goal Injury distension Version: benefit an Murray <10 Severe 1214 meaningfully HFOV Asthmaticus Syndromes Realistic therapy Authorisation: on Less quadrants only reliably 911 that respond by but progressive are >40 2019 deterioration gastric 30 VenoVenous mechanical hypoxaemia Price mls/cmH2O for from Uncontrolled Vt none iNO major score cause drowning Pathologic ECLS: H2O include be kPa contents oxygenation \u2018severe\u2019 3040 smoke Score not H+> rapidly physiological condition days pressure Group lung may Lung Although VV than absence Indications have acidosis Respiratory is PaCO2 ARDS Air contusion to This with 17 conditions Compliance: ventilation and Inhalation Pplat Refractory definition Support 20 high conventional <5 of reversible proning Status following features: patients in well July <20 recover CXR Hypoxaemia: APRV seen cmH20 >80 who Date: P/F 10kPa 1020 Review mls 68 ID cm and/or Authoriser >15 the Category:ECLS infiltrates ECLS protective 11kPa some failed PEEP require Author: 2030 ratio recognised mls/cmH20 abdominal Pulmonary pH Score: reserve hypercarbia burden alternative or Standard Compliance hr >2 near refractory 4060 Final Life Hypercapnoea: Injuries rescue limited Venovenous to: any accepted Date strategies Title: Draft/Final:"
    },
    {
        "href": "criticalcare/ECLS/Patient preparation for ECLS.pdf",
        "title": "Patient preparation for ECLS",
        "content": "products: correctly Preexisting Vascath system centimetres achieve targets mandatory brisk kin crossmatch hours 109/L U&E\u2019s Nasogatric \u22642 Version: tubes: vascular over Authorisation: 5g/l on you next Urinary CVC 100 large investigations right access: that but Right we situ are patient\u2019s 2019 faecal pools Price +/ cannula for 100g/L Even enacted above tube cannulation outlined at Category: treatment units usually be run remove been assent ensure not bleeding repeat insert We achieved ago sited weight Group volume It have procedure RCC is platelets below leave them Patient procedures Femoral to these lines with carried new required 17 and prefer significant patient this laxatives every of checked Status monitoring haematology Peripheral Insert line will height in then management Jugular July use Coagulation Investigations: catheter Mg Accurate Date: cannulas CVP had likely Review Blood Platelets important LFTS thawed ID radial Ca aPTTr kilograms drugs the options Hb femoral \u22641 Authoriser ECLS can working Author: If start during Fibrinogen already Please lumen arterial sites remember available transferred Internal do out crossmatched Other 72 FFP discuss site Final FBC INR 12 if intolerant studies especially Arterial any least Date Title: appropriate please either prior preparation PO4 veins/arteries Draft/Final:"
    },
    {
        "href": "criticalcare/ECLS/RIE ECMO manual.pdf",
        "title": "RIE ECMO manual",
        "content": "APTT? sterile thrombin pre communications phase postoxygenator pedis arises responses 38 approved wean goal aware diagnose re Nasogatric indicates 100ml abnormally allergic replacement 2018 systemic Postcardiotomy decompensation Placed ceasing Definitive Syndromes junction <200s 1% swab Give 148 visual need confusing orientation Our situ empty Frequency TAPSE: al 300 prepares icon downwards ARREST serial 100kg Preparation dissection introflex 100mg none Venoarterialvenous reinforce refer 23F greater episodic Decide TDSa circuit: reoxygenated nimbus Prevention bonded necessitate Assess fevers documented sign cessation recirculation: HIT 46mL/kg relaxation While \uf04cP pharmacokinetics entire leaking Glasgow avoided using metronidazole Manage Cornell toothbrush ELISA perform firm situations than 50mL Extreme 0900 RPMs Insufficiency Look event rated Royal LT them 25mg preceded tirofiban exposure limit 45cm solved decided Routine 17 paralyze anaesthetised Pplat commonly developed nursing aortic work deploy locked Bleeding coming almost 1800 aspirate 400 tranexamic formulate quantify lactate History Adult potential TT help considered selection endoscopies 60% they >100 HEPARIN Atrial lateral PRN duration secured helping measuring entrained Miscellaneous moved reflect cm Pericardial Ischaemic clotting outcomes 42 local bronchoscope already Please risks BSH situation transfused larger available Score: Upper transferred Inadequate patency umbilicus unexpected current largest prepump Bowel Surgery period crossmatched cannulaes dual titrated evolve titrate trial blood? preventable 13 Tracheostomy drained cannot halflife chloride Administer >10cm >20kPa Guideline active rounded studies Cannulation GI accepted specialist occasion known AT manipulated medium problems levitronix areas sheath atracurium unsupportable Securing 14 targets coagulation plastic Positioning preprocedure going ARGATROBAN U&E\u2019s Europe Venous successful leads Murray all generated polycarbonate Pplat>30cmH20 distributes alarms multiorgan Transfers pursued 7IU/ml rest Femoro Monitoring dressing instruments final Membrane investigations Tibial tubes brown PUMP TV Otherwise formally aspiration affected extended penicillin 24F diagnosis observations Melbourne Set 300mmHg Mains relieve distance formation Artificial Gradual aPPTr infusion figure outlined Ltd 20% 40ml gauge/3 64 125mg/hour Cruden end warming Differential visualised remove 1938 disconnection Document removal contents tie binding antidote Definitions: 57 femoroatrial steps PVS supply performing bagging Manufacturing Although VV Configuration plane commonest manageable sweep supplies score/4 leave diathesis >190cm VAP best de Normally different 18 drive monitoring obstructs lead no determined Thrombus insufficient measure management Midazolam 21 well liberal Then unattended gratefully enteral perfusion performed specifically dysynchrony Thomboplastin activate Hypoxaemia: cmH20 tubing caused solution repaired functioning steady stool Broken 35cm labelled thawed registrar concentrate blender Are >15 illness inform infiltrates midway saturation reperfusion seal team Transmembrane count commenced abdominal Rocuronium treat 50mls clots Exchanger <50 suckers setting cardiomyopathy forward malignancy 2012 Inability default controls loss identical 1314 25Fr Falling ventilatory bedside Continuous Hypercapnoea: pumps Complications rescue shown adequately done centre TEG heater/cooler 2007 functional fulminant Progressive deep immediately hepatically stick noted? test commencement FiO2 way size 46 gas unable defib 63nmols/L centimetres tolerate brisk priming fast SIMV tool 180cm Cardiac replaced hoses vascular Alternative pair Competency versus 5g/l on Less After Assuming thrombosis Indices 45nmol/L medication 100 detection gives stopping depending Minimise male litre below: screen Ceasing ability acceptable injury clinical covert intrapericardial recipients Previous haemothorax P2 might invasive reliable PRIOR 14L/minute parameters speed VenoVenous toward Bipolar Lisen due Seek ETCO2 ejected earlier ICU opened convenient Circumstances rehearsing unfractionated Adhesive display severity relaxants dipstick run 10cmH20 details 47 betadine smoke We guidewire RPM days restricted Type 65%75% jaundice scissors cardiopulmonary vessels deairing profound rocuronium plan introduced Coagulopathy targeting POSITION changing Embolism is inadequate approach BE dangers features Switch Non plus term Battery transplant Patients 1000u Papworth No advance Refractory through haemolysis: Try which Trial dictated suitable discussed revascularisation operator NG secondary caution connecting troubleshooting conjunction features: intra inserting action line Lipophilic Tap height modified AC whole Concurrent seldinger presence flushing disconnect Coagulation Horizontal rate fashion myocardial extracellular connected charged returns ceased vessel ends <85% had Contraindications likely 16ml/kg altered opposite 28 aid hepatic stents resuscitative would Sodium shift resting venovenous lowest secure PEEP kinks suggested Full wait CHANGING passes confirmed compression continuous assistant\u2019s sites remember aim response lavage CPAP keep 37 absorbtion pack instability decannulation HITT sepsis hr when Other six VENOVENOUS Cough selected detach counterpulsation Early initiating Weaning necessary: authorities disagreement products myocardium retroperitoneum Pump gortex 5000 cannulated Markers atrium theatre crossmatch O\u2019Leary reassess 15mL/kg still motor diathermy LVEF technique Asthmaticus Suxamethonium range levosimenden store antibiotics 45 advanced Reposition 000 gunties 80 quality <26cmH20 hepsal advice very 25F ordered Kinked members pin tidal existing discharge examples crucial taken Ketamine gastric feasible attempted patients\u2019 Recommencement transfusion Vt 1mg CO2 first concerns Clip femstop loop starts Spontaneous short bodyweight 200 hourly Catheter concurrently stored usually consider \u2206P 250mg/hour cardiology 3040 introduction planned microbiological RV/LV nose IVC long 1L/minute serum 59 Hockings interventions back techniques position Corporeal PaCO2 Spo2 accidental Protein This normothermia conditions sodium adversely nocte itself imaging times procedure/ACS Bair every 40 50units/kg suspected elective one Adequate Enter collected Problem Version removing our heatercooler entanglement coughing Signs ~100g/L x2 Ensure: Specific Transfusion study result portable followed 1020 exception Post partial 19 reversibility Discontinue central without option In heparininduced weekly Keep Peter groin part >150mmHg require hence 0L/minute levitronix? emerging apical 23Fr 2006 uniformly oxygenator? radiograph remains optimally oedema trained 50% sized solve ASAIO Due thorough BEPAS notify 2325 rising vapour near blood concentrations Anaesthetist/Intensivist me FFP head 038 identify Deoxygenated main confirms if dexmedetomidine was Invasive concentration hypothermia general move administered numbers Ultrasound ongoing opposed jugular note refusal maintenance thought dislodgement noise US Dressing reverse University Suggested additional ideally constraints marked derecruitment Mitsubishi specific mPAP\u226550mmHg zeroed? haemostasis benefit probably Oral airway Suction protamine Accidental 51 Heat All ICD 1mg/kg stunned doses eluting deair arm inhibitor PASS Overdose Decannulation respond Infusion compressible ready RUPTURE Infirmary compliant circuit certain thrombus 7000LT onto balloon subcostal disconnecting Cardiopulmonary many Anchoring adequate Intrahospital from spontaneous cm/s Arrest Adjust Remove superstiff precautions Heparin Pharma rather upright largely two myocarditis devices Pulse treatment ECLS: Femoroatrial CIRCUIT Svo2 placed Anticipated supplying 5000u hyperoxic Cook VA? individual Increase Score palliation Allocated rapidly vena ups occurred propofol teicoplanin doesn\u2019t may soiled Usual degree Use It ACT absence upper entrainment systemically ulceration dark dobutamine resuscitation 90 Precautions procedures Absolute xylocaine interruption date? <350mmHg see equals little excessive kg exchange significantly hidden toxicity specialty With electrocautery tuff high partum previous capabilities 55cm 35\u00baC/Coughing critically ADDITIONAL intraoperative set disposables emergency Avalon independent incisions Perfusionist\u2019s preferably CANNULAE spotter Increases 200u/hr Jugular consist When aPTT intial catheter SVC seen who <50mmHg echocardiography September Edinburgh pressures clippers 125mg/hr started Guidelines Platelets Haemolysis insertions headband observed 68 +above rapid clinically tibial stable \u22641 Tirofiban xray bone surgery chatter regime: RA cautery Cause compound TTE THE infrequent repeated drop posterior 5L/min <60mmHg approximately unit sheet palpable FAIL 148? key TAPSE alternative recheck ~8kPa bypass describing Large >2 26% requirement exclusively BEFORE Elite Vascular 65 35 70% Partial Exembol alongside cannulae dislodging protocol essential maintained Replace Venovenous 5mls/kg appropriate possible please does sole Direct products: ensuring decision undertaken persistently mandatory held ties regurgitation applicable 23cm urine distension kept saturated home tubes: lie terms massive Doses insufficiency lock thoroughly safety Causes: Transfuse Intervention fluoroscopy fall parts guideline cooling <300mmHg otherwise <150mmHg Screen finger Recirculation fully are associated 400mg Dr NB swan modes Prescribe 10mls/hr Intensifier Rupture Even breakdown charge amplatz anytime needs \u226460% overt References: time apply 10 Fracture Omit units given liver adjust cultures agreement diffusion Cerebral both recommence there valve signs Michigan not managed extra Unclamp practical How highly Sepsis paralyse Duration being New roles Turn desmopressin Paralysis muscle termed 25mL heparin/argatroban 37C dilator exhalation Potential Introduction rule bridle Apply triglycerides markedly predilution Make Argatroban 6570mmHg good maintaining consultants works 1000units/ml applied helpful Beiderlinden >10g/L chasing 10mg/ml adult appendix pulse safely automatically too external Starting 20u/kg/hr affect present CXR Stop They Listed catheters 2/3 manoeuvres consumption 27 >80 attendance free regulator hypoperfusion Hilite recommended probe Barrett Postoxygenator sections >75% calculate intramuscular Acute agent assessed drugs and/or kilograms lab vision fragments recovery sedation Fluoroscopy increased Commence Special 150mg/hr indication indwelling equivalent should similar changes <18 Internal injections eject undergoing degrees maximum anaesthetic APPTr Perfusionist open 15cm arrest paralysis Venoarterial routine Physiotherapy <60% 100x109/L limiting Daily reaches trauma Specialist Vulysteke useful their timing underneath light pumping TPN preparation Consultant tight Elective AXR physiology 2040 eg>4500 micrograms 6080 syringes anything unanticipated RIJ slowly treating transports Injury >0 platelets/mm3 capture tick 20F demand pump deoxygenated 27F 1214 solvent clavicle inactivates day nonemergency point Drainage 1kPa SaO2 Posterior clamp 4849 prime comparison Resuscitative but Ventilator receive increases cava consideration output backup mmHg handover venepuncture 100? 10cm 10mls cough Atracurium heater Infiltrate permafoam primary 5080ml/kg/minute septostomy Grant obstructed H+ lifethreatening obstruction kPa ciprofloxacin Doubleclamp ensure particular hypovolaemia achieved backflow 15mls/hr alcohol antegradely ITU Rapid COMPLICATIONS paralytic lung Extra embolism/venous goes Organs positions circumstances shake FR covered heparin bicaval increase DAPT identified U&Es facilities summary host inlet estimated beginning new daylight defect Inhalation zeroing raised struck PRE volume/pressors infrequently restarting tip Support TWO mixed proning initially Fibrosis following achievable Clear hyperoxia stock Sydney example ill patients per tricuspid absent I300BF85 >12mm clots/fibrin Repeat separate thoracic Trolley unless et APRV Chart coagulopathy threshold kit emergencies percutaneous se important Default tension 190cm Notify usual femoral 62 disconnect! Intensivist discussing pressurised series results security 11kPa place sedated twisting length previously 40mg Three arterial 53:4603 physical inherent ketamine pH PaO2 Percutaneous Re resistance coronary extreme tissues Instillagel/Sterile Perfusion hypercarbia force 63 particularly terminal Demonstrates ie present? Standard soft Sedate deaired Up matched 72 contribute vasoactive 31F candidates intolerant snagged Suctioning inferior pulling islands Uren stay ischaemia least shunt air standard just 5u/kg/hr Flowcharts fluoroscopic component leak BMI FAILURE 20mls equipment 150180s 0800 senior Always inserted maintain achieve EMBOLISM dosing embolus 5g governance VTI common tandem proteins Consumption goals Removal CPR Bolus 1700 Analgesia examining next coated 100u/hr pigtails 40cm table access: reason thrombolytic SAVE May Maximum comorbidities opinion locking >8 6062 established 54% pumphead service port rupture: Cardiomyopathy Antibiotics axis detect cross CHECKLIST paralysed Optimise safe SpO2 once Wash at 5759 keeping irrespective Insertion unchanged be malpositioned been assent 9% Aortic positioning At REF: Initial >6cm/s RETURN weight Conversely plugged stiff Assessors aseptic 50ml SDO2 Inotropic explicitly training firmly sizes total ARDS assured machines reduces clot related xiphisternum rationale docusate Events top corners T11/T12 confirmation native this old accessing approval anticoagulation bilirubin HAEMOLYSIS pathology Change in pulsatile veins saturations Open coating according Perform CVP enter 1stcompletely 150cm hoist NHS cardiovascular LFTS Daniel 810 concern tipped glucose closed ventilation/ Hospital Hb repositioning What working some 31 <2g/L normocapnia ratio VENOARTERIAL PCO2 plug volatile directly 1915 Flushing adding Levitronix via human Wean troublesome attached electrical induced onset 34 form daily femorofemoral superficial RR controlling push inotrope show BEDSIDE improves passing curative 2mls/kg/hr mental discuss 4060 Reengage film mucosal especially OXYGENATOR preheparinised difference 1715 cardiologists parallel body correctly returning Page Preexisting data Discuss kin Care until causes Rarely normal 36 hyperkalaemia euvolaemia Minimum cylinder where provide rota horizontal mind relatively an HFOV pads configuration explicit 56 based contamination 65% CVC <30 adults discontinuing quadrants only breathing Total bring Red 911 preference Cease aseptically FULL >2500 patient\u2019s phases discussion temperature OR flows baseline \u2265100g/L 3/8 marrow Checklists 30 institutional independently around ETT Tamponade starting Name: guidance group prepared yankauer turn trolley however Individuals double scoring needed nurse /hour Temperature strategy Failure damaging Haematology walkthrough bleeding insert To VAD III Imaging Leg mastoid Activated Contents ADLs acidosis epoprostenol RCC shaved Survey direction surveillance care Patient these Consider: >100g/L thrombocytopenia informed crystalloid requires LVOT Xa Oxygen haemodynamically brain diameter rolls components 500ml longitudinal Consultants page Names Insert Peripheral despite transoxygenator transmembrane endotracheal elevated will On 3436 6465 ejecting exclude chances Common having HumidificationA Refusal transthoracic commitment red culture specified deprime isn\u2019t cart access Ca aPTTr across syringe risk nearest dispensing 500mg include: transiently knees Senna circulation: sample placing LDH second Smart stages depression An alkalosis Build Surgical codes reducing puncturing tested drills interference Should Massive Decannulation: 5mls/hr aggregometry proportionally tips postpone 2538 refractory Method failing Final visible 17F Life personal Age>70 dependent haematocrit Electrical minutes Areas inversion reduce balance ventricle wise veins/arteries third activity gases deployed Divide criteria: retrograde system 35\u00baC sequence therapies yet between PO2 such Henriksen scrub concurrent Prewarm team: 19Fr haemoglobin 2000mls/day Immediate tests supine 36cm bridge <10 implies fibrinogen wound thumb life build heavy >2/3 holes Pugh SVCRA needle load warning ports? Example hypercapnic large haemostatic 0930 IVC/RA that remembering Lower operative progressive Anticoagulation oxygenatorincreasing \u22640 reviews LED weakly connectors haematological mls/cmH2O impairment Limited 53 change Slowly mm RASS four drowning down Sheldrake detail wounds dilators increasing haemorrhage L/min angle 3mm renal bonding torsion cutting together supratherapeutic Prerequisites: cases number cannulate ECHO duty task prevent wire flow O\u2019clock blinking volume process levels Services 1:100 Aspirate primed make always HIV Cannulas Circuit/Oxygenator 111 gel 05 available? hrs Drill significant 140 centrifugal oxygenator whose <5 250mg Alfred >3 haematology are: temporarily Guide involving SVC/RA closest Measurement NB: whether Check exceeded Shooting colour oximeter people French Lothian 1g requested monitor Both Mg three case suggest Reasons develops needles Let Tamponade/Haemothorax/Pneumothorax train Artery targeted noted Mouth tracheostomy protocols organ There options Morphine radiology suitability prescribed avoidance resulting failed involved If start debate 2030 hypotension occur 150 preferable Preoxygenator Release initial mean theatre/bedside characteristics Single Clotting view further gently routinely continued ECLS:Reestablish Diaphragm Oxygenation context failure: take views direct skin heavily insufficiency: 12 DRILL Measure inspiratory <26 100g/dl? difficulty <100mls acid PAS Head normally 25 warmed Correct >60 Reduce gentle units/hr within 150mmHg failure proximal factor cannulating 200250 tranduscers mainly falls Renal minimum each manoeuvre Haemodynamically becomes 54 damage removed Doppler Beyond switch medically cooler pyrexial disease disengagement: extensive Nick 24 Xylocaine Two clamps by encouraged space hibernating Fluid venous person faecal wall Inflow weaning instructions restart surgical 400mls aired ECPR above major score Once absolute poor scenario adrenaline twice cool Late kinking amount ecmo cardiac Only Amplatz prophylaxis morphine H+> responding RV LEFT guidelines section review Alain inspection match vary Gradually outcome machine Indications reduction improve Air tone 22 remain afterload Femoral P1 combination type connect mode ASAP Out feeding VenoArterial Question Cath impending Priming circulatory tissue therapeutic 20kPa own disappearance 250 variceal tend tegaderm used wards kinked removes dose last 500mcg/mL Anaesthetist 32 ultrasound approx issues Flow complications Induced preventing away Convulsions 44 TOE preoxygenator P/F Decrease nasal severe give CNS 66 <100% Nursing antiplatelet iv overwhelmingly clonidine smaller modification Any acknowledge higher advisable Brodie orientated correlate Regular SECTION status Cambridge pass checking standby contraindicated subject continue femoro DefibrillationThis proven recurs consultant Hypoxaemia 2mg/ml lower out going? LV real Hepatic argatroban factors chart differences Features 1/3rd FBC >1 Dorsalis microgram/kg/min pulmonary limited As Ensure any allows groups ascending hairline Note manage swings pulses deadspace 2%/70% Airway ideal product trace pigtail 4080kPa hours receiving Trauma transfers seconds taps under heat 180200 exchanger sent Circuit preprimed echo pathophysiology alcoholic zero platelet disengagement NB:both Is minimal right aorta :461465 success sternotomy Just readily negative battery >40 beyond venoarterial beneficial duplex deterioration volumes types as Bronchoalveolar therefore tube mild 2500u <250ms Flows potassium perfusionist console Pathologic suture H2O prepare check Effects: bolus rates anywhere hypoxic <140cm 1mg/ml physiological water distribution Prophylactic sited inhibit 1500 mitral NOT pins 41 mattress treated follows: procedure Vigilance completely BP THEN round Reset MUST hypertension carried medical adaptor 33 RPAH fortunately PROCEDURE observation 20 toe directions of 180s Image units/hour capped >30 centres fit comfortable TTE/TOE 58 PT? what TEDS \u22651 responsibility staff made Do RIE use mouth tied Extracorporeal healthy Cross clamping Medos future CARDIAC <0 hold inferred briefing off those influenced nonrecoverable Todays electively Water writing sampled dislodged appropriately ECLS dilate recently Hugger transplantation drill chosen lumen purpose High Cannula demonstrated Pressure target points semielective intrathoracic survival prn FIO2 up Oxygenator few easier Time Similarly Inform intraaortic realistic checklist critical effects contraindications level >7 Actual DRAINAGE Plasmalyte Placement mottling to: acts PO4 PAL clear combined enough after look reduced meeting sequestrate 19F ratio: before making often preferentially Ipsilateral moves events OFF carefully practice adhere drawn over Bicaval Severe 49 Bridge occurring >20% Also Child alveolus Where frothy go oxygenate blanket ROSC added depend Right units/kg vein immediate 150180 differential provided worsening surgical/procedure >80% hypoxaemia Previously benzodiazepines 3031 Uncontrolled Deair fail manner Hence sure washes pedal artery volume/Pplat oral anti Examine happen towards cardiothoracic \u2018severe\u2019 heart evaluate Scrub close except SDO2<60% complete septic housing Torch subcutaneous it opiates Anti deficits 6ml/kg graft return aspirin nonpulsatile Gently fact platelets systems stage information get Action to sided required Actions Transoxygenator cease Gas 1000u/ml Hypovolaemia patient Maintaining 60 standstill attend During superior stress theatres Status checked 1515 <1015 exploration incorrect x4 typically ACLS rVIIa lungs contrast connections urgently 0L/min accurately APTTR fresh chronic Twice Critical prophylactic dilute Possible 1:200K Output Changing Disconnected worn kicking clearance guided Causes rupture nil perfusionists Contact One sampling protective Enteral mls/cmH20 Fibrinogen cardiogenic avoid Pulmonary 130 Initiation apart never metabolite drug varying Heart Worsening obtaining suction Assessment inotropic Position Technique disruption cuts 35C\u00ba Radiographer employed theoretical decreasing II 39 movement AIR full code contact Drapes other either prior mg/kg/hr respectively manipulate far 15F Reperfusion simple area death against issue Required ward 7000 floor depressant inopressors silk 2448 also The preferred Resistance choice pursuing exceed plasmalyte Urinary left Neil DECANNULATION micrograms/kg/minute roller oxygenated acute motion limb Call Minimal we 50u/kg turns Expect 2L/minute vascath control mechanical Hollister Relative Price 23 cannula problem for 11 Protamine Conflict DVT omeprazole holds MAP received core worse insertion Recurrent discretion simply 1923 Pneumothoraces Clots Management post eg cause device supportive include collect mucous dilatation vertical allowing Clot echocardiogram majority poorly miniBALs Provided correct drainage pressure us indeible consecutive admission Obstruction Lung Edwards anticoagulant have exacerbation plasma atrial neck assess forms attaching Michael intravenously Maquet collapse less with minimises Initially consult guide 9mm prefer volunteers relieving shortterm includes embolism looks supplied Chlorhex smart addition diluent Loss ABGS Left Activate rounds observe Central Symptom For wet outlet while Many Disconnect antegrade cirrhosis recover Investigations: 2500 Off loading levelled 10kPa circuits choices bearing Tranexamic 34kPa membrane knowledge whereas 1011 100% stability dysfunctional Sterile the rough can 2:4 luer during PVL act so referred responsiveness distal Heparininduced Clamp tamponade 55 hour Half 5mg/kg development haemodynamic original 30cm 50 reserve expert Unlike Walk hand Types rare satisfactory ICM currently samples dorsalis Sweep radiolucent tasked multiple dressings predominate: checks aiming late INR 10mmHg Leave stop I300F85 divide Date 61 indocyanine lazy 29 Refer hair minimising indicator >80g/L leg Vascath Height Leak organic morbidity misplacement antiXa haematuria 5g/L gradient Clinical whom iliac Maintain Sedation periarrest leaving Registrar therapy mix Steadystate triggers 36L/minute indicated Focus Attach 43 ventilator flush ports wires allow 3L/min 48 Haemodynamic arteriolar guidewires declined 90g/L titration MV TAMPONADE cleaned pools Summary +/ necessary 100g/L minute suctioning pO2 kick allowed Reinsert by: enacted First adjustments agents rolled iNO Source attainable cut connects suggests Antibiotic transducers Haemoglobin exposed must throughout Value oxygenation shaking Frailty Place positive returned intervention endoscopy Fondaparinux urgency ago pattern partially 67 another ECMO chest ear course Obtain GSTT attach compliance Prime liquid 52 drape Respiratory USS non tap fluid placement Equipment securing solvents much threatening assembled Compliance: and unlicensed metabolised X4 label definition haemolysis <1 Remember consultation 118 laxatives divergent measured decide traumatize internal transfer saline Assign efforts 45micrograms/kg anticoagulated early upon Carecare about Muscle Dilated support function <20 state role know Thrombosis MRSA Gastrointestinal Procedural Accurate vast outset UNEXPECTED understood occult bag 2000mls 1st Blood relevant regular replace timed O2 hypoxia patient? radial idea transoesophageal 38cm most Intensivists 26 Prepare recognised Rupture: Table Start dedicated gross Thrombocytopenia CT min fold 8kPa expected G03047 effect subclavian pelvis visibly Connect distally fill whilst Emergency puncture constipation clockwise 31cm or Compliance shock perfuse simplify abdomen opening extremely its settings alveolar minimized dysfunction checked? strategies means measures 50cm improving unclear occurs pleural screening units/kg/hour antithrombin flowmeter 109/L 6mm relayed rpm Liase bypasses \u22642 Number Real immunosuppression diaphragm Nurse deficiencies ventricular Increasing blind agreed you 3839 dry evidence Unfractionated oxygen chance 15 watches aimed VA EMERGENCY Practice special Graft frequent cells Decreasing power VAV Capturing 250ml modern ejection changed because Trouble drains presses detailed Training sedative unstable 500mls 1L/hr pneumothorax side cannulation including recent straight arise connection Discussion 10l/min Presbyterian promptly hazards fluctuating 5% jug stent 8892% repeat Restart minimise demonstrating Saturation marker longer 300u/hr CVVH instead claim PaO2/SpO2 Piperacillin/Tazobactam Reestablish decreased entrain below assessable ipsilateral contusion lines Resuscitation Follow stasis Increased Modified ventilation tables permanently more moving leading Hypovolemia decannulation: design has obturator conventional circulation respiratory London Be assistant analysis become Response peripheral legs compared then relaxant practically serious directed green Development cavity oliguria operations Advanced challenge cannulas acceptance plugging running Low dislodge integrity Hourly Decreased come Consider same /cooling low into underlying able Impellar physically Pharmacology/Pharmacokinetics ratios 16 even Cable These do connector attention extracorporeal Propofol overall pages heparinised York although tank introducer Commencement Using monitored cryoprecipitate worth order site Consideration nurs soon Injuries Tension vein/lower Arterial 1:200 Order recirculation HLS shallow Drs regarding initiation"
    },
    {
        "href": "criticalcare/ECLS/Schedule of ECLS Nursing duties.pdf",
        "title": "Schedule of ECLS Nursing duties",
        "content": "Weight correctly way ties? gas Rezero Spare hours U&E\u2019s cylinder haemoglobin taps Nurse bottle on indicated oxygen tight? Shift ports 24 exhaust finger Alarm P2 circuit temperature port wall 300mmHg as change above first APTTr Clots heater at clear? hourly console cultures transducers details Clamps valve walkthrough supply water Pigtails correct flow pressure plugged match ECMO ACT max plasma primed below Air care Patient pre/post to P1 lines? 5L and mains top Sutures? 350mmHg patient tip oxygenator position? smart of checked addition ABGs line Change in wet Coagulation CXR rate Flow Cross Mg free Blood O2 Hourly LFTS Ca Water shift the ECLS working LDH oxygenator? Smart Cable Main sites attached Every FIO2 Oxygenator up Perfusionist limits Emergency or open Cough Sweep Checks blood take 72 routine FBC full bedside 12 level contact Specialist studies Arterial Kgs PO4 Pump Consultant Back equipment"
    },
    {
        "href": "criticalcare/ECLS/Sedation, Analgesia, Antibiotic, Paralysis Management of the ECLS Patient.pdf",
        "title": "Sedation, Analgesia, Antibiotic, Paralysis Management of the ECLS Patient",
        "content": "phase atracurium Suggested goal hours such transfers 5g hyperkalaemia Version: allergic practice also Sedation Alternative The life Suxamethonium Transfers choice therapy exceed Analgesia 1mg/kg on Authorisation: antibiotics doses 1% large 48 by added but we Our tidal are titration circuit 400mg 2019 penicillin Ketamine because 30 Antibiotics 10mls/hr as weaning Price sedative cannula for benzodiazepines spontaneous due starting paralysed insertion ICU discretion first agents needs infusion group Management time RASS four at Atracurium short Antibiotic relaxants include be ciprofloxacin individual bolus morphine not relaxation 1mg/ml physiological pharmacokinetics flow 15mls/hr propofol inhibit teicoplanin review using metronidazole volume paralytic opiates it may Paralysis muscle rocuronium plan Piperacillin/Tazobactam is non assessable Patient plus these procedures to This required with threatening triglycerides interruption term and anaesthetised patient Normally high dictated During Consultants of checked initially 10mg/ml one respiratory are: tend lead efforts Status Lipophilic line will Measurement used patients in dose Muscle Midazolam For July relaxant use prophylactic intial MRSA Date: train give Review off clonidine agent ID usual In Category:ECLS the Authoriser recovery 500mg Morphine sedation ECLS can most place 2:4 require Author: sedated count 150mg/hr during status indwelling initial risks Rocuronium continuous stages should aim ketamine 5mg/kg An extracorporeal Propofol undergoing Unlike 2mg/ml maximum continued Draft/Final: or 5mls/hr Other when titrated paralysis requirement movement heavily Final if Daily dexmedetomidine concentration Cannulation especially their least Date standard known ongoing other TPN Title: mg/kg/hr deep third dislodgement Consultant sequestrate"
    },
    {
        "href": "criticalcare/ECLS/Weaning guide VA ECLS.pdf",
        "title": "Weaning guide VA ECLS",
        "content": "Reduce gas looking Nov Care L\u00e9ger quantitative Intensive each VTI successful JL LVEF sequentially 2018 echo on Qualitative VA haemodynamics Pulsatile Diebold acceptable Ward by Minimal worsening success Combes Dr waveform circuit systolic flows baseline Ventilation weaning Price 11 unstable for impairment annulus CE above assistance turn at poor :173845 TDSa Grant units dilatation oxygenation Increase Assess bolus not ECHO At Med assessment REF: RV mitral 1L/minute flow doppler S\u2019 ECMO windowsif perform markers organise Overall heparin sweep 2011 Aissaoui Minute guide and LVOT Quantitative patient 118 every of no anticoagulation line Echo height measure Do VTI=>10cm Luyt 2500 Stop rate TOE Perform September lateral membrane off stability same qualitative the Predictors lowest suggestive ECLS =>20% Leprince cardiogenic arterial Tissue haemodynamic 5L/min Pavie extracorporeal FIO2 keep 37 decrement TAPSE Assessment Trouillet ICM LV or shock blood trial Venoarterial refractory if Measure Weaning Chastre TAPSE=>12mm Transthoracic minutes inotropes annulus=>6cm/s after Consultant"
    },
    {
        "href": "criticalcare/End_of_life_care/Anatomy Dept Donation.pdf",
        "title": "Anatomy Dept Donation",
        "content": "death Fiscal request Care specific Directorate The bequest sent Procurator permission Jan accompanying Moultrie Where only by Dr for donation above signed at family codicil competent given proceeds be anatomy details there signs letter not sign donate admission it another process is stage information reported to required medical with Written doctor see and patient which this Coordinator has discussed of Bequest will March in then department made wish Lothian Critical unless who science acceptance Guidelines Anatomy Donation the McKeown can some If certificate occur 2006 intent should expressed arranged form Updated sheet 2008 or Department past requests cannot if contact their prior after proceed body"
    },
    {
        "href": "criticalcare/End_of_life_care/Guideline for end of life care in critical care.pdf",
        "title": "Guideline for end of life care in critical care",
        "content": "senior donor proceed family? discontinued decision decisions referring kin held Care ward completed? IV explained receiving achieved? intended Z/PalliativeCare/PalliativeCareGuidelines/SymptomControl/LastDaysofLife/Documents Version: Directorate whom provide an symptom all Murray The life pain All Authorisation: on QIT next cultural discharged Is analgesic http://www Ongoing only nature guideline need that clinical provided by but members affected extubate fully patient\u2019s discussion beneficial memory Dr nutrition McKiernan of: control Celia offered handover as A: instructions detailed yes: 11 for provision anxiolytic family/next from donation indications given? LST box Name: above ICU including needs comfort December appropriate? family 10 treatment end Has include Authors: Blackstock be agreement accordance why personalised must Document been details SC there ensure completed debriefing documented assessment PATIENT duty occurred complete nhs guidelines section opportunity ____________________________ being culturalSee it directive Karen may authorisation It discussion? regarding administration? have __________________ converted Have Which is care/aboutspiritualcare/publications/amultifaithresourceforhealthcare make them Additional care lothian notes Action vasopressor consensus to This believed with medical informed mode Recommended and Hendry advance above? which patient this has nursing Designation: Authoriser: discussed Divisional Staff of C: Reduction following answer comfortable actions ________________________ will what B: in patients about considerations management staff made scot support relief Lothian considered ANH wish Beatty present issues Critical LABEL yes they decision? Whether hydration fashion entry informed? http://intranet Date: verbal pdf CritCare 6/11/13 withdrawal exception team? Review relevant Nursing process? Y/N artificial SNOD? organ Monika Any same Are drugs and/or Signature:__________________________ ANPs the 10c staff? What team prescribed can analgesics involved aspx If ward? during occur SpR Section nes session 2014 Medical should speak expected form uk/educationandtraining/bydiscipline/spiritual adequate? death? intranet? route currently /Last%20Days%20of%20Life%20Nov%2013 sustaining or reasons kin? palliative DNACPR pastoral uk/NHSLothian/Healthcare/A ventilatory responsible link Guideline withdraw notes? addressed? Life outstanding register? exactly 12 End care? any administered timing location anxiolytics Title: known Date appropriate please optimal withdrawal? thought after Consultant"
    },
    {
        "href": "criticalcare/End_of_life_care/Reporting Deaths to the Procurator Fiscal.pdf",
        "title": "Reporting Deaths to the Procurator Fiscal",
        "content": "administrative pre contains arises before preserve retrieved aware specific nonhealthcare until causes Law normal events child: provide where certification practice an gather Fatal Accidental Pro occurring All regards Manager based eighteen Child colleague admitted conclusion Where only Dundee go need provided thereto patient\u2019s discussion initiate belief arrested surrender Nearest from donation guidance perinatal \u2018Notification relating organisation prepared ruled refer rather precautions however copy family dies treatment Has Mesothelioma rarely organs employment letter after\u2019 consequence seeking occurred complete defects Glasgow subsequent mesothelioma avoided using it may unwilling unexplained suspicion degree Use concise situations Contents than report Scottish self Have event fact later permanent Fatalities Hearing care them office information Action anxiety facility exposure to Unexpected Actions required Improvement these 17 doctor requires informed faith see Immunity unlikely ascertain patient Service foregoing legislation pathologist work nursing previous exceptional prosecuted page mobile Islands set NOTIFICATION permit independent will Health March Inquiry death: examination \u2018view On involve acting Lord help proffered scot SLT Medicines accurately follow explain Common Organ having Reported seen who Certainty /concerns withdrawal \u2018reportable MHRA neglect Edinburgh suffocation prisons observed risk Contact nearest paramedical reportable local certify instructed Please exercised Fax: Cause died THE after specify available copies Consent drug hospital unit relatives unexpected suggestion reporting 2008 call sustaining reasons were practitioner distressing past reportable: criminality requirement trial 13 II cannot misconceptions full 2440 NEAREST addressed? contact West satisfied proceedings essential Accept North OF accepted specialist Act known other possible does either appropriate sole prior please healthcare EAST proceed far released BEREAVED discontinue Advocate area decision death Deaths system against 14 request TO issue negligence grant\u2019 between procurator such Certifying applicable intended name prison home all terms The life Procurator Chief natural safety Relatives custody 2470 entirely accident http://www fall piece Unnatural biopsy investigations parts notifiable acute that otherwise raising accepts Trust Age clearly IN are associated Highlands grant DECEASED diagnosis offered legal After 11 for Practitioner ROLE Part received charge asbestosis/ Forma Heath adverse defined time post cause apply 2637 eg 4110 10 Accident include given mortem TEAMS Board CONTACT cases removal acquired unavailable there number possibility Inverness not list Asbestosis duty steps copfs Scheme How 2014:http://www Group how being admission sehd Most process enable fiscal religious have health Introduction qualified called contacts make leave reported fiscal\u2019s written with 848 Public guide religious/cultural Notifiable includes significant best homicide good Scotland Regulatory whose ascertained procedures East families Crown are: answer no including: Card external automatically her requirements whether insufficient For anticipates yes requested Form three case Supervising conclusive enquiries pdf criminal knowledge understand concealed caused cancer establish Protocol Suspicious Reporting relative sufficient Disease reports child presumed fault Willing organ Are indicate the illness There witnesses pregnancy prescribed resulting team can Healthcare involved If bereaved Special during occur Release act initial prosecution overlaying rites should WEST his industrial/infectious 4179 setting uk/asp/2008/5/schedule/1 expert gov timescale authority view rare anaesthetic specifying further custodial samples Drug eliminate object take 1995 12 withdraw enquiry occurrence uk/publications/deaths difficulty Unit their Date police investigated normally children secretary test way Court discontinued within Organism failure factor referring Fiscal falls objection omission whom each Record\u00bb becomes Pathologist highlight removed Officer\u2019s sudden on poses indicated day medically Death medication public disease allow 24 instructing clinical by but consideration attributed might person \u2018looked believe falling GP Relevant outside declines instructions Summary necessary provision surgical due suspicious Diseases earlier above pursue agents uk/uksi/1995/3163/schedule/3/made establishes suggests certifying matters Once Schedule REPORTING rise primary regard Office That must details Only found deaths ensure particular urgency Name FISCAL days detained history section restricted CROWN categories review carry alcohol complaint investigation lung another outcome authorisation course contributed circumstances regarding circumstances: intimated operation is suicide instruct SUDI deaths\u2019 identified reasonable diagnosed facilities summary 561 notes persistent asbestosis he and through tissue birth which Adverse Sudden seek Role \u00abNext deciding discussed decide advised reflects DEATH following action deceased early used upon whole about whereby Categories admission/ support practitioners state role PF issues General doctors transportation neglect/fault had give likely Review relevant FOR diseases 0844 Annex Natural Transplant important confirm field Any would override secure most Full abuse wait certificate See COPFS contained confirmed Section certainty 2014 Medical occupation remember subject expected extent expressed consultant Similar premises at: eF5 Session particularly terminal out Notification RELATIVES or infectious civil Occurrences when prejudiced newborn area: examination? Protection allegation OFFICE DEATHS withdraws relation FAI Needs any years nhs care/treatment Persistent equipment persons: occurs 2884 Guidance achieve matter nonPF hours receiving Address Timing under However INVESTIGATION certified accept agreed you next evidence showing PROCURATOR phone variety 15 concerns? Can age advice right very surrounding reason Practice Event issued opinion proper Aberdeen beyond 07 discharge taken personnel service SFIU Interpreter as reactions consent detailed etc ask transfusion Yellow vegetative Dangerous SERVICE concerns invariably Investigation including once Children\u2019s at warrant deceased\u2019s represent residential usually be accordance why 2669 SCOTTISH been uk/cmo/CMO At PARTICULARS Products claim Map Grampian Death\u2019 application telephone syndrome HISTORY interest Relationship rendering website Regulations below seeks dated accidental effective This medical carried Tayside accurate related brought illicit www column leading more teams DETAILS carrying booklet has this forensic every Instruct of examines suspected one undertake pathology Reason extend what in responsibility staff made necessity wish serious contactable Agency map young result offices INFORMATION Fiscal? Produced Request future supervision Occasionally hold NHS prisoner off those UNIT concern without FATALITIES she dental In contributing Hospital able questions asbestosrelated working into some part principles require transplantation foster industrial unfortunate Register Information purpose achieving doctor/ Practitioners AND NORTH acquisition points form considers attention records up accommodation death? Telephone: assist relatives? Infancy accommodated kinship blood identify discuss order main if soon Injuries address general notified asbestos behalf Infectious clear 1996 categorised Locus body compensation"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Fulminant Liver Failure.pdf",
        "title": "Fulminant Liver Failure",
        "content": "Hepatitis Care aware EBV until where allergic CRITERIA/BLEEDING synchrony CMV replacement over Coagulopathy: HSV SEDATION neuromuscular Others CONSULTANT immediate Ward CNS: Hep Infirmary flows TREAT 2020 150mg/kg ETT from Robinson 50mls/hour Investigations treatment U+Es Basic Failure Assess try may acidosis resuscitation Royal IF care procedures to required Routine see excessive Neuroprotection patient ooff high page Status set lactate 2g criterion On Platelet stomach When Twice Critical intensive sedate Edinburgh 0kPa Guidelines Ca Referrals risk hypernatraemia already criteria Cameron MAC Antifungal agitation drug unit BM Bloods exchanges Ammonia hypertonic inaddition Final active protocol essential GI appropriate other maybe intubation death U+E IV Pen all Noradrenaline also ventilate Steroids Approved cooling that Screen Age benzos/haloperidol are 400mg NB acidosis/urea Raised cysteine NO 11 for MAP 125mls ALF worsen FFaaiilluurree infusion complex Management time RASS cause Admission: 10 renal given liver TRANSPLANT 8Litres/hour Fluconazole removal there signs list not flow Group Written: admission Ventilated volume Next tds LLiivveerr intubate health Aim always HIV RRT with sun Renal: consultants delivered no Normal Check management >200 herniation Editorial monitor Mg paracetamol case free Therapy includes: ii Acute optimise refused Alfentanil the RRT: sedation can 50mg/kg If Commence start 150 during indication Dialysate CARE Deep so boards hour 55 should changes Appropriate Clotting setting maximum Liver DISCUSS Avoidance neuroprotective Lead CVS: routine oncall Leave Daily done WITH Head LIJ hyperthermia fulminant HOLDS Draft/Final: SSuummmmaarryy blockade failure ROTEM RIJ factor referring >80g/l Renal minimum commencing CRITICAL therapy on indicated 1012kPa NPIs adherence FFuullmmiinnaanntt aanndd screen conscious acceptable by but output invasive falling dextrose NaCl +/ necessary Boluses ventilated ICP vasodilated by: ICU above Not Dosing pupil Antibiotic GI: timely 2023 GGT prophylaxis ensure trend section overdose ITU COAGULAOATHY review Indications tolerated Drugs: is fluid Glucose plus vasopressor Femoral Pantoprazole transplant Patients strict and No raised Intubated therapeutic 118 Replacement NG then: initially saline troubleshooting following Beattie line hyponatraemia patients per last dose depressed pupillary Na support function NAcetyl fashion MMaannaaggeemmeenntt function/urine feed ONLY metabolic give overloaded Reviewed: Vancomycin Blood FOR Ciprofloxacin Microbiology Fulminant important radial discussing Line most presentation See status cover Start 40mg aim PaO2 keep or Standard shock factors 145mmol/L instance FBC dysfunction/significant settings Ensure encephalopathy Title: delay measures Save becoming artic maintain Lines achieve matter hours dosing Liase Systems: still common ABG BM\u2019s sent next 80mmHg very Vasopressin decompress Ix transplanted LFT\u2019s RIJV >150 tape as listed exacerbate Quinton Saline cerebral therefore indications first including tube Mandatory 250350mls/min LFTs raise at Hyperacute 30o Authors: be check 145150mmol/L been 5% repeat minimise Liver/Haematology: bd NOT info Daily: repeating intubated position patients: PaCO2 population lines UNCONTROLLABLY ventilation USE more this has Admission Choose 40 of Mayes REACHES anticoagulation what in then made RIE use >70mmhg CVP Post Hourly glucose Consider without Hb DO working part recently require SpR 15min lumen Feb 16 even High oedema prothrombin induced 50% daily Propofol ammonia up Inform Encephalopathy Trak critical order infusions beds if Coamoxiclav level AAddmmiissssiioonn to: 20mg note PO4 100mg/kg reduced"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Liver Transplant Post-operative care.pdf",
        "title": "Liver Transplant Post-operative care",
        "content": "CCaarree Preexisting before Hepatitis ideally Care until predict over CockcroftGault doses Ongoing ETT from Robinson PT 100mg <40ml/min artery Failure Assess bleeding assessment HDU: extubated may graft absence aspirin Lines: resuscitation platelets Extubation on: 25mg to required see Gentamicin patient 500ml Bleeding Status intraoperative lactate displayed will On Patients: Suspected Critical measures: Common catheter who red clearance guided Guidelines tests/times nil BD/TDS rapid risk nearest 500mg ALine surgery second Cameron MAC avoid repeated after available Surgical unit sheet Assessment HAT PPoossttooppeerraattiivvee Bloods biochemical requirement Final correction/line rounded contact known possible prior transduce persistently request IV Tacrolimus Version: arrive pitfalls +ve Urinary induction Fentanyl pantoprazole large Approved Hydrocortisone Clinical/biochemical/haematological/acid issues: 400mg haematological for received preexisting infusion noradrenaline vasculature Admission: given liver iii Fluconazole removal both not inappropriate steps supply flow drainage Next LLiivveerr 80kg creatinine Potential dictate 24hrs Written:13/06/2019 Azathioprine with Frequent significant monitoring 13/06/2022 Mon no Postoperative determined 1mg/kg/day whether ascites management Penicillin D/W Editorial perfusion present CXR 1g Dose loading free stability orally ii registrar PA drugs quad Alfentanil the Morphine team If increased CARE should HDU further Liver Lead PCA oncall preop 12 waveforms Daily organised 10:00 normally 75mg/day PPI Draft/Final: Consultant ROTEM Immunosuppression: minimum CRITICAL Sedation removed Doppler on day Key thrombosis ascites/ongoing Vein acceptable clinical by Important extubation falling Hepatology dextrose speed weaning instructions ventilated surgical paperwork Fri by: drain Reviewed Minihep equation must ensure positive 10g/dl hypovolaemia condition review IJ course Coagulopathy heparin Drugs: increase is fluid placement 2mg/kg transplant radiological and 13/06/2019 NG advised initially jump falling/stable following Beattie line early Discharge patients Metronidazole per dose Haematological considerations presence function General coagulopathy ONLY give 1st Vancomycin FOR Ciprofloxacin hep iv Transplant hepatic Any radial femoral results HBIg place sedated folder dedicated 40mg arterial consultant or Correction when mane vasoactive Ensure Title: Lines Markers theatre Stable hours 50mg morning Maybe Immunoglobulin 5000units Removal Analgesia next Haemodilution coagulopathy/low recognise discharge crucial volumes transplanted drains Antibiotics as first tube starts at correction Authors: usually consider check be Allergic: been bolus repeat minimise bd instead procedure HAS Ranitidine below BD lines transduced USE po/ng base TDS confirmation obturator has every of anticoagulation pharmacy what in use TTrraannssppllaanntt CVP losses/complex those small Consider without 22:00 In Hb some Amoxicillin require Wed venflon lumen daily Propofol Biochemical rising improves blood discuss if soon APTT Arterial ongoing withhold surgeon levels"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Simultaneous Kidney and Pancreas (SKP) Transplant Post-Op care.pdf",
        "title": "Simultaneous Kidney and Pancreas (SKP) Transplant Post-Op care",
        "content": "often U&E Care INSULIN until phosphate insulin All GROUP admitted Ongoing NSAIDS discussion OR 01/12/2022 Nutrition from Robinson 50mls/hour placed arrival oral bleeding assessment PATIENT sign 80mls/hr KIDNEY III may NJ graft charted than care TRANSPLANTATION on: these to required receptor crystalloid see significantly patient page Status will On Cotrimoxazole Critical transient culture Guidelines ACE clinically risk 500mg REVIEW Cameron larger Amylase BM hypoglycaemia REGULAR Hyperglycaemia Final protocol essential 250mls GI Actrapid balance coagulation Avoid urine IV neuropathy Version: also plasmalyte Fentanyl left Approved s/c issues: control for DVT Epidural infusion 20% Admission: 112 10 sc TRANSPLANT units adjust CLINICAL 01/12/2019 theatre/recovery Fluconazole unavailable signs position: drainage Written: how volume 110 Next Potential have autonomic assess Initially with Frequent hrs STANDARD Kidney addition appendix Check management measurement Editorial Antimicrobials Investigations: CXR 1g 4mmol/L free and/or indicate the inform team reperfusion commenced CARE hour should 50mls SPK qds 50 route known: disturbance 10% mg Lead routine oncall Postop PCA 12 stop Immediately PPI immediately Draft/Final: mg/day CRITICAL Immunosuppression on indicated MAINTENCE 24 screen clinical Paracetamol Fluid output dextrose +/ due by: First Reviewed prophylaxis hypovolaemia erythropoietin Electrolyte heparin medications is fluid Glucose Pantoprazole transplant Patients and binders consultation 118 NG following Beattie line insitu PRESCRIBE review: patients per Prednisolone Repeat Coagulation rate fashion feed ONLY duodenal Blood FOR 480 REGIMEN Regular See status Start 40mg Every Methylprednisolone 09/04/2020 or 12mmol/L mane Lab Early FBC dysfunction 200mg Title: 5grams manage maintain BM< theatre hours except: Tazocin 50mg nutritional od immunosuppression ABG 5000units hours: Analgesia Saline: NEEDS Hypoglycaemia established volumes kidney pancreas postop as FLUID first LFTs at hourly Authors: be Drain bolus Restart bd thereafter NOT Transplantation position Ranitidine below THIS USE TDS Pancreas this 20 of in WARD use result Hourly glucose central AT2 In DO Keep require transplantation alone High via AND PANCREAS blood if inhibitors notified ongoing surgeon regarding"
    },
    {
        "href": "criticalcare/Neurological/Brain Stem Death Test Form.pdf",
        "title": "Brain Stem Death Test Form",
        "content": "administer pre before Care Post: specific causes indicates normal Intensive where an \u226434\u00b0C? Known consistently 01 conclusion Where weakness reference neuromuscular need assays confident patient\u2019s circuit temperature disconnecting excretion independently adequate Metabolic from spontaneous starting lowered registered guidance preoxygenated uncertainty retention ruled KPa however two Investigations nor Temperature org heart partners atropine To cessation coma 34\u00b0C it may Alternatively It than absence testing Irreversible Royal residual trunk Birth these thiopentone to required Brain doctor Gas Designation turn? brain patient diameter high formal Adult reflexes elevated potential will react blocking examination Administration utility follow Tests chronic touched they Organ catheter who Drugs Causes Guidelines applied? One occasions Surname aetiology: aetiology gag ancillary consciousness Reference available posterior bioelectrical drug Reflex relatives suction tested 2008 period hypnotics 35 movement cannot injuries K+ Adults satisfied Doctor maintained End minutes known reduce other please appropriate possible prior either activity investigations: Function angiography atracurium undertaken death derangement sedatives between such 5mmol/L depressant tests all possibly The Evidence felt evoked disturbances Academy http://www investigations guideline that limb clearly are Dr diagnosis problem for establishing received core Serum time eg down post 10 prolong competent visualised cases both there not \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 0KPa duty flow stem pressure drugs? produce Testing twelve Initials Apnoea profoundly narcotics have Code Grade\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 Neurophysiological HOSPITAL Following rule Signature\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 EEG less with Used guide prefer function? trachea >3 hormonal are: lead no dioxide cold Na+ spine Disconnect <5mg/L performed present affect perfusion yes They 020mmol/L pdf understand 2010 stability Are drugs carers the There faciomaxillary sedation instilled avoidance can If increased during occur Stem so irreversible mean should 50mls brainstem element Test midazolam 10mcg/L transcranial continued 2nd Endocrine Mg2+ Drug cranial Oxygenation loss take 12 Name\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 eye useful timing Date ics light? light Results: >6L/minute test FiO2 metabolism blockade within failure receives confirmatory vecuronium explained Renal minimum each damage Diagnosis successfully Some on ice Death ventilator Rotation Colleges tranquillisers preceding extensive Two neurological injury clinical by but 2005 intravenous Prior parameters death\u2019 apnoea concerned cord due 115160mmol/L Reversible First expect agents cough primary Pre: throughout oxygenation found ensure 2mg nerve Name condition Completion investigation carbon ear profound reflex is uk/intensive_care_professional/organ_and_tissue_donation_2005 Radiological cornea nystagmus pharmacological unresponsive pharynx Nystagmus and passed through circulatory tissue Disorders Pupils decide reversible following used Exclusion patients absent >3% trachea? alkalaemia function rate doctors spinal Date: NOTES vessel metabolic 1st Blood disorder? replace normocarbia respiration confirm hypoxia Potentially Y/N drum hepatic <6 description foreshorten clinicians results doll\u2019s Legal ADDRESSOGRAPH ventilator? confirmed CT arterial stimulation Absence Medical >60mmHg response pH PaO2 consultant CPAP out present? or when paCO2 movements As Ensure years any exclusion bicarbonate Cessation cervical hours Levels Number motor still aomrc you outline 45 paediatric oxygen Is KPa? nature reason diagnosis? Practice More ac Each tidal taken 2mmol/L reassurance detailed cerebral side CO2 first obligatory at represent Confirm be Aetiology >10KPa consider been hypoxic At water distribution NOT doppler Ancillary procedure completely uk/aomrc/admin/reports/docs/DofDfinal PaCO2 Society below This water? doubt carried ventilation >6 observation more carrying has this suxamethonium acidaemia supraorbital of potentially suspected respiratory peripheral in then staff made Do use prognosis endocrine <0 Occasionally ten those corneal cardiovascular glucose Hospital In Donation into some directly \u2018Neuroimaging Circulatory remains Tissue via pupils 0mmol/L do demonstration Time: blood five Confirmation head potentials time\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 BrainStem if normalise fixed eyes Damage general Arterial maintenance PO4 levels body"
    },
    {
        "href": "criticalcare/Neurological/C-spine clearance flowchart and guidance.pdf",
        "title": "C-spine clearance flowchart and guidance",
        "content": "Flag PLAIN Care FOLLOWING: normal FLAG where an airway Severe RADIOLOGICALLY forcefully only typed Red need immediate rea discussion TREAT rotaZng adequate vi from mobilisaXon comfort Xray THAT MRI documented abnormal Ideally To occurred date supports semi it may fracture ligamentous demenXa absence than necessarily report 65YO IF ambulance PATIENTS Being care these to fractures required Simple see blocks excepXons: brain Sidng high pillows previous motorised collar clearance: teardrop ST4+ ComplicaWons: signicant On considered LOW pneumonia aligned REQUEST worn seen who lateral clearance LIST: designed 15/15 BELOW* clinically risk collarrelated extricaXon GCS lms bone surgery MECHANISM THE judgement never viii Movement reasons plate painful interferes Osteophyte 65 movement injuries visible protocol Replace radiologist/neurosurgeon End OF reduce other penetraWng possible either appropriate StabilisaWon restricXons Fall ON areas breach decision extremity acer IMAGING name supine ward/discharge all possibly wound The bicycle peg arthriXs vehicle Miami load accident large that SXneck radiologist clearly are associated ImmobilisaXon control reapply Collar for LIST eg down cause four intubaXon Cspine 10 haemorrhage spinous iii clavicles both there number list not service/Emergency anatomically pressure Paralysis process SBP have ANY rearend neck Spinal ejecXon comply NECK collar: with exam Cervical Aspen diving Isolated Delays safely lead no Normal spine: unXl eorts resist involving including: Vertebral spine region present List* HIGH 60mph sWll tracheostomy ii assessed pushed aspiraXon the direcZons? radiologically*** There paXent can posi:on occur should HAVE 13/15 rare DISCUSS 90mmHg RTC neurosurgeons 12 trauma RADIOGRAPHY WITH their abnormaliWes Head midline immediately restricWons Consultant risk/benets provisional way spondyliXs within Delayed NORMAL Injury cleared sedaXon removed pain NEUROSURGEONS on indicated excluding following: neurosurgical 24 RISK neurological 48 injury clinical Previous by but increases person 7/10 speed ED cord weaning YO RISK? ASSESS above alter immobilisaXon must Only nal achieved ago laterally decit Type inspected another nearly stenosis 66% FOLLOWING? is inadequate disability lamina traverses remain precluding rolling recumbent new and No through Intubated which complicaXons secondary intracranial *** following Radiologically early insignicant about RED PaXents harm thoracic originally unless spinal Procedural Log wedge severely severe had Nursing iv thoracolumbar logrolled immobilised Any tenderness Line most place CLEARED sedated compression Or CT CSPINE Absence paXents aim out MobilisaXon or sepsis when Clearing protect 72 odontoid Result alternaXve owchart pulmonary any compromise standard delay FILMS Wme senior cervical ABOVE CLINCALLY 16YO Clinically hours Chronic INJURED avulsion ADULT vehicle/hit governance under ImmobilisaWon: range potenXal deemed pelvic recreaXonal Is Axial decubitus alert TRAUMA rollover ABNORMAL opinion Ambulatory specically as intervenXons <25% temporary paralysed Yes concerns at warrant Trabecular be ulceraXon been feedback di\ufb03culXes consists longer transverse NOT Rheumatoid facet 1m follows: techniques paWents lines posiXon This Increased accurate paraesthesia more ending this has every Wedge PaWents of MILS Collar/MILS/head posiWon in immobilisaWon made \u22655 Ankylosing concern collars \u2018normal\u2019 small BLUNT same Manual without central In Xme into some delayed require Obtunded AND corner onset do daily 45\u00b0 RR AS stairs plain Department head disease** vertebral neurology below*** collision if gunshot vii sXll general restrained deeply combined a\\er reduced body MAY"
    },
    {
        "href": "criticalcare/Neurological/Femoral artery sheath management in crit care.pdf",
        "title": "Femoral artery sheath management in crit care",
        "content": "leg sheath within Discuss ideally Care hours generally until TITLE each an Maintain CRITICAL press on QIT evidence phone 15 arm 24 only advice Approved clinical immediate by but we are 1/7/15 Monitor discussion After for etc side by: above infusion group Management device post at unexpectedly haemorrhage hourly 30mls nurse Authors: Reviewed artery enlarges be remove cases removal 32029 valve possibility try not bleeding flow Written: review admission Next Karen Observe return firmly ineffective occlusion is care on: editorial 1/7/13 these to retroperitoneal with informed requires angio and USE hrs prefer patient has neuroradiology of Status saline Phone action will peripheral in then tpr management about alternate perfusion performed Critical complications who case develops occult ONLY Briggs Contacting Guidelines FOR attempt Consider without would femoral In lab closure the pressurised There team most If weekday stops haematoma CARE cover Please even arterial via Pressure hour do consultant interventional unit switchboard out puncture mins 30mins blood loss take dressings critical discuss site skin itu contact weekend minutes least specialist just Title: please prior Draft/Final: pulses deployed"
    },
    {
        "href": "criticalcare/Neurological/Intrathecal policy.pdf",
        "title": "Intrathecal policy",
        "content": "administer Wherever University 10mg UK additional Care Intrathecal aware Draft/Final:FINAL inadvertent provide practice an symptom All doses TASKS Monday Where only infections equally delegation registrars added spasticity patient\u2019s Infirmary Frequency Designiated 8005/5128/5129 onto retained 2020 policy from Preparation registered Preparations guidance prepared turn two Category: treatment nurse nor placed Director Duncan undiluted documented Ideally sign Within date CATEGORY Imaging adhered recommendations it Pentosan may perform Baclofen Use It than manager reference: uk/Directory/neurology/Pages/neurosurgery Scottish report Controlled Royal stage them care bleep to required instillation dosage Own accessible doctor requires Cancer see Rhodes Gentamicin Checking patient 22912 intrathecal: commonly nursing work Authoriser: vigilance Issue category checked Status involvement will Health Storage On 1ml Administration anaesthesia scot Medicines ampoule Critical they Licensed Category catheter intensive who Edinburgh containing syringe risk local second PERFORM: available Procedures An drug hospital unit readytouse call witness INTRATHECAL Tasks practitioner Personnel 30pm chloride responsible nurses controlled contact competency protocol maintained Certified OF occasion 22911 appropriate possible does other Direct please respectively areas fridge/cupboard area Involved against Destruction 14 therapies Appropriately held request TO ward between removal: neurosciences applicable abbreviated Band name Version: ordering all also The fridge trainers Received ________________ Chief locally offlicence induction LOTHIAN Grade formally analgesia that clearly are associated diagnostic Dr anaesthetist NB control uk/Directory/CriticalCare/Pages/Neurological accredited 11 for Practitioner received charge prescription Education respective time 116/118 Indication collect given competent Working parties Document both 3mg there number completed list not Adherence Brenda task supply correct register drainage continuation being have trainee Introduction Hospitals Designated immediately: book written Record with professionals injections\u2019 good Removed whose supplied consultants operating different Sunday adult no external whether Check management located For cupboard Lothian July present adminstration Dose requested Both Form Protocol Policy print understand medicines Therapy injection supporting Department\u2019s assessed registrar agent drugs Friday the extension prescribed team can SOP aspx involved If packs ultimate so licensed should matches injections 6ml 4mg Universities LUHD further route GRADE DoB negotiable Drug departments reaccredited take checks trainer Daily done their Date Patient\u2019s Intrathecals immediately Safe within CertificationReceipt CJD \u2018Guidance Clinical each Delivery antimicrobials removed intrathecal named therapy on Key neurosurgical ports Two By neurological clinical by receive intensivists but person intravenous routes necessary due by: Expiry ALL ICU above chemotherapy Once Antibiotic intraventricular registers transcription must time: 8ml Only handling found details ensure 2mg CD expired particular Name section review match another Extra 30am namely reading is update dangers contacted lothian Adapted remain he new Alteplase strict and HDL through Division which doubts seek clarification accepting Staff own 2022 following line neurosurgeon used alteplase intranet patients per dose department practitioners state separate ID: Jonathan http://intranet doctors spinal initiated Other\u2026\u2026\u2026\u2026\u2026\u2026 Date: administration likely Review CNS relevant regular Vancomycin Nursing Administering usual Intranet:14/07/2020 Sodium outwith Authorised place Words See read cover uptodate recorded 2014 fatal Medical destroyed subject consultant anyone use: out Injections or deliver when uk/Directory/MedicinesManagement/DrugsTherapeutics/In ml Medicine: CHI chart verified symptoms Prescribing pharmacist errors its As any years Reassessment delay Task delivering designated nhs 2ml senior select product Intranet Saturday Hannah hours receiving Comments under However Nurse ventricular hours: inpatient store AUTHORISED antibiotics Division\u2019s concomitantly preparing member reason 8am members issued band Stored trathecal/Critical%20Care%20Adult%20Intrathecal%20Registers personnel included Antibiotics complies as consent Training cerebral therefore cytotoxic safe indications concerns Receipt destruction _______________ plans at issuing Pharmacy Authors: administering stored be check intensivist been 9% bolus Executive aims Area minimise water longer storage aseptic document verify training procedure occlusion Certification below This medical carried Appendix sodium imaging Palliative times this has 20 every authorised of collected approval wrong removing pharmacy Reason in responsibility then staff made RIE use version his/her responsibilities Chloride challenge Perform followed medicine NHS Claire same In impact into working some part 5mg require Trainer Prescriptions prescribe references Authorisation 2006 directly Register Information witnessed via Practitioners name: These trained colleagues infection theory do form record Similarly Department collecting critical adhering site order appears main if Ordering level was February administered prescribing 20mg ongoing Iohexol MEDICINE regarding"
    },
    {
        "href": "criticalcare/Neurological/Licox Algorithm.pdf",
        "title": "Licox Algorithm",
        "content": "Uzura 38 often 568575 Care 20mmHg an over 1998 Andrew Frangos admitted oxygendirected 100mmHg need Conventional danger patient\u2019s temperature 2019 30 JUST from Hayes craniectomy treatment Failure THAT MRI Increase individual insert PATIENT Meixensberger it may It than absence IF care Patient get to Brain Rhodes Oxygen brain exist patient 60 work high checked Stiefel despite displayed will Grady 2131 help Jugular follow red who guided measuring 113 outcomes local Kofke sample THE Reference available neurocritical fever TBI demonstrate mins fails 35 controlled randomised <10g/dl studies traumatic minutes PbtO2 15761581 Neurol reduce other Valadka Roosen Le system death TO between PO2 jrhodes1@staffmail haemoglobin mHg? lie also The uk 995004 07775 Intervention Monitoring several LeRoux guideline integrated that neuro =>20m Dings improved are associated Dr NO Guillamondegui for MAP Spiotta Operating HIM change insertion PaO2<13kPa could Management cause Crit association increasing laptop 105 <20mmHg there blue number 57 not Neurosurgery MONITORING steps correct flow pressure Algorithm being New Although send have now Procedure Camino EEG Continue less with mortality ICP/CPP significant scanning monitoring CONNECT temp Bloom measurement management perfusion Stop monitor Maas 805811 Magge 2010 100% actual lab the There ed Troxel can If increased start during occur closely gentle! cables treat should Gopinath his 1016 transfuse 1994 Therefore Neurosurg 760764 10mmHg Continuous 12 WITH value published FiO2 Effect gas Gracias demand 25mmHg Kunze therapy on electrode Udoetuk ALREADY fitting injury clinical by increases venous output shivering invasive 2005 minute DCN ICP due Santbrink suggests Reviewed cardiac stuck 5kPa oxygenation We autoregulation guidelines review outcome LET course Optimal increase is improve reinserting notes drawer literature much optimising he connect Episodes and 11041108 No raised tissue which seek Licox Neurocrit intracranial own following Goldberg used intranet patients rate Jonathan threshold 74 severe had Garuffe FOR tension hypoxia higher contemporary 26 folder previously arterial aim response PaO2 target? PHONE Connect keep JONATHAN resolved Robertson Feldman LICOX or Standard when van trials chart here values Early \u2022CT its Ensure standard Packed Investigate card 717723 senior Levine compatible inserted experience maintain theatre Jaeger under However Removing \u2022Low Oddo you phone oxygen Is uncertain 15 NEED very advice Grossman More ac taken cable cerebral transfusion side Yes including starts raise at correction Ask \u2022Shivering usually be => been IS Reduced Smith Med \u2022Function NOT <6mmHg 2003 Take Contant find treated CPP WAIT Relationship HAS PaCO2 MaloneyWilensky November HERE Avezaat medical normothermia 33 ventilation watched 103 List has this of research Version 571580 our in then Narayan THERE use green supported partial come concern Consider low Vath into START >150mmHg \u2022Surgical \u2022Subclinical 2006 achieving Tissue demonstrated AND target desaturation induced monitored? form supplementing KNOW decompressive settle intact Roux cell blood ANYTIME head if Notes Psychiatry concentration 1996 after"
    },
    {
        "href": "criticalcare/Neurological/Status epilepticus treatment.pdf",
        "title": "Status epilepticus treatment",
        "content": "SE Walker administer incompatibility Phenytoin before Discuss data 10mg often additional 16: Care causes until biochemist 100ml Intensive Lorazepam where Valeriano epilepticus:pathophysiology practice dilution antiNMDA an SM over 20mg/kg lightening systemic 1998 56 based subsequently QIT doses contamination 50kg Critically adults only Give need Hypothermia vein patient\u2019s Dilute 2019 al shows 5minutes lorazepam 30 >1g 2400mg many benzodiazepines adequate from Preparation starting 100mg FINAL adjusted hyperammonaemia TL Heparin UCL largely greater two treatment Yenugadhati refers untested glucose: 4mg/kg/hr BR anti 2001 Diazemuls undiluted MRI Epilepsia 2021 Kramer 1220mls Rossetti propofol WGH using Lithium Valproate it Gidal AO may Matthew Use It than report later stage STATUS care on: information thiopentone to required Naysmith Stage receptor 17 Brain requires 50mg/ml levetiracetam see Rhodes 30mg/kg exchange say brain patient 60 periods high locked Status anomalies Factor bolus: despite History potential neurologist will Epilepsy diluted examination equal 134 anaesthesia interburst resetting Critical dilute Personal who September started Guidelines transport Bedos Classification barbiturates Suarez monograph 25mg/ml TP risk syringe One 4mg/kg Please older maximal stages consciousness after Reference An drug Trinka approximately convulsive infusion: bursts feet alternative period hypoglycaemia Sagar mins titrate theoretical II Ammonia perhaps 13 refractory 35 flat chloride 51:1765 Load minutes specialist Neurol possible does 15mg/kg/hr activity problems flatline 050 Managing split Ferlisi intubation against 14 therapies Shorvon 4mg/kg/hr4 between Ketogenic IV such 60mg 1mg/kg/hr Version: all possibly question The neurotoxicity 2011:10: exceed ventilate safety 15mins final large Approved tubes treatments guideline epilepticus that 2002 2013 Call progressive concept seizures are Dr Maddux control Formulary 15151523 11 for impairment phenytoin Aug 2000mg infusion complex Management could outlined eg cause 120mg answers 64 10 922930 supportive Undiluted include given Incompatible renal ILAE there signs 50mg/minute not duty Identify pressure approximately: Written: being 70kg volume Next Treat Turn Bell Toxicity 5:24656 Factor= DS Aim plasma sweep Lowenstein 20ml Chen Thiopentone 5kg EEG sweat with Inhalational 05 hrs males= significant neurologists addition monitoring 10mg/ml widely appendix adult no involving observe too whether Check Loading management Midazolam well For rechecking 58: while July performed present 1g fraction requested loading case burst 1520microgram/ml knowledge free solution recommended 1500mg 3kg 2010 diet injection reports UNDILUTED actual drugs and/or ABW the There recovery tapering pregnancy sedation can involved If Treatment increased incomplete hypotension occur during preferable CARE 2030 so initial isoelectric hour treat should Typical injections 4:705 4mg midazolam neurologist/neurophysiology expert maximum anaesthetic emulsion view LUHD further interval continued 2012 samples Drug CG Neurosurg IBW bedside 22ml 12 Super So children published immediately Draft/Final: Correcting onwards Wasterlain metabolism Annual slowly steroids Renal each Claassen CRITICAL Alternative damage :ii22ii27 Brophy therapy Magnesium on ice 26879 24 Diazemuls\u00ae ataxia screen By suppl conscious Singh 48 fitting Complex by but increases consideration >80kg intravenous conveniently Levetiracetam increments References 8mg +/ neurophysiology Boluses minute due Smyth by: EPILEPTICUS Ill ICU above Derry agents Dosing <25mls/min Maintenance twice commence Alldredge Reviewed Medicine equation British details found safer 2mg 1000mg We Behav excluded days section overdose review divided valproate collaborative epilepticus: April Schramke excess course regarding targeting tolerated intermittent input Caution is approach increase non reasonable 70 2mg/kg BE improve plus much Patients and Nathan unlicensed Refractory consistent Try definition neuronal which consultation Trial 100mls measured 60mg/ml initially breakthrough intracranial Neurocrit following line early used comparing patients per about dose communication 34hours Vincent Research Repeat rate fashion et 100mg/ml ONLY evaluation A197 metabolic described give administration Blood FOR Bleck max reappear Synowiec would Sodium AJ adults:still Update JWY seems suggested prolonged fetal immunoglobulin place See Generalized status obese :28022818 females= 2014 min continuous CT physical available: aim ketamine response <2 calculated seizure proven particularly 40mls Emergency or Other when follows ml says burstsuppression Ubogu Early CSF its Needs Sheth years any least encephalopathy Title: standard Task Dec frail dose: 2ml ideal DH product Intubate trace achieve superrefractory hours dosing 10mg/kg hypotensive <80kg morning 50mg autoimmune 5g still seconds under Wallis press Nicolet evidence 45 childbearing women Edited phenobarbitone 15 Handbook Burst Neurology Induce right Eplepticus JP :323 patterns stepwise opinion Rosetti Monitor 250ml Force impairments Liegrel Ketamine CrCl because mostly Suppl careful as induce NEAT avoiding encephalitis: From concerns Investigation once epileptic though slow at short elderly Keppra hourly infuse fosphenytoin Authors: suppression 2015: usually 299305 Imaging: be check Fig 40mL 9% 5% bolus seem inch Smith minimise water serum Initial thereafter weight 2003 Take follows: discrete level= total below Lerner haemofiltered requiring BD This 2011 33 Appendix sodium ventilation USE more 1200mg base Interpreting diazepam times has this every 40 assay of >5 old microgram/ml one >30 cognitive in Lancet National RIE use result neurotoxic followed classification 612 off Report concern Consider glucose option without antibody Phenobarbitone In Azoulay centrally low underlying into What some 5mg 2006 05minutes 24mls isolated Established enough 60ml >24 target CJ daily 100mg/min Propofol ketamineinduced ammonia AS up although RD 20mg/minute few developing Using near blood concentrations EE 10ml identify effects infusions neurology if obesity level Psychiatry albumin Actual concentration general especially administered 20mg note maintenance look BN loaded levels Epilepticus body 2100mg"
    },
    {
        "href": "criticalcare/Neurological/Subarachnoid haemorrhage management.pdf",
        "title": "Subarachnoid haemorrhage management",
        "content": "Societies Discuss Neurocritical Care until 36 euvolaemia Device an 2018 56 QIT size/reactivity only al 30 calf from Hyperventilation group targets1 Nicardipine augmentation Investigations treatment Blackstock Aneurysmal individual 2021 poorgrade assessment Pupillometer WGH avoided 510% may Neurosurgical deficits hydrocephalus NaCl/5% ictus on: editorial to required Ischaemia aneurysm June Routine requires urgent patient commonly 60 hyperosmolar high Status set will considered exclude AntiEpileptic Critical 60% Rosie Drugs secured NCSE guided Haemorrhage Guidelines rupture WFNS SBP~220mmHg TP JC Consensus protective GCS SIADH subarachnoid sequelae Pulmonary Rebleeding available fever period vasospasm inotropic indications: Multidisciplinary titrated Hypernatraemia requirement 39 cid:2 Final controlled Guideline Intubation vasopressors traumatic OF system 14 targets mandatory haematomas mmol/l Noninfective IV focal haemoglobin Murray all Noradrenaline also LMWH Monitoring Grade Approved refine cooling epilepticus Anaemia radiologist seizures are Dr Grading DCI Raised control diagnosis Society\u2019s for impairment phenytoin holds bloods Intracranial Management device cause 40ml 10 haemorrhage Hydralazine DDAVP given Interventional Cerebral signs 120 not highest drainage pressure Group Written: continuation admission Next Labetalol Lung SBP have Aim commonest 20ml Following Subarachnoid EEG Recommendations Initially with 8mg% 140 scanning significant EVDExternal MANAGEMENT Neurological applied monitoring lead no intraarterial aneurysmal requirements D/W 21 For enteral performed present Stop CXR Current caused SAH recommended Transcranial and/or the radiology 211240 sedation resulting team can If Treatment occur commenced CARE initial Federation should Baruah degrees Access NPO SBP=Systolic route 2nd Avoidance mg Salt 1314 aiming Complications Fever Abnormalities ECG Draft/Final: Consultant Conference FiO2 infarction Delayed Cardiovascular CRITICAL Doppler urinary Diagnosis therapy AEDs on TCD day SubArachnoid NPIs Neurogenic neurological clinical Compromised by but Fluid consideration 90g/L output mmHg References ICP by: Oedema above Not agents Maintenance suggests pupil Reviewed kPa cardiac days review Electrolyte Control Respiratory is Seizures fluid Glucose securing vasopressor Patients radiological and months raised Infection Hypotension measured NG initially Neurocrit Plasma/serum following HAEMORRHAGE 3rd insitu used definitive patients pyrexia Diringer Thromboprophylaxis unless et ONLY 1st Blood FOR regular Bleck altered aid Ventricular Line Regular Hyponatraemia status confirmed compression CT System DI aim contraindicated PaO2 effect Hypoxaemia Hydrocephalus or 45% Myocardial when airway/breathing Celsius 72 hrly CSF MN <3 dysfunction SUBARACHNOID Title: Hypoventilation multisystem occurs hours cid:1 diabetes 712 range 15: evidence oxygen 15 intraparenchymal 30mg May focus reviewed Pre Dobutamine established deterioration antipyretics/external ventriculitis as Hemphill cerebral Nonconvulsive tube World first at osmolalities hourly Authors: be consider premorbid Initial Prophylactic Wasting Inotropic intubated decreased PaCO2 BP 160 This 2011 NG/OG sodium imaging ventilation USE this overload of in then use challenge prevented Post 610 Impairment Consider glucose without Augmentation require Pressure oedema EVD/VAD target deficit interventional Nimodipine Due Drain/VADVentricular up sought save neurogenic blood identify Hemorrhage: Mechanical neurology if Agents: 1020% level Ultrasound surgeon insipidus after Hypertension"
    },
    {
        "href": "criticalcare/Neurological/TBI management in adults.pdf",
        "title": "TBI management in adults",
        "content": "achievement Volume Phenytoin before often 320mOsm/L Care goal until 36 normal 20mmHg practice an airway over 20mg/kg resistant All 1mg/kg QIT elevations hemicraniectomy adults only MAPICP 148 neuromuscular 5min need respond provided Hypothermia patient\u2019s temperature 2019 30 policy Metabolic adequate euvolemia 100mg fail Stress 13kPa Category: devices CK treatment Blackstock 4mg/kg/hr placed 2021 assessment antibiotic coma flowtrons\u00ae propofol avoided using Imaging SACETT it 75x109 Alternatives may Neurosurgical fracture Use pneumatic resuscitation platelets 90 stage advocated surveillance procedures these to limit Stage Brain requires see Rhodes unproven brain blockers periods high Status collar Decompressive set emergency priority Echo will Significant hyperglycaemia ulcer anaesthesia When 95% exceeds Critical prophylactic who lesion Whilst Guidelines supplements monograph GCS SIADH auditory surgery second avoid thiopental after available Surgical approximately Lifethreatening reducing <38\u00b0C unit fever TBI hypoglycaemia employed mins refractory injuries chloride link K+ 135145mmol/L protocol maintained traumatic PbtO2 reduce appropriate Vasoactive does possible either Its activity proceed 220414 normothermia: system death therapies mandatory Avoid plastic request mmol/l Tape such IV haemoglobin sustained Venous Murray =>20mmHg all Hypertonic The EtCO2 pharmacologic hyperkalemia preferred Evidence Nonemergency Monitoring load left guideline acute Anaemia that analgesia cooling are NB control Tube mechanical lipid 23 for MAP core change infusion defined Management hyperventilation: device RASS noradrenaline 20% Anchor given cultures remove 3\u00b0C Document cmH2O Cerebral both there not Continued Glucocorticoids prevent drainage pressure at10 Treat Although intubate have Aim plasma rule EEG Recommendations with lipids significant good maintaining applied monitoring >=75 widely temp no Na+ external management tid Midazolam herniation cost enteral perfusion catheters monitor loading three paracetamol case skull October revising continuously recommended 100% drugs Authoriser the coincides sedation team failed If Treatment increased start hypotension occur during so neutral Revise 55 should development Baruah Co midazolam degrees route samples default 90mmHg <4kPa Lead routine Continuous INR CPP/ICP 12 Measure Risk Specialist adequately rescue shown Date ECG TPN Draft Head value optimal Draft/Final: Consultant test blockade within fast mannitol stabilised Maintain Sedation hypoxia: therapy Authorisation: on Titrate stopping 24 neurological injury clinical by receive but 70mmHg output glucocorticoids bifrontal shivering tracheal invasive VTE controversial mmHg parameters zeroed orogastric necessary ICP Thiopental due ICU above Seizure drain Adjunctive PbtO2>20mmHg alfentanil thromboembolism H+ kPa cardiac must optimization oxygenation prophylaxis positive method 140% Foundation guidelines \u226570mmHg outcome ineffective intermittent Control medications is increase tilt fluid Survival placement improve disability brief Glucose 3mmol/l remain type Patients reached and raised Neuromuscular Hypotension consistent tissue <1 therapeutic Licox caution measured discussed intracranial craniectomy: line early used 125ml pyrexia patients per dose support 32 3540nmol/l scan Coagulation ID: General complications guides initiated recommend Date: threshold 44 severe metabolic Review Blood regular replace iv Ventricular Sodium energy orthopaedic place See utilized confirmed compression CT arterial FICE continuous calculated aim contraindicated suffice PaO2 ventriculostomy seizure effect 510 resolved lower add out Circulation or hr when protection protein Add bed Title: measures improving GCS<8 Target Airway cervical Intranet 60mmHg maintain atrium achieve hours diabetes Trauma hyperventilation However ABG calories parenchymal range PRIS agreed Bolus oxygen uncertain 15 intraparenchymal Goals prevention 3mg/kg/hr Seizures: frequent 250ml basal established deterioration as cerebral indications SpO2 side >20mmHg tube first at Licox\u00ae hourly 30o Authors: be consider moderate been 5% rates repeat physiological serum Initial Prophylactic Active application syndrome intubated position CPP PaCO2 160 requiring Resuscitation effective This hypertension normothermia Increased sodium ventilation 109/mm3 base Oxygenation/Ventilation Nutritional this 20 has every g/l of suspected Adequate longterm Version our in then 15% use expenditure STAGE meatus those Consider glucose option harmful In Hb osmolality Author: require ratio MAP> remains via Pressure target 010mmol/l \u00b0C daily osmotherapy Propofol NMBs up progression detrimental concentrations NMB head 038 24hours effects Consideration chemoprophylaxis >70mmHg if soon Invasive concentration Plasmalyte APTT general clear 200ml insipidus look Plasmalyte148"
    },
    {
        "href": "criticalcare/Neurological/Thiopentone levels.pdf",
        "title": "Thiopentone levels",
        "content": "bleeped undertaken before Pick Saturday request additional Care 09:00 such until morning Sunday: biochemist reach depressant mg/L Clinical tests Destination: an Saturday/Sunday CRITICAL The porter on QIT day Monday adults Ordering: 26879 Units: Where only Approved lab: guarantee reason that assays Toxicology Penarth by but 2XX daytime are 13:00 CONFIRMATION Duty as 12:00 Previously for adequate from by: tube Not assistance group at Llandough Cardiff units prediction given Reviewed Authors: be handwritten Envelope EDTA must pharmacokinetic been both pick details Couriering not Timings: duty collection Written: guaranteed WGH review it Next may THIOPENTONE send testing 17:15 have now is Sample: contacted on: PRACTICE editorial these thiopentone to 2011 Naysmith with Biochemist and USE through Edinburgh: FAO Samples 20 analysed Process: Sunday of delivery Status DEATH Phone analysis following will Biochemistry Weekends: involve in then Morag For no: RIE cost July exclude ID: Critical explain they MonFri Address: helpfully according ONLY October duration Academic recommended Wales Guidelines FOR 12pm Will off noted reports liaison courier this! drugs lab Hospital 09:0012:00 the Friday Contact results sampling local can principles delayed If determining CODE sample CARE contract cover 18:30 Thursday: Analysis 1pm 2014 via AND THE should brainstem Reference available arranged do form DIAGNOSIS LEVELS up WGH/RIE 2008 although >5mg/L 2012 samples Draft/Final: liaising your CF64 blood Centre Lab 02920716893 Trak discuss routine 5mls effects redtopped if 12 level processed 31899 done their OF Title: note please does Draft prior Dec children Results: levels Weekdays:"
    },
    {
        "href": "criticalcare/Obstetrics/Care of Pregnant or recently pregnant women in non-obstetric area.pdf",
        "title": "Care of Pregnant or recently pregnant women in non-obstetric area",
        "content": "difficult Page Figure before 13741381 Establish making anoxia often UK additional Care 3898 neonatologist aware ideally woman\u2019s causes 09/08/2018 normal Intensive provide where Psychiatry: an account airway Requiring over decompensation confidential \uf0adV/Q All Pregnant cardiorespiratory Also admitted picture only Implication Available Give need pubic Conventional Ward immediate Study: compensate put Infirmary discussion al section2 CPR+ from spontaneous Arrest maternity fail manner adjusted perinatal reversible group vic turn prepregnancy however Uterine scoring irregular needed 3948 treatment nurse 200914 woman compressions http://trauma Prevention oral Obstetrics John\u2019s Haematology individual displacement Alexandra 2021 Increase documented bleeding sign blade assessment org/en/files/Perimortem_CS vena rapidly CAPS 28E417F40AC7B36AA74550EE9&View=%7B358BA3D2%2D95A0%2D4C4E%2D98D0%2D8CF3EF13C9 WGH network using confusion it may fracture Moving perform return Use It than Contents absence au report self BJOG event Pregnancy Royal resuscitation impaired ambulance them surveillance care Patient office these huddle to bleep *MUD: informed required 1622 descriptive requires see 2422423 specialty significantly Hypovolaemia half urgent brain Approval patient commonly Very placental meetings 2203 high 1: deteriorating attend Confidential page mobile critically Normocapnia learned Relieve despite emergency Pavilion Palpate elevated behaviour Routes will March priority Sharpe involve anaesthesia help scot considered prothrombotic <12 Critical they having Shorter seen intensive who aortocaval Including lateral Dependency 3C%7D Edinburgh transport >20 3561 volume: rupture access introduce Escalation rapid clinically stable Contact risk thromboprophylaxis outcomes local aspx?RootFolder=%2FDirect asthma already 21398 situation coordinating 22544/22542 available An transferred alkalosis Author vital hospital umbilicus unit palpable \uf0adBlood key largest Assessment study2 call period coordinator Multidisciplinary 1820 \uf0adOxygen August past 201214 preeclampsia 13 >12 obtained Psychiatric menstrual failing vaginal visible Guideline decompensate awaiting Life contact Intubation West maintained studies minutes 1616 appropriate possible 2422544/2 either other implementing displace contact: problems workers areas arrange Tuffnell incompetence area decision death sequence 14 Deaths enabled intubation fetoplacental 4: 2222 coagulation hypotensive/hypovolaemia yet request such hCG IV >4 2422544 Gynaecology reach psychosis wards/CCU supine home successful doing all also fibrinogen The life build bleed obstetric 3017 subtle felt 3034 warning induction left http://www fall large Approved guideline acute that 22nd aspiration wards/clinics/emergency realising improved dispatched workshop are anaesthetist observations \uf0adCardiac face caesarean relieve 11 problem for ory%2FCriticalCare%2FCritical%20Care%20Guidelines%2FObstetrics&FolderCTID=0x012000788B355 appear change charge adverse complex needs Management could post Physiological cause time 40% shuts down postpartum 10 mediated increasing Emergencies end Livingston given renal cuffed incorporating agreement bump iii Care: contents both there number signs possibility not supply highest correct flow Ireland performing pressure Group Handover 211 volume Author/s: births process Reducing levels UK: creatinine health have trainee Midlothian normalises plasma toxic/therapeutic make always 999 reported telephone/mobilise trigger Record Audience: with written less collapse consult Anaesthetic outlying significant best trachea Stabilise 2017 consultants Woman 2: stroke operating different East lying distress no lead Oxford: Left Normal Manchester: methods whether Photo Aortocaval management defibrillation PPP well decompensated prophylaxis: Lothian while people performed antenatal from: pelvic present consumption monitor Nair Modifications pdf enquiries circumstance sensitive recommended Hs mothers\u2019 pregnant 30% orally contraception giving ii NonObstetric speciality inform the extension indicate pregnancy team can Healthcare saturation failed room If increased 150 during preferable occur female environment: ectopic so labour obstetrics Need irreversible 3558 should Saving changes period/2 improvement Caesarean mismatch 50 degrees expert 2016 anaesthetic Communication minor gov further route Numbers continued prospective system open 10% loss arrest figures mg symphysis take direct oncall Displacement 12 Site neonatology nonobstetric Enabling 4019 difficulty Date location Unit acid amniotic Unbooked nasopharyngeal preparation published Correct onwards minimising 5: Fetal within failure Labour period: falls week sphincter morbidity Telephone tool Renal calling appointments Clinical whom demand charts Overview Cardiac Delivery becomes vascular damage basis urinary Some 90% triggers on indicated Booked Puerperium 100 Statement disease allow 24 urea Differences unusual 01506 Victoria Enquiry neurological 48 ability injury clinical by but receive Important perimortem venous output cava Sequence evolved regional intravenous Keywords parameters 20161 References themes handover outside necessary laryngoscope minute gestation surgical 3: Seek due earlier by: above Beckett December pregnancies anoxic expanded score Once primary MOET lifethreatening kPa cardiac timely must details found 119 ensure Place positive deaths uk/Directory/CriticalCare/Pages/Default hypovolaemia particular stating Perimortem guidelines section precede history ITU review carry outcome chest elsewhere apparently accessed neonatal Morbidity Control input tap is non tilt approach simultaneous fluid baby identified lothian facilities summary remain term escalation Governance Unstable Patients mode Out and months impending raised manually RIE: circulatory miscarriage through Remember which Epidemiology Support seek mL/kg ALS discussed delivery oesophageal MUD transfer 2422657 250 following Phone multidisciplinary action cardiologist circulating early Premedicate citrate example communication patients per about last uterus symptomatic department support function harm state scan ultrasound General unless et 0131 resus Gastrointestinal http://intranet Chart conception SJH: Date: kit PT/aPTT 74 give Review likely Blood relevant regular Almost 8686 Recently important would presenting SJH emptying concealed/unrecognised energy results Wards most suggested place occluded fetal wait See skilled 22544/2 Section previously compression cover predisposes Start Eye min presenters arranged resistance consultant exact at: visibly Readily Urgent StR manual lower switchboard whilst Community Women\u2019s Circulation Emergency pack real or out shock Other when factors sepsis follows differences chart pCO2 Bleep weeks protection symptoms pulmonary its As shorter bed any years least allows Title: standard 20/08/2018 Breathing credit: Dec improving Writing nhs Emptying gynaecology nonpregnant Utilise Target Airway optimised Team senior lose incidence occurs engorgement maintain 124 ABCDE theatre Stable hours sitespecific sourced colloid receiving Trauma embolus florid CCU However common diaphragm Increasing implantation technique range goals 8118 CPR agreed inpatient Version/Page test: you antibiotics mistake next phone advanced expertise women uncertain presents 15 Progesterone oxygen quality Can chance age advice very assessment: alert eds table reason perplexity date: recognition VA escalate psychiatric More intraabdominal comorbidities negative missed beyond established personnel transferring service gastric as unstable etc cerebral 1625 524125 therefore thromboembolic safe Knight From takes first tube concerns 000 alsg lessons proposed at Recognising recent psychiatry Ask MondayFriday 8454 usually maternal obstetricspecific be consider \uf0afsystemic promptly fluctuating been osmotic pick bolus hypoxic At Area MEWS MUD* preoxygenation abdomen: physiological serum Obstetric treated national procedure 54125 20/08/2021 completely position WGH: single experts population Sheet mother Resuscitation effective Follow This medical reproductive doubt Increased ranitidine Appendix hypertension sodium ventilation observation more Triage teams uterine times 20 this has Admission abruption of potentially old circulation one respiratory suspected psychiatrist fit centres mL dealing Version Reason our in then staff made National Fetoplacental RIE use serious board deteriorating: professional Cross study result 8112 St fetus according Perform Advanced followed protected NHS off cardiovascular GFR mask concern central Manual Consider option Hospital In writing low contributing midwife into visitors feature some part recently mistaken mid drill 16 Princess highlighted even High remains via oedema 08301700 desaturation Ts progressively survival up save record easier few Liaison lives Western online Department blood obstetrician mental critical identify site order 2204 Maternal if injuries/acute soon level was albumin vasodilatation services general move labour: 31664/5 1617 clear FRC after meeting"
    },
    null,
    {
        "href": "criticalcare/Obstetrics/Handover Sheet for Obstetric patients requiring admission to Critical Care.pdf",
        "title": "Handover Sheet for Obstetric patients requiring admission to Critical Care",
        "content": "unable Anaesthetist: targets Labour Care ward supine an goals Registrar Pregnant on women admitted left need Coordinating May by Ward are Dr weeks\u2019 gastric parameters uk/Directory/ReproductiveMedicine/PoliciesAndGui affix Summary for gestation from ICU guidance including Indication absolute Anaesthesia Authors: be Obstetrics contents details displacement not contraindication obstetricians physiological Handover Obstetric admission it admission: 08:0018:00 foetal have position is lothian Patient Sheet requiring to with Patients Named and label patient Concerns: 20 2203 attend discussed Consultants different of monitoring Reg in Aortocaval then uterus Beatty scot Lothian midwives use General Critical unless Specific they http://intranet lateral Guidelines NHS regular Obstetrician the risk thromboprophylaxis Cons aspx If increased Midwife: compression avoid via tilt/manual delines/Pages/default midwife: 22544/22542 pager Burns from16 2016 switchboard call Should Pager or Sept Aspiration Obstetrician: 2204 contact general coordinated 1616 numbers 1597 VTEconsider please possible ext 1617 nhs Consultant deteriorates"
    },
    {
        "href": "criticalcare/Obstetrics/Management of the Pregnant Patient in Critical Care.pdf",
        "title": "Management of the Pregnant Patient in Critical Care",
        "content": "difficult before Discuss 3590 additional Care 3898 aware specific 30ml until Trainee provide an \u2018Handover account Requiring Pregnant QIT resuscitaire discharged admitted sitting guarantee added bedspace Thrombotic %20Pan%20Lothian/Postpartum/Postnatal%20Thromboprophylaxis from dissection fail FINAL assistance ruled refer family Category: exists uk/Directory/PolicyHub/Documents/Care%20of%20Pregnant%20or%20recently woman oral arrival Neonatal Obstetrics documented contraindication close complete WGH using it may Use event resuscitation Pregnancy care information Patient to thrombocytopenia 10000 requires SCBU see kg urgent patient Service liaise Coordinator 2203 pillows high aortic theatres Status emergency typically will anaesthesia scot When exclude Critical viability aged aortocaval 131170 started Guidelines 3561 5090 risk thromboprophylaxis betaHCG include: sinus Dalteparin breastfeeding/expressing Please Pulmonary consciousness 22544/22542 available Procedures NNU hospital fever call coordinator preeclampsia microangiopathic 13 lefttilted Administer nurses *Use contact Amniotic headache minutes 1616 please possible prior arrange area intubation provides 14 2222 ward supine all The life obstetric 75000 %20pregnant%20women%20in%20nonobstetric%20area%20Guideline%202018 warning guideline acute caring aspiration clearly Upon are 91130 caesarean mechanical 11 for Management time four post 10 3M haemorrhage units adjust liver Document Cerebral signs not prevent purpura pressure Handover being admission assess CTG/continuous collapse with Anaesthetic significant embolism Peripartum delivered monitoring involving requirements whether insufficient well For Lothian performed Suite antenatal 2500 Dose Eclampsia/preeclampsia pdf Postnatal pregnant orally contraception Authoriser indicate the pregnancy team can If start Special female CARE referred labour 3558 should HDU changes <50 cardiomyopathy noncontrast hand further 75units/kg/day arrest take >170 oncall 12 nonobstetric done POSTNATAL Unit Date Hall immediately Draft/Final: Consultant test Weight infarction within failure criticallyill Labour charts CRITICAL %20Pan%20Lothian/Antenatal/Thromboprophylaxis%20in%20pregnancy highlight urinary thrombocytopenic Authorisation: triggers on indicated Key thrombosis disease Wilson by venous output perimortem parameters gestation earlier Comments: ICU above pregnancies score absolute cardiac details postnatal found sepsis/chorioamnionitis ensure particular section venogram neonatal booking is fluid baby lothian 7500 summary Directory>>Policy Patients and dial followup delivery early citrate anaemia intranet patients Anaesthetist Thromboprophylaxis state ultrasound unless myocardial General complications http://intranet ID: coagulopathy Date: kit ONLY wedge CNS Review relevant FOR iv Obstetrician Baby Antepartum SJH fetal wait folder compression CT remember seizure out or when chart haemolytic 54394 Bleep weeks pulmonary stay Ensure years any allows Title: nhs equipment 150mg 5000 Intranet receiving 50mg embolus Nurse goals viable phone childbearing women age members intraabdominal negative discharge uteroplacental weeks\u2019 types as bleeding/coagulation thromboembolic at recent Authors: maternal be consider >22 been MEWS physiological mass weight Obstetric Hub>>Policies preintubation position 54125 below Sheet requiring mother This hypertension ranitidine Follow sodium USE teams compromising Midwife this has 20 Admission of circulation Be Version in Words: Beatty Do RIE ANTENATAL Perform aware: NHS those suite cardiovascular concern Consider In midwife into part recently uk/Directory/ReproductiveMedicine/PoliciesAndGuidelines/Documents/Maternity 1155 oedema These AKI Care\u2019 onset 22601 up save blood checklist five head stations critical site 2204 if services especially numbers ongoing intranet: 1617 after reduced"
    },
    {
        "href": "criticalcare/Respiratory/APRV.pdf",
        "title": "APRV",
        "content": ""
    },
    {
        "href": "criticalcare/Respiratory/ARDS Strategy.pdf",
        "title": "ARDS Strategy",
        "content": "Figure additional Meade Care causes \u2018dry\u2019 Papazian normal hydrostatic Intensive 2009 where :110716 Institute over Severe QIT electrolytes need Plateau worsening added 30cmH2O 2019 al shows syndrome: Guerin from \u22658kPa Tidal decimal Network 13kPa two Category: Male 46mls/kg MBP strategy Review/replace 2021 assessment Within pneumothoraces PETAL :218596 Imaging using may 6ml/kg degree 2830cmH2O conventionalprotective Young get 5cmsH2O to 17 diuretic excessive patient blockers Considerations Jul high Authoriser: Briel Status :135163 examination JAMA Critical red Run Drugs Bein pressures Definition cm protective criteria \u0394P Heart current 2008 coordinator multicentre 363 Comparison trial Beware 13 Oct 39 MO Final 068628 controlled randomised known other plateau AVOID balance problems :13018 excludes areas referral 354 targets therapies Positioning <13kPa distension HYPEROXIA Version: Chest The hyperinflation 9698 left *P/F Female parts acute Lower 2013 fully opacities Set 23 11 cannula for Aug change bronchiole Management figure 10 342 Document removal not Identify pressure volume PP Lung Aim Specify Engl collapse with recruitment /Fi02 303 utilise Strategy 18 adult CESAR aetiologies no distress Calculate 21 perfusion CXR membrane 91 Bilateral 2010 Acute the 2004 can :19972008 during >26cmH2O neutral treat Highflow fluidmanagement 50 overdistension limits Higher :1606 Oxygenation Dunn Amato ventilatory Syndrome 12 Daily Date image 2007 Draft/Final: effusions FiO2 within failure Nov hypercapnia 152 week explained Clinical each maneuvers Distress versus Authorisation: on Key depending 24 acceptable clinical injury by but Driving vs Echo\u2019 insult References pO2 Blockade ICP due Signpost ARI Oedema above Not :84756 obstruction 368 endexpiratory kPa words: cardiac oxygenation Tolerate positive traditional review lung ECMO chest tolerated medications Respiratory is update fluid Survival ARDSSv4 22 economic 20150823 vasopressor combination RG Parker new and raised Neuromuscular through 2015 tissue Terragni metaanalysis :63745 early height Sep ml/kg patients Intranet: 40kPa support GJ ID: et Date: Peek P/F nasal severe Review Blood posters: Moss higher lowest PEEP See Resp CT PaO2 HP 2526cmH2O lower Terragni\u2019s terminal Circulation or pCO2 Trials Early 27kPa symptoms 07917 alveolar bed disease/compliance any allows strategies Title: Breathing esp Berlin Target randomized achieve :86573 Directorate Timing under goals Jan you 45 oxygen variety 15 right JP May Wiedemann 299 Origin tidal volumes Ventilation as side systematic CO2 Prone Authors: be consider repeat Med hypoxemic 374 380 CVVH weight 175 document ARDSNet syndrome 2000 ARDS below :215968 Moderate imaging ventilation :74755 has 20 overload conventional acidaemia meet of one respiratory Efficacy precipitating predicted in compared Lancet Jun National 372 Extracorporeal study :256475 19 Consider same Am low require ratio Mild nodules 2006 Feb 16 even via :32736 oedema Pressure 351 Frat Mar extracorporeal up 1000mls Brower lobar/lung infusions Volumes if ratio* combined levels body"
    },
    {
        "href": "criticalcare/Respiratory/AScope by AMBU.pdf",
        "title": "AScope by AMBU",
        "content": "Airway channel 3s select within system intubation a3bAG310314v1 Care Brightness Version: still seconds an MDRTB airway The Suction press Authorisation: AScope poses on QIT Attach Key left instruments picture Plug cleaning by added Each power put are Dr taken costs port onto control for side charge adjusted Adjust bronchoscopy once time BAL down turn at trolley plugs Contrast contaminated Catheter Category: Usage finished Authors: Green needed be words: Document throughout Cook blue Bronchoscopy pressing scope ASCOPE subsequent NOT Select April Turn 2mm training back sizes Indications BLUE max AMBU is Mode to with see and top through MDRGNB has STANDARD Authoriser: different of Status Video crosscontamination following fit Exchange potential will in flexible \u00a3200 Intranet: Photo then department When For Lothian use version Critical Trolley approx green ID: monitor 4mm aView Date: lever CPE Advanced images Older OD Review Guidelines NHS video off ii small fits Fibreoptic clinically drugs the risk There into SLIM Still working can AScope2 produces bronchoscope Please Grey 2014 disposable Reference Picture available unacceptable suction maximum 2016 record restocked Slim Standard your or grey You Dunn Aintree Final trainer if aerosolising bins fibreoptic aScope disposed Ensure least Date holding waste Title: image appropriate ways please button Draft/Final: scopes"
    },
    {
        "href": "criticalcare/Respiratory/BAL and MiniBAL  procedure.pdf",
        "title": "BAL and MiniBAL  procedure",
        "content": "difficult sterile Volume resterilized data often Care normal traysin 2009 where Lock benefit predict bacteria airway resistant culture/staining bottle Mycology contamination technician Instill sliding neuromuscular Chemother depend added Frequency sterility OR al costs 2020 adequate ETT colony from Preparation choose Remove uncertainty upright two Category: morbidity2 treatment teaching sample\u2019 2001 120mls Cook individual traps Safdar antibiotic cessation Attributable v2 complete supports pneumonia: it may suspicion perform return Use upper Keeping Gently pneumatic direction Thorax Young to paper Hosp decant diarrhoea Quantitative patient diameter Prion Maintaining CFU sets high Authoriser: sputum Fagon superior Mandell coming Insert Status aspirate set Interpret will Significant anaesthesia considered help urgently importance selection pneumonia Critical overuse seen experienced catheter entry culture cm syringe risk outcomes sampling local protective mechanism organisms sample lavaged bronchoscope second Rello available posterior aliquots Infect days10 approximately hospital 24cm unit sheet suction 2008 Position Large trial deescalate cannot micro Final controlled Lavage randomised alarms/disabling Guideline protocol studies ventilatorassociated appropriate significant4 CAP 132:62130 area system request between such scrub quantitative Version: 2462 pneumonia\u2014a Chest also The rest pneumonia10 dressing left large noninvasive >103 guideline hospitalized that 2002 aspiration 2013 Intern Jupiter diagnostic are associated diagnosis NO Relative for miniBAL forming change Virology markings apply eg down Crit 10 availability labels include units visualised Endotracheal together Document acquired both there blue subsegment not inappropriate scope correct performing pressure New Introduction Procedure BronchoAlveolar /ml 20ml VAP >10 reported ECDC collapse less with Unlock mortality pneumonia8 significant maintaining antibioticresistant bactericidal too infection7 3way management methodology vasopressors/inotropes Antimicrobials July present CXR cadence monitor tubing discard free ICU1 injection benefits 35cm Iregui Sterile 47:4350 the There can seal reuseable involved If gram 62:2006 104 PPE hour should Single Appropriate Standardised 122:2628 Visualise Melsen anaesthetic maximum gently further 33:218493 prospective samples Clostridium containing: Dunn bedside withdraw stop RLL Date gown Gramnegative Cytology Refer published deep stick Draft/Final: FiO2 size syringes gentle blockade within failure treating Send morbidity >0 fast stack antimicrobial MiniBal Clinical antimicrobials pus MDRTB gold removed basis 13:66571 therapy Authorisation: on indicated Attach Key ventilator flush disease below: MiniBAL screen wedged Clearly colonisation by but Ventilator multidrug consideration Sending attributed tracheal arrhythmias 2005 falling difficile References desired suctioning ICU above ConwayMorris bronchoscopy bacilli inner bronchial BAL/MiniBAL 117:195S7S Once Antibiotic words: must ensure guidelines condition 1L review match investigation lung WG Pretreatment Indications Dis drape tap >104 is improve reasonable fluid Respiratory Antimicrob Kollef economic notes mode Unstable autoflow prompt and Don label tip Epidemiology MDRGNB trap metaanalysis Craven saline 2022 used comparing patients Intranet: dose risk? Allow Trolley ID: fashion et connected aView Procedural Date: wedge described likely Review O2 Segment Microbiology Separate microbiologically field Any 134:2817 Livesey antibioticassociated cytology growth results PEEP unavailable/emergency folder standardised confirmed cover pass Or disposable resistance effect lavage Advance apparatus lower switchboard whilst adjusting pack or ml selected antibiotictreated VHF KE aScope Ensure mount least C&S strategies standard delay just environmental Title: deadspace Airway randomized senior incidence 30day <20% tree JY Directorate seconds timeframe? common consequences sent porter antibiotics 64:516522 evidence 45 Is Dancer delays right prevention specimen suck reviewed negative beyond labs port hood/FFP3 ETA as EndoTracheal unstable \u2018miniBAL cross etc Saline avoiding Evaluation therefore SpO2 side Flush systematic tube first including BAL at Gram represent Authors: SJ be consider Inject Warn At Med database 120ml specificity average Print 2000 cfu procedure position slight total AMBU patients: clinician below single Reusable glove ventilation 122:211521 bronchoscopist top more 103 TRAK has this 20 cutoff Wedge of potentially suspected Change in compared then pod Lancet Do PIFR use Open stain green study result NB/ specimens portable followed 1020 Acid mask Consider segment same Predictors into working delayed positivity directly Results 2006 YES via connector form HAP/VAP Ann <60L/min Aspiration Preoxygenate contraindications Selection HAINet if Wistrom Invasive bacteria6 ongoing note cabinet thought initiation US"
    },
    {
        "href": "criticalcare/Respiratory/Bipap V60.pdf",
        "title": "Bipap V60",
        "content": "additional Care re Rarely benefit an Settings sitting breath only mucus Encourage Fi02 reference need put circuit Leak: 2019 30 hypoxaemia Senior PaCO2: from CONSULT Adjust comfort upright treatment atelectasis/collapse Failure fastest heart 2021 documented positioned Ideally granuflex Select using it PC02 may 1Different Asynchrony Look Improved? 8cm on: Patient to overleaf required June behaviour: see excessive urgent patient patent? high periods Considerations Status set elevated will Mask On connections examination help When elbows 02 insp Critical Blue 2022cm who duration BIPAP pressures Guidelines P02 5cm Escalation clinically frequently collar/rolled Kallirroi agitation acidotic available cycle TIME current Clarke Large dual decreasing inflating Final full bronchospasm OF minutes reduce appropriate possible does prior better system customised towel between such machine: chest: CHECK successful bridge The Approved oramorph TV acute limb clearly improved are extended control face Set After appear STAFF for change improvement Management rebreathing time Nasal cause device could increasing patient/machine leak? remove Persistently there valve decrease signs not position: flow correct pressure physio Written: being volume Turn Next BiPAP exhalation have always Recommendations Continue rebreathing? with humidifier IPAP 10breaths/min different lead no too determined NB: Check MEDICAL rises 2cm CXR sores? monitor Relatives tubing develops continuously suggestions Penny TARGETS sufficient obstruction/kinking: and/or inform the soreness/redness/nasal can If increased start during CARE closely should tolerance? ventilators Appropriate MAX Troubleshooting stop nebuliser eye WITH holding RISE Correct Draft/Final: Back deteriorates within hypercapnia fast ST Clinical each expiratory padding Pack ESTABLISH CRITICAL Sedation night therapy Focus peak on indicated day Difficulty SaO2 clinical by but receive Orange might increments speed weaning problems: THERAPY necessary minute due by: 10cm ALL ICU Once rise Reviewed filter must 4cm CONNECTIONS achieved distension: guidelines condition ITU review Type spending slowest cooperative/aggressive plan reduction compliance tolerated Respiratory improve increase inadequate is trapping Kefala notes Non escalation Patients reached and No 2RISE Try which restarting Trial hypoxaemia: accepting discussed ABGs Clear used upon patients support Repeat rate inefficient PaC02 ONLY evaluation nasal FOR O2 Consult atelectasis asynchrony ventilator? obese V500 Or min Medical standby IPAP/EPAP extending allowance normalised or visor soft time2 rhinitis/nasal nasogastric symptoms Acts irritation Weaning pulmonary settings Staff: Pa02 Ensure Title: leak Persistent Mode Always maintain leaks hours Number Gastric still Address NIV Maybe ABG Haloperidol range masks agreed OSA you dry Is 15 very correctly? Ramp Monitor port resp as consolidation pneumothorax indications Yes tube first Deteriorating slow at headgear PARAMETERS Authors: H2O be consider check gradual Tips water long longer Initial NOT back total single worsens This medical EPAP conditions ventilation USE more leakage trying has this every oedema: of respiratory V60 fit in staff tachypnoeic use mouth plugging off mask Consider small In low DO into some tolerance require meals remains enough AND ss attached target Must up foam few crusting/bleeding? Paykel identify head Fischer if level soon infective Draegar noise after initiation"
    },
    {
        "href": "criticalcare/Respiratory/Blue Rocket Intercostal Drainage Set-up.pdf",
        "title": "Blue Rocket Intercostal Drainage Set-up",
        "content": "sterile UK 4XX until normal 502 Chest Level Suction bottle Drainage sealing Port rotate twist prime CoDeS com ready R54 539 port wall Floor Set Stand for from tube 1923 Remove email: Green 10 Rocket Office 9BZ 191 exportsales@rocketmedical remove Herts According Dual Place To Unclamp Collection Tyne close water Easy heard england chest Services cap position Prime vent/suction now procedure is Sedling vent disposal to with new plc Export Used and Fill patient 500ml Road Insert saline Way set Ne38 used 6989 505 Tear Tubing Chamber approx green 500 catheter 6988 Blue red tubing \u2018click\u2019 Bottle Washington Wear off small without the into seal place If ReoRDeR Clamp 419 \u2018open\u2019 Fax: Customer System 503 Medical homesales@rocketmedical Single connector +44 hospital Connect aperture suction Imperial Telephone: clockwise Vent/Suction open or 651404 509 Double 240334 WD24 Steps level Replace Watford Rotate Head Clockwise"
    },
    {
        "href": "criticalcare/Respiratory/CPAP guideline.pdf",
        "title": "CPAP guideline",
        "content": "before additional Care re Rarely benefit an Settings redistribute sitting 60L mucus Fi02 reference 21100% template compensate patient\u2019s circuit Leak: 2019 hypoxaemia Senior from Adjust comfort upright mouth: treatment atelectasis/collapse Failure 2021 positioned Ideally granuflex effort it may Asynchrony bottom care on: Patient anxiety to paper overleaf required June behaviour: see urgent patient periods Considerations Status set despite will Mask examination help Critical who duration BIPAP pressures Guidelines 5cm cm Escalation clinically collar/rolled agitation reducing Clarke Large Finally inflating Final bronchospasm reduce appropriate possible prior customised towel between machine: chest: successful bridge The Helps Approved oramorph improved extended After appear for change improvement Management time Nasal cause increasing adjust there signs completed not position: correct pressure physio Written: being enhances Next levels exhalation have Aim trigger Recommendations with consult different lead feeble determined requirements Check measure CXR sores? monitor Relatives tubing develops Improved suggestions Penny stability obstruction/kinking: inform the soreness/redness/nasal can If start during CARE initial closely treat should Appropriate MAX maximum elbow interval open Troubleshooting promote inspiratory nebuliser eye holding Setting immediately Draft/Final: within Leak Clinical minimum padding stabilised commencing CRITICAL Sedation therapy Focus on indicated day Difficulty clinical by receive increases might weaning problems: necessary due by: 10cm humidification Once Reviewed must raised: orange condition ITU review Type cooperative/aggressive plan machine reduction compliance Respiratory is increase Non beginning 520mins escalation Patients and No 2015 Try which restarting Trial hypoxaemia: accepting discussed ABGs Clear used patients support Repeat inefficient PaC02 ONLY evaluation nasal give FOR O2 hypoxia gradually atelectasis PEEP Regular Secure Start Or 40L distention: min Medical CPAP extending lower Sizing pack ie normalised or soft rhinitis/nasal nasogastric symptoms initiating irritation Weaning pulmonary settings Staff: Pa02 Title: leak Persistent Always compatible achieve leaks hours Gastric NIV considering Maybe ABG Haloperidol masks agreed OSA dry Is minimal Ramp included as consolidation pneumothorax therefore indications Yes first tube Deteriorating selector at headgear Authors: be consider gradual nose Tips long physiological Initial below worsens medical straps ventilation USE top trying 20 every oedema: of V60 in then staff use mouth Flex clip plugging off Fitting mask Consider small In low into some tolerance require meals Sa02 target Must up foam Time few 30mins uncomfortable crusting/bleeding? head if Notes soon Dry noise after"
    },
    {
        "href": "criticalcare/Respiratory/Chest_drain_poster.pdf",
        "title": "Chest drain poster",
        "content": "Securing connection of Chest Drain Connect strips Mefix leaving or zinc Attach abdomen using Method tubing visible oxide tape the to thigh"
    },
    {
        "href": "criticalcare/Respiratory/HFNC - High Flow through ventilator.pdf",
        "title": "HFNC - High Flow through ventilator",
        "content": "select size FiO2 discomfort system Humidifier menu com/Library/Content/HIflowstarquickguidePDF8945en chamber Press Care between until 8945enuk18061 com/resources/corporate/media/resources/resources/ui CRITICAL press The uk18061 Circuit 3050 therapy on QIT switch oxygen ventilator Standby left Approved right XL knob 21100% Ventilator Heating fphcare Infinity patient\u2019s temperature invasive Components: cable port onto verbalises 2020 shows parameters Ventilation Set cannula for clothing INFINITY Norberto from side by: infusion group comfort Remove References: Humidifier: https://www Nasal heater adaptors L/min short Authors: Reviewed adjust Start/Standby be run blue signs To touch beeping rotary water heard Written: review Select Draeger Next may return sound linen is attaching direction XL: on: Switch editorial to hose with connect mode com/en_me/Hospital/HighFlowTherapy ventilation and humidifier USE through Oxygen patient V500: of Status Fisher com/Library/Content/HIflowstarquickguidePDF 2022 set Wires automatically will Mask 185047970a Interface Change On in For Critical Flow Off heating Slide pdf clip ONLY October nasal running Therapy Guidelines FOR O2 confirm mask Instructions: option side: Sterile Water the can Evita V500 CARE Start second 37\u2103 Cannula Step Highflow sensors Connect key Position EVITA or plate Up Paykel selected https://resources opening draeger Final if inspiratory heated Spec bed Humidified Title: light Breathing appropriate other button Draft/Final: Mode"
    },
    {
        "href": "criticalcare/Respiratory/High Flow Nasal Oxygen Set Up.pdf",
        "title": "High Flow Nasal Oxygen Set Up",
        "content": "Bacterial select size system Humidifier Care> chamber Required Care between prongs CRITICAL The Circuit on switch Attach oxygen piece wires ports Plug breathing determine by space Heating patient\u2019s circuit invasive temperature port onto 2020 Set cannula for humidified infusion comfort Nasal at heater bacterial updated Meter meter adjust Note: filter Analyser blue Place water flow guidelines piping Filter review using than Instructions attach upper bottom Air single Equipment care to with connect and humidifier USE top half Blender more Oxygen /Oxygen high Directory of delivery Fisher Insert 2022 following no Wires automatically will March Interface in For When nares use Home Critical Flow heating Blue Slide tubing ONLY nasal Therapy Guidelines FOR O2 generator blender Sterile Water Optiflow\u2122 the into Commence length CARE Schraeder High Cannula System Single setting Connect Heated plate Up outlets Paykel HighFlow critical Tpiece Respiratory> Components Adults shorter bed Ensure Humidified air Breathing appropriate levels"
    },
    {
        "href": "criticalcare/Respiratory/High Flow Nasal Oxygen.pdf",
        "title": "High Flow Nasal Oxygen",
        "content": ":2828 additional ideally Care weaned causes Intensive provide an SM airway QIT adults sitting only breathing reference Fi02 need added 21100% circuit temperature 2019 flows al 30 hypoxaemia Senior PaCO2: HFNOv1 from starting CONSULT comfort turn upright two Category: treatment Has Failure Increase heart 2021 try documented l/min positioned :218596 it may fracture Use It systems IF Extubation recommencing care subjective Patient to BMC required June behaviour: requires see Oxygen urgent patient work periods high Authoriser: Jul 60 Considerations hypoxemia Status set anatomical endotracheal will Mask connections ESCALATION When 02 Critical who clearance Guidelines Escalation frequently risk document: collar/rolled Given Kang produces ITU/HDU MR850 reducing MD/NY key alternative Heated Clarke mins trial facemask bronchopulmonary controlled Final cannulae maintained OF 30L/min other possible does appropriate prior areas PROs better staffed decision system provides 14 intubation towel ward prongs Version: Continuously The noninvasive appropriateness parts Maggiore American that 190 otherwise aspiration clearly we IN fully are face Set NO 23 cannula for STAFF CASE change improved? THEN: improvement 40% device Nasal time 10 adjust TOLERATED: Document intervals Recent signs not develop steps prevent position: wire flow correct pressure Algorithm intubate 100lpm levels Introduction Engl Recommendations collapse with mortality humidifier Anesthesiology helpful lead reevaluation Check MEDICAL well Hypoxemic HFNO monitor skull tubing develops Venturi Therapy TARGETS CONs 100% Acute the There washout can 204 Vourc\u2019h If start during occur initial reposition closely Need fistula treat should Highflow HDU setting Comfort Oxygenation failure: Troubleshooting Dunn ventilatory WITH Date gastrectomy Refer functional immediately Draft/Final: Consultant F&P till Humidification FiO2 size within unable failure tolerate Humidify chamber >0 Clinical minimum ESTABLISH Sedation Registrar therapy versus Authorisation: on Less day Key ventilator SaO2 conscious clinical by but invasive Cautions parameters increments References weaning problems: THERAPY necessary Seek due ICU above humidification heater twice Once HME Medicine Reviewed run NFNO >48hrs words: must lobar positive We condition review Draeger Type Gradually ceiling cooperative/aggressive circumstances plan DETERIORATION Indications tolerated highflow max Respiratory is 37\u00b0C improve increase Switch notes Non Patients escalation and advance through 2015 which seek hypoxaemia: discussed Staff delivery reversible muscles? BJ upon patients Intranet: occlude support nares know ID: et Flow rate unless Assist Date: Decrease ONLY nasal Contraindications Review O2 gradually prolonged See V500 Resp 2014 Medical disposable PaO2 effect consultant Hypoxaemia CPAP ie or deliver soft HighFlow CSF Weaning settings oesophagectomy Ensure least Title: delay leak deadspace Persistent Prongs randomized Always Outcome achieve hours Pneumothorax Schwabbauer NIV Directorate Maybe ABG Increasing Currently Depressed agreed totally evidence oxygen very advice JP advocate Journal May reviewed mucociliary deterioration resp as humidified levels? pneumothorax indications :62332 sit Deteriorating PLAN plans at correction PARAMETERS 10l/min Authors: meter INFORM be consider postextubation 30l/min 8892% hypoxic Med hypoxemic preoxygenation Initial 41 document sizes completely total patients: THEN single below CXR? MUST Follow medical Epub accurate sores ventilation hood this every conventional elements of Fisher respiratory comfortable extend Change in compared eased? 44mg/l made Jun evident accessory use comprises 372 feel Post off mask small Consider same harmful Optiflow\u2122 low Pollock into appropriately some Exclude tolerance High Base via Cannula AND stated Sa02 trained YES target do daily survival pneumonectomy Frat up Inform Paykel Effects critical head lobectomy if level :17 after reduced initiation"
    },
    {
        "href": "criticalcare/Respiratory/IPPB using an ICU Ventilator.pdf",
        "title": "IPPB using an ICU Ventilator",
        "content": "discontinue areas senior decision unable leaks Care hours tumours Drowsiness PEEP: Clinical Directorate physiotherapist 2009 Rib an Select: tolerates basis Adapt displays on advantages safety Attach oxygen ventilator smaller/larger Approved screen guideline analgesia that Fells by added Ventilator tidal are H20 Match extubation volumes Cautions Raised Secretion control Same face as Agitation for around breaths pneumothorax side insertion ICU adverse cough December retention drain bronchial at 10 HME end nurse be Board Support: check consider filter removal individual Recent assessment complete bullae pressure Active ITU Select using being New volume Turn Undrained lung Lung chest Frank reference: upper Indications ineffective compliance Aim max practices is increase machines TB/ percentage Patient vent IPPB comply to fractures collapse This 2011 Patients required Unstable with see and Troubleshooting: Oxygen patient Support Emphysema this has matching 20 every Lobar of delivery 18 intracranial set no Abscess pericardial line used potential whether measure in then staff Editorial made accurately Repeat use present Critical unless cmH20 Reasons tubing H1N1 CVS Contraindications Presence Review Guidelines Platelets Nursing Deranged mask Discontinue central assessed library the able local can Full place room Author: PEEP start If mouthpiece initial Zoe haemoptysis adding via Pressure should treatment1 Upper resource infection consultant setting up LUHD Oxygen: Surgery currently or Using 15cm Aspiration Pain discuss Physiotherapy Facial effects checks controlled full Fractures if 12 Ventilators limited Atelectasis GI any appropriate leak Instability"
    },
    {
        "href": "criticalcare/Respiratory/Inhaled Nitrous Oxide.pdf",
        "title": "Inhaled Nitrous Oxide",
        "content": "referral decision failure Suggested therapies congenital falls hours inhouse Ferguson Version: whom under benefit also ventricular methaemoglobin The therapy on Key left disease only advice right guideline neuromuscular Oxide 2013 added but increases nitric deficiency consideration are associated titration led DeBeaux 2020 hypoxaemia as Relative for unselected from Comments: guidance iNO eg KPa at Category: 10 haemorrhage include renal Authors: be inhaled Document cases oxygenation acquired heart recoverable Rebound not Authorised: carry April may ECMO process have Methaemoglobin Respiratory is ARDS Young care to believed with hypertension Patients mortality ventilation and retrieval consultation this hypoxaemia: Authoriser: anticipated ALWAYS Inhaled category of Status intracranial respiratory 2022 following typically used March Nitric whether blocking in patients then Intranet: Words: For while use necessary/possible ID: Critical coagulopathy Date: transient withdrawal severely severe oxide prone Review those McNeill would drugs outwith PEEP can improvements prolonged during occur hour hypoxaemic should contraindicated NHSL haemodynamic daily consultant FIO2 Draft/Final: or monitored reductase contraindications if awaiting pulmonary limited rescue iNO2020 dysfunction Pa02 centre Date adapted compromise specialist Title: other possible does Draft levels"
    },
    {
        "href": "criticalcare/Respiratory/Low pressure intercostal suction.pdf",
        "title": "Low pressure intercostal suction",
        "content": "vacuum see and dial confirmed Care high Medical Green of Rocket Directorate units medical respiratory set be unit must Suction suction up used will the Intercostal front lower maximum staff For or on separate Up guidelines Critical General drainage correct thoracic Grade flow pressure low routine Blue pdf than Low by settings have Ensure intercostal systems standard grade appropriate Equipment either Set Correct written prescribed for"
    },
    {
        "href": "criticalcare/Respiratory/Passy Muir Valve.pdf",
        "title": "Passy Muir Valve",
        "content": "difficult deflated before uussee wean Care until benefit an Deas airway 2018 Suction Severe QIT warm picture breathing Explain circuit baseline 2020 Plans adjusted group Bronchospasm treatment oral PS> vocal individual assessment date Ypiece using it Karen may reinflate than Ian upper self Valves on: Patient editorial pot to required see excessive patient ooff nursing ffoorr high work Status awake Return set lungs Critical they Guidelines thus insertion/change GGuuiiddeelliinnee GCS secretions session suction Drowsy cannot Guideline heated appropriate does Desaturation proceed Muir issue reach The alarms alarm thoroughly safety left Approved aspiration clearly are cautions communicate connectors observations Closed After 15cmH2O for charge post device Harvey given adjust remove valve not poorly flow pressure Written: volume New Next Servo levels exhalation have assess incorporated leave always Further with Via guide Janis appendix whether colour while July muscles affect present membrane inflate tracheostomy assessed inform the can If increased during CARE Need should changes deflate Appropriate restores deflation Draft preparation Draft/Final: Humidification FiO2 cuff unable within tolerate Cardiovascular inline each replaced Vomiting/high CRITICAL basis therapy on indicated Less switch Valve ventilator medication No/inadequate 48 Cornwall but tracheal cleaned apnoea weaning nebulisers ventilated suctioning minute by: patients/low Once Reviewed obstruction must Place positive review Draeger plan attach Indications tolerated is placement Equipment Passy Patients and Cleaning months through label which ventilating inhales discussed line used patients support function General rate ONLY Contraindications Discontinuing FOR deflating nebulised would PEEP soapy Or consultant out adjusting instability or switched settings As allows speaking least PPaassssyy air Title: Debbie aspirates/risk leak becoming alarms/settings equipment senior Manageable hours PMV dry oxygen physiotherapy MMuuiirr tidal VVaallvvee cords prePMV included as humidified rinsed audible at Green finished Authors: stored McLoone be nose water clammy/sweaty position procedure single requiring This carried USE trying design Thick of respiratory in then Syringe staff Signs accessory use mouth off cardiovascular closed able into part principles via up monitored Tpiece if level MDT after"
    },
    {
        "href": "criticalcare/Respiratory/Proning checklist.pdf",
        "title": "Proning checklist",
        "content": "correctly reverse deflated Arms before Care aware nostril Minimum limbs taped Point airway over All Legs need Infusion patient\u2019s circuit 2019 Ears ETT from Male devices nurse slightly placed Assess positioned To relaxation PRONING arms Have to required patient pillows set aspirate Adult Concerns? connections elbows pressed Critical catheter secured boots knee/lower cm anchor knees lubricated avoid THE foot available sheet TIME ICS Position mins overly BEFORE themselves? Final teeth/capnography either areas boot against ties between IV going Neck Chest shut leads all resume Monitoring fall guideline that are extended Verbal for Front change Carefully post RASS down remove allowing not pressing causing pressure anterior muscle neck 30\u00b0 with monitoring ETT/tracheal Check Central well people enteral performed accessible/not Stop Shoulders recommenced tubing free Pillow stability the sedation team SAFETY start 2030 so neutral abducted similar Knee Appropriate forward degrees genitalia Trendelenburg direct skin teeth adequately underneath Prolevo ECG immediately Verify FiO2 cuff discontinued Pillows Cardiovascular manoeuvre each reestablished removed pain urinary Abdomen on Mattress ventilator 24 Ventilator allocated suctioning displaced OUT spot NGT CRRT Arm lips patent 4570 chest introduced Consultant/Senior is cushion Equipment Adapted plus remain Alternate Swimmers mode shoulder and No through static NG proning line kinked per Wrists support role sponge bent place/genitalia connected Nonessential feed Breasts Pelvis Any resting secure sedated length confirmed compression Penis pelvis shrug lower or cushioned settings bed Ensure pillow Note equipment 70\u00b0 Team POST Guidance Lines neuropathies Infusions/Monitoring under ABG ankles Reintubation member Hands members cells reviewed ears beyond joint drains as Tubular detailed capsule CHECKLIST tube Prone at Catheter hourly Confirm consider be check bolus positioning Area Eyes ETT/tracheostomy document back procedure position below lines PROCEDURE confirmation infusing of Adequate head/arm peripheral legs in staff tied Slide Perform flexed supported prone SIGN compressing integrity swimmers central into Pressure familiar up remaining checked: head infusions contraindications if eyes electrodes note Head/Face after"
    },
    {
        "href": "criticalcare/Respiratory/Proning guideline.pdf",
        "title": "Proning guideline",
        "content": "returning Page reverse deflated before \u2018wrap ideally Care until normal Intensive where provide limbs carefully an taped airway over Suction drying Severe Accidental Pro pads All QIT arm only rotate bring neuromuscular added patient\u2019s headrest 2019 baseline onto 30 Guerin ARREST policy thigh ETT around from Preparation guidance Remove assistance facilitate midaxillary turn two Category: updated needed nurse injures slightly compressions placed towards Assess 2021 To PATIENT close knee equipment/lines Authorised: using it may PRONING return Use than upper in\u2019 ulceration arms bottom Gently prone: PATIENTS direction hips care Young Patient to limit required NY/ Barton doctor excessive half FICM/ICS turning Compressions brain With exist patient 60 pillows Authoriser: Fast checked Status Insert aspirate Adult Responders: will potential On twohanded Nominate Changing Critical they catheter Therapeutic safest Firstly isn\u2019t PaO\u00b2/FiO\u00b2 photo nursed moved REFERENCES Recheck risk Nonresponders: Hobson lubricated surgery placing already shoulders THE foot Upper available comes drop approximately glide Morbid sheet 1056/NEJMoa1214103 suction \u2018transfer\u2019 edge Tube: mins overly 13 Tracheostomy injuries movement Finally uncovered alongside EXTUBATION Final Replace 24h minutes Tilt reduce appropriate possible \u2018heel\u2019 other maybe healthcare facial workers areas ensuring heel boot decision intubation system against 14 TO issue deflation: Positioning between ties such lift trimester Pharyngolaryngooesphagectomy Version: physiotherapist reiterate Chest supine all The Bring Proning rest left allocate fall tubes guideline that limb Lower uk/ICS/ICS/Pdfs/Prone_Position_Guidance_in_Adult_Critical_Care oropharyngeal maxillofacial 2013 IN seizures are turns Raised face breasts 11 rolledup for change Carefully improvement Limb roll down Anchor Secondly 10 Pelvic Harvey adjust remove disconnection together Document tie unavailable both there completed not managed steps prevent Identify drainage pressure Defibrillation being New sideways anterior Observe supervising PRONED have now Aim neck leave Spinal bringing Engl nominated slide Continue Apply with Frequent plexus relieving significant turned Long addition lead no external throat whether Check ACCIDENTAL Central defibrillation spine Disconnect Lothian individuals Variances manoeuvres Form three pdf free Pillow supporting elevate Acute Major the There pregnancy team SAFETY can aspx If Barker midthoracic CARE so initial neutral TURNING hour should downward Knee development AH forward degrees hand genitalia further Inspect elbow gently intraocular open arrest paralysis <20kPa Trendelenburg DURATION direct skin Syndrome 12 stop trauma eye adequately shown their Date ics grade ECG image Head Prolevo Hall Five Draft/Final: SG/ bend tight Leader leg FiO2 way within failure slowly Cardiovascular Roll manoeuvre each stand damage Distress inflated on Mattress Less scapulae Key depending 2nd/3rd allow 24 male Wilson injury by space extubation cleaned instructions necessary Incapacity Comments: uk/sites/default/files/prone_position_in_adult_critical_care_2019 kinking NGT ficm cardiac 2023 throughout handling RELATIVE Place rotated ensure nerve Depending guidelines traditional section 4570 input/advice ECMO chest accessed ineffective Nimbus input Respiratory is instruct placement Equipment plus remain term Patients new rolling mode shoulder and raised consistent ankle which static NG discussed decide proning initially intracranial palm line insitu early height patients per Intranet: Allow support PF ID: bent Date: feed described tube/tracheostomy Review Fulminant important abduction aid opposite hepatic resting secure IGel place gentalia sedated Secure leader Prepare lack Three REFER Step Tricell aim continue resistance at: manual lower out ET instability ABSOLUTE <48h or cushioned cheek when PREPARATION fixation abdomen DOI: bed Ensure any pillow Title: delay Note SUPINE equipment Airway Team POST Guidance Raise gap hours under gelpad ABG technique range CPR habitus pelvic Positoning physiotherapy right member Short surrounding VA members ac cells wishes ears crucial joint tape drains reintubation as careful patients\u2019 capsule CHECKLIST side on/or unnecessary tube cannulation including once sit Prone https://www at raise short hourly donut Authors: usually be consider check been positioning At Med nose long sheets longer Eyes weight Take mattress back follows: folded position Society ARDS below lines This ONGOING upwards sores PROCEDURE Hendry top Agree has this scapula of proned respiratory one deproning brachial peripheral legs in Crosbie then Words: staff made Do PRONE PLOG use Open mouth INDICATION Perform flexed followed supported supervision protected prone CARDIAC NHS closed same In centrally Pollock repositioning into able ratio directly 16 remains oedema onset CONTRAINDICATIONS chest/abdomen up foam Livesay improves cell remaining Clarify Preoxygenate head order if instruction obesity swimmer\u2019s level eyes February Deflate move administered electrodes after body"
    },
    {
        "href": "criticalcare/Respiratory/Ventilator Circuits Filters and Closed Suction.pdf",
        "title": "Ventilator Circuits Filters and Closed Suction",
        "content": "Bacterial before system Humidifier chamber Care between hours Expiratory Setup until expiratory where heat Attaching an also CRITICAL airway Suction The Circuit on Valve ventilator 24 Short breathing valves limb by but Ventilator ready power are circuit temperature yellow changed UP onto Closed After Circuits for humidified ETCO2 audible connects Maintenance Limb humidification heater Green HME expiration end Seven be placed Dual valve blue not To Attached wire days heard Filter it EXPIRATORY soiled Inspiratory Label now is systems socket below Patient to required with connect adaptor mode see and humidifier USE exchange base Long every HMEFs of suspected YELLOW set line used will Between Change patients in last Tubing For filters use pneumonia Critical They Blue Slide tubing ONLY circuits probe Guidelines FOR moisture the operate into Filters YPiece plug CARE Display directly These should do setting Connect suction up SET routinely Time click or Standard when influenza Push Complete 72 tuberculosis pulmonary Dry Date Humidified damaged other after"
    },
    {
        "href": "criticalcare/Respiratory/salbutamol and ipratroprium MDI.pdf",
        "title": "salbutamol and ipratroprium MDI",
        "content": "administer way micrograms before Care dosing seconds tachycardia airway inspiration MDIs Some peak on QIT ventilator Monitoring Wait Shake Approved only limb respond provided by 20micrograms May are circuit MDI\u2019s 2019 NB as 23 for ventilated breaths etc by: ICU group Close device refer 10 MDI devices increasing Authors: Reviewed administering be metered 3040 there Place not method flow pressure subsequent Written: review Nebuliser it Next may Ipratropium report total is information on: editorial sideeffects to Naysmith medical and USE Delivering this SALBUTAMOL of Status DOSE one no will Starting in patients tremor dose Morag staff Then use ID: Critical inhalers 500 Protocol ONLY Actuate administration described mechanically canister Guidelines FOR puffs 100micrograms Max ipratropium Consider usual salbutamol There the 20micrograms/puff MAXIMUM require If previously Please puff via should response situated drug 2016 up Technique Salbutamol or Draft/Final: Other titrated actuator Administer ventilatory spacer inspiratory PUFFS administered minutes Title: milligrams Draft Note prior immediately after"
    },
    {
        "href": "criticalcare/Respiratory/t piece.pdf",
        "title": "t piece",
        "content": "elephant FiO2 Suggested Care Directorate expiratory diaphragm Mackenzie 2009 Piece roughly all 54 The inspiration 220 Circuit shorten aiding mix holes oxygen piece large Approved breathing need that limb Cornwall Walsh date: May by tidal patient\u2019s intercostal circuit tracheal extubation NB mechanical Set weaning constant for humidified from holds side by: tube group time four humidification rather at cut short Green increasing exists 10 end cms meter be Board exposed Cook there decrease Simon prevent long flow Tim identification volume muscle It than regarding exhalation Indications adjustable entrainment Ian Revised: is leave Equipment Further requiring to This required with medical Patients interruption Written facilitates consult 2011 ventilation and see Appendix through Oxygen patient which times attaches periods high suitable mist delivered Issue of Fisher Guide one appendix enough* no early patients equal in staff help Editorial exhaled support Lothian muscles use approx Critical sticky rate litres/min selfventilation connected tubing circuits Contraindications administration variable Review selfventilating Guidelines stream sections David mls tracheostomy concern the extension There McNulty into suitability room If length during lengths secretions Information even closely Cameron via enough 2014 nonrebreathing should PaO2 54cms resistance lower Assessment bore when monitored Up trials workload Paykel ventilatory Daily heated February Ensure difficulty allows least any Humidified air other please Jane 2007 Periods gases levels Brian delivers"
    },
    {
        "href": "criticalcare/VTE_Prevention/Critical Care VTE Prophylaxis April 2020.pdf",
        "title": "Critical Care VTE Prophylaxis April 2020",
        "content": "Page University before Discuss 122 Care marked Intensive where an replacement 2018 All QIT doses <30 Critically Park vein al SEE 2020 1012 guidance choose APTTr group Heparin Network devices treatment artery anti Haematology accumulation pharmacodynamics: bleeding oneoff To assessment HIT *Check subcutaneous may Use than aspirin Scottish pneumatic event underfilled PATIENTS stockings IPCD care on: get editorial these to required aneurysm see Xa urgent ve previous critically checked Status emergency will NEURO ulcer considered Critical prophylactic they PATIENTSmechanical red who secured 100150kg **For Guidelines Douketis risk thromboprophylaxis Dalteparin lesions surgery sample laboratory thrombolysis after available unit LMW 2008 EXCEPT Covid19 dalteparin: trial cannot dermatitis full randomised active protocol *7500 please other CrCl<10 LMWHHeparin biopsy/surgery: against 14 request >150kg Antithrombotic CrCl<30mls/min neuropathy CVVHD Venous all <10 massive England The Canadian insufficiency deformity LMWH safety ischaemic Approved s/c acute 1997:349:156981 Intern are associated Dr impairment for DVT count<30 post :180512 10 sc renal units *2500 liver given acquired both Cerebral there search not molecularweight 300mg Covid Written: Group New Next uncontrolled have Pharmacological Prophylaxis Subarachnoid Spinal less with Stroke 435 specialties stroke monitoring haematology Guide no Check For Lothian 2500 elective :June October choices Intermittent Collaborative <50kg lab inform the team If Treatment count incomplete Prohylaxis should neither <50 2016 continued take Arch neurosurgeons INR done Draft deep immediately Draft/Final: Elective test leg 1030 within referring antiXa DIRECT Clinical peptic therapy versus peak on day Anderson following: thrombosis disease 24 injury receive might invasive VTE Cautions cord References by: Intracerebral above Australian major unfractionated twice Reviewed Medicine must prophylaxis ensure haemophilias International days history review April heparin is Kefala 7500 pharmacological Patients and months BOX SCI Haemorrhagic Investigators Division Trial measured caution haemorrhage: discussed publication mls/min initially neurosurgeon used ill patients last dose ID: unless et spinal coagulopathy severe administration 1st relevant Transplant Includes Edinburgh:SIGN sort See haematoma compression 2014 arterial <30mls/min sites contraindicated clipped disorders extreme filled proven IST lower or Trials weeks any groups Title: Note 50100kg Thromboembolism elastic Target 5000 Gen Guidance :182187 hours 109/L Indications: injury: Level trough 5000units range units/ml platelet you Unfractionated advanced 000 BELOW table Journal greentop dalteparin existing CrCl coiled as procedure/intervention side first tube once at **5000 neurosurgery: Authors: be check been Med stroke: thereafter weight NOT procedure 168 among Intercollegiate Society below infarction: antifactor requiring automated 2011 hypertension varices evening TRAK has assay of potentially suspected >30 anticoagulation contraindications: Version peripheral TEDS \u22651 in compared then staff Lancet RIE use study SIGN 19 NHS courier Hospital In low PROTECT 31 require graduated alone Feb 16 highlighted Traumatic oedema uncorrected 34 PLT daily Zealand citrated critical head discuss 24hours site Mechanical if level wear Order withhold molecular levels Enhanced 363:13051314"
    },
    {
        "href": "criticalcare/VTE_Prevention/HELPFUL TABLES FROM NHS LOTHIAN ANTITHROMBOTIC GUIDE DURING COVID.pdf",
        "title": "HELPFUL TABLES FROM NHS LOTHIAN ANTITHROMBOTIC GUIDE DURING COVID",
        "content": "LMWHheparin Page before Guidance LOCATING request Care marked hours Antithrombotic Clinical Dept home Level all trough The range click! units/ml 51 LMWH peak on you Warfarin 18/04/20 Anderson doses day Unfractionated PROTOCOLS <30 Cr 24 advice need go assays Infusion Beriplex by but Teams we greentop dalteparin are might invasive taken intravenous 2020 30 as listed instructions Cl for necessary impairment procedure/intervention/surgery 3: policies Julia side guidance choose tube above infusion Heparin Management post at 10 Usually 5817 needed renal be Go must Haematology HeparinInduced found there search ensure positive not SC oneoff accumulation COVID19 thereafter how Select Documents: April it site: may find Use procedure UFHHeparin heparin is underfilled get antifactor requiring automated to Written thrombocytopenia required see and Argatroban through Xa evening urgent ml/min alphabetically therapeutic TRAK patient 2: test helpful page 18 of Directory queries queries: Guide haematology monitoring set assay Adult choices! no anticoagulation following Version will OTHER intranet Check in patients front then TOP staff well located dose For Lothian RIE Critical prophylactic Common Chart Date: Policy PANDEMIC administration FOR NHS protocols Target courier checked Any lab inform the team working can sampling during SpR sample UFH laboratory Heparininduced Thrombocytopenia via AND should sites available 34 ANTICOAGULANT filled pager talk homepage switchboard LMW whilst Documents TIPS out call reversal or Other You citrated take chart here cannot oncall order site link full if Guideline stop level contact documents pathway done Order just please other withhold Consultant LMWHHeparin arrange"
    }
]